Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,-0.8587883305349115,-2.053890642627538,0.0,0.0,0.0,18/47,3.48%,RSAD2;SAMD9L;IFI44L;DDX60;GBP4;EPSTI1;GBP2;EIF2AK2;ISG15;CD74;IFIH1;IL15;IFI27;MX1;TAP1;HERC6;PARP14;IRF1
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,-0.7813760845988194,-1.9637749353796097,0.0,0.032000403154685414,0.05,24/81,3.48%,RSAD2;SAMD9L;IFI44L;VCAM1;DDX60;GBP4;XAF1;RNF213;EPSTI1;EIF2AK2;ARID5B;OAS3;PLA2G4A;ISG15;CD74;IFIH1;IL15;IFI27;MX1;TAP1;HERC6;PARP14;STAT1;IRF1
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.9013738032978378,-1.921578595735536,0.0,0.04000050394335677,0.12,7/20,4.47%,RSAD2;EIF2AK2;OAS3;ISG15;IFIH1;MX1;FAM111A
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,-0.9037056695838288,-1.864040474822366,0.0,0.04800060473202813,0.19,4/20,2.41%,RSAD2;IFI44L;SLC38A3;MX1
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),-0.8573692434192521,-1.8258009511732562,0.0,0.056000705520699474,0.31,9/23,3.48%,RSAD2;XAF1;GBP2;OAS3;ISG15;IFI27;MX1;STAT1;IRF1
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),-0.8573692434192521,-1.8258009511732562,0.0,0.056000705520699474,0.31,9/23,3.48%,RSAD2;XAF1;GBP2;OAS3;ISG15;IFI27;MX1;STAT1;IRF1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),-0.7154534924175956,-1.808105304324949,0.0,0.0811438794279523,0.49,5/32,3.48%,RSAD2;VCAM1;IL15;HERC5;IRF1
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,-0.9332912403822122,-1.7974020805240816,0.0,0.08500107087963314,0.55,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),-0.8403670422241373,-1.7907598237390316,0.0,0.08088990797434367,0.57,7/25,4.47%,RSAD2;EIF2AK2;OAS3;ISG15;IFIH1;MX1;FAM111A
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),-0.8262960138556518,-1.7552584980671153,0.03225806451612903,0.1320016630130773,0.69,9/22,4.47%,RSAD2;EIF2AK2;UBP1;OAS3;ISG15;IFIH1;MX1;STAT1;FAM111A
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),-0.8438625724854618,-1.7041841544577452,0.029411764705882353,0.25818507090712095,0.9,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.8362344822018593,-1.6969445148027482,0.0,0.2680033764204903,0.93,6/13,11.76%,OAS3;ISG15;SAMHD1;NLRC5;STAT2;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.8638184913817901,-1.6475203266952105,0.06666666666666667,0.4726213388999692,0.99,6/8,11.76%,OAS3;ISG15;SAMHD1;NLRC5;STAT2;PTPN2
prerank,MSigDB_Hallmark_2020__Hypoxia,0.7979342882861318,1.6472496426457603,0.0,0.36763154930731184,0.21,30/73,11.84%,MAFF;ANGPTL4;DDIT4;ADM;SERPINE1;AKAP12;DTNA;ATF3;LDHA;PCK1;KLF6;HSPA5;BNIP3L;BHLHE40;PLIN2;GAPDH;PGK1;MT2A;NDRG1;ERO1A;FOS;DUSP1;P4HA1;CDKN1B;FOSL2;SLC2A1;ANXA2;JUN;SLC2A3;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.9219385628976742,-1.6389514374398952,0.0,0.4885775838795719,0.99,3/10,2.18%,RSAD2;IFIH1;IL15
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.7927347692632761,1.6374663160669662,0.0,0.27572366198048387,0.35,24/67,11.84%,PIK3R3;DDIT4;PNP;PSMC6;LDHA;HSPA5;CANX;BHLHE40;PPA1;CD9;CALR;STARD4;GAPDH;PGK1;PLOD2;ERO1A;P4HA1;HSP90B1;MTHFD2L;SLC2A1;INSIG1;HSPA9;SLC2A3;CDKN1A
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.8696165753700733,-1.6373640948311983,0.041666666666666664,0.46187248553262616,0.99,5/11,9.01%,PRIMPOL;ATR;FAM111A;THOC1;SAMHD1
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.9677796166173991,-1.6170507740399311,0.0,0.5148300154592036,0.99,1/5,0.26%,DDX60
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.9677796166173991,-1.6170507740399311,0.0,0.5148300154592036,0.99,1/5,0.26%,DDX60
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),-0.9126996553653386,-1.6010653403045205,0.0,0.556217533780782,1.0,2/5,1.82%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),-0.9126996553653386,-1.6010653403045205,0.0,0.556217533780782,1.0,2/5,1.82%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),0.9243499986320007,1.5822718016186506,0.0,0.6631784811033862,0.81,3/13,2.31%,NRCAM;RTN4;MAP2
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),-0.7808021767752066,-1.5815992505501162,0.1111111111111111,0.6472081538035125,1.0,7/16,7.40%,GBP1;GBP4;GBP2;CD74;STAT1;SP100;GCH1
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),-0.8785502362379412,-1.5758183025064032,0.02857142857142857,0.6525796500473346,1.0,3/10,3.48%,XAF1;STAT1;IRF1
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.8638673518115425,-1.5688189934860515,0.04878048780487805,0.6712811843585145,1.0,1/8,0.21%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.9526013396667781,-1.5645398104743964,0.08571428571428572,0.667486670150449,1.0,1/6,0.21%,CEMIP
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.8246706812768836,1.562229338833905,0.013333333333333334,0.8785312759182086,0.93,1/18,0.13%,CCDC3
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),-0.9109511000799286,-1.5576372305485906,0.03571428571428571,0.6896753554900429,1.0,2/6,0.88%,GBP4;GBP2
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.9585079268698935,-1.5520773368835854,0.02040816326530612,0.7033688613399853,1.0,1/6,0.05%,RSAD2
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.755226425736043,1.5482941702907584,0.0,0.9861175675537307,0.98,4/49,1.90%,PIK3R3;PKM;PDK4;PCK1
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),-0.8604042442709858,-1.5460211784021392,0.034482758620689655,0.7203167671646015,1.0,2/11,4.96%,DDX60;BMP6
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),-0.6650719005826886,-1.5444593670911477,0.05,0.7054903695491294,1.0,7/32,3.48%,VCAM1;GBP1;GBP4;GBP2;OAS3;STAT1;IRF1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),0.9191683126724409,1.5443238817112073,0.0,0.8830365645126609,0.99,1/10,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.9365094030482256,1.5329916222030422,0.014285714285714285,1.0,1.0,3/8,2.60%,PDK4;PCK1;PRKAG2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),-0.8746534017102221,-1.5320500229070362,0.0,0.7680096757124499,1.0,2/7,5.48%,GBP1;ZDHHC2
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.8326021643713832,1.5308223499523894,0.0,0.9231336330032868,1.0,6/16,6.88%,GRIA2;CADM2;ANK2;MAP1B;CTNND2;LRRC4C
prerank,PanglaoDB_Augmented_2021__Immature Neurons,0.7651579354594407,1.5218886963235054,0.0,1.0,1.0,15/37,10.90%,GRIA2;ATRNL1;CADM2;ANK2;NES;LSAMP;GPM6B;NPAS3;ROBO2;CTNND2;LRRC4C;SNAP25;PPFIA2;ADGRB3;NRXN1
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),0.7472911711003162,1.5202084002006286,0.0,0.9385417199963138,1.0,12/48,8.83%,NRCAM;DDIT4;WNT2B;BHLHE40;SPOCK1;IL1RAPL1;ELP3;MAP1B;PTPRD;FGFR1;NAV1;CDK6
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.7599781953970622,1.519360191698704,0.0,0.8777940468754799,1.0,6/43,7.35%,PIK3R3;TTC7A;INPP5F;MTMR12;ARF1;PIK3R1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.852295819526548,1.5178386633338252,0.0,0.8388847362870278,1.0,3/17,7.35%,PIK3R3;TTC7A;PIK3R1
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),0.7256270772497838,1.5131221048731553,0.0,0.8525392263348296,1.0,15/65,12.98%,RFTN1;LRRC7;KCNIP4;EHD4;ANK2;TTC7A;DPP10;CD81;PACS1;ANK3;NRXN1;RAP1A;ATP1B3;MAGI2;MAP7
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.6579699381041332,1.510036544289443,0.0,0.8403006841309986,1.0,37/142,20.07%,PIK3R3;CEP57;DDIT4;ERBB4;NEDD9;PDK4;FES;GRIN2B;FGFR1;PIK3R1;GRB2;HSP90AA1;COL4A2;ANKS1B;BCAR1;FLT1;SHC2;ARPC2;GIGYF2;PAK2;RASA1;GRB10;SHOC2;KIF16B;RAC1;SDCBP;CRK;FOXC1;SPRED1;PLAT;NAMPT;PXN;VEGFC;STAT3;KALRN;SULF2;ABI1
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),-0.8245391089168697,-1.5097626238360835,0.1,0.913114952086282,1.0,3/7,12.05%,TAP1;HLA-F;HLA-A
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),-0.6789407681783227,-1.5095867943556278,0.0,0.8834777970956065,1.0,8/26,7.09%,VCAM1;GBP1;GBP2;OAS3;STAT1;IRF1;SP100;TRIM25
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.8837496121888129,-1.503574025231062,0.03333333333333333,0.900398440376592,1.0,1/6,0.13%,VCAM1
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),-0.8953470601233764,-1.503163825412647,0.0,0.8755110300602212,1.0,3/7,7.66%,ARID5B;PKD2;TGFBR3
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),0.8091202788276408,1.5021961238972057,0.0,0.9111495653420435,1.0,6/27,4.80%,DDIT4;PBX3;WNT2B;SPOCK1;IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),0.9795351555626486,1.5013384929821412,0.0,0.8751523094723693,1.0,1/5,0.03%,PIK3R3
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,-0.8508406955528907,-1.4972807858608115,0.0,0.8943142972548068,1.0,6/16,5.74%,SAMD9L;GBP2;IFIH1;IRF1;DDX60L;SP100
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.8835723449491526,-1.496345288081642,0.0,0.8753051451134539,1.0,1/7,0.13%,VCAM1
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.8074006560533371,1.4960002197875084,0.0410958904109589,0.9025418139568782,1.0,2/17,2.00%,DIXDC1;WNT2B
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.943410966104165,1.4950822492851652,0.027777777777777776,0.8686196410104134,1.0,1/7,0.88%,MTFR1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),-0.7057369599799924,-1.4938868071324,0.07407407407407407,0.8455662083581805,1.0,10/37,3.48%,RSAD2;IFI44L;EIF2AK2;OAS3;ISG15;IFIH1;IFI27;MX1;STAT1;IRF1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),-0.7057369599799924,-1.4938868071324,0.07407407407407407,0.8455662083581805,1.0,10/37,3.48%,RSAD2;IFI44L;EIF2AK2;OAS3;ISG15;IFIH1;IFI27;MX1;STAT1;IRF1
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.7560071130470664,1.4904225167620948,0.02531645569620253,0.8951771316724482,1.0,4/33,7.87%,PIK3R3;PDK4;PIK3R1;GRB2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.920450595427744,1.489263385065941,0.028169014084507043,0.8715030257108628,1.0,5/10,5.24%,PKM;LDHA;PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.8015954287833725,1.4876822677918342,0.014925373134328358,0.8598665088840487,1.0,6/18,13.73%,MTHFD1L;SLC52A3;MTHFD2L;SLC2A1;SLC2A3;BTD
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),-0.8962737942666184,-1.4872138390759106,0.058823529411764705,0.8661730745788498,1.0,3/5,8.98%,PKD2;OFD1;RFX3
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,0.856437084799226,1.4871998711499876,0.02857142857142857,0.8291369300553946,1.0,6/11,10.90%,GRIA2;ATRNL1;CTNND2;HS6ST3;SNAP25;NRXN1
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),0.7970226140498297,1.4869770105500026,0.012345679012345678,0.7963783178089339,1.0,7/21,8.02%,NRCAM;DDIT4;SPOCK1;ELP3;MAP1B;FGFR1;NAV1
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.7929057908925842,1.486006313948253,0.015625,0.7744591093863592,1.0,4/15,5.24%,ERBB4;PCK1;ANXA1;PGK1
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),0.8974807883436763,1.484309531038649,0.0,0.762943591738939,1.0,5/9,6.33%,PNP;BCL6;PCK1;ZBTB1;VSIR
prerank,MSigDB_Hallmark_2020__Glycolysis,0.7993431976506307,1.4842926465795796,0.012048192771084338,0.7335996074412875,1.0,9/34,8.28%,PKM;ANGPTL4;DDIT4;LDHA;HSPA5;PGK1;PLOD2;ERO1A;P4HA1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.9712096023561263,1.4842749713071033,0.0,0.7072301918046979,1.0,2/6,2.31%,RTN4;MAP2
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.9065838597373719,1.484142707897142,0.04285714285714286,0.6835166410440567,1.0,4/6,5.24%,PKM;LDHA;GAPDH;PGK1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.736433765968336,1.4799686697299685,0.05,0.7080449413129668,1.0,5/34,8.90%,LAMC1;PLS3;NES;GAPDH;COL4A2
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.7189811364264967,1.4790900124161401,0.0,0.6995812129465612,1.0,13/49,16.02%,TRIM5;AFF3;NFKBIZ;SLC8A1;YBX3;ARF1;SCARB2;AFF4;CDK6;HIF1A;REST;RASA1;KIF16B
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.7614731071321562,1.478999922431504,0.024096385542168676,0.6777116701177486,1.0,12/24,10.90%,GRIA2;CADM2;SPOCK1;LSAMP;NFASC;LRRC4C;SNAP25;NEGR1;PDE10A;PPFIA2;ADGRB3;NRXN1
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,0.7296064657970521,1.4766317035271226,0.02564102564102564,0.6845786019270347,1.0,13/34,14.17%,GRIA2;CADM2;LSAMP;PTPRD;ROBO2;SGIP1;CACNA1C;NFASC;CPEB4;ADGRB3;NRXN1;MAGI2;MAPK10
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.8970075547294616,-1.4738191812645611,0.04878048780487805,0.9446434799675885,1.0,3/5,5.37%,SLC22A5;SLC25A26;SLC25A29
prerank,PanglaoDB_Augmented_2021__Tanycytes,0.7258520130432748,1.4728988843476358,0.0379746835443038,0.7074122236671001,1.0,13/40,14.17%,CCDC3;ADM;DOK5;MAP2;ANK2;NES;MAP1B;PTPRD;NFASC;GJA1;BOC;SHC2;MAPK10
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.7003732079446612,1.470165820767666,0.03614457831325301,0.7199981207887146,1.0,12/52,12.98%,KCNIP4;EHD4;ANK2;TTC7A;DPP10;CD81;PACS1;CCDC88A;ANK3;RAP1A;ATP1B3;MAP7
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,0.7187629908522917,1.4697961337471628,0.011764705882352941,0.7056054274100003,1.0,11/47,14.17%,PIK3R3;CALR;ARF1;GRB2;CDKN1B;HSP90B1;SLC2A1;CDKN1A;PIKFYVE;ADCY2;MAPK10
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.7659066496839427,1.4689820002623464,0.012195121951219513,0.6977190269941876,1.0,2/26,1.01%,ST18;PSMC6
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.7917671774136424,1.4681225274413945,0.013888888888888888,0.6882132739417485,1.0,6/22,14.88%,SCP2;ACOX1;ESR2;ACSL5;CNBP;SMARCC1
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.7811120822853042,-1.4668248233667716,0.0,0.9733455959550147,1.0,3/11,2.18%,RSAD2;CD74;IL15
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),-0.8322287992387684,-1.4665006935308162,0.05714285714285714,0.9510119812533071,1.0,1/7,2.75%,HERC5
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,-0.9026070540501718,-1.464095396624361,0.0625,0.9426460221968611,1.0,1/5,0.13%,VCAM1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,0.6954292681135742,1.462825879901939,0.03409090909090909,0.7344094649862012,1.0,14/39,14.17%,ERBB4;GRIA2;MAP2;CNTN1;ANK2;PTPRD;NFASC;SNAP25;PPFIA2;PPP1R9A;NRXN1;UNC5C;SHC2;MAPK10
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.9831586976808632,1.461618259880648,0.0,0.7269456427479425,1.0,1/5,0.08%,CEP57
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,0.7023672932901228,1.4605696557820362,0.038461538461538464,0.7209362808842653,1.0,7/42,8.90%,LAMC1;PLS3;TBX3;NES;PLOD2;MYO1B;COL4A2
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),0.9703225599472034,1.460179568669259,0.0136986301369863,0.7080995049427061,1.0,2/5,0.75%,NRCAM;RTN4
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),0.6696770656195797,1.4599520060839049,0.011627906976744186,0.6943293336707425,1.0,14/71,10.20%,NRCAM;DDIT4;PBX3;GRIK1;TBX3;NES;SPOCK1;ELP3;GRIN2B;ROBO2;MBP;SEMA6B;SLC2A1;CNTNAP2
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.701194289020351,1.4594929324400687,0.024390243902439025,0.6842171310979451,1.0,11/49,12.98%,KCNIP4;EHD4;ANK2;TTC7A;DPP10;CD81;PACS1;ANK3;RAP1A;ATP1B3;MAP7
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),0.7610537134338516,1.4586322226856097,0.025974025974025976,0.6819368645239241,1.0,9/32,11.84%,RTN4;BCL6;MAP2;HYAL2;ESR2;CDKN1B;GJA1;ADAM15;CDKN1A
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.8658218304041967,1.4584388133809354,0.02564102564102564,0.6687049684459144,1.0,4/12,8.00%,CALR;UFL1;KDM1A;CBFB
prerank,MSigDB_Hallmark_2020__UV Response Dn,0.6778828095967775,1.4580628998812417,0.0,0.6586340160863733,1.0,19/81,13.03%,PIK3R3;LAMC1;SERPINE1;BHLHE40;MGLL;MAP1B;PRKCE;SMAD7;DUSP1;CDKN1B;ATP2B1;DLC1;GJA1;YTHDC1;WDR37;INSIG1;ANXA2;MAGI2;ACVR2A
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),0.8034274979647922,1.456648356697626,0.0,0.6595742502278242,1.0,3/22,1.71%,MTHFD1L;LDHA;SCP2
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.7432706794271101,1.4541187179283739,0.0,0.6757932891678526,1.0,10/35,11.84%,RTN4;BCL6;MT2A;MT1M;HYAL2;ESR2;CDKN1B;GJA1;ADAM15;CDKN1A
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),0.8302321278864346,1.4492449266645444,0.014084507042253521,0.7204783964516046,1.0,2/15,3.40%,PBX3;NES
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.8406343736258993,1.4483880217469387,0.02857142857142857,0.7175302827068593,1.0,6/15,9.87%,PKM;ADAMTS9;KLF2;GLUL;JAK1;KLF4
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.8911216350459045,1.4480498620572553,0.07575757575757576,0.7093974417429444,1.0,1/7,0.99%,AKAP12
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),-0.7614633675409406,-1.4476422592353462,0.04,1.0,1.0,3/12,7.32%,SLC22A5;SLC25A29;PKD2
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.8209336308248377,-1.44579423402406,0.06666666666666667,1.0,1.0,1/7,0.91%,EIF2AK2
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),0.8125125946603828,1.4454537190504837,0.0,0.7244504059879382,1.0,3/16,2.60%,PSMC6;PDK4;PRKAG2
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),0.7469719821507568,1.4442907681309318,0.04878048780487805,0.7256744843985063,1.0,2/25,0.75%,LAMC1;RTN4
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),-0.8572218802950022,-1.4442093832176037,0.06666666666666667,0.9959236581808205,1.0,3/5,12.05%,HLA-F;HLA-C;HLA-A
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",-0.8572218802950022,-1.4442093832176037,0.06666666666666667,0.9959236581808205,1.0,3/5,12.05%,HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.8228452191596626,-1.4434310580430045,0.08571428571428572,0.9612035990133433,1.0,2/8,3.45%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.8228452191596626,-1.4434310580430045,0.08571428571428572,0.9612035990133433,1.0,2/8,3.45%,IFIH1;STAT1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.869208849460581,1.442939637774496,0.0,0.7316588677390619,1.0,1/10,0.03%,PIK3R3
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.7254297018575055,1.4427932994588022,0.024096385542168676,0.7201253289372638,1.0,14/37,10.90%,SERPINE1;GRIA2;AKAP12;MAP2;CNTN1;ANK2;LSAMP;MAP1B;PTPRD;NFASC;SNAP25;TTLL7;ADGRB3;NRXN1
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),0.8263848598380988,1.4415268605509863,0.0379746835443038,0.7211679814405514,1.0,1/15,0.36%,NRCAM
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.7703706760149971,-1.441293831682275,0.030303030303030304,0.9556787067133654,1.0,4/12,3.48%,OAS3;ISG15;IFIH1;IRF1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),0.7350037367242107,1.4409982893050564,0.012345679012345678,0.716862551513071,1.0,9/40,13.42%,ERBB4;NEDD9;FES;PTPRD;FGFR1;BCAR1;FLT1;ACVR2A;SHC2
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.6887507564027715,1.4406886550180495,0.024691358024691357,0.7086042185177953,1.0,18/50,16.12%,ADM;CANX;HSPH1;CD9;CALR;CD81;INPP5F;SGIP1;SCARB2;LRP1B;GRB2;HSP90AA1;PICALM;HSP90B1;PIKFYVE;ITGB1;HIP1R;AP1G1
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.8743252761111062,-1.4406615525695103,0.0,0.9410730805286057,1.0,1/5,0.47%,RNF213
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.7876308212569296,-1.4405023574521212,0.08695652173913043,0.923531635044221,1.0,5/13,8.54%,PRIMPOL;ATR;FAM111A;THOC1;MSH3
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.7667713661417621,-1.4402387325570116,0.10344827586206896,0.9073055482681394,1.0,4/10,8.75%,COL8A1;RTF1;LAMA3;FN1
prerank,PanglaoDB_Augmented_2021__Neuroblasts,0.8022467461429633,1.4389269398329338,0.038461538461538464,0.7154703731284874,1.0,3/17,4.41%,ERBB4;NES;MAP1B
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),-0.8039655904559655,-1.4372731893351496,0.14285714285714285,0.908626831882558,1.0,1/5,1.82%,CD74
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.7397596493165847,-1.4360421853478544,0.034482758620689655,0.9012943737576727,1.0,3/14,6.36%,ATM;ATR;PARN
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",-0.8197576427119369,-1.435638318487912,0.06896551724137931,0.8869741374402851,1.0,3/7,12.05%,HLA-F;HLA-C;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.8873882800628269,1.4353868077646548,0.03125,0.7401288102966324,1.0,1/8,1.01%,PSMC6
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),-0.8556301426294695,-1.435022019248809,0.02702702702702703,0.8771019591943321,1.0,2/5,2.18%,RSAD2;IL15
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,0.7111558913808196,1.4344700759570836,0.0125,0.7384537292257769,1.0,12/50,11.94%,ADAMTS9;AKAP12;DIXDC1;ANK2;NES;MAP1B;NFASC;NAV1;COL4A2;PDE10A;GJA1;MYH10
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),0.8848255591533257,1.4340119079824036,0.03125,0.7303799471057979,1.0,1/6,2.00%,WNT2B
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),0.9506288140961711,1.4332349000092945,0.0,0.7302858274055145,1.0,3/6,3.71%,RIMKLB;GLUL;GLUD1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.9330373686881466,1.4314053097975343,0.015873015873015872,0.738473116738171,1.0,4/5,5.24%,PKM;LDHA;GAPDH;PGK1
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.783870896285273,1.430018082164946,0.056338028169014086,0.7454103947719749,1.0,2/19,5.09%,CCDC3;PLCL1
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.9014659214811962,-1.4298537768858148,0.058823529411764705,0.8904397895676527,1.0,2/5,1.92%,CD74;IFIH1
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,0.688863142866787,1.4295511199626092,0.036585365853658534,0.7388673294901856,1.0,14/48,10.90%,GRIA2;ATRNL1;MAP2;CNTN1;CADM2;ANK2;LSAMP;MAP1B;NFASC;LRRC4C;SNAP25;PPFIA2;ADGRB3;NRXN1
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.9053034349077097,-1.4293716712814706,0.05555555555555555,0.8788882655905266,1.0,3/6,5.22%,TAP1;ABCG2;DISP1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),0.9491175337620763,1.42936380664978,0.0,0.7286463762609804,1.0,1/5,0.03%,PIK3R3
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.7384335397625132,1.428465056829109,0.0136986301369863,0.7289026911871617,1.0,13/27,14.38%,GRIA2;CNTN1;CADM2;LSAMP;ROBO2;CTNND2;NFASC;LRRC4C;SNAP25;ADGRB3;NRXN1;MAPK10;ERO1B
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),0.7900816055923535,1.4281396048317592,0.10144927536231885,0.7236668775367291,1.0,4/17,7.89%,MAP2;GPC5;KDM1A;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.7877152742219716,1.4276154889816837,0.0,0.7188895926370712,1.0,6/14,16.10%,PDK4;ARF1;PINK1;SSH1;KIF16B;NCOR2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.8387736903180676,1.427370172002152,0.04411764705882353,0.7124193817976823,1.0,7/15,8.49%,SERPINE1;SPOCK1;TIMP3;GAPDH;VSIR;PICALM;SERPINB6
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.7376130842906838,-1.4272796520490583,0.07692307692307693,0.8765627674483871,1.0,6/13,11.76%,OAS3;ISG15;SAMHD1;NLRC5;STAT2;PTPN2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.7491842330265958,1.427229141543794,0.0,0.7052278413182749,1.0,13/29,12.46%,GRIA2;CNTN1;ANK2;LSAMP;GPM6B;MAP1B;PTPRD;ROBO2;NFASC;SNAP25;ADGRB3;NRXN1;MAGI2
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.9013668916743705,1.4246134635001912,0.03333333333333333,0.7257834776816392,1.0,2/7,2.60%,PDK4;PRKAG2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.792895342951033,1.4226581858472414,0.030303030303030304,0.7280546368634999,1.0,3/13,9.01%,ATG12;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.792895342951033,1.4226581858472414,0.030303030303030304,0.7280546368634999,1.0,3/13,9.01%,ATG12;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.9065788230546764,1.4225047038606145,0.057971014492753624,0.7210358714742479,1.0,1/7,6.83%,KDM1A
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,0.7455543310559969,1.4220073134511824,0.02631578947368421,0.7168674786913014,1.0,10/28,14.85%,GRIA2;PDK4;GLUL;SLC8A1;ENPP2;VWF;NRXN1;GAS7;TMEM132C;TNS1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.7718256955183564,-1.421849536135527,0.125,0.8962824781884348,1.0,2/10,5.74%,EPSTI1;SP100
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.8538778328852855,1.4216237725326777,0.03125,0.7112811008656927,1.0,1/8,1.06%,BCL6
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.9120519893046081,1.4211330910280622,0.06451612903225806,0.6912113879133118,1.0,3/6,5.24%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.9120519893046081,1.4211330910280622,0.06451612903225806,0.6912113879133118,1.0,3/6,5.24%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.9120519893046081,1.4211330910280622,0.06451612903225806,0.6912113879133118,1.0,3/6,5.24%,PKM;GAPDH;PGK1
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.8322783403570526,-1.4205514312911809,0.13793103448275862,0.889211202660821,1.0,1/8,0.13%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.8055412877577472,1.4198792413117085,0.02857142857142857,0.6980779849472415,1.0,2/14,3.43%,RTN4;SPOCK1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.821311464323121,1.4196924636795105,0.04054054054054054,0.6905793206513325,1.0,8/16,11.21%,MAFF;SERPINE1;BHLHE40;NFKBIZ;TINAGL1;FOSL2;KLF4;ANXA2
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),0.9553086973213547,1.4194574322574975,0.015384615384615385,0.6844176987629472,1.0,1/5,0.13%,CCDC3
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),-0.8481086870958654,-1.418932283351625,0.05128205128205128,0.8863062480301804,1.0,5/6,14.77%,PLA2G4A;PLA1A;PLAAT3;MBOAT2;OSBPL8
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.8874659076236986,1.4184953856054663,0.03076923076923077,0.686669585868813,1.0,1/7,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.856669767648321,1.417437854995901,0.043478260869565216,0.688617645539038,1.0,1/7,0.78%,ERBB4
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),-0.6973489480960693,-1.4159355117304666,0.14814814814814814,0.8911080007510381,1.0,3/14,3.82%,PLA2G4A;PLA1A;GPCPD1
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.6333633611124453,-1.4147468864622212,0.06666666666666667,0.882931758470348,1.0,4/24,8.46%,RNF213;UBE3D;NFX1;MDM2
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.6935547775497306,1.414362367726629,0.05063291139240506,0.7122705913050048,1.0,11/43,11.34%,GRIA2;DTNA;GRIK2;GRIK1;GRM7;KCNMB4;GRIN2B;MBP;SNAP25;NRXN1;SLC12A6
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),-0.7478908439497265,-1.4133151268723303,0.037037037037037035,0.8770110489580971,1.0,3/12,6.36%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),-0.8577704048450291,-1.412810743204066,0.1111111111111111,0.866841690070959,1.0,2/6,3.48%,STAT1;IRF1
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,0.797642081154273,1.4110245736369877,0.02857142857142857,0.737351914235688,1.0,9/15,9.63%,GRIA2;MAP2;CADM2;ANK2;CTNND2;HS6ST3;SNAP25;PPFIA2;ADGRB3
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),0.7446190517657139,1.4098159502216527,0.0,0.7390293173947053,1.0,5/26,11.03%,PKM;PCK1;PIK3R1;OGT;INSIG1
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.8727715685205922,-1.4093105533858596,0.10638297872340426,0.8635332672189735,1.0,2/5,6.83%,GBP1;EFNA5
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.8727715685205922,-1.4093105533858596,0.10638297872340426,0.8635332672189735,1.0,2/5,6.83%,GBP1;EFNA5
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),0.9221856315275708,1.4066541701438398,0.04054054054054054,0.7668601892903829,1.0,1/5,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.7873666329465406,1.4062425726531973,0.012658227848101266,0.7629483445708628,1.0,7/18,11.21%,RFTN1;IL1RAPL1;PTPRD;PICALM;ANK3;NRXN1;ANXA2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.8647346946924406,1.405914077639701,0.047619047619047616,0.7575936594740832,1.0,2/7,4.41%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.7098227284087639,-1.4052005217955572,0.17857142857142858,0.8740110111623455,1.0,1/10,0.13%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.881496489401445,1.4040140873940117,0.01282051282051282,0.7671198489341062,1.0,5/9,9.50%,ATF3;KLF2;HSPA5;NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),0.8737142892002522,1.403541915242705,0.04411764705882353,0.7649404890155269,1.0,4/8,8.80%,KCNIP4;ANK2;DPP10;ANK3
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,0.7533835472536792,1.403353160622534,0.057971014492753624,0.7592786580275781,1.0,6/18,13.29%,GRIA2;DPP10;SNAP25;MTUS2;ADGRB3;BTBD10
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),0.933126857003103,1.4030923874893015,0.0,0.7537347818518785,1.0,1/5,0.36%,NRCAM
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),-0.8660749907676779,-1.4028045301213121,0.08571428571428572,0.8758371211249769,1.0,2/5,3.43%,PGM5;TTN
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.7663619961660018,1.4017889510798005,0.04411764705882353,0.7591179050281364,1.0,4/17,8.33%,CANX;INPP5F;SGIP1;PICALM
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.8314694307992777,1.4014924956040395,0.04285714285714286,0.7552334798945227,1.0,5/11,8.49%,SERPINE1;SPOCK1;TIMP3;GAPDH;SERPINB6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.850520227637353,1.4011702726229671,0.1,0.7514275279959316,1.0,4/8,11.71%,PKM;YBX3;CPEB4;CNBP
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.9367832103366732,1.4007988676412022,0.028985507246376812,0.7474814412827785,1.0,1/5,0.73%,ADAMTS9
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.836410952402488,-1.4005671798752126,0.125,0.8758967492053893,1.0,1/6,0.13%,VCAM1
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.7179629638752034,-1.400314591522334,0.13793103448275862,0.8644615950800932,1.0,4/10,16.25%,TENT2;PARN;LARP1;CIRBP
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.6622511986881038,1.399948060026531,0.034482758620689655,0.748109862131478,1.0,12/57,12.72%,RTN4;CHPT1;BCL6;SPOCK1;HYAL2;ESR2;CDKN1B;NRG3;GJA1;ADAM15;CDKN1A;BCAR1
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.8419220947101238,1.397504979621061,0.06557377049180328,0.7674891629137653,1.0,2/8,4.41%,MAP2;MAP1B
prerank,GO_Biological_Process_2021__bone development (GO:0060348),0.7579472133806846,1.393992314263623,0.034482758620689655,0.7940505536723321,1.0,4/11,20.04%,PLS3;GJA1;TGM2;SULF2
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),-0.7297458482894352,-1.3938149578050778,0.14705882352941177,0.8904556627835031,1.0,2/10,3.48%,HABP4;IRF1
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,0.7966224846765033,1.393506593261944,0.041666666666666664,0.7918217985080563,1.0,2/13,4.08%,ERBB4;CCDC60
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),0.7109709095702896,1.3926085875349423,0.11688311688311688,0.7935486607737102,1.0,5/21,11.84%,MAP2;NES;KDM1A;ADAM15;CDKN1A
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),0.837832384512969,1.3923142099267882,0.013888888888888888,0.7895305748164801,1.0,7/15,12.56%,DDIT4;MAP3K5;GRIN2B;PRNP;FOS;PICALM;REST
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.8114218891633417,-1.3921191447493837,0.029411764705882353,0.8884495492295708,1.0,1/6,1.38%,MLLT3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),0.8878931721698293,1.3911556183055978,0.014084507042253521,0.7946823814603355,1.0,3/6,3.71%,RIMKLB;GLUL;GLUD1
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),-0.7421257404443959,-1.3897758303425451,0.0,0.8902814864149811,1.0,1/14,0.13%,VCAM1
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.8523813041901965,-1.3896367628941844,0.1111111111111111,0.8789444066486927,1.0,2/7,11.58%,CAPRIN1;CPEB3
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),0.8929489329106076,1.389140234348479,0.057971014492753624,0.808949596515,1.0,3/6,9.29%,ADM;KCNMB4;ATP2B1
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.7617209002286376,-1.3890430984182678,0.24242424242424243,0.8708530766405014,1.0,2/7,11.81%,PLAAT3;MFF
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.812420223369862,1.388862780959736,0.06944444444444445,0.8053968021656949,1.0,2/12,12.56%,RTN4;REST
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.6832737742214757,1.3876808274668675,0.06097560975609756,0.8104604609729376,1.0,13/54,11.34%,GRIA2;DTNA;SYN3;GRIK2;GRIK1;GRM7;KCNMB4;GRIN2B;MBP;SNAP25;DNAJC5;NRXN1;SLC12A6
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),-0.8110587029003451,-1.3856837461386857,0.10810810810810811,0.8779331384970511,1.0,1/6,4.05%,EZH1
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.8067692352620958,-1.3836468952540533,0.1111111111111111,0.878575171227677,1.0,4/6,11.84%,PARP14;PARP9;PARP12;PARP11
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,0.6467885552983188,1.3815100653501744,0.0,0.870275638980266,1.0,18/70,11.84%,MAFF;SERPINE1;BCL6;ATF3;KLF2;KLF6;JUNB;BHLHE40;REL;NFE2L2;FOS;DUSP1;ATP2B1;FOSL2;KLF4;JUN;SLC2A3;CDKN1A
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),-0.7518036672500942,-1.381341495188546,0.09090909090909091,0.8792009499651227,1.0,3/9,5.84%,PLA2G4A;PLA1A;PLAAT3
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.9292007455827185,1.3807955892196886,0.0273972602739726,0.8715802592296249,1.0,1/6,0.65%,ADM
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.7785206993815846,1.3793059002560417,0.04225352112676056,0.8820477932105156,1.0,7/22,9.14%,DDIT4;MAP3K5;GRIN2B;PRNP;FOS;PICALM;CDKN1B
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),0.7822014575062817,1.3788204632108079,0.02857142857142857,0.8789580927324199,1.0,7/18,17.55%,IL1RAPL1;PTPRD;CNTNAP2;NRXN1;CLDN5;RAC1;LIMS1
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.8467472470572308,-1.3783726338900468,0.12121212121212122,0.8855111560460605,1.0,1/6,0.05%,RSAD2
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.7015771603369534,1.3771564824678968,0.07792207792207792,0.8902136851257363,1.0,10/35,14.33%,PKM;ANGPTL4;SERPINE1;RAPGEF3;JAK1;HIF1A;KLF4;FLT1;AGO2;ITGB1
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),0.8576284806495426,1.3757725935713947,0.030303030303030304,0.8978263394847942,1.0,3/9,5.48%,RTN4;CD81;SCARB2
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),-0.9391294306291771,-1.3730892395919085,0.06976744186046512,0.9017397555625858,1.0,3/5,5.74%,ISG15;MX1;SP100
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),0.869779031991563,1.372307695039829,0.09333333333333334,0.930630895305337,1.0,2/7,8.00%,MAFF;CBFB
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8223409507958612,1.371990800177268,0.05555555555555555,0.9258597144070487,1.0,4/10,5.61%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.7726149593638998,-1.3714603795018758,0.15384615384615385,0.9004991497492267,1.0,1/7,0.05%,RSAD2
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),0.8719600971838307,1.3701931195304808,0.03278688524590164,0.9224745949196356,1.0,2/6,9.42%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),0.8719600971838307,1.3701931195304808,0.03278688524590164,0.9224745949196356,1.0,2/6,9.42%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),0.8719600971838307,1.3701931195304808,0.03278688524590164,0.9224745949196356,1.0,2/6,9.42%,MTHFD1L;DLC1
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),-0.7494741625825514,-1.369677324959016,0.06451612903225806,0.9007342393992024,1.0,4/10,9.40%,IL15;STAT1;PKD2;STAT2
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),0.7180553451457151,1.3694308365530607,0.056338028169014086,0.922889904276046,1.0,4/27,7.87%,CEP57;FGFR1;HYAL2;GRB2
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),0.8916683928623477,1.369264001145034,0.03278688524590164,0.916705355374617,1.0,1/5,2.31%,MAP2
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),0.9462512191774983,1.3682160853866778,0.01639344262295082,0.9216948472908648,1.0,2/7,3.19%,KLF2;KCNMB4
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.703279555022439,1.3678029533644636,0.0375,0.9178678516940909,1.0,5/30,12.69%,PKM;PCK1;PIK3R1;INSIG1;ADCY2
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.9163699739657303,1.3674340400249054,0.08333333333333333,0.9134150818923966,1.0,2/5,2.10%,ADAMTS9;KLF2
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),0.8586412357164535,1.367408178991833,0.029850746268656716,0.9063931157771288,1.0,2/8,5.48%,PDK4;SCARB2
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.8718582924098396,-1.3672200597656516,0.1935483870967742,0.9017256460373854,1.0,2/5,4.23%,ATM;ATR
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.7050508862345934,1.3668745491862666,0.08974358974358974,0.9045493175511709,1.0,11/25,21.75%,ITPR1;SLC8A1;ANK2;SMAD7;ATP2B1;ATP1A1;ATP1B3;RYR3;ATP2B4;ATP1B1;AHCYL1
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),0.6700610891333516,1.3666028263659584,0.07407407407407407,0.8995489710820955,1.0,15/47,17.58%,RTN4;ERBB4;NRG2;PINK1;FGFR1;HYAL2;PIK3R1;GRB2;HSP90AA1;PHLPP1;MAGI2;ITGB1;RAC1;MTDH;DAG1
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.7427466818492725,-1.366598401037093,0.05,0.894505387006265,1.0,1/13,0.13%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.7424220588605894,-1.3651490152441543,0.10344827586206896,0.8921042623646311,1.0,2/7,0.67%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.7067551207044755,1.3648297170775854,0.025,0.9110109410775988,1.0,5/39,7.35%,PIK3R3;INPP5F;MTMR12;ARF1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),-0.7246585442178796,-1.3633406004504331,0.16666666666666666,0.8906778878054107,1.0,1/9,1.17%,UBP1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),0.6919321574532122,1.3625535775630861,0.07792207792207792,0.928570931681019,1.0,8/38,7.89%,RTN4;ERBB4;NRG2;PINK1;FGFR1;PIK3R1;GRB2;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.8391231796508085,1.3611190726109044,0.057971014492753624,0.9349702548559844,1.0,5/10,8.49%,SERPINE1;SPOCK1;TIMP3;GAPDH;SERPINB6
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.8421802647644108,1.3605103230284041,0.0684931506849315,0.9348507707838963,1.0,3/7,11.84%,IPO7;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),0.8779165700001479,1.3602275309741942,0.03125,0.9305370997831257,1.0,3/7,5.24%,PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.6998597049812528,1.3598005780287235,0.13924050632911392,0.9275688393307143,1.0,6/21,9.50%,BNIP3L;PGK1;NDRG1;PINK1;CPEB4;HIF1A
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.8849900782541201,1.3597971152215889,0.0684931506849315,0.9208279853108319,1.0,1/5,4.21%,STARD4
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),0.7079522005395933,1.358462892746581,0.0821917808219178,0.9271291991655202,1.0,7/26,13.24%,SLC8A1;IPO7;PKIG;HYAL2;DUSP1;CDKN1B;STK38
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),0.7906652827427643,1.358367146549882,0.06493506493506493,0.9218212228475116,1.0,7/14,17.86%,RTN4;SLC2A13;PRNP;PICALM;TMED10;IFNGR1;RTN3
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.6043696825397522,-1.3573165840122625,0.08,0.909466003293957,1.0,1/19,0.13%,VCAM1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.7196771687788016,1.3565335268191356,0.12,0.9357257525640404,1.0,6/25,8.33%,TRIM5;MAP2;UFL1;KDM1A;HSP90AA1;PICALM
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.7376172631273352,1.356507291604146,0.10144927536231885,0.9290419971885829,1.0,6/19,19.42%,ADAMTS9;MGAT4A;HIF1A;GOLPH3;FUT8;ST6GALNAC3
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.6495310580371374,-1.3562631704084367,0.1111111111111111,0.9056293870321784,1.0,3/15,4.83%,VCAM1;LEPR;TOX
prerank,PanglaoDB_Augmented_2021__Keratinocytes,0.8565064395370636,1.3553620637719261,0.17543859649122806,0.934952826273414,1.0,2/5,6.41%,LAMA5;REL
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,-0.6846649578924373,-1.354852218092881,0.16216216216216217,0.9033002690497588,1.0,5/11,12.56%,GBP2;GIMAP8;TNFRSF1B;HLA-F;GIMAP4
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),0.8563579142404132,1.354613580457992,0.07462686567164178,0.9375061381672791,1.0,2/5,13.50%,TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.8949156392647567,1.3544698352446438,0.1,0.9320843497143633,1.0,1/6,1.01%,PSMC6
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),-0.7757612087887249,-1.3540668100311002,0.23529411764705882,0.89741789945887,1.0,2/7,8.70%,IRF1;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),0.8209192007007229,1.354065329599528,0.046875,0.9290655963193158,1.0,4/8,17.52%,GRB2;ERBIN;SHOC2;TGM2
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.6845244736507201,1.3536593668162094,0.07894736842105263,0.9278035976636053,1.0,9/29,16.74%,LAMC1;PLS3;TBX3;TIMP3;COL4A2;BOC;WWTR1;FZD4;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.6935816646417075,-1.3536006579477933,0.11538461538461539,0.8705641592268009,1.0,1/8,0.18%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.6935816646417075,-1.3536006579477933,0.11538461538461539,0.8705641592268009,1.0,1/8,0.18%,GBP1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.6935816646417075,-1.3536006579477933,0.11538461538461539,0.8705641592268009,1.0,1/8,0.18%,GBP1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.8297390718490619,-1.3527512528155197,0.05714285714285714,0.8648530010489978,1.0,1/5,2.73%,ATM
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.7724548904899817,1.3519890118825972,0.05970149253731343,0.9384824723654829,1.0,4/15,11.06%,HSPA5;PRKAG2;CPEB4;SIK2
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),0.7671439862270619,1.3511691758590374,0.08955223880597014,0.9390124766821015,1.0,5/9,21.42%,RTN4;ANO6;AHCTF1;TPR;AFDN
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.6791211161841334,1.350637510768414,0.0,0.9370513218234465,1.0,6/53,7.35%,PIK3R3;CHPT1;INPP5F;MTMR12;ARF1;PIK3R1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8459760776756011,1.3499303825069078,0.04411764705882353,0.9378015222460305,1.0,4/8,5.61%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.900477001280173,1.349752358589145,0.03076923076923077,0.9332795429179933,1.0,1/5,4.36%,ACOX1
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,0.6000798096457803,1.3495561590340626,0.022727272727272728,0.9294619224793355,1.0,13/72,14.33%,LAMC1;PLS3;NES;CD9;SMAD5;MYO1B;COL4A2;CTNNA1;GJA1;KLF4;PECAM1;ANO6;ITGB1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),0.6772570770583222,1.3490460306443233,0.1111111111111111,0.9286111154523315,1.0,4/28,6.91%,CCDC3;PCK1;PRKAG2;SIN3B
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.8908222758714853,1.3470570201034857,0.029850746268656716,0.9440964758162974,1.0,1/6,2.60%,PRKAG2
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),0.8346253696618444,1.3467371652968647,0.08196721311475409,0.9411255322603529,1.0,1/6,0.73%,ADAMTS9
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),0.8572542022101473,1.3466449911469354,0.041666666666666664,0.935890866320094,1.0,3/8,5.24%,PCK1;GAPDH;PGK1
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,0.7318727566885634,1.3460840310146163,0.0425531914893617,0.9355751607371976,1.0,9/24,13.58%,CCDC3;CNTN1;ANK2;GPM6B;PTPRD;NFASC;NRXN1;SHC2;TMEM132C
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.6950244433868019,-1.3460703970182557,0.15151515151515152,0.8891778689075348,1.0,5/11,11.84%,PARP14;PARP9;ZC3HAV1;PARP12;PARP11
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),-0.8493360297198933,-1.345663054636644,0.19148936170212766,0.8808358394124748,1.0,2/5,7.32%,TTN;PKD2
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.6376676541002735,1.3445151487426374,0.023529411764705882,0.9482111597720251,1.0,16/65,14.98%,RTN4;ANK2;CALR;GAPDH;PINK1;RPL23;PIK3R1;SMAD7;HSP90AA1;RAB21;LAMP2;CDKN1A;ATP1B3;CCNH;NAA16;HIP1R
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),0.6731061283915253,1.3444133923917856,0.0625,0.9432363447696722,1.0,5/36,9.01%,PRKAG2;BNIP3L;GAPDH;PINK1;RB1CC1
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.8986134134164565,1.3443324894580557,0.08064516129032258,0.9384601147689426,1.0,2/5,2.60%,PDK4;PRKAG2
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.7997564350878894,1.344163162795534,0.06944444444444445,0.9344869602613067,1.0,4/12,8.07%,PLS3;NEDD9;EPS8;MYO1B
prerank,MSigDB_Hallmark_2020__Coagulation,0.6888209427251908,1.3441310680600826,0.05263157894736842,0.9288841721719823,1.0,12/30,12.90%,MAFF;SERPINE1;CD9;ANXA1;TIMP3;RAPGEF3;DUSP6;CRIP2;LAMP2;VWF;PECAM1;CFH
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),0.7571970696973855,1.3429292921143088,0.10606060606060606,0.9356316372893787,1.0,4/11,11.40%,SLC8A1;CACNA1C;ATP2B1;MICU2
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.8853596665629155,1.342056104907334,0.12121212121212122,0.938780527931627,1.0,2/6,1.82%,TSG101;TRIM5
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.7891289917678543,1.3418626320051201,0.0945945945945946,0.9352319811557065,1.0,6/13,10.90%,GRIA2;CTNND2;NFASC;SNAP25;ENPP2;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),-0.8444754856008336,-1.3415829265788053,0.10638297872340426,0.8943786147008506,1.0,2/5,13.81%,PDGFB;STX3
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),0.819723033781289,1.341523704151485,0.07575757575757576,0.9332992023591329,1.0,3/8,7.97%,ANK2;CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),-0.8155370351165876,-1.341145737674518,0.17073170731707318,0.8870414783560145,1.0,2/5,12.05%,TAP1;HLA-A
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.8641187137906908,-1.3410695122520155,0.0967741935483871,0.8784910676040012,1.0,1/6,0.86%,ATG10
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),0.8256635215383341,1.3394022640595549,0.15873015873015872,0.9502793537994991,1.0,4/10,10.90%,IL1RAPL1;PTPRD;ROBO2;NRXN1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.7685948745054643,1.3392083194693105,0.08974358974358974,0.9460134848413411,1.0,6/15,13.89%,GPM6B;PICALM;CTNNA1;OTUD7B;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),0.6880120179660181,1.3386290442957238,0.1267605633802817,0.946496772428804,1.0,5/19,15.94%,MTHFD1L;MTHFD2L;NSMAF;BTD;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.8347547288462158,1.3378690848521169,0.08823529411764706,0.9484458905206389,1.0,2/9,4.23%,PNP;ANXA1
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.7549098425335393,1.3372444331689446,0.06451612903225806,0.9489727881773518,1.0,4/14,6.93%,ITPR1;SLC8A1;GRIN2B;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.8701009610157641,1.3370416592482235,0.03125,0.945509899689067,1.0,3/7,9.50%,PINK1;NFE2L2;HIF1A
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.7214179401986769,1.3353548823129073,0.10294117647058823,0.9571118909377263,1.0,6/19,14.93%,ANK2;SYTL4;PLSCR4;ANK3;ANO6;DYSF
prerank,PanglaoDB_Augmented_2021__Nuocytes,-0.7887602563246146,-1.3338736955554764,0.28125,0.8993380629165796,1.0,5/6,20.17%,GIMAP8;GIMAP4;CYLD;RORA;GIMAP7
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),0.6593656331289232,1.3328899996005203,0.09333333333333334,0.9777049176834887,1.0,12/34,15.78%,SYN3;GRIK2;GRIK1;GRM7;KCNMB4;BCR;LRRC4C;NRG3;DLGAP2;ITGB1;SYT1;DGKI
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.6668720597777846,-1.332673304434076,0.16,0.8957759912491718,1.0,1/12,0.13%,VCAM1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.7229554560684437,1.332497122921671,0.0684931506849315,0.9768708511005652,1.0,8/21,9.55%,ADM;PCK1;LSAMP;PTPRD;SGIP1;NFASC;ENPP2;ITGA1
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),0.7119758562988718,1.3317674932540315,0.14473684210526316,0.9782088552324978,1.0,4/15,9.50%,PRKAG2;SCARB2;OGT;HIF1A
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.7869358578494886,1.3316745434527169,0.04285714285714286,0.9740024369515579,1.0,7/15,14.59%,DTNA;CADM2;ANO5;LRP1B;CTNNA3;ADCY2;PIAS2
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),0.8782905394030409,1.3312660284902285,0.078125,0.9727758044482611,1.0,3/6,5.24%,PCK1;GAPDH;PGK1
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.6460631221372847,1.3300551588099525,0.07894736842105263,0.9780627190014919,1.0,11/40,16.23%,RAPGEF5;CCDC88A;BCR;GRB2;RASSF1;JUN;CDKN1A;SHC2;KRAS;SHOC2;RAC1
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.8483350252546817,1.3300400431665715,0.1076923076923077,0.9727194936732901,1.0,2/6,9.01%,ATG12;RB1CC1
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.6665611876722631,1.3300074183291661,0.09210526315789473,0.9674356375154017,1.0,11/30,19.99%,HIF1A;SLC2A1;VWF;LRRC32;KCTD12;ITGB1;TNS1;DYSF;PSAP;EGFL7;GSN
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),0.819627755945135,1.3298577580818618,0.0625,0.9638828482407341,1.0,3/14,5.61%,AFF3;TBX3;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),0.628362266688238,1.3288060133808026,0.07058823529411765,0.9680924524826513,1.0,14/50,22.30%,TBX3;CALR;ZFPM2;SMAD7;CDK6;TRIB2;REST;WWTR1;HDAC7;SPRED1;GATA2;NOTCH4;SMAD6;PPARG
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.8192358531452215,-1.3286187379172643,0.13513513513513514,0.9049434396971838,1.0,2/5,9.06%,ATG10;UGCG
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),0.7360628736241602,1.3280080725285652,0.11864406779661017,0.9711925065837809,1.0,5/17,7.89%,MAP2;FES;PINK1;KDM1A;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.8834884715448522,1.3277970099671572,0.1267605633802817,0.9680885778914091,1.0,1/5,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.7916883768230027,1.3276093823251889,0.07042253521126761,0.9651935461464146,1.0,5/13,9.79%,PLS3;NEDD9;EPS8;MYO1B;HSP90B1
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.6107374460327081,1.3275643981638283,0.04597701149425287,0.960236864556954,1.0,11/57,18.51%,PSMC6;LDHA;CANX;PGK1;RPL34;CNBP;DDX18;SMARCC1;SRSF7;PSMA7;TRA2B
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.7664650097886205,1.326504987596256,0.1,0.9667819289742456,1.0,8/16,10.90%,RTN4;GRIA2;MAP2;CADM2;GRIN2B;SNAP25;ADGRB3;NRXN1
prerank,GO_Biological_Process_2021__limb development (GO:0060173),-0.697646808440574,-1.32645882245497,0.24242424242424243,0.9059344902709858,1.0,1/7,3.14%,ZNRF3
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.5883510113657154,1.3260544244452726,0.05555555555555555,0.9662406177038234,1.0,26/106,16.28%,NRCAM;ZEB2;ERBB4;GRIK1;RAPGEF5;TBX3;NES;SPOCK1;LSAMP;GPM6B;ELP3;ROBO2;MBP;NFASC;NAV3;NAV1;SEMA6B;SLC2A1;NRXN1;BTD;TRAK1;PRX;ECT2;WWTR1;FEZ2;NAV2
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),0.6450922200039633,1.3259377300127855,0.07058823529411765,0.957549295455856,1.0,12/45,18.46%,PSMC6;PIK3R1;FOS;GRB2;JUN;MAPK10;TAB2;PAK2;RAC1;MALT1;TEC;PSMA7
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.6450922200039633,1.3259377300127855,0.07058823529411765,0.957549295455856,1.0,12/45,18.46%,PSMC6;PIK3R1;FOS;GRB2;JUN;MAPK10;TAB2;PAK2;RAC1;MALT1;TEC;PSMA7
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),0.7733519826467782,1.3258829796912877,0.08571428571428572,0.9529888360085137,1.0,1/14,0.03%,PIK3R3
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.8686084504049891,-1.32575694033355,0.0625,0.9000494344435686,1.0,1/6,0.83%,MVB12B
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.7270610550646525,1.3255600076247283,0.125,0.9513480028260446,1.0,10/18,21.75%,ITPR1;SLC8A1;ANK2;ATP2B1;ATP1A1;ATP1B3;RYR3;ATP2B4;ATP1B1;AHCYL1
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),0.7784120011311697,1.325465840064027,0.09333333333333334,0.9475952491593832,1.0,3/15,7.24%,DOCK3;NEDD9;PRNP
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.8752716930637074,1.3249758150932833,0.11864406779661017,0.9473367864730715,1.0,1/5,5.06%,GAPDH
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),0.8574034434818743,1.3248255203470316,0.046153846153846156,0.9435876432221004,1.0,2/6,1.90%,MTHFD1L;PCK1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.6552181307792171,-1.3244910080317929,0.08333333333333333,0.898652831044432,1.0,2/14,3.74%,FAXDC2;TNRC6C
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.8606768975479955,1.3244109522174279,0.11320754716981132,0.9420282617004289,1.0,2/6,7.55%,RPL23;SMAD7
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.796023104315483,-1.323511499814711,0.21621621621621623,0.8942916404981126,1.0,1/5,2.21%,CTNNA2
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),-0.8102294100622006,-1.3233178574647146,0.25925925925925924,0.8789101554526555,1.0,4/5,18.87%,HIBCH;ACAT1;HIBADH;AUH
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),-0.8102294100622006,-1.3233178574647146,0.25925925925925924,0.8789101554526555,1.0,4/5,18.87%,HIBCH;ACAT1;HIBADH;AUH
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),-0.5930157754081904,-1.323187302142173,0.21428571428571427,0.87157461683125,1.0,5/27,3.48%,OAS3;ISG15;IFIH1;STAT1;IRF1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),-0.7890600122085349,-1.3231379211577836,0.16666666666666666,0.863938812196428,1.0,1/6,1.53%,STARD3
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),0.8975390290157358,1.3226426750300257,0.05357142857142857,0.9547003834952796,1.0,1/5,0.42%,ANGPTL4
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.8723054947303723,1.322024950172547,0.11428571428571428,0.9556126680523843,1.0,1/5,8.83%,CDK6
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.7858275197878812,-1.3212885421266478,0.2962962962962963,0.8644394620044707,1.0,1/8,0.26%,DDX60
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),-0.8545475591509151,-1.3206016543487857,0.07142857142857142,0.859763044049778,1.0,3/5,12.28%,HLA-F;HLA-A;SERPINB9
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.7241801456879597,-1.320532337830009,0.13333333333333333,0.8527124972205755,1.0,1/6,4.13%,BCOR
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.812607176126303,1.3186879860979808,0.1076923076923077,0.9818359586141184,1.0,4/10,5.61%,CLIC2;SLC8A1;ANK2;CACNA1C
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),0.7754202767340125,1.3185683556530134,0.11428571428571428,0.97806211154685,1.0,5/10,9.45%,GRIK2;GRIK1;BCR;LRRC4C;NRG3
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.8572599695764209,1.318511771895397,0.046875,0.9736802813085083,1.0,2/6,9.14%,IPO7;CDKN1B
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),0.8523813978039777,1.3183976598438618,0.1,0.969823589159854,1.0,2/5,7.89%,MTHFD1L;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.8232522701127133,1.3183622262551946,0.08823529411764706,0.9652059265427121,1.0,3/8,14.98%,RTN4;CCDC88A;HIP1R
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),-0.5465047678758597,-1.3182687912749171,0.08695652173913043,0.8549672929806168,1.0,7/28,5.82%,SLC22A5;SLCO1A2;TAP1;ABCG2;DISP1;CHKA;MIA3
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.8259867738729656,1.318127255254103,0.125,0.9625946607511666,1.0,1/6,2.26%,DOK5
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),0.7966062796785784,1.3173262131734509,0.10526315789473684,0.9654415894578244,1.0,5/9,14.77%,PPM1D;DUSP6;DUSP1;PPM1A;DUSP16
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.7757436852702196,1.3170596913479315,0.09859154929577464,0.9634319085573544,1.0,2/13,9.24%,SPOPL;OGT
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.8574707952262518,1.316940541129916,0.06451612903225806,0.9600312936514755,1.0,2/5,5.11%,ADM;PRKCE
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.7683242969886731,1.3160114646452616,0.10294117647058823,0.9634213098575242,1.0,5/12,10.80%,FES;JUNB;MBP;PRNP;MSRA
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.7143330573664521,1.3156883746272328,0.16176470588235295,0.961915760803666,1.0,7/13,14.90%,ANO5;SLC20A2;ANO2;SLC12A6;ANO6;SLC26A2;SLC20A1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.7254000499721962,1.315559623640347,0.1267605633802817,0.9587769019119685,1.0,6/18,14.23%,ADM;S1PR1;ADGRB3;GNA13;ADCY2;ADGRG1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.7140031289751798,1.3151220365405145,0.022727272727272728,0.9579738197310969,1.0,6/27,9.50%,PSMC6;ATF3;KLF2;NFE2L2;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),0.7349361845608384,1.3151183766368275,0.11475409836065574,0.953455075298403,1.0,3/22,7.87%,CEP57;FGFR1;GRB2
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.6665367374222643,1.3150690224121395,0.17857142857142858,0.9493848709120888,1.0,8/25,10.90%,GRIA2;CADM2;CTNND2;PDE5A;SNAP25;ADGRB3;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),0.8882092507314481,1.3148960327968233,0.057971014492753624,0.9464137644413495,1.0,3/5,10.90%,IL1RAPL1;PTPRD;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.7061419925906308,-1.3144286858193246,0.10256410256410256,0.8635281204737416,1.0,1/8,1.58%,ISG15
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),0.8888700276912407,1.3143233790704443,0.029411764705882353,0.9465883749743124,1.0,2/5,3.97%,KLF2;CALR
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),0.7275576714368752,1.314111125368553,0.13157894736842105,0.9443084893972128,1.0,9/20,18.07%,SYN3;GLUL;SNAP25;DNAJC5;PPFIA2;SLC38A2;NRXN1;SYT1;SLC1A2
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.8319641528422603,1.3137686108206863,0.1267605633802817,0.9382738826560199,1.0,1/6,6.02%,NDUFA12
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.8319641528422603,1.3137686108206863,0.1267605633802817,0.9382738826560199,1.0,1/6,6.02%,NDUFA12
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),0.6942598845370611,1.3104438910281977,0.09876543209876543,0.9625765089034855,1.0,10/17,21.81%,MGAT4A;MCFD2;UBE2J1;TMEM165;MGAT5;FUT8;MGAT1;UGGT2;PMM2;B4GALT1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.6632555494370438,1.310151473793339,0.125,0.9608060370867164,1.0,2/33,1.01%,ST18;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.8303996862639196,1.309916771469722,0.08771929824561403,0.958415546896584,1.0,1/6,2.44%,FES
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.7946837095514041,1.3099011330311547,0.08333333333333333,0.9541957713936866,1.0,3/10,12.25%,SUN2;MYO1B;MYO1E
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.8766233400909526,1.3092970555095336,0.11764705882352941,0.9544746832121385,1.0,3/6,8.72%,PRNP;PICALM;TMED10
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),0.8820506691845778,1.3086590759993089,0.10344827586206896,0.9558613365787013,1.0,3/6,7.24%,ARF1;MT2A;PRNP
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),0.7750055737574011,1.3083706388361322,0.10126582278481013,0.9541119973787412,1.0,1/12,3.09%,BHLHE40
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.7705614904699349,1.3075231264249405,0.10294117647058823,0.9567797661436261,1.0,5/14,15.08%,NRCAM;CDK6;UNC5C;ADGRG1;RASA1
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,0.6918196666592599,1.3072249273583354,0.10256410256410256,0.9547083626284597,1.0,6/31,6.44%,SERPINE1;PDK4;ACOX1;UPP1;MT2A;PINK1
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.7832103208945697,1.3071080251908722,0.1016949152542373,0.9513746788769328,1.0,3/10,13.71%,ADAMTS9;SMAD7;FOXF1
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.8973160743946658,-1.3064443746542451,0.027777777777777776,0.8909513955246815,1.0,2/5,3.14%,RNF213;ZNRF3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.8994360297047037,1.3064300570742613,0.05970149253731343,0.9535472820782384,1.0,1/6,0.55%,DDIT4
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.8005369040593425,1.3062441291272746,0.1267605633802817,0.9511408574917563,1.0,4/9,8.33%,GRIN2B;MBP;VSIR;PICALM
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.7613587018819452,1.3060998010468738,0.09722222222222222,0.9485680349774224,1.0,1/13,0.55%,DDIT4
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),0.8656577064847178,1.3057991270760798,0.109375,0.9473223721121223,1.0,2/5,12.56%,CALR;REST
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),-0.6111761061841082,-1.305547410144923,0.16666666666666666,0.8865196433276832,1.0,4/20,5.37%,SLCO1A2;SLC38A3;ABCG2;SLC25A29
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),0.7840256784077794,1.3054523333876842,0.0821917808219178,0.9459481824135629,1.0,2/12,4.36%,SCP2;ACOX1
prerank,PanglaoDB_Augmented_2021__Podocytes,0.6016589325882916,1.3052257656369448,0.034482758620689655,0.9437077842512859,1.0,18/88,16.74%,LAMC1;ADM;PLS3;EHD4;PLOD2;MYO1B;PLSCR4;COL4A2;SRGAP1;GJA1;TRIB2;MYO1E;MAGI2;BCAR1;WWTR1;NAV2;FZD4;FOXC1
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.8177131904244344,1.3051561930144981,0.07042253521126761,0.940244143941792,1.0,2/8,4.47%,B3GNT2;GPC5
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.7934395132025122,1.3049286741786021,0.07352941176470588,0.9380927183533413,1.0,2/7,7.89%,MAP2;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),-0.8218424098591185,-1.3047846473392755,0.1111111111111111,0.881759007934567,1.0,3/5,17.50%,RFX3;FOXO1;CLOCK
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.7359184008681705,1.3043080481076683,0.0945945945945946,0.9397917950088506,1.0,4/15,15.08%,SERPINE1;DLC1;ADAM15;RASA1
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.9017629745704919,1.303159898928083,0.08823529411764706,0.9459743103901196,1.0,1/5,0.60%,B3GNT2
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.7752974414141794,1.3026671479389507,0.16176470588235295,0.9462237083143524,1.0,3/10,3.37%,HSPA5;BCAP31;ANK2
prerank,PanglaoDB_Augmented_2021__Sebocytes,0.8239067383175356,1.3026001585340914,0.12903225806451613,0.9428667970469882,1.0,3/7,9.87%,ANGPTL4;TMEM45B;KLF4
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),0.8931183051075436,1.3024463778884368,0.03076923076923077,0.9402107331320513,1.0,1/5,1.40%,ATF3
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),0.8381173053441915,1.3022420304857925,0.03571428571428571,0.9380234256390018,1.0,3/7,5.61%,SLC8A1;GRIN2B;CACNA1C
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),0.6531972066092875,1.301545056505783,0.09090909090909091,0.9389243914226081,1.0,11/38,17.78%,ERBB4;FES;NRG2;INPP5F;CDK6;ENPP2;PRAG1;RAC1;CRK;PLXNA2;PRKX
prerank,MSigDB_Hallmark_2020__DNA Repair,0.6848796924747662,1.3007616694256137,0.12987012987012986,0.9415462304884832,1.0,6/23,10.72%,PNP;TSG101;BCAP31;POLA1;SMAD5;RFC3
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.8363636040546176,1.3000200574758718,0.078125,0.9431757311220362,1.0,2/6,10.15%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.6737571523411431,1.3000135775328818,0.16666666666666666,0.9393416834345484,1.0,13/29,22.59%,ANGPTL4;SERPINE1;RAPGEF3;HIF1A;FLT1;AGO2;ITGB1;MTDH;GATA2;VEGFC;BTG1;ANXA3;ETS1
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),0.6736367209451279,1.2991507966060756,0.13513513513513514,0.942455301862005,1.0,8/29,16.02%,ERBB4;NRG2;PIK3R1;GRB2;HSP90AA1;BCAR1;ERBIN;KIF16B
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.7445248747410221,1.2986433214235484,0.1527777777777778,0.9441050247510118,1.0,4/14,15.08%,PINK1;CPEB4;PRNP;RASA1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),0.899937657382353,1.2986145872855244,0.09090909090909091,0.9405739851165101,1.0,1/5,0.21%,LAMC1
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.6413616091763324,1.2984050097618935,0.09859154929577464,0.9383687169142868,1.0,8/38,11.29%,ADAMTS9;ANK2;NES;MAP1B;TIMP3;COL4A2;GJA1;BOC
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.6274280516571471,1.2979385660071399,0.07407407407407407,0.9382057080342097,1.0,20/63,17.52%,MAFF;PNP;KLF6;BHLHE40;NFKBIZ;CD81;PLIN2;NDRG1;PRNP;EMP1;P4HA1;SERPINB6;AHNAK;SLC2A3;MYO1E;IFNGR1;PLPP1;BCL2L1;ALCAM;TGM2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.6797848865311877,1.2976667804308344,0.13513513513513514,0.9370571201356658,1.0,5/27,9.50%,RTN4;GLUL;PRKCE;ENPP2;HIF1A
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.6901197072651433,1.2973967154966568,0.15873015873015872,0.9354047569971093,1.0,4/20,12.59%,ADAMTS9;HSP90AA1;LAMP2;DENND3
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),0.7601711886462929,1.297373865130197,0.1267605633802817,0.9317646307594306,1.0,5/15,7.89%,ERBB4;NRG2;PIK3R1;GRB2;HSP90AA1
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.8152434400371389,1.2969154488535273,0.13043478260869565,0.9315452718261055,1.0,3/6,17.86%,RTN4;REEP3;RTN3
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),0.7334751436719565,1.2957595876660748,0.11594202898550725,0.9370718695923738,1.0,4/17,17.52%,BHLHE40;SPEN;REST;TGM2
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.7854051367322443,-1.295648335935565,0.2391304347826087,0.9156115352634364,1.0,1/5,7.32%,PKD2
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.8443807088502989,1.2951787916184772,0.06349206349206349,0.9344597189814333,1.0,3/5,15.55%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.8443807088502989,1.2951787916184772,0.06349206349206349,0.9344597189814333,1.0,3/5,15.55%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.8459247199570854,1.2944042797495985,0.05555555555555555,0.9367799608115798,1.0,3/7,8.33%,RTN4;PRNP;PICALM
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),-0.7641960399385774,-1.2941990112908133,0.21428571428571427,0.9147883843971639,1.0,2/6,1.82%,EIF2AK2;CD74
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),0.826728602721341,1.2940366947676964,0.06349206349206349,0.9360048959569761,1.0,1/7,1.71%,SCP2
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.6819327548370253,1.294014604404161,0.10465116279069768,0.9325843820663621,1.0,3/27,3.97%,PSMC6;SEC22B;CALR
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),-0.6886232849885032,-1.2932298503066355,0.21621621621621623,0.911814766118649,1.0,3/11,5.74%,ATM;ATR;SP100
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.8475977670551694,1.292914661001739,0.13432835820895522,0.9387645770199173,1.0,1/6,7.68%,ACSL5
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),0.7940325413453471,1.2928180394166533,0.1125,0.9359351621539873,1.0,2/9,7.06%,SERPINE1;NFE2L2
prerank,PanglaoDB_Augmented_2021__T Cells,0.7444954179490189,1.2923904161062898,0.07142857142857142,0.9358713125748748,1.0,3/16,4.31%,MAFF;JUNB;CD81
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.8126496071813605,1.2921119089312898,0.1917808219178082,0.9337270115814121,1.0,2/8,4.57%,HSPA5;VAPB
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.638100541673514,1.2916343601152251,0.125,0.9337532418330673,1.0,7/39,9.50%,PSMC6;BNIP3L;PGK1;NDRG1;PINK1;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.7110633651826379,1.2916067605050747,0.1038961038961039,0.9304990205369138,1.0,4/19,7.17%,SERPINE1;NFKBIZ;CD81;HYAL2
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),0.7066749437264637,1.2914772927683889,0.1267605633802817,0.9281970394385445,1.0,4/15,9.50%,PRKAG2;PINK1;OGT;HIF1A
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),0.8470870603470633,1.29146905019859,0.10294117647058823,0.9247866887069018,1.0,3/9,4.65%,GRIA2;LRRC7;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),0.8447974725974101,1.2912577678641641,0.05714285714285714,0.9233639033092255,1.0,2/6,7.24%,RTN4;PRNP
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),-0.664093280883082,-1.2903440075861328,0.20588235294117646,0.9155237292791705,1.0,3/8,9.40%,STAT1;PKD2;STAT2
prerank,GO_Biological_Process_2021__cardiac atrium development (GO:0003230),0.8617776117533276,1.2902213222093932,0.0967741935483871,0.9298516666601805,1.0,1/5,3.37%,ANK2
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),-0.6909613513102354,-1.290171095939672,0.14705882352941177,0.9088501597581722,1.0,1/10,0.05%,RSAD2
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),0.6546242111412662,1.2901452530525346,0.10526315789473684,0.9268306198204993,1.0,10/31,17.94%,MYO9B;EPS8;BCR;GRB2;OGT;DLC1;DENND3;ERBIN;SHOC2;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.6684408603373079,1.2889577220197133,0.06756756756756757,0.9326244442511605,1.0,5/35,7.89%,DDIT4;RAPGEF3;PINK1;SMAD7;HSP90AA1
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),0.8284061394778648,1.2877427404579185,0.15942028985507245,0.9348457450621013,1.0,2/5,13.79%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),0.8284061394778648,1.2877427404579185,0.15942028985507245,0.9348457450621013,1.0,2/5,13.79%,CCNH;TAF1D
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.7880387482385924,-1.28663275323388,0.2571428571428571,0.9156595358681684,1.0,3/5,6.59%,PARP14;PARP9;ZC3HAV1
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),0.6972178074741148,1.2857247650820107,0.0945945945945946,0.9466590747508402,1.0,5/22,15.94%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),0.8592544117178456,1.2856164082038561,0.171875,0.943748987853353,1.0,3/5,7.24%,MT2A;MT1M;PRNP
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.7755445098956824,1.2854919340188817,0.09722222222222222,0.941170993455177,1.0,1/12,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.6938517865509785,1.2854443050196833,0.18571428571428572,0.9379913965723033,1.0,5/19,16.90%,RTN4;ROBO2;LRRC4C;PAK2;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.7171979465252829,1.2853628106073085,0.16176470588235295,0.9355682295239753,1.0,2/10,10.10%,PINK1;MICALL2
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),0.7697162187663067,1.2849954477014256,0.11594202898550725,0.9347399618770379,1.0,1/9,1.35%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.875022345683938,1.2849707681666407,0.10144927536231885,0.9315019669244717,1.0,3/6,10.98%,ANXA1;KLF4;OTUD7B
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),0.8110269949798583,1.2838005434164848,0.11764705882352941,0.9381443630941317,1.0,2/8,13.50%,TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),0.8075046416566238,1.2833383205357105,0.17391304347826086,0.9382675953945105,1.0,2/7,4.34%,GRIK2;SLC4A10
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.6630246255433964,1.2829530143568277,0.1,0.9378208738212014,1.0,11/31,19.42%,SPNS2;VAPB;KDSR;ENPP2;SAMD8;NSMAF;SERINC1;PLPP1;PSAP;ESYT2;ST6GALNAC3
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.7640413450240126,-1.282923337483055,0.25806451612903225,0.9243925982719543,1.0,3/6,15.45%,RC3H1;ZC3HAV1;PNPT1
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.7057771782201054,1.2821933154370957,0.14473684210526316,0.9407798717568027,1.0,4/18,5.50%,BCAP31;CANX;CALR;SEC24D
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.7621263835249248,1.2815171969742398,0.19444444444444445,0.9422489288968918,1.0,4/7,20.74%,SEC22B;PINK1;FEZ2;CHMP4B
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),0.8073066464322054,1.2809069633317614,0.2,0.9440456808958699,1.0,3/6,17.73%,PGK1;VSIR;PLAT
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.759778132859559,1.2803537898146968,0.19047619047619047,0.9448946445915084,1.0,2/12,7.81%,ST18;JAK1
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.7353217724784282,-1.2803521995683693,0.25,0.9285156348426435,1.0,3/7,9.61%,ATM;NLRC5;LDB2
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.7820977993788168,1.2795664774369382,0.125,0.9479002918904453,1.0,3/7,15.01%,CD81;HSP90AA1;PTTG1IP
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.8487536792287886,1.2791781273483074,0.1746031746031746,0.9471324228667253,1.0,3/5,12.77%,SERPINE1;DUSP1;ANO6
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.7532480336417166,1.2785692868601184,0.11267605633802817,0.949035956607282,1.0,4/11,15.08%,PINK1;CPEB4;HIF1A;RASA1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.6653597827839554,1.278464543650869,0.16049382716049382,0.946793317509375,1.0,5/27,6.36%,LAMC1;GRIA2;ANK2;NDRG1;NFASC
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.8373843701755366,1.2781103197378143,0.09090909090909091,0.9465519392279198,1.0,1/6,7.06%,NFE2L2
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),0.8669028282469841,1.2775539614462985,0.12698412698412698,0.94748509966042,1.0,1/5,3.19%,KCNMB4
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.855831078999602,1.2770097640247542,0.11290322580645161,0.9488868367256293,1.0,3/6,9.87%,PKM;JAK1;KLF4
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.8661254524059712,1.276471072926789,0.13432835820895522,0.9495874134068742,1.0,3/5,9.79%,HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.8748817486630525,1.2763163868035323,0.04838709677419355,0.9474894045659134,1.0,1/5,1.71%,SCP2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),0.8271620013746374,1.2757774237538517,0.14492753623188406,0.9487685744271724,1.0,2/7,5.66%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),0.7391175303509079,1.275329503844804,0.2054794520547945,0.9488137779916652,1.0,2/10,6.54%,KLF2;CPEB4
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.8143593338689608,1.2747279184186826,0.0684931506849315,0.9505470418429528,1.0,1/8,0.78%,ERBB4
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.776932729985192,1.2745692011668504,0.1111111111111111,0.9487242689467421,1.0,2/12,4.36%,SCP2;ACOX1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.6837916480581374,1.2744968825780938,0.1411764705882353,0.9462355039247411,1.0,3/26,3.97%,PSMC6;SEC22B;CALR
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),0.6075017206211348,1.274235703431679,0.08888888888888889,0.9451858350708693,1.0,22/91,18.46%,ERBB4;PSMC6;LRRC7;MAP3K5;NRG2;GRIN2B;MBP;FGFR1;DUSP6;PIK3R1;JAK1;GRB2;RPS27A;PEBP1;SHC2;RASA1;KRAS;SHOC2;BCL2L1;SPRED1;PPP1CB;PSMA7
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.6639463696255455,1.2741791484054563,0.2236842105263158,0.9428313455957531,1.0,4/21,12.69%,ADM;CD81;GGT5;ADCY2
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),0.7856693493956921,1.2741399384960073,0.15942028985507245,0.9400682177789047,1.0,2/8,8.18%,PPP2R2B;DUSP1
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),0.7069755991691817,1.2734541166571143,0.12162162162162163,0.9425357243737281,1.0,8/23,13.29%,DDIT4;MAP3K5;GRIN2B;PRNP;FOS;PICALM;REST;BTBD10
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.81883195556905,1.272225339670902,0.12,0.9491999455854754,1.0,1/7,4.21%,STARD4
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.7457352096999866,1.2720584809547473,0.22535211267605634,0.9472828546828709,1.0,5/10,15.26%,SYN3;SNAP25;DNAJC5;NRXN1;SYT1
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),-0.6527394108168908,-1.2720329632160297,0.16666666666666666,0.9548245292854083,1.0,2/12,5.48%,GBP1;ZDHHC2
prerank,PanglaoDB_Augmented_2021__Interneurons,0.5939133028843921,1.2717329226126057,0.07058823529411765,0.9469825961758556,1.0,13/62,10.90%,GRIA2;MAP2;CADM2;OXR1;CTNND2;TRIM9;ATG12;SNAP25;ARHGAP21;SRGAP1;PPFIA2;ADGRB3;NRXN1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),0.832606212401617,1.2716967461473563,0.1206896551724138,0.9443200785640153,1.0,1/5,6.52%,FGFR1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.637653246547729,-1.271696627711288,0.17857142857142858,0.948787147022349,1.0,4/16,3.48%,OAS3;ISG15;IFIH1;IRF1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.8037009138285824,1.2715962579665152,0.1746031746031746,0.9419865329677644,1.0,1/8,2.60%,PRKAG2
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),0.8422619435352537,1.2714130107395796,0.16417910447761194,0.9373640318185028,1.0,2/5,7.22%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.8422619435352537,1.2714130107395796,0.16417910447761194,0.9373640318185028,1.0,2/5,7.22%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.7933188374402349,1.2709757522176222,0.2537313432835821,0.937443287729476,1.0,1/6,5.61%,CACNA1C
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.7950299949306678,1.2705189619131212,0.14285714285714285,0.9377615636928693,1.0,3/6,16.93%,ERBB4;CRLF3;MGAT5
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),0.8948283877197892,1.2699167831634537,0.05970149253731343,0.9388964581771264,1.0,2/5,2.73%,ERBB4;TBX3
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7676292464974599,1.2689841488801483,0.16176470588235295,0.9416223173295771,1.0,2/9,7.55%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.6860395345990234,1.267650460817373,0.17647058823529413,0.9492459467408509,1.0,8/21,17.81%,SERPINE1;ARF1;SGIP1;RAB21;PICALM;HIP1R;RAC1;TF
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.5577549559887449,-1.2676097068804069,0.18181818181818182,0.9516455770218755,1.0,5/29,5.19%,SLC22A5;SLC4A4;SLC38A3;LEPR;ABCG2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),-0.5577549559887449,-1.2676097068804069,0.18181818181818182,0.9516455770218755,1.0,5/29,5.19%,SLC22A5;SLC4A4;SLC38A3;LEPR;ABCG2
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),0.7864071633763432,1.2673711953384201,0.13513513513513514,0.9487124089982899,1.0,4/11,11.84%,TBX3;CALR;SMC6;CDKN1A
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.6882179128862753,-1.2673432356816106,0.1724137931034483,0.9457694909637612,1.0,1/9,0.91%,EIF2AK2
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),0.695974030597967,1.266959835096962,0.08333333333333333,0.9486874614890171,1.0,5/22,15.94%,SPNS2;VAPB;KDSR;SAMD8;PLPP1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.7495555630994168,1.266103134970467,0.20270270270270271,0.9523564459174891,1.0,4/12,13.84%,SPOCK1;ANXA1;CDK6;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.6453636749517092,1.2660480049871612,0.11764705882352941,0.9503787729771067,1.0,6/28,13.63%,PKM;YBX3;RPS9;LARP4;CNBP;AGO2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),0.6864571205642033,1.2656061747281568,0.1111111111111111,0.950582520921339,1.0,6/27,8.83%,ERBB4;FES;CD9;NRG2;INPP5F;CDK6
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.8177575890587451,1.265344798047821,0.18461538461538463,0.9496538410342001,1.0,1/5,2.60%,PRKAG2
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.7738422129089967,1.265312572749861,0.22535211267605634,0.9468734635172447,1.0,3/9,14.98%,SGIP1;PICALM;HIP1R
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.6549142284105184,1.2645274917090232,0.11904761904761904,0.9496321698647859,1.0,8/42,9.87%,SERPINE1;BCL6;NFKBIZ;MGLL;ANXA1;UFL1;HYAL2;KLF4
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),0.6877289706350794,1.2644558265129906,0.10526315789473684,0.9470666050977191,1.0,1/20,0.55%,DDIT4
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.6018419784206996,1.264187568949019,0.125,0.9453711349745063,1.0,7/58,5.35%,ANGPTL4;BCL6;SCP2;MGLL;ACOX1;PLIN2;DHRS7B
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),-0.6921533175593657,-1.2641368421782997,0.26666666666666666,0.9511097268456499,1.0,1/8,2.73%,ATM
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),0.770377165844458,1.263987303558957,0.12698412698412698,0.9438825348391919,1.0,1/8,1.84%,SUN2
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.8708169355859974,1.2639658863194894,0.14492753623188406,0.9410962594627997,1.0,2/6,7.24%,ARF1;PRNP
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.667431899411938,1.26366732982131,0.13157894736842105,0.9402808699549435,1.0,10/30,17.47%,ADAMTS9;SERPINE1;KLF2;PGK1;COL4A2;KLF4;CLDN5;FOXC1;ATF2;SPRED1
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),-0.6557369467462114,-1.2633310118737622,0.13333333333333333,0.9472955165212564,1.0,2/11,1.48%,CPQ;PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.7760928370530217,1.2620126870517099,0.16923076923076924,0.9483348374023449,1.0,5/8,21.86%,TSG101;HYAL2;ZFYVE28;DUSP22;SH3BP5
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.7033712683358695,1.2619666571328634,0.13513513513513514,0.9457544981916,1.0,9/25,17.50%,ADM;AKAP12;S1PR1;ADGRB3;GNA13;ADCY2;ADGRG1;PSAP;GRK5
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),0.62419576647543,1.2615865725993376,0.16455696202531644,0.9459976364045656,1.0,6/40,10.20%,PBX3;MAP2;GPM6B;PPP1R9A;MICALL2;CNTNAP2
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),0.692042987766119,1.261508510214202,0.1375,0.94369705737368,1.0,5/23,10.10%,LAMC1;ATRNL1;LAMA5;PIK3R1;MICALL2
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),0.7094883526119672,1.2615008818873463,0.18666666666666668,0.9409288545109293,1.0,9/15,23.78%,KCNIP4;KCNMB4;DPP10;NOS1AP;NEDD4L;NEDD4;CAB39;AKAP6;YWHAE
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.7585392830713402,1.2611655354328433,0.2,0.9402244052985732,1.0,3/10,10.54%,UFL1;CBFB;ZNF366
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.613507280940045,1.260886975962172,0.1625,0.9398430706133308,1.0,12/51,11.84%,DDIT4;ATF3;PPM1D;CD81;UPP1;NDRG1;FOS;KLF4;JAG2;PITPNC1;JUN;CDKN1A
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.7376250371462366,1.260710661362203,0.19696969696969696,0.9354723104764804,1.0,6/9,25.29%,EPS8;ADD3;TRIOBP;GSN;ADD1;CAPZA2
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.7376250371462366,1.260710661362203,0.19696969696969696,0.9354723104764804,1.0,6/9,25.29%,EPS8;ADD3;TRIOBP;GSN;ADD1;CAPZA2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.7898132247155116,1.259794066993071,0.11290322580645161,0.9400403212551002,1.0,5/11,12.72%,DDIT4;GRB2;RAP1A;MAGI2;BCAR1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.7221595893305367,1.25974832660661,0.1935483870967742,0.9376149177711693,1.0,2/10,7.55%,ROBO2;SMAD7
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.6289551073301094,1.2596765990389702,0.15853658536585366,0.9354236411923393,1.0,11/44,18.56%,PSMC6;RFTN1;NFKBIZ;PIK3R1;BCAR1;TAB2;PAK2;MALT1;TEC;PSMA7;PDE4B
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),0.7337262995199658,1.2592021979268306,0.14705882352941177,0.9359090644002512,1.0,4/10,20.28%,MAP2;HSP90AA1;RASA1;ESAM
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),0.8070752923140342,1.2588782880020244,0.13114754098360656,0.9356729188890025,1.0,1/5,0.75%,RTN4
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),-0.8044719419440599,-1.2588508930710571,0.26666666666666666,0.9601306146522464,1.0,1/5,0.47%,RNF213
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.715332176570153,1.2579604165619862,0.1527777777777778,0.9387411471802066,1.0,3/14,8.05%,ERBB4;PKN3;SEMA6B
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),0.5933839759572551,1.2571897747358673,0.18518518518518517,0.9415742452847177,1.0,8/50,13.76%,ZEB2;KLF2;STARD4;HSP90AA1;HIF1A;KLF4;LARP4;NOS1AP
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.6287613280874434,1.2570015333221107,0.1643835616438356,0.9400226561211149,1.0,14/36,14.17%,GRIA2;MAP2;CADM2;ANK2;LSAMP;MAP1B;PTPRD;NFASC;SNAP25;PPFIA2;ADGRB3;NRXN1;MAGI2;MAPK10
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.8149272194443635,-1.2568459573437292,0.2857142857142857,0.9618356470262154,1.0,3/6,10.96%,ATM;ATR;STK33
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.8445207712320941,1.2567093882162619,0.06557377049180328,0.9390669079238958,1.0,1/5,3.37%,ANK2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),0.7453051965597287,1.256695195221539,0.18055555555555555,0.9365147251962115,1.0,5/10,13.76%,KCNMB4;ANK2;ATP1B3;ANO6;NOS1AP
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.7229941380559534,1.2565734917170581,0.12162162162162163,0.934775708303042,1.0,4/14,4.23%,SLC8A1;ANK2;MGLL;ANXA1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.8269674134991727,1.2563734227075178,0.17543859649122806,0.9335978996281918,1.0,3/6,8.05%,RTN4;MAP2;SEMA6B
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",0.825210529305362,1.255813567924487,0.19047619047619047,0.9323891456002843,1.0,2/6,7.27%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),0.825210529305362,1.255813567924487,0.19047619047619047,0.9323891456002843,1.0,2/6,7.27%,GRIN2B;INSYN2A
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.6567049152820816,1.2557176546604836,0.09090909090909091,0.9303775296085244,1.0,7/25,17.86%,RTN4;VAPB;PRNP;TOR1AIP2;REEP3;TRAM1;RTN3
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.7856648795228844,1.2557171134986627,0.21428571428571427,0.9277714300858113,1.0,1/7,1.90%,PCK1
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),0.8064860249677559,1.2556180879799428,0.09090909090909091,0.9259047630270254,1.0,1/8,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.8101396560613641,1.255568421450422,0.14035087719298245,0.9236870681760315,1.0,3/8,9.19%,POLA1;PURA;NOC3L
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),0.6449737539600517,1.2551070868925334,0.14864864864864866,0.9246353958681043,1.0,9/32,20.15%,NEDD9;S1PR1;ANXA1;GRB2;MICALL2;BCAR1;PARVB;GSN;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),0.7863501120652194,1.2547878826863985,0.109375,0.9241707229816775,1.0,5/9,17.52%,IL1RAPL1;PTPRD;NRXN1;SPEN;TGM2
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),0.867212042186932,1.2545562257222216,0.16901408450704225,0.9230514923825041,1.0,3/5,9.87%,KLF2;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),0.7765487948612773,1.2541293948130339,0.1527777777777778,0.9228916133680477,1.0,4/7,22.30%,CDK6;HDAC7;SMAD6;PPARG
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),0.6113062345770927,1.2537153438889372,0.13414634146341464,0.9234752427978111,1.0,19/48,23.78%,CEP57;NES;TUBB4B;HSP90AA1;CDKN1A;CCNH;CEP70;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;DNM2;PAFAH1B1;PLCB1;CCNY;ARPP19;CEP290;YWHAE
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),0.6121459600237915,1.2532241182417898,0.15853658536585366,0.9236705646576941,1.0,19/47,23.78%,CEP57;NES;TUBB4B;HSP90AA1;CDKN1A;CCNH;CEP70;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;DNM2;PAFAH1B1;PLCB1;CCNY;ARPP19;CEP290;YWHAE
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.8304727468238695,1.25314307917891,0.14705882352941177,0.9215604748547321,1.0,2/6,5.66%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),0.7697604494113504,1.253096668448589,0.15714285714285714,0.9167576702315727,1.0,4/8,11.27%,MT2A;MT1M;FOS;JUN
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),0.7697604494113504,1.253096668448589,0.15714285714285714,0.9167576702315727,1.0,4/8,11.27%,MT2A;MT1M;FOS;JUN
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),0.7437496196506764,1.25290203748054,0.20270270270270271,0.9156211558429439,1.0,6/15,11.19%,ITPR1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.6512864541155573,1.2528404944320053,0.19444444444444445,0.9137017504485224,1.0,5/22,10.31%,PSMC6;HSPA5;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.8367056287911783,1.2523968625446886,0.1780821917808219,0.9140659807297623,1.0,2/6,3.56%,PNP;HSPH1
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.8763319910124947,1.252299141583456,0.12,0.9123354735656154,1.0,3/5,11.71%,PKM;YBX3;CNBP
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,0.6414968044014415,1.252284960208785,0.14473684210526316,0.9100634646706947,1.0,13/40,11.86%,GRIA2;ATRNL1;MAP2;CADM2;ANK2;GPM6B;MAP1B;SNAP25;INSYN2A;PPFIA2;ADGRB3;CNTNAP2;PREPL
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.6489548062663948,1.2517328568509969,0.15476190476190477,0.9112150968125082,1.0,6/32,10.90%,ST18;GRIA2;GPM6B;MBP;ENPP2;NRXN1
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.6903706257687114,1.251519401389809,0.19718309859154928,0.9100250453088683,1.0,3/15,10.38%,TSG101;RPL23;LAMP2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),0.8278067699291322,1.2515014848347452,0.23880597014925373,0.9078060660617351,1.0,1/5,3.19%,KCNMB4
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),0.6628961811641135,1.2511483945447257,0.15789473684210525,0.9082088188769962,1.0,3/26,7.89%,CEP57;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),0.6118697210066121,1.2504878388385554,0.1411764705882353,0.9106117912114041,1.0,8/38,12.56%,NRCAM;PTPRD;CTNND2;LRRC4C;ANK3;PPFIA2;NRXN1;REST
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.7450938640913783,1.2501734619227942,0.13846153846153847,0.9102347183493548,1.0,3/11,12.56%,PINK1;NFE2L2;REST
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.6877975433573306,1.2501441106907958,0.15151515151515152,0.9080385450073479,1.0,4/17,15.71%,SEC22B;PINK1;PIKFYVE;FEZ2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),0.7541650849776383,1.2498526258173535,0.19718309859154928,0.9073580279800352,1.0,4/9,11.84%,RTN4;MAP2;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.8263605994161908,1.2498002628962654,0.1746031746031746,0.9052091890089184,1.0,2/6,11.21%,RFTN1;ANXA2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),0.7517170812328478,1.2492690020227188,0.16129032258064516,0.9063182020743844,1.0,4/11,16.23%,PRKCE;HYAL2;ITGB1;RAC1
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.6948222375865178,1.2492148234774876,0.2,0.9043522111751635,1.0,5/18,14.95%,PSMC6;UFL1;PINK1;COMMD1;TMF1
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),0.8099857613469947,1.2490130238393182,0.23076923076923078,0.9031828108612562,1.0,1/5,2.31%,MAP2
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),-0.681166810977616,-1.2484896941357495,0.28125,0.9892095427743994,1.0,1/8,5.48%,ZDHHC2
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),0.6426981323214669,1.2477634291849604,0.19736842105263158,0.909470703395344,1.0,7/24,22.66%,PICALM;NEDD4L;HIP1R;LGALS3;PTPN1;ABL2;RUFY2
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,0.6555485657913056,1.2475108412945446,0.1267605633802817,0.9083779397385108,1.0,14/30,19.89%,GRIA2;CADM2;LSAMP;SGIP1;SNAP25;PPFIA2;ADGRB3;CNTNAP2;NRXN1;MAGI2;SLC1A2;FRMD3;GRIA4;GRM5
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.7726748642535675,1.2474088837867845,0.1746031746031746,0.9072350733550286,1.0,2/6,7.55%,PINK1;SMAD7
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,0.6402510893839829,1.2473121410521246,0.08536585365853659,0.9055977526411781,1.0,19/45,14.33%,ZEB2;GRIA2;CADM2;LSAMP;GPM6B;NPAS3;GRIN2B;UFL1;NFASC;LRRC4C;NRXN3;PPFIA2;ADGRB3;GJA1;NRXN1;MAGI2;ADCY2;MAPK10;ITGB1
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),0.8175884485572278,1.2471409686846886,0.19117647058823528,0.9040797278553645,1.0,1/6,0.80%,PNP
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),0.6239374011838387,1.2470300764815876,0.1388888888888889,0.9025141600115414,1.0,12/30,22.40%,PRKAG2;SLC8A1;HYAL2;CDKN1B;TRIB2;CDKN1A;PAK2;WWTR1;SPRED1;PTPN1;SH3BP5;NPM1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.7517598517362842,1.2468584744840345,0.2222222222222222,0.9011772469552211,1.0,3/10,7.55%,SLC8A1;ANK2;SMAD7
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.7079161271038912,1.245928913748651,0.19444444444444445,0.9051847008090527,1.0,7/16,14.25%,PCK1;TMEM45B;TTC7A;PLIN2;ACSL5;SLC26A2;CD55
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),0.8688193039790275,1.2458881250761513,0.0967741935483871,0.9031617115335647,1.0,1/5,1.12%,RFTN1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.5702152051715192,1.2455249627747849,0.13253012048192772,0.9024355387947991,1.0,8/53,8.80%,SEC22B;BCAP31;ANK2;VAPB;SEC24D;MCFD2;TMED10;ANK3
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,0.6246100254700835,1.2451123504110269,0.1375,0.9027779199901702,1.0,13/48,12.98%,ANGPTL4;AKAP12;DUSP6;ERO1A;SNAP25;EMP1;TOR1AIP2;KLF4;PTBP2;TRIB2;PECAM1;CFH;MAP7
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.7667675373076592,1.244989520027986,0.21212121212121213,0.9013482362406414,1.0,4/9,16.23%,PDK4;PRKAG2;NOS1AP;RAC1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.7144124468504929,1.244807118701566,0.203125,0.8999257368315626,1.0,3/17,5.61%,BCAP31;SLC8A1;CACNA1C
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.7987167866744138,1.2446211285139275,0.2028985507246377,0.8988084620282776,1.0,2/6,7.55%,DDIT4;SMAD7
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.6649742001743787,1.2444897855637773,0.16216216216216217,0.897399424551775,1.0,11/22,23.78%,CEP57;TUBB4B;HSP90AA1;CEP70;ALMS1;CSNK1D;DYNC1H1;PAFAH1B1;NPM1;CEP290;YWHAE
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),0.7951684334335196,1.2444500338395617,0.1875,0.895323306674489,1.0,1/6,0.75%,RTN4
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),0.7756310807188515,1.2439952572627029,0.21739130434782608,0.8970231320894682,1.0,1/6,2.60%,PRKAG2
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,0.6993911462113592,1.2439308432249656,0.19753086419753085,0.8951192342716785,1.0,8/18,9.63%,GRIA2;MAP2;ANK2;CTNND2;NFASC;LRRC4C;SNAP25;ADGRB3
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),0.7577150119585586,1.2432101065270076,0.14925373134328357,0.8980958261907512,1.0,2/10,9.24%,PDK4;OGT
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),-0.7451872678736688,-1.2431336020481896,0.30303030303030304,1.0,1.0,2/5,16.28%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.809423383224441,1.2422701801549751,0.16393442622950818,0.9014848869942405,1.0,2/6,7.71%,SNAP25;DNAJC5
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),-0.6815351604772594,-1.2420378549548925,0.3076923076923077,1.0,1.0,1/6,1.82%,CD74
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),0.7306472515515959,1.241905972101387,0.1891891891891892,0.8993397316917994,1.0,6/9,20.53%,MCFD2;UBE2J1;MGAT5;FUT8;MGAT1;UGGT2
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),0.7306472515515959,1.241905972101387,0.1891891891891892,0.8993397316917994,1.0,6/9,20.53%,MCFD2;UBE2J1;MGAT5;FUT8;MGAT1;UGGT2
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7860341063849238,1.241810428036545,0.15492957746478872,0.8977185049910527,1.0,4/8,17.13%,SERPINE1;CALR;ANO6;LGALS3
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),0.7809810571448421,1.2417344170384546,0.2,0.895867273937644,1.0,2/8,9.01%,UFL1;RB1CC1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.7307330571276535,1.2414733215530849,0.2972972972972973,0.8952382046474899,1.0,3/9,9.50%,NFE2L2;SMAD5;HIF1A
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.5547592160157686,1.2401716652914052,0.10588235294117647,0.8994480623829377,1.0,22/118,17.13%,PKM;PNP;LRRC7;NFASC;SNAP25;DNAJC5;TUBB4B;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;ANXA2;PECAM1;SLC2A3;ANO6;EEF1A1;CD55;RAC1;SDCBP;PSAP;LGALS3
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.5547592160157686,1.2401716652914052,0.10588235294117647,0.8994480623829377,1.0,22/118,17.13%,PKM;PNP;LRRC7;NFASC;SNAP25;DNAJC5;TUBB4B;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;ANXA2;PECAM1;SLC2A3;ANO6;EEF1A1;CD55;RAC1;SDCBP;PSAP;LGALS3
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.7344572579051623,1.2396118994626393,0.2727272727272727,0.9007522755959312,1.0,4/11,14.51%,MAP3K5;ANXA1;NFE2L2;ECT2
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5755644982214417,1.2388215667861815,0.1125,0.9036433627794603,1.0,11/51,15.47%,RPS11;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;RPLP2;RPS12;RPL13A
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),-0.6134952729738365,-1.2385883590664635,0.21875,1.0,1.0,2/17,1.92%,OAS3;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.6134952729738365,-1.2385883590664635,0.21875,1.0,1.0,2/17,1.92%,OAS3;IFIH1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6959090141248123,1.2385684415388731,0.20634920634920634,0.9029249710308216,1.0,2/12,10.10%,PINK1;MICALL2
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),-0.6822756837002059,-1.2382993000188962,0.1794871794871795,0.99578719323779,1.0,2/6,12.15%,TAPT1;MBOAT2
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.5964998873060273,1.2375313792502742,0.14473684210526316,0.9069145940632585,1.0,10/51,17.96%,LAMC1;TIMP3;EPS8;EMP1;COL4A2;WWTR1;ZC3H7A;NAV2;PLAT;AFAP1L1
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),0.7714551119419886,1.2374308392401787,0.2318840579710145,0.9053101927292627,1.0,3/8,17.13%,PICALM;RAC1;LGALS3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.7754423623681701,1.2367955992025124,0.17391304347826086,0.9074125470131715,1.0,3/8,6.93%,ITPR1;MAP3K5;ERO1A
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),-0.6748275771247435,-1.2366842042044768,0.3076923076923077,0.9955929624838838,1.0,2/7,9.71%,HABP4;LARP1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),-0.8043809583222485,-1.2362166885774943,0.2222222222222222,0.9905680351528487,1.0,3/6,13.53%,MSH3;XPC;MCM9
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),0.7356566682567953,1.2362035630890942,0.15714285714285714,0.9090145531622955,1.0,7/9,23.78%,SLC8A1;ANK2;CACNA1C;ATP1A1;DMD;ATP1B1;YWHAE
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.5752861248074099,1.2356408511961123,0.1111111111111111,0.9105574416982012,1.0,24/73,23.91%,SERPINE1;PDK4;FES;RAPGEF3;CPEB4;FOS;SSH1;HSP90B1;INSIG1;RAP1A;JUN;FZD4;TGM2;RYR3;PDE4B;PXN;ABL2;ZFP36;ATP2B4;ACTB;AKAP6;SETX;ADAM9;MEF2C
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.7409716763331549,-1.235521791519577,0.17142857142857143,0.9861641482531845,1.0,1/8,1.06%,CARMIL1
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.5674822912149262,1.2354214963963612,0.125,0.9099099153876935,1.0,12/54,16.20%,RPS11;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;RPLP2;RPS12;RPL13A;TRAM1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.7945123338785021,1.2353105882523727,0.14864864864864866,0.9084711605966023,1.0,2/8,5.66%,ERBB4;ZFPM2
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),0.7389876746373827,1.2346222306434562,0.2535211267605634,0.9083936888093617,1.0,4/10,13.76%,KLF2;HSP90AA1;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7389876746373827,1.2346222306434562,0.2535211267605634,0.9083936888093617,1.0,4/10,13.76%,KLF2;HSP90AA1;KLF4;NOS1AP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.7482670044788766,1.2345573755241595,0.15151515151515152,0.906587033080744,1.0,2/11,3.97%,SERPINE1;CALR
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),0.8036681714892653,1.2344709042070623,0.1694915254237288,0.9049411507493503,1.0,3/8,14.93%,CRTC3;IFNGR1;DYSF
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.830389787231851,1.233836283202777,0.19298245614035087,0.9069494124528642,1.0,1/5,1.82%,TRIM5
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.6448588692959787,1.2336465301528174,0.20689655172413793,0.9061945899981637,1.0,6/20,21.68%,ADM;SMAD7;FLT1;RASA1;EGFL7;RASIP1
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),0.7545336727819363,1.233455128638472,0.2786885245901639,0.9051912424120937,1.0,3/8,20.09%,NUDCD3;CCDC14;CSNK1D
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),0.7147720065828007,1.2328804380101677,0.22784810126582278,0.906631703849188,1.0,1/12,0.67%,PBX3
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),0.7209065446181303,1.2327917146040097,0.18309859154929578,0.9051302489053162,1.0,4/10,16.61%,PCK1;ADAM15;ADCY2;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),0.777476911430607,1.232735087462158,0.1875,0.903360421949857,1.0,1/7,4.10%,MAP3K5
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.619921253745556,1.2327299504270166,0.14473684210526316,0.9012741392201807,1.0,14/41,26.69%,RTN4;CALR;PRKCE;ENPP2;HIF1A;BCAR1;RAC1;ATOH8;ANXA3;ETS1;ADAM9;SCARB1;MTOR;SPARC
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.826433027019113,1.2324883808573792,0.11475409836065574,0.900468086650459,1.0,4/8,9.87%,KLF2;NFE2L2;SMAD7;KLF4
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,0.7335621897028832,1.2319594072422004,0.1917808219178082,0.9008091512438798,1.0,6/14,13.60%,ST18;GRIA2;SLC4A10;NRXN1;ADCY2;DLGAP2
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.5511449303447138,1.2319230652378934,0.12790697674418605,0.898991072746226,1.0,30/120,22.51%,PKM;PNP;LRRC7;NFASC;SNAP25;DNAJC5;TUBB4B;HSP90AA1;SERPINB6;BRI3;LAMP2;RAP1A;ANXA2;PECAM1;SLC2A3;ANO6;EEF1A1;CD55;RAC1;SDCBP;PSAP;LGALS3;GSN;KMT2E;DYNC1H1;HSPA8;B4GALT1;DNAJC13;ANXA3;CAB39
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.5282030831652363,1.2316044247260336,0.10989010989010989,0.898690638201028,1.0,42/147,22.87%,ST18;RTN4;ERBB4;BCL6;BNIP3L;PBRM1;PPM1D;CD9;HYAL2;ESR2;DUSP1;CDK6;CDKN1B;DLC1;ITGA1;GJA1;KLF4;ADAM15;CDKN1A;MAGI2;REST;ADGRG1;DYSF;RASA1;CTTNBP2NL;PLPP1;CRLF3;PLXNA2;ACTN1;TMBIM6;BTG2;NPAS2;PODXL;ABI1;NACC2;CHMP4B;NOTCH4;SMAD6;BTG1;NPM1;ETS1;NCK1
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.6198181043336402,1.2314801588598074,0.1375,0.8974041149892158,1.0,14/35,25.57%,PIK3R1;HSP90AA1;BCAR1;FLT1;SHC2;PAK2;RAC1;CRK;PXN;VEGFC;ABI1;NCK1;FYN;CDC42
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),0.7413872690039692,1.2306192493116181,0.2647058823529412,0.901172660194019,1.0,3/11,7.97%,ANK2;CACNA1C;CTNNA3
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.6224789249032877,1.230249051778247,0.1375,0.9015819706541883,1.0,14/38,21.55%,ANGPTL4;TBX3;TIMP3;LAMA5;EPS8;PLSCR4;SHC2;CD55;TNS1;FZD4;TF;GSN;EPAS1;DIAPH2
prerank,MSigDB_Hallmark_2020__E2F Targets,0.6503520907251048,1.2297967411734376,0.15789473684210525,0.9023081663370938,1.0,8/36,11.84%,PPM1D;LBR;IPO7;CDKN1B;RFC3;SMC6;RAD21;CDKN1A
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.6701635685958482,1.229685880164071,0.14285714285714285,0.9008538596780515,1.0,4/15,12.82%,HSPA5;GLUD1;MBP;CCDC14
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.6022996190016652,-1.2291977457464713,0.2692307692307692,1.0,1.0,5/14,12.31%,CD74;PARP14;PARP9;NLRC5;HSPA1A
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.6552587548641846,1.228172487818077,0.28,0.9072898652802681,1.0,7/25,12.46%,STARD4;INPP5F;GRB2;KLF4;ANXA2;CDKN1A;MAGI2
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.8457544871407428,1.228151311903846,0.18181818181818182,0.9055143016622799,1.0,3/5,13.63%,CALR;GJA1;AGO2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.5657871069265097,1.228142452413558,0.15555555555555556,0.9035523326200727,1.0,24/72,23.78%,CEP57;NES;EPS8;TUBB4B;HSP90AA1;CDK6;CDKN1B;CDKN1A;CCNH;CEP70;CRLF3;ENSA;PPP1CB;ALMS1;CSNK1D;DYNC1H1;DNM2;CHMP4B;PAFAH1B1;PLCB1;CCNY;ARPP19;CEP290;YWHAE
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.6541796391168411,1.2279307787481346,0.18666666666666668,0.9030780276772201,1.0,8/20,22.30%,ATF3;CD9;STARD4;LSS;LGALS3;ALCAM;PNRC1;PPARG
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.6377715445252486,1.2278038358349121,0.24358974358974358,0.9017834029593753,1.0,6/28,11.01%,ADM;MGLL;ANXA1;REL;FOS;GGT5
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),0.715008606730348,1.2275639139894725,0.2153846153846154,0.9013634349022367,1.0,2/14,7.81%,ST18;JAK1
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,0.6294487130972001,1.227548107894627,0.17142857142857143,0.8995004342805394,1.0,7/32,16.10%,SERPINE1;JUNB;SMAD7;PPM1A;SLC20A1;WWTR1;NCOR2
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.6991441637427431,1.2274482857415696,0.16176470588235295,0.8960389672499983,1.0,1/14,2.28%,ELL2
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.6991441637427431,1.2274482857415696,0.16176470588235295,0.8960389672499983,1.0,1/14,2.28%,ELL2
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.7952046768256867,1.227369798112422,0.25,0.8944871741084724,1.0,3/6,12.46%,LRRC7;NRXN1;MAGI2
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.6348824496896484,1.2270548021407055,0.15853658536585366,0.8941356860830998,1.0,10/35,11.27%,ATF3;ITPR1;HSPA5;BCAP31;MAP3K5;UFL1;ERO1A;PIK3R1;HSP90B1;JUN
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.7488931384544802,1.2267889727331216,0.17647058823529413,0.8935237649237121,1.0,1/9,0.78%,ERBB4
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.6745134694280543,1.2267431170057281,0.22857142857142856,0.8918689105044225,1.0,1/14,0.73%,ADAMTS9
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.6075043407306451,1.2265365867124505,0.14666666666666667,0.8911223719374411,1.0,14/38,23.91%,SERPINE1;PDK4;FES;ADAM15;INSIG1;ATP1A1;ADCY2;FZD4;PDE4B;ABL2;ZFP36;SETX;ADAM9;MEF2C
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.7004491030454798,1.225576992745559,0.16,0.8946379291033645,1.0,4/14,15.55%,SCP2;ACSL5;AGPAT4;LSS
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.7657977274205896,-1.2254185658504912,0.2777777777777778,1.0,1.0,3/5,12.12%,MRPS31;GSPT1;PTCD3
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),0.6804781138045367,1.2238125075883846,0.21739130434782608,0.9034028298095039,1.0,6/18,17.81%,SERPINE1;SGIP1;RAB21;ANO6;NEDD4L;TF
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),0.6659019024077372,1.2237764075727646,0.19718309859154928,0.9016702025686705,1.0,8/23,20.33%,ERBB4;FES;FGFR1;FLT1;TPST2;TEC;ABI1;ABL2
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.8041957664016901,1.223412119115898,0.2,0.900103887726005,1.0,1/6,6.02%,NDUFA12
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.8041957664016901,1.223412119115898,0.2,0.900103887726005,1.0,1/6,6.02%,NDUFA12
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),-0.708788552153594,-1.2228960989805915,0.25,1.0,1.0,2/6,12.05%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.7078952785816853,1.2227182574796243,0.1780821917808219,0.902344944203171,1.0,7/11,24.90%,SLC8A1;SLC12A6;ATP1A1;ATP1B3;ATP2B4;ATP1B1;SLC24A2
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.7836130551320124,1.222528217912062,0.21212121212121213,0.901213409209069,1.0,2/6,16.69%,POLA1;BRD4
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),0.5306194548833995,1.2224457450182205,0.11702127659574468,0.899783809701694,1.0,45/180,20.51%,ST18;ERBB4;BCL6;FES;TBX3;JUNB;PBRM1;PPM1D;CALR;CD81;UFL1;FGFR1;CCDC88A;RPS9;RPL23;JUND;CDK6;CDKN1B;DLC1;ITGA1;KLF4;JAG2;JUN;CNBP;CDKN1A;MAGI2;REST;FLT1;CLDN5;CNOT6L;ADGRG1;WWTR1;KRAS;PLPP1;SDCBP;GRK5;LIMS1;ARHGEF2;BTG2;NAMPT;VEGFC;STAT3;ABI1;NACC2;DUSP22
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.8274610394147802,1.2224301021331845,0.14285714285714285,0.8978952969609449,1.0,2/5,11.21%,RFTN1;ANXA2
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.5540917203037432,1.2221435979117712,0.15,0.8980103648883858,1.0,15/67,15.47%,PPA1;RPS11;RRBP1;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;EEF1A1;AGO2;RPLP2;RPS12;RPL13A
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,0.6623646266027013,1.2218906468573725,0.27941176470588236,0.8973145669104969,1.0,10/20,19.89%,GRIA2;LSAMP;GRIN2B;SNAP25;PPFIA2;NRXN1;MAGI2;SLC1A2;GRIA4;GRM5
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),-0.6821763019728098,-1.2218483427269455,0.2222222222222222,1.0,1.0,3/10,1.82%,EIF2AK2;OAS3;CD74
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7850183919478204,1.2215182075222317,0.1896551724137931,0.8974996961030566,1.0,1/6,1.82%,TRIM5
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),0.7569457545015432,1.2208413704022956,0.2222222222222222,0.8998281305320697,1.0,2/8,14.82%,JAK1;PAK2
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),0.8449009135714074,1.2206811874838674,0.18181818181818182,0.898925854670457,1.0,3/5,8.83%,CD9;ANXA1;CDK6
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7642893967768944,1.220655702894193,0.25396825396825395,0.8972927898230043,1.0,2/7,17.13%,MGAT5;LGALS3
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.6511895028522652,1.219784035322289,0.21794871794871795,0.9002712024070321,1.0,4/22,14.46%,RFTN1;RPS27A;HSP90B1;TAB2
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.662550648771643,1.219185396098313,0.24,0.9013167967969589,1.0,1/16,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),0.8192806107779179,1.218661942146377,0.24242424242424243,0.9026773416256911,1.0,4/6,13.76%,KCNMB4;ANK2;ANK3;NOS1AP
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),-0.6247488336291904,-1.2185582821081904,0.16666666666666666,1.0,1.0,2/19,0.88%,GBP1;GBP2
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),0.8190327311503197,1.2182043844512205,0.16393442622950818,0.9036679408298245,1.0,1/6,1.71%,SCP2
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),0.80333475603751,1.2181802505008585,0.25,0.9018376259916949,1.0,1/6,6.10%,CRTC3
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.7774783690952869,1.2180542267807384,0.23943661971830985,0.89670856347069,1.0,4/6,13.89%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.7774783690952869,1.2180542267807384,0.23943661971830985,0.89670856347069,1.0,4/6,13.89%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.7774783690952869,1.2180542267807384,0.23943661971830985,0.89670856347069,1.0,4/6,13.89%,SLC8A1;ATP1A1;ATP1B3;NEDD4L
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),-0.7875844190311889,-1.2179287031294277,0.2222222222222222,1.0,1.0,1/5,2.28%,IFI27
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.7580874761250745,1.217853026212547,0.1917808219178082,0.8958315841209056,1.0,2/8,13.50%,TSG101;ZFYVE28
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),0.6869579289140344,1.217799364109547,0.19480519480519481,0.8941939444995873,1.0,4/14,13.45%,SPOCK1;GRIN2B;PRNP;PRAG1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),0.6024586232882985,1.2177148603719616,0.2073170731707317,0.8927201308692017,1.0,12/32,21.81%,B3GNT2;MGAT4A;PLOD2;OGT;TRAK1;TMEM165;MGAT5;FUT8;EOGT;MGAT1;PMM2;B4GALT1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.7682196292779944,1.2176664411685065,0.18181818181818182,0.8910733277693486,1.0,4/7,17.11%,AKAP12;GRM7;ADCY2;PSAP
prerank,MSigDB_Hallmark_2020__Notch Signaling,-0.6683701773795101,-1.2175855255032872,0.25,1.0,1.0,3/9,17.39%,ST3GAL6;MAML2;PPARD
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),0.6032104622148265,1.2171977124313598,0.22077922077922077,0.8915333153990578,1.0,7/27,13.94%,SLC8A1;GRIN2B;CACNA1C;ATP2B1;MICU2;ANO6;TMEM165
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.7659648811778251,1.2170855953724211,0.23943661971830985,0.890207869244449,1.0,4/10,17.73%,TIMP3;PRNP;TMEM59;PLAT
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.6940648206358402,1.2169530449166002,0.21428571428571427,0.889154857665621,1.0,8/12,23.78%,ANK2;ATP1B3;NEDD4L;ITGB1;NEDD4;ATP1B1;CAB39;YWHAE
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),-0.75898504593344,-1.2163106295878703,0.2926829268292683,1.0,1.0,1/5,1.06%,CARMIL1
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.7379603053125773,1.2162655978443513,0.208955223880597,0.8914587713635632,1.0,1/9,1.35%,PDK4
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6851042204099246,-1.2162610312756192,0.2857142857142857,0.996428137840943,1.0,3/7,15.81%,ARHGAP12;SPRY3;CD2AP
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),-0.5836261087061703,-1.215675061490256,0.16,0.9927350875439019,1.0,6/20,6.18%,GBP4;GBP2;OAS3;ISG15;NOD1;OPTN
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.6165244791898771,1.2151032311542704,0.1744186046511628,0.896257001535726,1.0,4/39,7.89%,CEP57;PSMC6;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.6055411407966453,1.214945816501122,0.15853658536585366,0.8953086389662612,1.0,11/48,18.56%,PSMC6;RFTN1;NFKBIZ;PIK3R1;BCAR1;TAB2;PAK2;MALT1;TEC;PSMA7;PDE4B
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),0.7006209029540351,1.2149252746387083,0.24324324324324326,0.8935476786375138,1.0,6/22,9.32%,GRIA2;LRRC7;ANK2;GRIN2B;ANK3;AHNAK
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),0.6118298923236413,1.2138641026631993,0.2328767123287671,0.8967708129203519,1.0,3/32,8.75%,DIXDC1;WNT2B;RPS27A
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.6551303563881329,1.2138079812591445,0.20588235294117646,0.8953656713491867,1.0,10/20,28.56%,CADM2;SMAD7;CTNNA1;PAK2;TBCD;AFDN;ACTB;CDH18;CDH5;PIP5K1C
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.7348547929594283,1.2134139314906447,0.20634920634920634,0.8958085550595303,1.0,3/9,7.55%,ROBO2;ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.6389163739953853,1.2130581567478422,0.21621621621621623,0.8958556609668354,1.0,10/22,21.52%,ADM;CD9;CD81;GRB2;PICALM;ITGB1;KIF16B;ARFGEF2;DNM2;NEDD4
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),0.8172783870777345,1.2127713740193284,0.22641509433962265,0.8957715136063129,1.0,1/5,0.80%,PNP
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),0.5579087976807672,1.2126513224185076,0.15730337078651685,0.8945759165900646,1.0,6/78,7.89%,CEP57;EHD4;RAB11FIP3;NUDCD3;TUBB4B;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.7038264863858087,1.2125127411608116,0.2692307692307692,0.8934721545125272,1.0,5/18,13.89%,SPOPL;KLF2;SSH1;KLF4;NEDD4L
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),0.7609753168879656,1.2123216203865586,0.18309859154929578,0.8929156310691708,1.0,3/14,4.65%,GRIA2;LRRC7;GRIN2B
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.6744662369251752,1.212241944650664,0.25,0.8916029328862408,1.0,5/18,8.33%,ADM;CD9;CD81;GRB2;PICALM
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.6354060556968734,1.211895379588779,0.22666666666666666,0.8915281324554846,1.0,8/22,17.89%,PINK1;KDM1A;SMAD7;COMMD1;PTTG1IP;NDFIP1;CRY1;MALT1
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),0.5123236825623542,1.2118848081223066,0.08333333333333333,0.8897702174059262,1.0,52/279,18.51%,PIK3R3;CCDC3;BCL6;TRIM5;AFF3;BHLHE40;NFKBIZ;SLC8A1;ANK2;CALR;YBX3;ZNF280D;AFF4;VSIR;REL;PINK1;RPL23;NFE2L2;ESR2;PICALM;ANK3;CDK6;AHNAK;HIF1A;GJA1;KLF4;SLC38A2;YTHDC1;CREM;PTBP2;LARP4;CNBP;REST;AGO2;CLDN5;NOS1AP;IFNGR1;PRX;SBNO1;ZBTB38;WWTR1;KRAS;ZC3H7A;NDFIP1;FOXC1;ATF2;ATOH8;LIMS1;HNRNPH3;DIP2A;GATA2;TRA2B
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),0.8066963309771136,1.2118790004548434,0.16176470588235295,0.8880623844586635,1.0,2/6,8.00%,CD81;CBFB
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.75458794503256,1.2117976142455,0.2535211267605634,0.8866622917950353,1.0,3/8,11.89%,SCARB2;ANXA2;PIKFYVE
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.7987371614506503,1.2114676727106934,0.21428571428571427,0.8864477115913176,1.0,4/6,11.63%,SLC8A1;CACNA1C;GJA1;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),0.7735509631584883,1.2109504463904084,0.20833333333333334,0.887154665928897,1.0,3/8,14.36%,SLC2A13;PICALM;IFNGR1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),0.7887776542089641,1.2108539528107893,0.25,0.885807406035573,1.0,3/7,13.76%,KCNMB4;ANK2;NOS1AP
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.7037751121390028,-1.2093797224265732,0.25806451612903225,1.0,1.0,3/7,7.58%,PLXND1;SP100;WARS1
prerank,GO_Biological_Process_2021__skin development (GO:0043588),0.7515450810108583,1.209235543764987,0.2465753424657534,0.8929535311229347,1.0,2/10,6.70%,ANXA1;BCR
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),0.8424940770160794,1.2087986428383437,0.14516129032258066,0.8935796493179462,1.0,1/5,6.52%,FGFR1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),0.6585282488996306,1.2085723266224204,0.25882352941176473,0.8929924556934861,1.0,1/16,1.01%,PSMC6
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),0.7330374313365495,1.208439395216546,0.2714285714285714,0.8919199335530164,1.0,2/10,14.33%,HIF1A;ITGB1
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),0.6904394705843931,1.208108042317971,0.1780821917808219,0.8922481604490285,1.0,2/15,4.36%,SCP2;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.6968084898412261,1.207994221397037,0.17105263157894737,0.8912868742512517,1.0,1/11,0.55%,DDIT4
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),0.7270114553276058,1.2075477476788627,0.23636363636363636,0.891825829279382,1.0,4/8,17.52%,BCAP31;MICU2;PDZD8;TGM2
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),0.6024021288397318,1.2075436729746347,0.19480519480519481,0.8901117959395907,1.0,11/34,24.51%,ADAMTS9;GLUL;CALR;BCAR1;RAC1;ATOH8;ANXA3;ETS1;RHOJ;SCARB1;EMP2
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.6606390392793948,1.207432022694606,0.22535211267605634,0.8890552801495215,1.0,7/17,23.91%,SERPINE1;PRKCE;MTDH;PDE4B;ZFP36;ADAM9;MEF2C
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.629298469095084,1.207154015564263,0.2716049382716049,0.8886524591327225,1.0,3/30,6.44%,ZEB2;SCARB2;PINK1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.6466734815828975,1.2066835290159705,0.22535211267605634,0.8896106258582216,1.0,16/28,27.10%,SLC8A1;ANK2;CALR;VAPB;MT2A;MT1M;ATP2B1;TMEM165;SLC30A1;ATP2B4;ATP1B1;ATP13A3;MT1E;SLC24A2;CDH5;RYR2
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.7534224199573218,1.2064601152079188,0.2054794520547945,0.8893335315828993,1.0,3/9,14.36%,SLC2A13;PICALM;IFNGR1
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),0.8244157149247328,1.2063548069834311,0.25,0.8881408221110001,1.0,1/5,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),0.7111353069355024,1.206219523999411,0.21621621621621623,0.8870358745418901,1.0,7/14,21.86%,NEDD9;HYAL2;PRNP;GRM5;PTPN1;GPRC5B;SH3BP5
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.6582873338591999,1.2053306721075967,0.23684210526315788,0.8901481755300843,1.0,7/14,26.14%,MAP2;NAV3;ARHGEF2;TBCD;TAOK1;HDGFL3;CDH5
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.4855665864954044,-1.205189298440169,0.13636363636363635,1.0,1.0,4/36,5.22%,RSAD2;TTN;BMP6;DISP1
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),0.6830740903749716,1.2051700494243422,0.19718309859154928,0.8894371814123656,1.0,1/15,0.36%,NRCAM
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.5627740969445763,1.204663995486449,0.19318181818181818,0.8903621809958775,1.0,9/62,9.84%,ADM;CALR;RAB11FIP3;PLCL1;CHSY1;SMAD7;SRGN;ATP2B1;GJA1
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.7659601399053456,1.2045095126510263,0.26865671641791045,0.8894471430928588,1.0,2/8,9.87%,KLF2;KLF4
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.5338560337146699,1.2044927640318357,0.1511627906976744,0.8878559360834123,1.0,25/102,21.63%,CEP57;NEDD9;SUN2;RAPGEF5;MYO9B;CCDC88A;BCR;MYH10;MYO1E;BCAR1;STK38L;ECT2;DOCK4;RASA1;ARHGEF2;PXN;ALMS1;GSN;ABI1;CSNK1D;DYNC1H1;PREX1;TBCD;PAFAH1B1;ARFGEF1
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),0.862071152689605,1.204042968676916,0.22950819672131148,0.8886964403742846,1.0,2/6,4.78%,SERPINE1;INPP5F
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),0.7229833344709563,1.203686327625427,0.2463768115942029,0.8887540920496054,1.0,1/8,3.74%,MGAT4A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.7611939824969097,1.2035164003641243,0.23529411764705882,0.8880742963046394,1.0,5/9,13.89%,ANK2;CACNA1C;GJA1;ATP1A1;NEDD4L
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),0.6389448978196788,1.2033005266622088,0.1927710843373494,0.8877241086381553,1.0,5/32,10.10%,LAMC1;ATRNL1;LAMA5;PIK3R1;MICALL2
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.827721233299859,1.2032565378779845,0.19402985074626866,0.8862123679445237,1.0,2/5,12.62%,LAMA5;RPL8
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),0.647197296662154,1.2032476679614654,0.17721518987341772,0.8845841438716593,1.0,6/27,12.36%,POLA1;RPS27A;RFC3;USP45;COMMD1;CCNH
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.6681930348455641,1.2031432270107478,0.2714285714285714,0.8835108054173401,1.0,4/13,20.74%,SUN2;REEP3;TPR;CHMP4B
prerank,GO_Biological_Process_2021__axon development (GO:0061564),0.6527401473849413,1.2030292707160526,0.25,0.8825226404103294,1.0,5/25,8.80%,NRCAM;RTN4;GRM7;MAP1B;ANK3
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.727630889764336,1.2027882147563724,0.2923076923076923,0.8819836431332831,1.0,7/11,21.50%,SYN3;SNAP25;DNAJC5;NRXN1;SYT1;RIMS2;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.8309016129070876,1.201767503316186,0.18032786885245902,0.8855696314457662,1.0,2/5,15.21%,HIF1A;GRB10
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),0.6453007679858168,1.2012126026492909,0.26582278481012656,0.8867820059262579,1.0,6/19,21.00%,DPP10;PRKCE;PIK3R1;ITGB1;LGALS3;ATP2B4
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",0.6773322312732258,1.2009127774587385,0.2676056338028169,0.8867414722283222,1.0,6/13,19.89%,GRIK1;GRM7;NRXN1;SYT1;DGKI;GRM5
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.6928835297975249,1.1999677501738517,0.3108108108108108,0.8893138216323662,1.0,2/11,6.44%,SEC22B;PINK1
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.8113095650792825,1.1999644133393899,0.2698412698412698,0.8877040100620899,1.0,2/5,7.06%,BCAP31;NFE2L2
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.693425876094216,1.1997957370916692,0.2222222222222222,0.8868410304368651,1.0,3/12,5.11%,SERPINE1;ANXA1;PRKCE
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.7070978450011416,1.1997476503715196,0.26666666666666666,0.8854815788034764,1.0,2/8,6.44%,BCAP31;PINK1
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.7356165500007648,1.1993484558096736,0.25609756097560976,0.8859625083968808,1.0,1/9,1.90%,PCK1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),0.6942128381856059,1.1991951255409188,0.23529411764705882,0.8852668068224009,1.0,6/13,6.54%,GRIA2;GRIK2;GRIK1;GRM7;GRIN2B;CPEB4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),0.569434817248298,1.1990428726607185,0.16049382716049382,0.8845736629742976,1.0,18/60,23.86%,PPP2R3A;PPP2R2B;PPM1D;PTPRD;DUSP6;DUSP1;SSH1;PPM1A;DUSP16;CTTNBP2NL;PPP1CB;MTMR6;PTPN1;DUSP22;PPP3CB;PPP3CC;NCK1;PPP4R2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.7566442321752873,1.1989841449979664,0.2833333333333333,0.8831886696688773,1.0,1/6,1.51%,CLIC2
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),0.7400979924440357,1.198980335127998,0.2631578947368421,0.8816305184018647,1.0,1/8,1.90%,PCK1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),0.7198483565871104,1.1983991624657386,0.15,0.8832803607510444,1.0,5/12,16.23%,PINK1;GRB2;CDKN1A;PIKFYVE;RAC1
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.7257309648139673,1.1981820455999466,0.2839506172839506,0.881086734694734,1.0,1/11,1.01%,PSMC6
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.7257309648139673,1.1981820455999466,0.2839506172839506,0.881086734694734,1.0,1/11,1.01%,PSMC6
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.7493877383425995,-1.1975488638711027,0.23529411764705882,1.0,1.0,4/5,24.01%,PDGFB;PDCD4;NFATC3;NFATC2
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.749101069582339,1.1974235681767802,0.19402985074626866,0.8836525603350295,1.0,1/8,1.35%,PDK4
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),0.6929363784561287,1.1973885937785698,0.3188405797101449,0.8822058252727402,1.0,4/12,7.68%,SCP2;MGLL;ACOX1;ACSL5
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.5601386614576843,1.1966880398188302,0.20512820512820512,0.8839376222315515,1.0,16/60,16.82%,RPS11;RRBP1;RPS9;RPL23;RPS18;RPS27A;GGT5;RPL34;RPL8;RPL37;EEF1A1;AGO2;RPLP2;RPS12;RPL13A;DMD
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),0.79763945719305,1.1963687060033945,0.11864406779661017,0.8838251936915813,1.0,4/8,12.23%,ARF1;MT2A;PRNP;COMMD1
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.7614165585950693,1.196278364381131,0.18840579710144928,0.8813026372265799,1.0,1/8,0.70%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.7614165585950693,1.196278364381131,0.18840579710144928,0.8813026372265799,1.0,1/8,0.70%,ZEB2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),0.7900409965302375,1.1959875030846496,0.26229508196721313,0.8811955544970861,1.0,3/5,18.30%,ZBTB1;CBFB;ZMIZ1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),-0.7166049154788228,-1.1957723947689696,0.30303030303030304,1.0,1.0,1/7,0.21%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),0.6168519408473627,1.195739313211205,0.2676056338028169,0.8806811964000855,1.0,7/21,17.52%,IL1RAPL1;PTPRD;ROBO2;KDM1A;SPEN;PLXNA2;TGM2
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.6292979786874565,1.1955558161040951,0.1625,0.8800717939537308,1.0,14/38,23.94%,FES;INPP5F;RAB21;PICALM;STXBP5L;HIP1R;SYT1;PTPN1;ABL2;RIMS2;DNAJC13;RAB8B;RUFY2;SCARB1
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.6695444963586044,1.1955446116930177,0.26666666666666666,0.8785361116483636,1.0,10/20,27.10%,BCAP31;SLC8A1;CACNA1C;ATP2B1;CD55;ABL2;ATP2B4;YWHAE;CAV2;RYR2
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.7780527721008014,1.1951428296717146,0.29310344827586204,0.8790332937901618,1.0,4/6,20.33%,FGFR1;GNA13;FLT1;ABL2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),0.7171723990230924,1.1948073082501713,0.23809523809523808,0.8789504845895639,1.0,3/10,19.29%,TMED10;MALT1;STAT3
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),0.785501984323428,1.194783519463181,0.24074074074074073,0.8774827140887522,1.0,3/7,11.40%,SLC8A1;CACNA1C;MICU2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.7856575619221717,1.193630252268715,0.208955223880597,0.8815321342182433,1.0,3/6,12.56%,PINK1;HIF1A;REST
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),0.7345267394458956,1.193511678353358,0.2537313432835821,0.880525105764264,1.0,4/11,13.76%,ANK2;CACNA1C;CTNNA3;NOS1AP
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.6468184249516769,1.193278398609285,0.24285714285714285,0.8801531798122113,1.0,13/26,22.35%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;ATP1A1;ATP1B3;NEDD4L;TMEM165;SLC30A1;ATP2B4;ATP1B1;ATP13A3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6838699292224266,-1.193243254509896,0.34285714285714286,1.0,1.0,3/7,11.42%,SHLD1;PARP9;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),0.5380498495946389,1.19254610687428,0.15384615384615385,0.8823042561192164,1.0,19/112,14.36%,PIK3R3;KLF2;ANK2;INPP5F;PPHLN1;VSIR;RPL23;NFE2L2;ANK3;HIF1A;GJA1;KLF4;SLC38A2;ANXA2;MAGI2;AGO2;CLDN5;NOS1AP;IFNGR1
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.6363927194447824,1.1919593162122446,0.2638888888888889,0.8832844745728846,1.0,14/23,27.10%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;TMEM165;SLC30A1;ATP2B4;ATP1B1;ATP13A3;SLC24A2;TMTC2;CDH5;RYR2
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.7196595067532657,1.1919346973429463,0.32786885245901637,0.8819007241487075,1.0,2/10,5.84%,FES;RAPGEF3
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.7551070349955308,1.1918680872410197,0.2647058823529412,0.88065485834533,1.0,1/8,7.68%,ACSL5
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.5978916936414855,1.1915405442779141,0.1728395061728395,0.880570511808329,1.0,8/39,15.60%,BHLHE40;UFL1;KDM1A;PRNP;SMAD7;KLF4;COMMD1;ERBIN
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),0.6830450678766299,1.1915357241544584,0.2647058823529412,0.879047293210813,1.0,1/12,2.31%,MAP2
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.7851388190640765,1.1914670326909775,0.1875,0.8748108808071102,1.0,3/6,14.25%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.7851388190640765,1.1914670326909775,0.1875,0.8748108808071102,1.0,3/6,14.25%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.7851388190640765,1.1914670326909775,0.1875,0.8748108808071102,1.0,3/6,14.25%,CD81;CFH;CD55
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),0.6620171164734115,1.1913950822357873,0.2535211267605634,0.8735903455048839,1.0,3/14,9.50%,PRKAG2;OGT;HIF1A
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.5925639086582692,-1.191337936910905,0.2608695652173913,1.0,1.0,3/16,4.67%,MGMT;BABAM2;SLF2
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),0.5711088961145677,1.1910679392261452,0.2682926829268293,0.8736317745717416,1.0,24/61,23.13%,ANGPTL4;SERPINE1;GLUL;PGK1;RAPGEF3;COL4A2;HIF1A;KLF4;FLT1;AGO2;CLDN5;ITGB1;MTDH;FOXC1;ATF2;SPRED1;GATA2;VEGFC;ATP2B4;BTG1;PPARG;ANXA3;ETS1;RHOJ
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),0.7423345350933936,1.1906668133474434,0.22058823529411764,0.872516949483123,1.0,1/8,6.33%,VSIR
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.7423345350933936,1.1906668133474434,0.22058823529411764,0.872516949483123,1.0,1/8,6.33%,VSIR
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),0.7873170215828007,1.1901696530357266,0.35185185185185186,0.8731949599975255,1.0,2/6,14.93%,SYTL4;DYSF
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.6190971353772508,-1.190000390485551,0.21212121212121213,1.0,1.0,4/8,15.06%,EVL;SRGAP2C;KANK1;ODF2L
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6917462362137607,1.1899590997187999,0.22058823529411764,0.8729944315904058,1.0,3/10,3.43%,MAP2;MDGA2;SPOCK1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),0.49996027514383634,1.1898269577113512,0.0707070707070707,0.8721432264446977,1.0,66/264,22.87%,MAFF;ST18;ZEB2;SERPINE1;ATF3;KLF2;KLF6;TBX3;JUNB;PHF10;CD81;ZFPM2;CRTC3;REL;KDM1A;NFE2L2;HYAL2;PIK3R1;FOS;SMAD7;SMAD5;JUND;RPS27A;OGT;HIF1A;FOSL2;KLF4;JUN;CNBP;CCNC;SETD3;REST;ACVR2A;AGO2;FOXF1;ZBTB38;TMF1;WWTR1;CRLF3;BRD4;FOXC1;ATF2;ATOH8;LPIN2;ARHGEF2;GATA2;ZMIZ1;NPAS2;NAMPT;BCLAF1;STAT3;TNKS;NR1D2;NFIB;NFIC;NOTCH4;RLF;EPAS1;CDK8;PPP3CB;PPARG;TFCP2;NPM1;ETS1;MED4;NCK1
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.7534025034744734,1.18973504524287,0.2857142857142857,0.8708862191898904,1.0,1/7,5.61%,CACNA1C
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.7259895165468477,1.189285618863011,0.3013698630136986,0.8715438283245485,1.0,4/9,13.89%,GPM6B;PICALM;COMMD1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.7943698770337886,1.1892428259203132,0.25396825396825395,0.8704032415635596,1.0,2/5,7.06%,BCAP31;NFE2L2
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.7174726287425043,1.1888035544618636,0.2112676056338028,0.87131819335827,1.0,1/8,3.09%,BHLHE40
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.6937438565806375,1.188510037334035,0.2571428571428571,0.8714365996128149,1.0,4/11,16.61%,CTNNA1;ADAM15;ADCY2;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.582445447423182,1.1882834860957645,0.16666666666666666,0.8709283135985074,1.0,3/36,4.10%,ST18;BCAP31;MAP3K5
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),0.6434421952435753,1.188218410468794,0.2361111111111111,0.8697413659257668,1.0,2/22,10.12%,KHDRBS3;YTHDC1
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.5531854344685967,1.1876084339534756,0.20512820512820512,0.8711101706646641,1.0,16/55,23.99%,RPS11;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;RPLP2;RPS12;RPL13A;CHMP4B;RPS27;RPLP1;RPL10;RPL37A
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),0.8243818637428957,1.187151635435906,0.1746031746031746,0.8721627832270674,1.0,3/6,12.72%,DDIT4;GRB2;BCAR1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.6183837943791947,1.1867024921209097,0.21794871794871795,0.8726995571791966,1.0,10/35,16.74%,ADM;TIMP3;PDE5A;MYO1B;PLSCR4;ALPL;COL4A2;PECAM1;TNS1;FOXC1
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.7363356487038546,1.1866790778026044,0.2835820895522388,0.8713715199897276,1.0,2/8,14.98%,CCDC88A;HIP1R
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.6595299771968101,1.1865067562628653,0.2898550724637681,0.8707773171669471,1.0,1/17,0.73%,ADAMTS9
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),0.7581114577896216,1.1862265681725639,0.18309859154929578,0.8705309755656355,1.0,3/9,12.56%,PCK1;ANXA1;REST
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,0.6253564965016166,1.1855909436669965,0.27058823529411763,0.8720663760830094,1.0,8/32,13.47%,DDIT4;ATF3;HSPA5;CALR;ERO1A;HSP90B1;HSPA9;DCP2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),0.6563541073021731,1.1850741459751923,0.2702702702702703,0.8732882085203693,1.0,2/17,3.32%,ZEB2;PKN3
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.651879935835958,1.1837863479488584,0.25,0.8782912957217202,1.0,3/24,7.97%,ADM;ZFPM2;CTNNA3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),0.8003449106380118,1.183626417857721,0.18571428571428572,0.8778351410250189,1.0,2/6,7.06%,SERPINE1;NFE2L2
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.8118798101325488,1.1835868925460338,0.29411764705882354,0.8765501523526347,1.0,2/5,7.97%,CACNA1C;CTNNA3
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.643869332856906,1.1835209413360248,0.3013698630136986,0.8725232266098591,1.0,4/20,8.72%,SEC22B;SEC24D;MCFD2;TMED10
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.643869332856906,1.1835209413360248,0.3013698630136986,0.8725232266098591,1.0,4/20,8.72%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.643869332856906,1.1835209413360248,0.3013698630136986,0.8725232266098591,1.0,4/20,8.72%,SEC22B;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),0.7408709538076268,1.1831092646842323,0.25316455696202533,0.8731025152337489,1.0,2/8,17.06%,RAD21;NAA50
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.7980032567286688,1.182976733672415,0.27692307692307694,0.8724625626724363,1.0,2/5,8.80%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),0.721210983340937,1.1829378451277452,0.203125,0.871181325764945,1.0,3/8,18.15%,RFTN1;BCAR1;TEC
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.8124842828218504,1.182918386952332,0.20967741935483872,0.8698151037265651,1.0,2/5,9.84%,KDM1A;GJA1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.8192641994281831,1.1828396108534391,0.19672131147540983,0.8688452765512228,1.0,2/5,8.80%,SLC8A1;ANK3
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),0.5538939890364091,1.182404897370613,0.17582417582417584,0.8698526673625793,1.0,23/101,16.38%,LAMC1;ERBB4;TBX3;NES;CALR;CD81;UFL1;ZFPM2;FGFR1;RPS9;RPL23;KDM1A;CDK6;GJA1;CNBP;CDKN1A;FLT1;CLDN5;CNOT6L;WWTR1;KRAS;S100A6;SDCBP
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6919769413922816,1.1822811522110344,0.22058823529411764,0.8689747376483998,1.0,3/13,12.46%,ITGA1;HSP90B1;MAGI2
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.7227890375331881,1.1820160025214344,0.2948717948717949,0.8688973440450879,1.0,1/9,1.90%,PCK1
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.7258913588667978,-1.181897926440584,0.2682926829268293,1.0,1.0,1/6,1.92%,IFIH1
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),0.5472026777906985,1.1818262804624546,0.1839080459770115,0.8684485727691839,1.0,7/85,9.79%,LAMC1;PSMC6;FEM1C;MGAT4A;DCAF10;HIF1A;HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.6921644191902474,1.1818166714537415,0.24324324324324326,0.8671355459440054,1.0,9/15,22.59%,FOS;HIF1A;KLF4;JUN;ATOH8;GATA2;STAT3;PPARG;ETS1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.6335999757890081,1.1814415328068324,0.2972972972972973,0.8673437550397823,1.0,3/17,11.19%,PINK1;HSP90AA1;RAP1A
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.7361542309694521,1.181369848154317,0.3,0.8662481275352879,1.0,1/8,7.68%,ACSL5
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.5104984661466031,1.1813473024687104,0.11627906976744186,0.8648923388366615,1.0,22/125,14.07%,LAMC1;RPS11;MGAT4A;RRBP1;PLOD2;RPS9;RPL23;ERO1A;RPS18;RPS27A;MSRB3;HSP90B1;MSRA;RPL34;DENND3;RPL8;STK38;RPL37;EEF1A1;AGO2;RPLP2;RPS12
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.769686875866063,1.1809530822974004,0.3225806451612903,0.8654542369459993,1.0,2/7,5.61%,NES;CACNA1C
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.7226655533278201,1.1806652220983525,0.3770491803278688,0.8639831304180643,1.0,2/9,6.93%,ITPR1;ERO1A
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.7226655533278201,1.1806652220983525,0.3770491803278688,0.8639831304180643,1.0,2/9,6.93%,ITPR1;ERO1A
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.6092978513641943,1.1803083872843458,0.23684210526315788,0.8644564341024541,1.0,5/26,18.46%,PSMC6;MAGI2;RAC1;FZD4;PSMA7
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.7623520519059157,1.1797587237508087,0.21666666666666667,0.8658350819952615,1.0,1/7,6.44%,PINK1
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.6205053878425103,1.1794654048657185,0.24358974358974358,0.86574670335598,1.0,3/29,3.71%,PDK4;LDHA;GLUD1
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.6549349201657805,1.1792190546889236,0.3058823529411765,0.8654847713903507,1.0,7/20,16.82%,LAMC1;MBP;GJA1;PECAM1;CLDN5;ITGB1;DMD
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.6350679125884972,1.178954486245849,0.20588235294117646,0.8652583919916309,1.0,5/23,8.72%,SEC22B;VAPB;SEC24D;MCFD2;TMED10
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.7655058037772906,1.1789262834090608,0.25,0.8640450402837387,1.0,3/6,20.40%,CDK6;HSPA9;ZFP36
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.6714875175580916,1.178758272053759,0.2,0.8632334783899737,1.0,11/20,22.59%,FOS;HIF1A;KLF4;JUN;REST;ATOH8;GATA2;STAT3;NFIB;PPARG;ETS1
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.7109011846239158,1.178709881475547,0.26153846153846155,0.8620445105633021,1.0,3/11,7.55%,ROBO2;ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.5577092878346045,1.1786955793037537,0.22784810126582278,0.8607041291832225,1.0,10/51,15.47%,RPS11;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;RPS12;RPL13A
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.6002579163424819,-1.1786616928041256,0.4375,1.0,1.0,3/11,11.42%,SHLD1;PARP9;SHLD2
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),0.5935185128717058,1.1780570312547374,0.275,0.8625360666026178,1.0,6/30,13.94%,ITPR1;SLC8A1;ANK2;CACNA1C;ANO6;TMEM165
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.8112126326280844,1.1779491915573366,0.2318840579710145,0.8616804938080198,1.0,3/5,11.34%,SLC8A1;ANK3;SLC12A6
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),0.7629503370463679,1.1776679844690972,0.2835820895522388,0.861531320288475,1.0,2/5,15.68%,ATG12;AGTPBP1
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.5953575896106245,1.177590817791164,0.24285714285714285,0.8605258293611722,1.0,18/34,27.10%,SLC8A1;ANK2;CALR;VAPB;ATP2B1;MICU2;TMEM165;SLC30A1;PDZD8;HERPUD1;ATP2B4;ATP1B1;ATP13A3;YWHAE;SLC24A2;CAV2;CDH5;RYR2
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),0.7739775847772388,1.1774280746259025,0.273972602739726,0.8597630420392937,1.0,3/7,18.02%,BHLHE40;CRY1;PPP1CB
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.7449967834974073,1.1769931227217576,0.27692307692307694,0.8604546061359177,1.0,3/6,16.82%,ANK2;SMAD7;DMD
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.7193533562107491,1.176137912733883,0.2727272727272727,0.8628494606654682,1.0,4/9,21.52%,SCARB2;LAMP2;HSPA8;NEDD4
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.6705610550862842,1.1758060517123987,0.273972602739726,0.8630231502335567,1.0,6/14,17.94%,YBX3;HSP90AA1;OGT;PELI1;SDCBP;ARHGEF2
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),0.7730210997568316,1.175525952781897,0.29850746268656714,0.8629922805396067,1.0,1/7,0.67%,PBX3
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.72097455503538,1.1748177728226359,0.3230769230769231,0.8647438197392047,1.0,4/9,18.56%,ANXA1;PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.6784143242994751,-1.1741471548856097,0.25,1.0,1.0,1/9,0.13%,VCAM1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.6660750954592151,1.1740342040173601,0.2972972972972973,0.8670491454251371,1.0,2/13,9.42%,ROBO2;DLC1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.7292954277677418,1.1740096613045852,0.2916666666666667,0.8658276311772317,1.0,2/8,6.83%,NES;KDM1A
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),0.8146098823778725,1.1737720733959245,0.19117647058823528,0.8658432569140821,1.0,3/6,18.02%,BHLHE40;CRY1;PPP1CB
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.541720881992218,1.1737248081079643,0.18888888888888888,0.8647455145310652,1.0,11/86,10.88%,LAMC1;RTN4;PLS3;NEDD9;GPM6B;EPS8;MYO1B;PICALM;ANK3;SLC2A1;RAD21
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),0.7061215727641122,1.1733263322036327,0.26865671641791045,0.8653017275408541,1.0,3/8,13.27%,PPHLN1;RAD21;WAPL
prerank,PanglaoDB_Augmented_2021__Germ Cells,-0.6037128375220706,-1.1731257570118183,0.3333333333333333,1.0,1.0,3/11,6.36%,UBE3D;CREB5;PARN
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),0.76493373583521,1.1729683404015063,0.2537313432835821,0.8655871543794974,1.0,3/6,8.00%,BCL6;VSIR;CBFB
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),0.7767498562398276,1.1728515264111596,0.31666666666666665,0.8647467718087225,1.0,2/5,15.03%,UNC5C;SEMA3F
prerank,PanglaoDB_Augmented_2021__Delta Cells,0.6486647129475525,1.171942871676609,0.2777777777777778,0.867630573002701,1.0,8/20,14.17%,GRIA2;CNTN1;PTPRD;NFASC;SNAP25;NRXN1;SHC2;MAPK10
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),0.6809162678202458,1.1717241533429457,0.2361111111111111,0.8674089318772912,1.0,4/16,12.67%,EHD4;RAB11FIP3;MICALL2;ACAP2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),0.7108888195053036,1.1716411897571621,0.2465753424657534,0.8663356616302273,1.0,3/11,12.77%,SERPINE1;NFE2L2;ANO6
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.5853249976165813,1.1715860507559277,0.2,0.8653991939780826,1.0,6/34,12.72%,PLS3;GAPDH;MYO1B;PEBP1;FKBP5;BCAR1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),0.5787006175014899,1.1714866092165583,0.23076923076923078,0.8643489884013115,1.0,10/36,23.94%,CALR;FGFR1;HIF1A;BCAR1;RAC1;ATOH8;GATA2;ANXA3;ETS1;SCARB1
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),-0.6817500817098063,-1.1710507269775379,0.3611111111111111,1.0,1.0,1/5,1.82%,CD74
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.6817500817098063,-1.1710507269775379,0.3611111111111111,1.0,1.0,1/5,1.82%,CD74
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.6817500817098063,-1.1710507269775379,0.3611111111111111,1.0,1.0,1/5,1.82%,CD74
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.6002599416663539,1.1705994518849037,0.3048780487804878,0.8668785202489881,1.0,5/38,5.04%,BCL6;TRIM5;MGLL;ANXA1;UFL1
prerank,PanglaoDB_Augmented_2021__Monocytes,-0.5885897250076672,-1.170311500363724,0.3333333333333333,1.0,1.0,6/17,9.84%,GBP1;MGMT;MX1;TNFSF10;FN1;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),-0.5592630120502265,-1.1699739291661884,0.25925925925925924,1.0,1.0,3/17,6.36%,ATM;ATR;PARN
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.7661601726839411,1.1699389818637325,0.27419354838709675,0.867502992794365,1.0,1/6,0.60%,B3GNT2
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.7661601726839411,1.1699389818637325,0.27419354838709675,0.867502992794365,1.0,1/6,0.60%,B3GNT2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5708481082019876,1.169772703044369,0.2535211267605634,0.8667871683447372,1.0,7/25,23.39%,SMAD7;RPS27A;PPM1A;STRAP;SPRED1;SMAD6;UBC
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),0.6495587659885452,1.1696605015645944,0.2125,0.8659908671149348,1.0,1/22,0.21%,LAMC1
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.6843180156305364,1.1696371486987582,0.3466666666666667,0.8647347753643879,1.0,1/8,3.37%,ANK2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.6195611629837763,-1.1694592914549602,0.3,1.0,1.0,1/9,2.73%,ATM
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),-0.7351649727287524,-1.1691787790306651,0.3142857142857143,1.0,1.0,2/5,5.22%,CLYBL;DISP1
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),-0.7351649727287524,-1.1691787790306651,0.3142857142857143,1.0,1.0,2/5,5.22%,CLYBL;DISP1
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),0.639838780409525,1.1684658458829744,0.2222222222222222,0.8684767903964429,1.0,3/15,9.50%,PRKAG2;OGT;HIF1A
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),0.759411716337939,1.1677771374754278,0.2878787878787879,0.8698045936270364,1.0,2/9,6.70%,ANXA1;BCR
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.7403475736588447,1.1667050941670676,0.25757575757575757,0.8730674152823835,1.0,2/8,15.73%,AGO2;ZC3H7A
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),0.8238468276848823,1.1666835799982247,0.2857142857142857,0.8717918017203161,1.0,2/5,10.72%,POLA1;RFC3
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.7909036081676251,1.1664159998646462,0.27419354838709675,0.8716668543870247,1.0,2/6,14.12%,FGFR1;ANKRD11
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.750220733285823,1.1661457729603846,0.328125,0.8714932108612774,1.0,1/7,5.84%,RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.6568307808667826,-1.1658488853904951,0.3870967741935484,1.0,1.0,1/8,1.09%,SLC4A4
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.6568307808667826,-1.1658488853904951,0.3870967741935484,1.0,1.0,1/8,1.09%,SLC4A4
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),0.7900272423567313,1.1650280916662172,0.2413793103448276,0.8758607695066328,1.0,1/5,4.65%,GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.7388159183915065,1.1643801787164523,0.25757575757575757,0.8773937415129125,1.0,3/9,16.38%,PICALM;RAC1;SDCBP
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),0.640862008756887,1.1641872607628079,0.2894736842105263,0.877130836812945,1.0,4/15,18.28%,ZFPM2;TRIB2;WWTR1;GATA2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.7058366532407553,1.1636800465381802,0.29577464788732394,0.8776491878355052,1.0,6/10,25.57%,ITGB1;RAC1;PARVB;GSN;RHOJ;CDC42
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.692451211654426,1.1634597545732412,0.25333333333333335,0.8773379832634616,1.0,5/10,21.37%,PINK1;HSP90AA1;HIF1A;ZMIZ1;EPAS1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),0.55480116146488,1.1634247821393153,0.18604651162790697,0.8761685323644762,1.0,5/51,8.75%,CEP57;PSMC6;TUBB4B;HSP90AA1;RPS27A
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),0.6665124947121978,1.163375680300159,0.2898550724637681,0.8750997028091406,1.0,3/12,5.11%,SERPINE1;ANXA1;PRKCE
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.7334178755042569,1.1631889030721254,0.30303030303030304,0.8746320799597811,1.0,3/8,14.33%,CD9;CD81;ITGB1
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),0.7313806301223068,1.1631534457017572,0.24193548387096775,0.8734880424169558,1.0,4/6,26.79%,CTNND2;DIP2A;CDC42;WASL
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.6390041067528891,-1.163127337318385,0.23076923076923078,1.0,1.0,2/13,7.09%,UBE3D;TRIM25
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),0.6333507977081856,1.1628343971164088,0.24285714285714285,0.8736365585033714,1.0,5/22,14.51%,NRCAM;CALR;FGFR1;REST;ECT2
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),-0.623044705209503,-1.1621879760501783,0.2903225806451613,1.0,1.0,2/6,1.82%,PLA2G4A;CD74
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.6338647047789648,1.1617711882379047,0.2073170731707317,0.8772923215547341,1.0,4/24,9.50%,PSMC6;NFE2L2;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.6206977035241124,1.1616990774030806,0.3037974683544304,0.8763100950034398,1.0,4/25,5.04%,BCL6;MGLL;ANXA1;UFL1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.7033169574724498,1.1614635232217,0.30985915492957744,0.8759404007561763,1.0,3/7,4.36%,SCP2;MGLL;ACOX1
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.7258154954692739,1.161293077718625,0.3076923076923077,0.8756839335265147,1.0,1/9,2.73%,TBX3
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),0.692423980961427,1.1612407368255555,0.2982456140350877,0.8746444648112787,1.0,1/8,6.78%,RPL23
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.6189096512964785,1.160984445296211,0.28378378378378377,0.8745184413207864,1.0,8/25,17.89%,WDR48;PINK1;SMAD7;COMMD1;PTTG1IP;NDFIP1;CRY1;MALT1
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),0.5587857744634248,1.1605407937911614,0.2073170731707317,0.8752220816408675,1.0,12/63,14.82%,LRRC7;FES;SPOCK1;IL1RAPL1;SCARB2;CCDC88A;LRRC4C;PPFIA2;RAP1A;MAGI2;PRAG1;PAK2
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.6489647974929433,1.1604641716981887,0.28,0.8741719613282893,1.0,5/13,12.77%,SLC4A10;ANO5;ANO2;SLC12A6;ANO6
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),-0.5951712454093899,-1.1604581068709763,0.21875,1.0,1.0,1/12,0.60%,PRIMPOL
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.7883033455420837,1.1603800105636528,0.26229508196721313,0.8733157418276896,1.0,2/5,7.17%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.5517369138140026,-1.160083052385217,0.22580645161290322,1.0,1.0,1/14,2.08%,RHOBTB1
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.7223842224988953,1.160080324603393,0.19696969696969696,0.8734940854104024,1.0,4/8,12.77%,ANO5;ANO2;SLC12A6;ANO6
prerank,GO_Biological_Process_2021__brain development (GO:0007420),0.5668914990136782,1.1600743537915115,0.17721518987341772,0.8722450110699962,1.0,5/48,4.88%,DDIT4;PBX3;NES;GRIN2B;ROBO2
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.6060899680586742,1.1590452370599906,0.2916666666666667,0.875463985733113,1.0,7/29,16.67%,WNT2B;TIMP3;PLSCR4;TPM4;COL4A2;TNS1;FZD4
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.683822609617474,-1.1588250751622708,0.36363636363636365,1.0,1.0,2/5,10.33%,MX1;DNM3
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.683822609617474,-1.1588250751622708,0.36363636363636365,1.0,1.0,2/5,10.33%,MX1;DNM3
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),0.7458776972879398,1.158165488475681,0.288135593220339,0.8777724904707219,1.0,1/6,1.84%,SUN2
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.6853610749567942,1.1579817603948537,0.2777777777777778,0.8759069124745595,1.0,1/9,0.21%,LAMC1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.6853610749567942,1.1579817603948537,0.2777777777777778,0.8759069124745595,1.0,1/9,0.21%,LAMC1
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.5442502207376148,-1.1578991042989542,0.2962962962962963,1.0,1.0,7/14,15.16%,CTNNA2;SRGAP2C;SRGAP2;NTNG1;SEMA6A;RAPGEF2;ULK4
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6199835933091665,-1.1578847281512257,0.2727272727272727,1.0,1.0,3/10,8.75%,COL8A1;LAMA3;FN1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,0.6501196793788041,1.157708485611638,0.2465753424657534,0.8759067977588202,1.0,7/21,19.08%,TINAGL1;SMIM3;EMP1;COL4A2;SEMA3F;WWTR1;PXN
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),-0.6376848690244774,-1.1576442422689983,0.2692307692307692,1.0,1.0,1/10,3.45%,STAT1
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),0.5548423352226077,1.1573243079646192,0.19480519480519481,0.8761267090986113,1.0,14/41,24.45%,KHDRBS3;PIK3R1;AHNAK;SLC38A2;YTHDC1;PTBP2;PRX;HNRNPH3;TRA2B;TMBIM6;ZNF326;SETX;CWC22;PTBP3
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.730586433018114,1.1562888726775706,0.31343283582089554,0.8796572711228017,1.0,3/10,11.14%,HSPA5;ERO1A;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.7747324813244046,1.1560874910144283,0.3448275862068966,0.8780501032723756,1.0,3/5,17.94%,YBX3;PELI1;ARHGEF2
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.7747324813244046,1.1560874910144283,0.3448275862068966,0.8780501032723756,1.0,3/5,17.94%,YBX3;PELI1;ARHGEF2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.7409508015061438,1.156028892817651,0.373134328358209,0.877015623917069,1.0,3/8,11.19%,TMEM45B;ACSL5;RAP1A
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.5619142872255488,1.1550391928005959,0.273972602739726,0.8797443882583599,1.0,7/38,17.47%,ZEB2;SMAD7;RPS27A;PPM1A;STRAP;SDCBP;SPRED1
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.7066641775078399,1.1537016521148864,0.3382352941176471,0.88411679509208,1.0,2/6,17.91%,FGFR1;STOX2
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.780198628913454,1.1535580414473736,0.2698412698412698,0.8837470388003615,1.0,1/6,1.82%,TRIM5
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),0.5443668101120338,1.1535088200804855,0.29545454545454547,0.8827103194765109,1.0,16/63,17.58%,DDIT4;ITPR1;PINK1;HYAL2;DUSP1;PDE10A;PEBP1;OTUD7B;PHLPP1;PPM1A;MAGI2;BCL2L1;HDAC7;UBE2B;SPRED1;DAG1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.7460546847184736,1.1535061616685733,0.2876712328767123,0.8814593903131682,1.0,4/7,20.15%,PIK3R1;PXN;STAT3;PTPN1
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),0.7410955387596204,1.153370412124517,0.2903225806451613,0.880924629801909,1.0,1/6,9.79%,HSP90B1
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),0.6452151085379755,1.1529603004756188,0.2857142857142857,0.8811493706636542,1.0,7/24,23.13%,ANXA1;FGFR1;HIF1A;HDAC7;GATA2;ETS1;RHOJ
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),0.7943845476842601,1.1528674039197233,0.3333333333333333,0.8803848803684976,1.0,1/5,13.63%,AGO2
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.5901048395910656,1.1525823520621998,0.2222222222222222,0.8806251746686686,1.0,6/30,12.36%,TSG101;SLC8A1;CDKN1B;TRIB2;CDKN1A;CCNH
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.6203009341288032,1.1524711023031984,0.3333333333333333,0.8799252199106801,1.0,3/20,12.69%,ADM;GGT5;ADCY2
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.6566933513146865,1.1523657981039377,0.2777777777777778,0.8790273062698595,1.0,7/12,27.05%,EDEM3;RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.6763246295147791,-1.151812494165681,0.32,1.0,1.0,2/8,10.10%,CLCN3;ATP6V1H
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.6344821286725015,-1.1518079952611717,0.3235294117647059,1.0,1.0,2/8,15.78%,YEATS2;KAT6B
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.7065867790617899,-1.1517608782581423,0.36363636363636365,1.0,1.0,2/5,8.83%,HABP4;HIPK2
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),-0.5234477846214638,-1.1516747380283199,0.25,1.0,1.0,1/11,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5670011590720458,1.1515573740424325,0.2631578947368421,0.8789830810633745,1.0,15/35,26.79%,PRKCE;PIK3R1;GRB2;HSP90AA1;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;CDC42;FGR;WASL
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5670011590720458,1.1515573740424325,0.2631578947368421,0.8789830810633745,1.0,15/35,26.79%,PRKCE;PIK3R1;GRB2;HSP90AA1;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;CDC42;FGR;WASL
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.5670011590720458,1.1515573740424325,0.2631578947368421,0.8789830810633745,1.0,15/35,26.79%,PRKCE;PIK3R1;GRB2;HSP90AA1;ARPC2;RAC1;CRK;ABI1;WIPF1;ACTB;NCK1;FYN;CDC42;FGR;WASL
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),0.7059376651168778,1.1511507170500406,0.3484848484848485,0.8792844938982145,1.0,4/8,23.91%,FGFR1;FLT1;PPARG;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.5378788679719575,1.1511066083866444,0.20689655172413793,0.8783174656120313,1.0,17/90,15.03%,PIK3R3;RTN4;NEDD9;SUN2;HSPA5;ELP3;PRKCE;VSIR;SEMA6B;ENPP2;HIF1A;PECAM1;BCAR1;FLT1;AGO2;ITGB1;SEMA3F
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.7206681361623248,1.1509704307361637,0.35714285714285715,0.8777344307986821,1.0,2/8,16.46%,AGO2;TUT7
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.6955872832728741,1.150789459396011,0.3013698630136986,0.8772596423487321,1.0,4/12,18.74%,TSG101;SYTL4;SDCBP;CADPS2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),0.7767185295288748,1.150542073363021,0.2876712328767123,0.8770447207786044,1.0,2/5,11.84%,LBR;CDKN1A
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),0.6461086401108468,1.1502541976030343,0.3108108108108108,0.8773619257324574,1.0,5/11,20.51%,DUSP6;DUSP1;DUSP16;PTPN1;DUSP22
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),0.6244253021305495,1.1501473497441423,0.2714285714285714,0.8765105307674289,1.0,8/24,12.56%,ITPR1;GLUD1;CACNA1C;RAPGEF3;SNAP25;SLC2A1;RAP1A;REST
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.7150205747270522,1.1500144010629283,0.28125,0.8757978151071206,1.0,2/8,10.98%,CTNNA1;OTUD7B
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),0.5816225414425551,1.1496398718884047,0.3333333333333333,0.8762364142313559,1.0,4/23,17.06%,SRGN;OGT;NAA16;NAA50
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),-0.6599402933702356,-1.1492393323837624,0.3333333333333333,1.0,1.0,7/10,19.26%,ZSWIM5;PTPN2;PDGFB;STX3;USP14;MYCBP2;ZSWIM6
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.6533224715582168,1.1490620003563408,0.2926829268292683,0.8777308950394177,1.0,3/16,9.50%,PCK1;PIK3R1;HIF1A
prerank,PanglaoDB_Augmented_2021__Transient Cells,0.5775550312247276,1.1483052708242474,0.25925925925925924,0.8799450694101915,1.0,11/34,23.29%,LAMA5;SCARB2;CTNNA1;ATP1A1;BCAR1;DAG1;CADPS2;EPAS1;ATP1B1;HDLBP;COL18A1
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),0.7529730172917799,1.1482058927157888,0.32142857142857145,0.8789905894629355,1.0,2/5,12.05%,ATP2B1;SETD3
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.6854245063516068,1.148062581117822,0.29577464788732394,0.8782192267220975,1.0,2/13,5.61%,PBX3;CACNA1C
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),-0.7326405193080481,-1.1480314503724818,0.3333333333333333,1.0,1.0,2/5,17.45%,ARHGAP35;CXCL12
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.5446936836079534,1.1479363371410471,0.2222222222222222,0.8774800419128365,1.0,18/61,25.21%,LBR;MT2A;PURA;CDKN1B;HIF1A;YTHDC1;RAD21;SMARCC1;TENT4A;DMD;TRA2B;HSPA8;PAFAH1B1;NSD2;TMPO;SLC7A5;MTF2;XPO1
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.672956460606478,1.1476222333605592,0.34328358208955223,0.8775227411343741,1.0,5/18,12.46%,SERPINE1;SGIP1;RAB21;ANXA2;MAGI2
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.6668515030760027,1.1473994954278002,0.3548387096774194,0.8770860891613178,1.0,5/10,16.82%,SLC8A1;ANK2;KDM1A;DYSF;DMD
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.7075773354816067,1.1473162359948474,0.2413793103448276,0.8762917175214641,1.0,2/9,10.59%,FGFR1;JAG2
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.5788211801748645,-1.1472836377230153,0.2857142857142857,1.0,1.0,2/16,5.30%,EIF2AK2;NOD1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.7190214051871036,1.146953046897999,0.35135135135135137,0.8768884635025519,1.0,1/8,2.39%,KLF6
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),0.7533789784123677,1.1468024519875517,0.3424657534246575,0.8762307823490137,1.0,1/6,1.48%,TSG101
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.7055139889581338,-1.1465172944852604,0.3235294117647059,1.0,1.0,1/5,3.27%,ARHGAP12
prerank,PanglaoDB_Augmented_2021__Neurons,0.5452817493175216,1.1458944767715042,0.27058823529411763,0.8785238291602012,1.0,10/61,10.90%,GRIA2;CADM2;SGIP1;SNAP25;RB1CC1;PPFIA2;PPP1R9A;ADGRB3;CNTNAP2;NRXN1
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.556732847143063,-1.145815309509608,0.2692307692307692,1.0,1.0,4/13,10.38%,ALS2;CLCN3;TMCC1;EEA1
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",0.6156782953147634,1.1455440598394961,0.3188405797101449,0.8788473278003502,1.0,3/25,12.56%,KHDRBS3;YTHDC1;REST
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.7139535138910986,-1.1449120333361282,0.2631578947368421,1.0,1.0,1/5,1.48%,PLA2G4A
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),0.5442739883634948,1.1447678595513022,0.2840909090909091,0.8805363768860691,1.0,14/69,16.38%,PIK3R3;ERBB4;PINK1;FGFR1;HSP90AA1;RB1CC1;HIF1A;PECAM1;FLT1;ACVR2A;BTBD10;KRAS;RAC1;SDCBP
prerank,MSigDB_Hallmark_2020__Myogenesis,0.5791854140937185,1.1446776869378283,0.3132530120481928,0.8797141459277809,1.0,9/38,16.82%,DTNA;BHLHE40;PRNP;COL4A2;CDKN1A;ITGB1;WWTR1;NAV2;DMD
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),0.7522562982168797,1.1446383567312968,0.3103448275862069,0.8786719890414325,1.0,3/5,19.99%,NEDD9;BCAR1;GSN
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),-0.6954106060001091,-1.1441636230902428,0.3939393939393939,1.0,1.0,1/6,0.21%,CEMIP
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),-0.6954106060001091,-1.1441636230902428,0.3939393939393939,1.0,1.0,1/6,0.21%,CEMIP
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.626446014915064,1.1439469444505828,0.35365853658536583,0.8804874709932826,1.0,1/17,1.01%,PSMC6
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.6723854490711998,1.143530798286747,0.3142857142857143,0.8809685631906172,1.0,7/15,24.79%,MAP3K5;ANXA1;NFE2L2;ECT2;SETX;ADAM9;FYN
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),-0.6275422878458854,-1.1433667746939318,0.43243243243243246,1.0,1.0,1/9,0.21%,CEMIP
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),0.6388875513986452,1.1433141030788976,0.2328767123287671,0.8804010014167521,1.0,6/23,14.51%,MAP3K5;ANXA1;NFE2L2;FOS;JUN;ECT2
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),-0.4117455389110329,-1.1428753975218575,0.0,0.9994095759114062,1.0,14/165,3.48%,RSAD2;VCAM1;GBP1;XAF1;GBP2;OAS3;ISG15;IL32;IL15;IFI27;MX1;LEPR;STAT1;IRF1
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.594712421025978,1.1426451981034849,0.3194444444444444,0.88195627732925,1.0,7/28,14.85%,TIMP3;SEC24D;PLSCR4;COL4A2;MSRB3;ITGA1;TNS1
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.7109181725183206,1.1426210741509701,0.3333333333333333,0.8808446036944619,1.0,3/8,15.03%,ERBB4;SEMA6B;SEMA3F
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),-0.6363879162054205,-1.1423876756599174,0.3793103448275862,0.9960925491974703,1.0,2/7,16.28%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.776960863518557,1.14230201666048,0.3,0.8810140816979772,1.0,1/5,6.83%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.6719967096725428,1.1418982702045515,0.3333333333333333,0.8817699487775584,1.0,7/10,29.91%,HYAL2;PHLPP1;MAGI2;DAG1;RACK1;PLEKHA1;PIK3CB
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),-0.5718910892874085,-1.1417265989139411,0.25,0.9931667411926183,1.0,5/13,21.29%,STAT1;PDGFB;IGFBP3;IL6R;CDH13
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.5340253615151109,-1.1414168846994635,0.22727272727272727,0.9891609767220579,1.0,4/28,8.80%,CEMIP;TPD52L1;PKD2;PDGFC
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),0.6834958013754762,1.1410064121365753,0.32,0.8844430936348314,1.0,3/12,7.24%,ARF1;CTNND2;PRNP
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),0.7325684539820199,1.1408479805951006,0.3333333333333333,0.8839339643517723,1.0,2/7,21.88%,PRNP;MCL1
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),0.7361027771323485,1.1404331618310564,0.3382352941176471,0.8845951508372282,1.0,1/6,6.57%,DUSP6
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),0.5829156850514863,1.14019943371036,0.24358974358974358,0.884379031073599,1.0,11/29,23.94%,SERPINE1;GGT5;PELI1;TAB2;ERBIN;PDE4B;ZFP36;SMAD6;ADAM9;MEF2C;SCARB1
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.6715240504472222,-1.1398610199233563,0.358974358974359,0.9890567955334233,1.0,1/5,8.54%,MSH3
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),0.6929168255238526,1.1396668316759626,0.3387096774193548,0.8855624405979603,1.0,5/9,23.91%,WNT2B;SULF2;NFIB;CREB3L2;MEF2C
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.7569909318127079,1.1395927426790948,0.2222222222222222,0.8845451995090267,1.0,4/6,22.56%,FES;RASSF1;GATA2;GUK1
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),0.756649623165606,1.1394712299394942,0.32142857142857145,0.883763223963379,1.0,1/5,4.28%,TRMT9B
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.6646605686943852,1.1392095705667291,0.28378378378378377,0.8833607033967719,1.0,7/16,23.60%,ACOX1;ACSL5;GGT5;PON2;LPIN2;PPARG;PNPLA8
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),-0.5328841193304641,-1.1390209983956703,0.35135135135135137,0.9868359619908135,1.0,4/11,7.32%,HOMER2;STIM2;HOMER1;PKD2
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.5565796669478358,1.1386512379790503,0.25316455696202533,0.8844231788039293,1.0,11/46,11.29%,DOK5;GLUL;ANK2;NES;TIMP3;PTPRD;NFASC;PLSCR4;COL4A2;GJA1;BOC
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.6845830812455745,1.1383504568935947,0.29411764705882354,0.8844695719692096,1.0,1/10,4.88%,ROBO2
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),0.7601132274675975,1.1382374734004903,0.3142857142857143,0.8837930675172907,1.0,2/5,13.68%,SPIRE1;ARPC2
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.6227809676853294,1.137743713554162,0.26666666666666666,0.8845908590023892,1.0,9/19,26.90%,ARF1;JAK1;HSPA9;ANXA2;PAK2;CFL1;PLCB1;CDC42;MSN
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.5829921209401875,1.1376707740403225,0.24,0.8837718276112755,1.0,4/37,6.44%,TRIM5;BNIP3L;UFL1;PINK1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.7236210254544929,1.1376670997081697,0.352112676056338,0.8826238296853661,1.0,3/8,24.51%,MYO1B;SEMA3F;EMP2
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.7265512887779262,1.1375789542361612,0.39473684210526316,0.8818095922997037,1.0,4/9,23.13%,ANXA1;HDAC7;GATA2;RHOJ
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.7202854382385182,1.1374827580813265,0.3188405797101449,0.8808970011642198,1.0,3/6,25.44%,HS6ST3;EXT1;NDST1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),0.6845157544572416,1.136745615420172,0.36231884057971014,0.8824820674548822,1.0,2/10,6.62%,PINK1;CCDC88A
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),0.694978685160629,1.1362774067630403,0.3787878787878788,0.8831750051688083,1.0,5/8,25.57%,RAC1;PARVB;GSN;RHOJ;CDC42
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.5849815388829399,1.1361887687716545,0.28,0.8824644643736826,1.0,3/29,11.42%,PSMC6;SMAD7;TRIB2
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.7328877927224032,1.1361874044722622,0.3076923076923077,0.8813130089288388,1.0,1/5,1.71%,SCP2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.676766289712186,1.135813455936624,0.375,0.881605332990835,1.0,5/11,21.68%,ADM;RASA1;SPRED1;EGFL7;RASIP1
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.46176147812182794,-1.1357338026645465,0.3125,0.9922856719685196,1.0,5/46,2.75%,GBP1;HOMER2;ISG15;IFIH1;HERC5
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.653604549704792,1.1356219664482012,0.3287671232876712,0.8811988341452796,1.0,5/16,16.23%,KLF2;HSP90AA1;KLF4;NOS1AP;RAC1
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.7127214963033646,-1.1354839863277468,0.3,0.9883231309266858,1.0,2/5,19.91%,RPS8;RPS16
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.7144958558705079,1.1344961930673634,0.3582089552238806,0.8845209385443068,1.0,3/8,9.84%,ADAMTS9;SMAD5;GJA1
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),0.7450217256781522,1.1339542467457668,0.359375,0.8856746152323559,1.0,2/5,16.10%,PIAS2;NCOR2
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6631035655712156,1.1339237560128514,0.3493975903614458,0.8846684013263996,1.0,5/17,23.13%,ANXA1;KLF4;HDAC7;GATA2;RHOJ
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.6280284585372277,1.133368580320232,0.34210526315789475,0.8859464022837568,1.0,4/22,15.60%,UFL1;KLF4;COMMD1;ERBIN
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.5250160934258687,-1.1328021562458606,0.2857142857142857,0.992824102223084,1.0,4/17,4.67%,MGMT;SHLD1;PARP9;SLF2
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),0.5778753932548792,1.1327095748243179,0.30952380952380953,0.8873625850792711,1.0,8/37,15.19%,ERBB4;PINK1;FGFR1;HSP90AA1;KLF4;RFC3;FLT1;SERINC1
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.5770599347970597,1.13241597936068,0.22784810126582278,0.887460581234429,1.0,6/33,11.29%,PBX3;TIMP3;EMP1;COL4A2;GJA1;BOC
prerank,PanglaoDB_Augmented_2021__Basal Cells,0.5909859113010286,1.1323289001699428,0.30434782608695654,0.8867819532554119,1.0,6/23,11.21%,MT1L;CD9;TINAGL1;EMP1;BACE2;ANXA2
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,-0.5510619281192264,-1.1322089249633374,0.35714285714285715,0.9901663206901699,1.0,3/19,3.04%,PLA2G4A;NKD1;OCLN
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.704313333474666,1.1320204310882143,0.38571428571428573,0.8870214247244946,1.0,3/8,15.03%,ERBB4;SEMA6B;SEMA3F
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),0.7353155359546757,1.131994844960067,0.29411764705882354,0.8859650020990549,1.0,3/7,13.76%,ANK2;PRNP;NOS1AP
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),0.5400028976106163,1.131477517964419,0.3068181818181818,0.886851706167677,1.0,16/53,22.53%,PPP2R3A;PPM1D;PTPRD;DUSP6;DUSP1;ALPL;SSH1;PPM1A;DUSP16;CTTNBP2NL;PLPP1;PPP1CB;MTMR6;PTPN1;PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.743835460497715,1.1314122958667017,0.38461538461538464,0.8859807998642563,1.0,3/6,15.03%,SEMA6B;UNC5C;SEMA3F
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),0.6603120070133741,1.13097425504187,0.2777777777777778,0.8867389651007868,1.0,1/12,0.73%,ADAMTS9
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),0.6850852083293186,1.1309300902707096,0.31746031746031744,0.8856883820480483,1.0,6/10,23.91%,WNT2B;HYAL2;SULF2;NFIB;CREB3L2;MEF2C
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.7261902907976635,1.1307354414137796,0.29850746268656714,0.885283963325107,1.0,3/8,15.65%,TMEM45B;MAP7;VWA2
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.6097864951976458,1.1304684654656196,0.2318840579710145,0.8851180776927334,1.0,9/23,21.88%,YBX3;PINK1;NFE2L2;PTTG1IP;BCL2L1;ARHGEF2;TMBIM6;HERPUD1;MCL1
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.696398192459057,1.1302911079098352,0.28378378378378377,0.8846596310617849,1.0,2/10,16.23%,EPS8;RAC1
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.7169688757118501,1.130229173306895,0.3389830508474576,0.8837007462332862,1.0,3/7,17.13%,ANXA1;FLT1;LGALS3
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),0.6197694351684301,1.1299457935487003,0.36,0.8835653705870676,1.0,6/21,18.17%,ITPR1;SLC8A1;CACNA1C;NDFIP1;SLC30A1;RYR3
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.7043587372677584,1.129671576344221,0.34285714285714286,0.8834998332627332,1.0,2/9,6.70%,ANXA1;BCR
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),0.5918090215732498,1.129325965686279,0.3132530120481928,0.8837675895169469,1.0,11/28,26.14%,MAP2;NAV3;SSH1;HIP1R;ARHGEF2;TBCD;HSPA8;ARFGEF1;TAOK1;HDGFL3;CDH5
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),0.6996344036949085,1.1287535886084339,0.29577464788732394,0.8847139181124416,1.0,2/11,23.21%,YTHDC1;SETX
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.6852573277169426,1.1285211818846792,0.37681159420289856,0.8844118024139636,1.0,2/11,8.18%,PINK1;DUSP1
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.6280288864351082,1.1282581750289264,0.34285714285714286,0.8841795942532483,1.0,5/17,20.74%,ANK3;MYH10;ECT2;RASA1;CHMP4B
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),0.7099066234668808,1.1281318648340606,0.375,0.8834646532373446,1.0,2/6,18.04%,UFL1;MBD2
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.7253640802418517,1.1279586044963437,0.4090909090909091,0.8830549534456995,1.0,1/6,0.91%,CHPT1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.5551583454828433,1.1279370903782122,0.25925925925925924,0.8820126874613865,1.0,14/57,16.23%,MYO9B;EPS8;RAPGEF3;GRB2;RASSF1;GNA13;RAP1A;JUN;CDKN1A;SHC2;ADGRG1;KRAS;SHOC2;RAC1
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.5448391875781443,-1.1278070836392435,0.2727272727272727,0.9980604208795065,1.0,1/15,0.18%,GBP1
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.7629521909758783,1.1277929470129535,0.30985915492957744,0.881537094415576,1.0,2/5,8.75%,PGK1;RPS27A
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.5931608435835842,-1.127477354814026,0.28,0.9940696665694776,1.0,1/10,0.67%,HOMER2
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.5634665955961742,1.126998810732399,0.29333333333333333,0.8829861877151626,1.0,12/46,18.17%,FES;RAPGEF3;SSH1;CTNNA1;HSP90B1;INSIG1;RAP1A;ATP1A1;ADCY2;GOLPH3;TGM2;RYR3
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),0.7170010222038319,1.1266503927641438,0.36619718309859156,0.8831554858359663,1.0,2/7,11.84%,CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),0.7415644805439131,1.126645411378396,0.3333333333333333,0.8820361506194441,1.0,3/5,23.57%,HS6ST3;SULF2;EXT1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.5246642582303596,1.1265158368947583,0.24719101123595505,0.8814945011760281,1.0,17/82,15.71%,NRCAM;DOK5;MAP1B;LAMA5;ROBO2;PIK3R1;GRB2;HSP90AA1;SEMA6B;ANK3;NRXN3;NRXN1;UNC5C;SEMA3F;GRB10;S100A6;FEZ2
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.5184004578127182,1.1261094941995093,0.2261904761904762,0.8820204539118387,1.0,24/90,23.81%,SUN2;ANK2;VAPB;SGIP1;SCARB2;CCDC88A;GRB2;PICALM;RPS27A;ANK3;TOR1AIP2;ARPC2;DYSF;HIP1R;REEP3;SYT1;FZD4;TF;DNM2;CHMP4B;HSPA8;ACTB;UBC;SH3KBP1
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),0.6405913328800025,1.1258309680591887,0.4027777777777778,0.8819307209485681,1.0,1/9,0.88%,MTFR1
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.6878904156371928,1.1258054295533488,0.3132530120481928,0.8809549280170652,1.0,5/9,23.91%,TBX3;BOC;BTG1;PLCB1;MEF2C
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.7477118040109978,1.1254093977270214,0.3333333333333333,0.8816974611017153,1.0,2/5,18.07%,GJA1;SLC1A2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),0.7228304130380309,1.1250858698075235,0.3333333333333333,0.8820845035266635,1.0,6/9,25.93%,ANK2;ANK3;ATP1B3;DMD;ATP1B1;WNK1
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.706959884608638,1.1244944852953245,0.3384615384615385,0.8835980276138791,1.0,1/8,1.06%,BCL6
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.5537664488054176,1.1243460145312008,0.35135135135135137,0.8832491101226375,1.0,9/50,12.72%,RTN4;BCL6;BNIP3L;CALR;NDRG1;PINK1;HSP90AA1;PHLPP1;BCAR1
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),0.689879779998028,1.123476035561558,0.35294117647058826,0.8856381146183295,1.0,5/12,23.91%,KCNMB4;PREPL;SLC30A1;RIMS2;MEF2C
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7304362720350738,-1.1229385546963113,0.38636363636363635,1.0,1.0,1/5,1.48%,PLA2G4A
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.5998052158221353,1.1226553863051563,0.32051282051282054,0.8877098851473069,1.0,10/27,22.30%,PCK1;ANXA1;ALPL;GGT5;PELI1;TAB2;ERBIN;STAT3;SMAD6;PPARG
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.7068350465304273,1.1219345430307979,0.3442622950819672,0.8891277146923604,1.0,2/8,12.25%,MYO1B;MYO1E
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.5003439833917165,1.121627719102499,0.29213483146067415,0.8892461008525802,1.0,22/90,23.39%,BCL6;BNIP3L;MAP3K5;ARHGEF4;DUSP6;RPS27A;GNA13;JUN;REST;ANO6;ITGB1;ECT2;HIP1R;TGM2;ARHGEF2;BCLAF1;KALRN;DNM2;PREX1;TNFRSF10B;TNFAIP8;UBC
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),0.5282349409655023,1.1210727056165384,0.27710843373493976,0.8899169603611462,1.0,4/42,6.44%,MTFR1;BCAP31;BNIP3L;PINK1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.8041527488950051,1.1205146413140845,0.29850746268656714,0.8909901101060552,1.0,1/6,2.73%,TBX3
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),0.632259533076529,1.120344078105246,0.38666666666666666,0.8882908713101612,1.0,4/12,20.74%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),0.632259533076529,1.120344078105246,0.38666666666666666,0.8882908713101612,1.0,4/12,20.74%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),0.632259533076529,1.120344078105246,0.38666666666666666,0.8882908713101612,1.0,4/12,20.74%,LBR;AHCTF1;REEP3;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),-0.6003983125574459,-1.1202331365095006,0.3125,1.0,1.0,2/5,26.27%,GAS6;ROCK1
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.6844753299618747,1.1202199284407615,0.3283582089552239,0.8875786993335363,1.0,4/9,18.56%,PECAM1;PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.5981478690688876,1.1199959367570562,0.30434782608695654,0.8872697515187354,1.0,5/23,14.02%,B3GNT2;CHSY1;CHST11;GGT5;SLC26A2
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7853436869365016,1.1199730550188345,0.3972602739726027,0.8861997337606817,1.0,2/5,5.04%,HSPA5;UFL1
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.5773952879277562,1.1197365994367507,0.3625,0.883817777116231,1.0,9/29,26.53%,PSMC6;TAB2;PAK2;KRAS;MALT1;PSMA7;FYN;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.5773952879277562,1.1197365994367507,0.3625,0.883817777116231,1.0,9/29,26.53%,PSMC6;TAB2;PAK2;KRAS;MALT1;PSMA7;FYN;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.5773952879277562,1.1197365994367507,0.3625,0.883817777116231,1.0,9/29,26.53%,PSMC6;TAB2;PAK2;KRAS;MALT1;PSMA7;FYN;CREBBP;PSMB9
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.7062142617157511,1.119504935147782,0.37681159420289856,0.8837148515040029,1.0,2/10,5.66%,ROBO2;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.5758276568787021,-1.118968492052748,0.32,1.0,1.0,5/15,9.35%,ISG15;IFIH1;HERC5;TRIM25;NLRC5
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.6771464068721976,1.1188493988201624,0.36619718309859156,0.8855117058633231,1.0,2/10,7.55%,ZFPM2;SMAD7
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.6105889260727397,1.1187316792714401,0.36231884057971014,0.8848099345508209,1.0,4/16,21.52%,TRIM5;PELI1;UBE2B;NEDD4
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),0.5611717872321403,1.118545541958479,0.34285714285714286,0.8843616493933822,1.0,11/32,17.89%,SPOPL;UFL1;PINK1;SMAD7;HSP90AA1;OGT;COMMD1;PTTG1IP;NDFIP1;CRY1;MALT1
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.6258843543194784,1.118525875665319,0.2361111111111111,0.8833453725436148,1.0,5/14,20.74%,SEC22B;PINK1;FEZ2;LIMK2;CHMP4B
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.700074632531926,1.1184748926554335,0.3972602739726027,0.8825034203366914,1.0,3/8,10.72%,RPS27A;NPLOC4;RFC3
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),-0.6450341646154987,-1.1181059858364546,0.3793103448275862,1.0,1.0,1/5,7.74%,ACVR1
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.6335378047081035,1.1181039526003296,0.3287671232876712,0.882719709051073,1.0,1/13,0.55%,DDIT4
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.6680395584972691,1.1181026850979479,0.34328358208955223,0.8816564078115311,1.0,5/12,26.90%,EPS8;PICALM;RAC1;MTOR;MSN
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),0.597241902280688,1.1180669944603274,0.3373493975903614,0.8807537386231454,1.0,10/22,27.41%,DPP10;PRKCE;PIK3R1;CNST;ITGB1;LGALS3;ATP2B4;PRKCH;RACK1;EGFR
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),0.5369178200864726,1.1179100160744402,0.33783783783783783,0.8800768858739696,1.0,9/48,12.56%,BCL6;FES;PLEKHB2;FGFR1;SMAD7;CBFB;CDK6;KLF4;REST
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.6926001670358469,1.1175224497951743,0.39705882352941174,0.8801374140392443,1.0,3/12,11.14%,HSPA5;ERO1A;HSPA9
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.7218433939507234,1.1174477997628858,0.417910447761194,0.8794235855039059,1.0,3/5,7.24%,RFTN1;VSIR;PRNP
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.5308413433881961,1.1172889337107481,0.2857142857142857,0.8789474007556598,1.0,16/59,19.57%,RTN4;RAPGEF3;PINK1;FGFR1;ZDHHC6;ENPP2;GJA1;NRXN1;REST;SPIRE1;AGO2;FZD4;DAG1;DDHD1;RIF1;CFL1
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),0.7194790145281333,1.1169713208915875,0.3380281690140845,0.8788650818043834,1.0,4/9,24.40%,CBFB;FOXC1;ZFP36;PRKCH
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),0.6901076520966651,1.1165308934589224,0.36764705882352944,0.8793843934440745,1.0,2/10,3.53%,KCNIP4;DPP10
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),0.7216338713060358,1.1162285561791565,0.2878787878787879,0.8782149818335317,1.0,1/8,2.73%,TBX3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),0.7216338713060358,1.1162285561791565,0.2878787878787879,0.8782149818335317,1.0,1/8,2.73%,TBX3
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),0.6307287936925987,1.1155962099312355,0.3611111111111111,0.8799186876829579,1.0,5/17,20.77%,TBX3;FGFR1;HIF1A;LIMS1;NOTCH4
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.6784790585942411,1.1151145896103691,0.33783783783783783,0.8805123017333865,1.0,5/12,17.32%,CALR;ZNF366;PIAS2;NCOR2;CRY1
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.5990775540839748,-1.1144489441912522,0.40625,1.0,1.0,3/9,12.59%,PPP2R5A;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.7129503525379898,1.1142381059008755,0.3384615384615385,0.8826250237275908,1.0,3/6,12.67%,RAP1A;MAGI2;ACAP2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.6811058351335993,-1.1138875886642312,0.37142857142857144,1.0,1.0,1/7,2.73%,ATM
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),-0.5859843888363723,-1.1131259067464927,0.4166666666666667,1.0,1.0,3/10,5.84%,PLA2G4A;PLPPR4;PLAAT3
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),0.6505982342515423,1.1130776128817907,0.36,0.8857581266023709,1.0,1/14,0.60%,B3GNT2
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6291814881351872,1.1128302402949304,0.35064935064935066,0.8855776769285247,1.0,2/17,4.96%,PNP;LBR
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),-0.5659196632087299,-1.112685569154383,0.41379310344827586,1.0,1.0,4/13,15.86%,SHLD1;MSH3;SHLD2;POLR2A
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.6569307254391268,1.112493594375935,0.39436619718309857,0.8858638354389997,1.0,6/12,25.99%,CD9;VWF;PECAM1;GATA2;PPARG;FGR
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.604448722909168,1.1117313747735185,0.3382352941176471,0.8874168259595161,1.0,3/18,4.65%,BCAP31;MAP3K5;GRIN2B
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.6950621823205395,1.1111565855223464,0.3870967741935484,0.8883718596797112,1.0,4/8,23.21%,JUN;BCLAF1;MED4;SETX
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.6235653977973912,1.1109628521889139,0.3291139240506329,0.888098831506141,1.0,5/18,10.98%,SERPINE1;ANXA1;HYAL2;KLF4;OTUD7B
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.7166418577874379,1.1104195926172098,0.36363636363636365,0.8888445742191682,1.0,4/8,23.49%,MT2A;MT1M;SLC30A1;MT1E
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.7096136832394028,-1.1101171817768247,0.5128205128205128,1.0,1.0,2/5,8.93%,PARN;ST3GAL1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.6869676637355069,-1.1100258496715278,0.3548387096774194,1.0,1.0,1/5,0.13%,VCAM1
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.4886804963746057,-1.1099174523436688,0.27586206896551724,0.9963202443737632,1.0,6/25,7.53%,RNF213;ALS2;HOMER1;PKD2;HGSNAT;ZNHIT6
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7679092725259544,1.1099015564852408,0.36619718309859156,0.8898459864168474,1.0,3/5,19.29%,BACH2;CD55;STAT3
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.7658998388062024,1.1097933863492,0.3333333333333333,0.8892250417829479,1.0,1/6,6.26%,WDR48
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),0.5603121032891105,1.1093944512024563,0.3146067415730337,0.8896072229378242,1.0,6/31,18.72%,PSMC6;CDK6;KLF4;CDKN1A;PSMA7;SLFN11
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),0.5425777176167973,1.1088884903075247,0.2619047619047619,0.8903476378189608,1.0,7/65,8.05%,PIK3R3;NEDD9;SUN2;HSPA5;ELP3;VSIR;SEMA6B
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.6211740453874306,1.1087111329400088,0.3287671232876712,0.8897923621964748,1.0,9/20,22.64%,IL1RAPL1;ANXA1;SYTL4;RAB21;STXBP5L;SYT1;CADPS2;RIMS2;RAB8B
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",0.46168854955158567,1.1081333327601637,0.18,0.8911194254702819,1.0,78/334,22.87%,MAFF;ST18;ZEB2;ERBB4;SERPINE1;ATF3;KLF2;KLF6;TBX3;JUNB;PHF10;MAP3K5;CD81;NPAS3;ZFPM2;CRTC3;REL;KDM1A;NFE2L2;HYAL2;PIK3R1;ESR2;FOS;SMAD7;SMAD5;JUND;PICALM;RPS27A;OGT;HIF1A;FOSL2;KLF4;JUN;CNBP;CCNC;SETD3;PPM1A;REST;ACVR2A;AGO2;FOXF1;ZBTB38;NAA16;SMARCC1;TMF1;WWTR1;CRLF3;FZD4;BRD4;FOXC1;ATF2;ATOH8;LPIN2;ARHGEF2;GATA2;ZMIZ1;NPAS2;NAMPT;BCLAF1;STAT3;TNKS;NR1D2;NFIB;KMT2E;NFIC;DNM2;NOTCH4;RLF;EPAS1;CDK8;PLCB1;PPP3CB;PPARG;TFCP2;NPM1;ETS1;MED4;NCK1
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),0.5048603321115483,1.1079525288934091,0.25,0.8907562646858501,1.0,25/89,22.59%,ST18;ERBB4;TBX3;PBRM1;PPM1D;CDK6;CDKN1B;DLC1;ITGA1;KLF4;CDKN1A;MAGI2;REST;ADGRG1;PLPP1;GATA2;BTG2;ABI1;NACC2;SMAD6;MORC3;BTG1;PPARG;NPM1;ETS1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),0.587441520921469,1.1079355620327955,0.3157894736842105,0.8898322631056623,1.0,4/24,18.46%,PSMC6;RAC1;FZD4;PSMA7
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.7538231100688958,1.1071866285690581,0.3442622950819672,0.8916263647479329,1.0,1/5,4.31%,CD81
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.513723916791938,-1.1071503236943243,0.28,1.0,1.0,3/26,6.33%,VCAM1;SNED1;PODN
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.6289746613614069,1.1069482412863818,0.3188405797101449,0.8912638901155335,1.0,2/13,5.79%,PPM1D;PPHLN1
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.7402191149768114,1.106668704437143,0.29411764705882354,0.8912838928102701,1.0,2/5,14.25%,CD81;CD55
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.57468064281977,1.1065551355164633,0.36486486486486486,0.8907447903569882,1.0,5/27,10.31%,PSMC6;HSPA5;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),0.6496232825073902,1.106196586179342,0.36363636363636365,0.8910318653985905,1.0,4/12,26.79%,PIK3R1;CDC42;FSCN1;WASL
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.501013838592933,1.1056753808230926,0.313953488372093,0.8921295361940316,1.0,25/95,23.39%,BCL6;BNIP3L;MAP3K5;ARHGEF4;DUSP6;PRNP;RPS27A;DLC1;GNA13;JUN;REST;ANO6;ITGB1;ECT2;HIP1R;TGM2;ARHGEF2;BCLAF1;KALRN;DNM2;PREX1;BTG1;TNFRSF10B;TNFAIP8;UBC
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),0.546521293461127,1.1055235282042333,0.2839506172839506,0.8916419822588794,1.0,7/37,11.27%,PINK1;ERO1A;NFE2L2;FOS;HIF1A;MSRA;JUN
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.5343395853350463,1.105403564601957,0.379746835443038,0.8911555688007687,1.0,6/38,9.84%,PLS3;TBX3;FGFR1;HYAL2;ALPL;GJA1
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.6359730761780327,1.1052701165274659,0.3717948717948718,0.8905818702708466,1.0,4/12,23.60%,ACOX1;NR1D2;PPARG;PNPLA8
prerank,PanglaoDB_Augmented_2021__Ductal Cells,0.6911081741930569,1.1050364750360004,0.35294117647058826,0.8904384855639899,1.0,2/8,7.01%,TINAGL1;ATP8B1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.653402303853484,1.1048719467637838,0.4342105263157895,0.8898543578821678,1.0,1/11,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.6475500210112857,1.1045891471088385,0.36507936507936506,0.8897247414808164,1.0,7/9,25.93%,ANO6;NEDD4L;NEDD4;AHCYL1;AKAP6;YWHAE;WNK1
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.7108690188458935,1.103705221711073,0.4084507042253521,0.8920219959047593,1.0,3/8,11.34%,GLUL;SNAP25;SLC12A6
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.6359746638290844,1.1035278961563266,0.39473684210526316,0.8916641136816889,1.0,1/11,4.57%,VAPB
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",0.4587200878406098,1.1034980027532981,0.16,0.8906924191914936,1.0,111/490,22.40%,MAFF;ST18;PBX3;ZEB2;ERBB4;BCL6;ATF3;KLF2;KLF6;ZNF160;TBX3;MAFK;JUNB;BHLHE40;PHF10;CALR;MAP3K5;ELP3;NPAS3;BAZ1A;ZBTB1;ZNF280D;ZFPM2;POLA1;PURA;REL;KDM1A;ATP8B1;NFE2L2;ESR2;FOS;BACH2;SMAD7;SMAD5;ZNF586;CBFB;JUND;ARID5A;PICALM;CDKN1B;OGT;HIF1A;FOSL2;ELP4;KLF4;CREM;ZNF366;RAD21;JUN;SPEN;CNBP;CDKN1A;CCNC;SETD3;CCNH;PPM1A;REST;FOXF1;TRAK1;PIAS2;SBNO1;ZBTB38;NAA16;ZBTB10;SMARCC1;WWTR1;LRRFIP1;BRWD3;CCNL1;NCOR2;CRLF3;MTDH;CRK;FZD4;BRD4;FOXC1;ATF2;NR2C1;CRY1;ATOH8;LIMS1;MBD2;GATA2;ZMIZ1;NPAS2;BCLAF1;STAT3;ZNF43;NR1D2;HBP1;NFIB;NACC2;KMT2E;NFIC;DNM2;NOTCH4;RCOR3;RLF;ATP2B4;SMAD6;CREBZF;EPAS1;DENND4A;HSPA8;BTG1;PLCB1;PPP3CB;ZNF326;PPARG;TFCP2;NPM1
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),0.7237493401305025,1.1034960288944649,0.31343283582089554,0.8896603306408661,1.0,2/7,4.80%,IL1RAPL1;PTPRD
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),0.4756316978579699,1.103480624782527,0.3020833333333333,0.8886806899462665,1.0,53/209,23.39%,ANGPTL4;RTN4;BCL6;HSPA5;TBX3;BNIP3L;CALR;MAP3K5;ANXA1;NDRG1;PINK1;ARHGEF4;DUSP6;PIK3R1;HSP90AA1;RPS27A;HSP90B1;GNA13;HSPA9;JUN;PHLPP1;REST;BCAR1;ANO6;ITGB1;ECT2;NAA16;PAK2;HIP1R;RASA1;BCL2L1;MTDH;GOLPH3;GRK5;TGM2;MALT1;ARHGEF2;ACTN1;TMBIM6;BCLAF1;CFL1;KALRN;DNM2;PREX1;SMAD6;MCL1;TNFRSF10B;NPM1;TNFAIP8;SETX;RPL10;AVEN;UBC
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),-0.5792612930558774,-1.1034003406787403,0.38235294117647056,1.0,1.0,5/12,6.70%,CEMIP;HOMER2;TBL1X;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.5792612930558774,-1.1034003406787403,0.38235294117647056,1.0,1.0,5/12,6.70%,CEMIP;HOMER2;TBL1X;CLIC5;CDC14A
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.5682849106520184,1.1031000507690296,0.29577464788732394,0.8893533437119117,1.0,6/24,20.74%,ANK3;MYH10;SPIRE1;ECT2;RASA1;CHMP4B
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),0.6097890087495853,1.1028921204444357,0.36764705882352944,0.8892628109212528,1.0,8/19,23.91%,PINK1;CPEB4;REST;BTBD10;RASA1;INPP5A;CHMP4B;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.5645679163607925,1.1023741247278462,0.3466666666666667,0.8902699690380099,1.0,6/29,20.09%,BCAP31;NFE2L2;SMAD7;TRIB2;HERPUD1;CSNK1D
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),0.6841741293864493,1.1022079128122095,0.352112676056338,0.8898173352727905,1.0,3/12,16.10%,KDM1A;PIAS2;NCOR2
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.46900294317889185,-1.102180271296817,0.4,1.0,1.0,7/42,8.93%,PKHD1L1;GBP2;COBLL1;LAMA3;PTPN21;FN1;ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.6680039398125981,1.1020667634294459,0.391304347826087,0.8893906286108897,1.0,3/12,11.53%,ANXA1;ANXA2;KATNBL1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.779352318969971,1.1011502569709297,0.3582089552238806,0.8917861456726456,1.0,3/5,17.45%,ACOX1;ENPP2;LPIN2
prerank,MSigDB_Hallmark_2020__Apical Junction,0.5122952040648905,1.1009934475372163,0.30952380952380953,0.8913085019641512,1.0,15/64,15.08%,PIK3R3;CNTN1;CADM2;NFASC;NEGR1;CTNNA1;ADAM15;VWF;INSIG1;PECAM1;MYH10;CLDN5;ARPC2;ITGB1;RASA1
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),0.661641015420272,1.1001119537095903,0.3709677419354839,0.8932375298806502,1.0,2/7,17.47%,SMAD7;SPRED1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.6213539611262945,1.0999122822981025,0.36507936507936506,0.8930565740601852,1.0,3/16,7.58%,MAP2;FES;NAV3
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.579786575226253,1.099454044736827,0.4,0.8934203784081585,1.0,3/21,10.28%,ITPR1;SCARB2;DEPP1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.5009072482807688,1.0994515513710925,0.3176470588235294,0.8924116839101224,1.0,18/73,21.88%,ITPR1;TRIM5;PRKAG2;UFL1;GAPDH;PINK1;RB1CC1;DEPP1;EEF1A1;TAB2;TMEM59;MTDH;PSAP;STAT3;ABL2;NEDD4;RASIP1;MCL1
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.7346424532523417,1.0986465950357407,0.3283582089552239,0.8943923604219655,1.0,4/7,23.49%,MT2A;MT1M;SLC30A1;MT1E
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.6870856636088426,1.098400501671521,0.3389830508474576,0.8941246088710029,1.0,3/8,20.40%,SMAD7;CDKN1B;ZFP36
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.6087692985368635,1.0982886386182853,0.36363636363636365,0.8935126433218111,1.0,5/15,20.20%,CDK6;KLF4;CDKN1A;SLFN11;NACC2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.4938070544724488,1.098046360826788,0.3411764705882353,0.8933941153564258,1.0,11/60,15.47%,RPS11;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;RPLP2;RPS12;RPL13A
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.6332789369610062,-1.097434010326165,0.4634146341463415,1.0,1.0,3/6,19.42%,MRPS31;PTCD3;LARS2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.7395488454894728,1.096940667729296,0.3088235294117647,0.8961756243408455,1.0,2/5,12.56%,PINK1;REST
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.5812075121603164,1.0968057579237127,0.32926829268292684,0.8956002342275877,1.0,4/27,8.80%,NRCAM;MAP2;MAP1B;ANK3
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.46243668301385243,-1.0963546118919338,0.28,1.0,1.0,2/33,0.70%,VCAM1;THSD1
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.6341574654414671,1.0960153873479626,0.37142857142857144,0.8972083022410607,1.0,5/11,25.86%,MAP1B;NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.6308348309249558,1.0958072948914828,0.4383561643835616,0.8969269355993393,1.0,7/13,21.96%,BCL6;CDKN1B;TOM1L2;FOXC1;BTG2;BTG1;CHFR
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),-0.48160626098896553,-1.0946429693715578,0.3333333333333333,1.0,1.0,6/30,9.01%,RNF213;ALS2;CLYBL;DISP1;PKD2;SAMHD1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.6044947816344921,1.094056896559276,0.34210526315789475,0.9023461091129561,1.0,9/20,26.90%,ARF1;JAK1;HSPA9;ANXA2;PAK2;CFL1;PLCB1;CDC42;MSN
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,0.5982304815335442,1.093709800173279,0.4084507042253521,0.9023283629957533,1.0,9/19,36.03%,BCAR1;SHC2;CADPS2;EPAS1;ATP1B1;EFNB2;DAB2IP;TEAD1;AIF1L
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.6374154291511034,-1.0936407407858728,0.34285714285714286,1.0,1.0,3/7,21.00%,HLA-F;HLA-A;NECTIN2
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),0.6112080902570086,1.0936343104997701,0.3291139240506329,0.9016272361845772,1.0,6/16,19.55%,GLUL;CTNNA1;OTUD7B;WWTR1;TPR;LIMK2
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.5355153680024725,1.0932782873626705,0.3375,0.9017688129189069,1.0,15/47,22.66%,CHPT1;SPOCK1;PINK1;HSP90AA1;PICALM;NRG3;RAP1A;BCAR1;STK38L;HIP1R;PTPN1;ABL2;HSPA8;NEDD4;RUFY2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.5882374871374582,1.093010804032457,0.345679012345679,0.9018613649640752,1.0,6/15,21.88%,BCAP31;PINK1;BCL2L1;BCLAF1;HERPUD1;MCL1
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),0.7370844586150433,1.092752532224825,0.42857142857142855,0.9017104536159658,1.0,2/5,21.91%,AGO2;PLCB1
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.745775929295555,1.0926076612381923,0.3787878787878788,0.901231855887829,1.0,5/5,25.52%,APOLD1;ATOH8;NOTCH4;BTG1;ZEB1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),0.6284740442802064,1.0925640324025592,0.3048780487804878,0.9003174559833683,1.0,7/21,13.24%,TSG101;FGFR1;HYAL2;DUSP1;TRIB2;FLT1;STK38
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.6784204936730408,1.0924466178019854,0.47058823529411764,0.8996717870627599,1.0,4/9,26.14%,JAK1;PAK2;ACTB;CDH5
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.5077005492669371,1.0923304268048408,0.313953488372093,0.8989428062602413,1.0,8/86,9.01%,PIK3R3;ERBB4;ATF3;PINK1;CCDC88A;PRNP;HSP90AA1;RB1CC1
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),0.5527249490243091,1.0921286471009588,0.4,0.8987839088079012,1.0,11/33,26.64%,PINK1;CCDC88A;ADCY2;ECT2;PAK2;MALT1;TNFRSF10B;TAOK1;ADCY9;EMP2;MTOR
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),0.5999196889189394,1.09201557908593,0.4266666666666667,0.8981662800428128,1.0,4/15,13.50%,TSG101;GRB2;ITGA1;ZFYVE28
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),0.7446607874919291,1.0919856775576517,0.3559322033898305,0.8972362687433901,1.0,3/5,18.17%,SLC8A1;TGM2;RYR3
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),0.45590578409739874,1.0919065828032044,0.17,0.896537362441187,1.0,113/514,21.37%,MAFF;ST18;PBX3;ZEB2;SERPINE1;BCL6;ATF3;KLF2;KLF6;ZNF160;TBX3;MAFK;JUNB;BHLHE40;PHF10;PPM1D;CALR;CD81;ELP3;NPAS3;BAZ1A;ZBTB1;ZFPM2;CRTC3;PURA;REL;RPL23;KDM1A;SIN3B;NFE2L2;HYAL2;PIK3R1;ESR2;FOS;BACH2;SMAD7;SMAD5;ZNF586;CBFB;JUND;ARID5A;RPS27A;OGT;HIF1A;FOSL2;ELP4;KLF4;CREM;ZNF366;RAD21;OTUD7B;JUN;SPEN;CNBP;CDKN1A;CCNC;SETD3;CCNH;PPM1A;REST;ACVR2A;AGO2;FOXF1;TRAK1;NEDD4L;PIAS2;ZBTB38;ZBTB10;SMARCC1;TMF1;WWTR1;LRRFIP1;BRWD3;CCNL1;NCOR2;CRLF3;SDCBP;MTDH;CRK;BRD4;FOXC1;ATF2;NR2C1;CRY1;ATOH8;LPIN2;ARHGEF2;MBD2;GATA2;ZMIZ1;MCPH1;TPR;NPAS2;NAMPT;BCLAF1;STAT3;TNKS;ZNF43;RIF1;NR1D2;HBP1;NFIB;NACC2;NFIC;ZFP36;DUSP22;NOTCH4;RCOR3;RLF;ATP2B4;SMAD6;CREBZF;EPAS1
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),0.6463629657144256,1.091655971474205,0.373134328358209,0.896442055742479,1.0,4/8,27.65%,RAB21;DNAJC13;MSN;MAP2K1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),0.6028200382434076,1.0912415304585292,0.32432432432432434,0.8968761696099241,1.0,1/16,3.27%,GLUL
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.6014443115388556,1.091029782077211,0.40298507462686567,0.8967446559427145,1.0,7/19,26.79%,MYO1B;PPFIA2;MYO1E;TRAK1;PAFAH1B1;TANC2;WASL
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.6477957823852022,1.0907243607131891,0.3972602739726027,0.8967334418910448,1.0,5/13,25.57%,HSPA5;PPM1A;RPL13A;SMAD6;CDC42
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),0.48634342771345074,1.090020007587269,0.3522727272727273,0.8981247860050353,1.0,26/113,18.82%,CCDC3;PPM1D;CALR;GAPDH;PPHLN1;REL;PINK1;SRGN;PICALM;ATP2B1;HIF1A;KLF4;PTBP2;REST;DCP2;AGO2;CLDN5;GIGYF2;RPL13A;NDFIP1;NCOR2;ATOH8;DIP2A;GATA2;TMBIM6;BTG2
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.7485495935200224,1.089979119130045,0.3611111111111111,0.8963052374704816,1.0,4/5,21.73%,SLC12A6;ATP1A1;ATP1B3;ATP1B1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.7485495935200224,1.089979119130045,0.3611111111111111,0.8963052374704816,1.0,4/5,21.73%,SLC12A6;ATP1A1;ATP1B3;ATP1B1
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.5730327218080016,1.0899711208261782,0.38271604938271603,0.8953387403962085,1.0,10/29,23.05%,BCAP31;ZDHHC6;LAMP2;ZDHHC14;PIKFYVE;TRAK1;SDCBP;VPS37A;CDC37;AKAP6
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),0.5169661902155572,1.0893736766679314,0.3493975903614458,0.8962958377005723,1.0,14/65,18.28%,CCDC3;REL;PINK1;PICALM;HIF1A;KLF4;REST;AGO2;CLDN5;NDFIP1;SDCBP;ATOH8;DIP2A;GATA2
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.7364904347537347,1.0891145914432692,0.42028985507246375,0.8961182933355383,1.0,3/5,26.17%,HIF1A;EPAS1;DCUN1D4
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.4939571729468326,-1.088690940888618,0.36363636363636365,1.0,1.0,7/17,23.16%,BICD1;EFNA5;CLASP1;CYLD;PHLDB1;MARK2;PHLDB2
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),0.7112861758589422,1.0882806142382782,0.38235294117647056,0.8980727171080666,1.0,3/8,9.87%,KLF2;NFE2L2;KLF4
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.49328800669835093,-1.0882638269942302,0.3181818181818182,1.0,1.0,4/22,9.40%,ATG10;WARS1;FN1;STAT2
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),-0.4800381358877038,-1.088154241818609,0.3125,1.0,1.0,9/42,9.97%,GBP1;GBP2;ISG15;DCP1A;OPTN;BICD1;MDM2;COG3;CEP68
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.5509265877388646,-1.0873322076915126,0.36,1.0,1.0,3/12,8.70%,BABAM2;USP25;OTUD4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.6101401194737233,-1.0872645691328389,0.46875,1.0,1.0,1/10,1.09%,SLC4A4
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),0.718166858796851,1.087109612917814,0.4426229508196721,0.9009268722250208,1.0,2/6,20.09%,CCDC14;CSNK1D
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6733117095932125,1.0870833594778244,0.4393939393939394,0.9000437814133891,1.0,5/7,28.56%,SMAD7;PAK2;TBCD;ACTB;PIP5K1C
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.5437790799604119,1.0869759285856733,0.352112676056338,0.899483093326833,1.0,8/55,11.84%,PDK4;HSPA5;PRKAG2;MAP3K5;CPEB4;LAMP2;SIK2;CDKN1A
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),0.6874552858927141,1.0867049125499932,0.4393939393939394,0.899480867882412,1.0,5/7,29.49%,CACNA1C;ATP1A1;GSN;FGF12;CAMK2D
prerank,PanglaoDB_Augmented_2021__Platelets,0.5592627497056096,1.0866656127733423,0.3783783783783784,0.8985904195506825,1.0,8/35,11.79%,SERPINE1;CD9;ERO1A;SRGN;VWF;LRRC32;PECAM1;SLC2A3
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.7384128463375161,1.0866186797221242,0.4142857142857143,0.8977255798424946,1.0,2/5,21.88%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),0.6990885477013682,1.0863783043559667,0.38571428571428573,0.8977134653239653,1.0,1/7,2.41%,HSPA5
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.5296347105596181,1.0862609448241147,0.30864197530864196,0.8970993605271349,1.0,14/42,28.58%,UFL1;SMAD7;OGT;TRIB2;COMMD1;SDCBP;HERPUD1;CSNK1D;XPO1;RACK1;VCP;EIF3H;TLK2;RNF19A
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.5826086126907536,1.0859979405787814,0.37037037037037035,0.8971587035921526,1.0,9/27,19.08%,DTNA;SLC8A1;TPM4;ITGA1;MYL6;DYSF;MYL12B;DMD;PXN
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),0.6064653570697883,1.0856207509923101,0.4155844155844156,0.8975241592085469,1.0,4/14,18.72%,CDK6;KLF4;CDKN1A;SLFN11
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),0.5615227736807393,1.0855084079363189,0.3116883116883117,0.8969593279601524,1.0,10/29,21.68%,MYO9B;EPS8;BCR;DLC1;PRAG1;ADGRG1;RAC1;ARHGEF2;ABL2;RASIP1
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),0.675207170179763,1.0853837775879123,0.4090909090909091,0.8964427363128487,1.0,1/9,4.28%,TRMT9B
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.5143553021375061,1.085061762725973,0.34146341463414637,0.8964673140945592,1.0,7/65,9.42%,PIK3R3;ERBB4;RAPGEF3;PINK1;HSP90AA1;RB1CC1;DLC1
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),0.5695109043428912,1.0850044495789422,0.410958904109589,0.8956357360006609,1.0,5/27,13.84%,B3GNT2;PLOD2;TMTC1;OGT;TRAK1
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),-0.6315608362819236,-1.0848065534644624,0.3448275862068966,1.0,1.0,1/5,3.30%,GMDS
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.7199150976567678,1.0846429158067448,0.4126984126984127,0.8958602852010089,1.0,1/7,2.73%,TBX3
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.5639154534705045,-1.0844424944077542,0.3888888888888889,1.0,1.0,2/9,2.83%,ATM;BABAM2
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.6623359928086568,1.0836540263889944,0.39705882352941174,0.8985300764582581,1.0,4/11,22.77%,PIK3R1;DLC1;PAK2;TMEFF2
prerank,PanglaoDB_Augmented_2021__Myoblasts,0.5470240596097078,1.083458496239496,0.3875,0.898260056437872,1.0,7/33,17.96%,TBX3;NES;TIMP3;COL4A2;BCAR1;WWTR1;AFAP1L1
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),-0.5820894295144325,-1.0829378065257245,0.35294117647058826,1.0,1.0,1/9,1.58%,ISG15
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.6212101395968289,1.0828887357053234,0.3670886075949367,0.8993100950641989,1.0,2/21,6.41%,PSMC6;REL
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.6686891040675964,1.0825002485616428,0.4166666666666667,0.8997280026451173,1.0,2/11,4.78%,MAP2;INPP5F
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.5899055943347277,1.082219539553333,0.39473684210526316,0.8996905968342227,1.0,4/17,13.50%,TSG101;GRB2;ITGA1;ZFYVE28
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),0.5863001872809511,1.0819433393022233,0.3611111111111111,0.8996532715525225,1.0,7/25,22.30%,ZFPM2;AAMDC;TRIB2;WWTR1;GATA2;ZFP36;PPARG
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.5085506411974879,1.0814940476991364,0.35526315789473684,0.9003252461641464,1.0,11/39,23.39%,SMAD7;SMAD5;RPS27A;PPM1A;MAGI2;ACVR2A;STRAP;SPRED1;SMAD6;PPARG;UBC
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.7253876502264035,1.081354317273491,0.4305555555555556,0.8998692131130294,1.0,3/7,10.77%,GLUL;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.7355115375645126,1.0811869087267738,0.375,0.8983922105259068,1.0,4/6,21.73%,SLC8A1;ATP1A1;GSN;ATP1B1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.7355115375645126,1.0811869087267738,0.375,0.8983922105259068,1.0,4/6,21.73%,SLC8A1;ATP1A1;GSN;ATP1B1
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),0.49618651891490595,1.0810611984254224,0.2840909090909091,0.8978470978107406,1.0,29/140,17.78%,PIK3R3;ERBB4;SERPINE1;NEDD9;SUN2;HSPA5;ANXA1;ELP3;VSIR;SMAD7;NAV3;SEMA6B;SRGAP1;ENPP2;DLC1;ADAM15;PECAM1;MAGI2;BCAR1;FLT1;CLDN5;ITGB1;SEMA3F;RAC1;SDCBP;PLXNA2;MGAT5;DAG1;PRKX
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.5957892401847321,1.08061034685209,0.3888888888888889,0.8984595888261615,1.0,7/15,25.93%,ANK3;ATP1A1;NEDD4L;SYT1;TF;NEDD4;WNK1
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),-0.6562051388918512,-1.0802393814560152,0.40625,1.0,1.0,2/6,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.6481353184386882,1.0798409266981286,0.43243243243243246,0.899971828818987,1.0,3/12,11.01%,ANXA1;ALPL;GGT5
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.5499497590047515,-1.079687447288951,0.35714285714285715,1.0,1.0,2/14,1.51%,COL8A1;TLL1
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.6931067479278961,1.0795446328174778,0.421875,0.8999806808486801,1.0,2/5,7.55%,NFKBIZ;SMAD7
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),0.6975195498601323,1.0794703951291893,0.4375,0.8992748157707893,1.0,2/7,16.20%,PRNP;TRAM1
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),0.6284096137804774,1.079404747028414,0.47058823529411764,0.8984322727574733,1.0,3/13,17.55%,PIK3R1;RAC1;LIMS1
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.5690084070712478,1.0793241565948486,0.4230769230769231,0.8977985739498026,1.0,8/28,9.09%,LDHA;GLUL;HSPH1;MGLL;ACOX1;ACSL5;HSP90AA1;XIST
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),-0.676043958686325,-1.0791377094029797,0.4166666666666667,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.6449322656888077,1.0789823918485604,0.36486486486486486,0.8981314357991532,1.0,5/8,34.58%,PINK1;DCUN1D4;ARRDC3;CDC14B;RAB1A
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.6685937490496829,1.0789469556379392,0.45454545454545453,0.8973846173612352,1.0,4/8,28.89%,WAPL;TERF2IP;YLPM1;SMG1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),-0.6540845622625406,-1.0788384437513652,0.45454545454545453,1.0,1.0,1/7,0.73%,SLCO1A2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),0.5667556093502452,1.078331192627115,0.3375,0.8987262439868726,1.0,5/30,12.46%,LRRC7;FES;SCARB2;RAP1A;MAGI2
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),0.6527951762781374,1.0779616533596625,0.4533333333333333,0.8988050745932441,1.0,2/12,4.93%,INPP5F;MTMR12
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),0.6684072420465158,1.077713479777088,0.40625,0.8987235503234398,1.0,4/7,25.70%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),-0.586040610479072,-1.0769565965853427,0.48484848484848486,1.0,1.0,2/10,2.18%,VCAM1;IL15
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),0.6205902903244624,1.0768434841055627,0.3684210526315789,0.9007795911379163,1.0,8/19,23.91%,KCNMB4;ANXA1;RAB21;STXBP5L;SYT1;RIMS2;RAB8B;MEF2C
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),0.7455065141319139,1.0764765273287455,0.42424242424242425,0.9010272713223557,1.0,3/5,19.29%,PIK3R1;PXN;STAT3
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.5917026885444199,1.0764179736002542,0.40963855421686746,0.90022509593504,1.0,8/20,27.41%,HYAL2;FOS;HIF1A;JUN;PXN;ADAM9;FYN;EGFR
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.5699576984381111,1.0763704107750716,0.35802469135802467,0.8994360048927201,1.0,7/25,27.41%,RAPGEF3;PINK1;HSP90AA1;SH2D3C;ATP2B4;TERF2IP;EGFR
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.7220156291305673,1.076329194175826,0.453125,0.8986144297495631,1.0,4/6,27.41%,FGFR1;FLT1;ABL2;EGFR
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),0.6604371870291956,1.076149504214387,0.42105263157894735,0.8972717620884095,1.0,2/6,20.04%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),0.6604371870291956,1.076149504214387,0.42105263157894735,0.8972717620884095,1.0,2/6,20.04%,HIF1A;SULF2
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),0.6385001844264295,1.0760847929881794,0.37142857142857144,0.8964777361094572,1.0,2/9,19.29%,MALT1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7416168442942553,1.0758988584743168,0.4305555555555556,0.8962860799011257,1.0,5/5,25.93%,ANK3;ATP1B3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),0.7198710373383066,1.075666424925558,0.4117647058823529,0.8961854025969097,1.0,2/5,19.47%,KDM1A;RIF1
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),0.6820788023110224,1.075543956315588,0.4153846153846154,0.895587280605491,1.0,1/7,8.83%,CDK6
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),0.7192468713814786,1.0754994344324662,0.42857142857142855,0.894787035078756,1.0,3/5,16.23%,CFH;CD55;RAC1
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.7127255757715973,-1.075352810289636,0.45,1.0,1.0,3/5,20.30%,BICD1;CCDC68;NIN
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6997199368956275,1.0751631742635024,0.4915254237288136,0.89494783272981,1.0,3/7,15.03%,ROBO2;SEMA6B;SEMA3F
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.587559571426778,1.075157204103733,0.36046511627906974,0.8940371732433903,1.0,5/27,9.68%,PDK4;PCK1;PIK3R1;HIF1A;BACE2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.7148141218722088,1.0747547243755462,0.45454545454545453,0.8943898917706808,1.0,1/8,12.56%,REST
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.5553339380316862,-1.0746832734447933,0.36,1.0,1.0,3/16,2.18%,VCAM1;CD74;IL15
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),-0.5174253682251136,-1.074557525574502,0.37037037037037035,0.997498281193194,1.0,3/13,10.80%,SLC38A3;SLC25A29;SLC38A6
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),0.7054355937399228,1.0737218046743675,0.4714285714285714,0.8968234039492534,1.0,2/5,13.84%,HIF1A;TRAK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.7033165353208676,1.0730082714305622,0.3870967741935484,0.8980267180813959,1.0,1/5,4.23%,ANXA1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),0.6767649565635689,1.07297836116249,0.45588235294117646,0.8952797446267458,1.0,2/9,7.42%,PPM1D;FOS
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),0.6767649565635689,1.07297836116249,0.45588235294117646,0.8952797446267458,1.0,2/9,7.42%,PPM1D;FOS
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),0.6767649565635689,1.07297836116249,0.45588235294117646,0.8952797446267458,1.0,2/9,7.42%,PPM1D;FOS
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.6442940802788338,1.072601967759828,0.42857142857142855,0.8955730197320065,1.0,4/13,22.77%,PIK3R1;DLC1;PAK2;TMEFF2
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.6404349326722574,1.0725652988740744,0.5166666666666667,0.8929230925490319,1.0,1/10,7.89%,HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),0.6404349326722574,1.0725652988740744,0.5166666666666667,0.8929230925490319,1.0,1/10,7.89%,HSP90AA1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.6404349326722574,1.0725652988740744,0.5166666666666667,0.8929230925490319,1.0,1/10,7.89%,HSP90AA1
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5749876975007745,1.0725555955635435,0.3972602739726027,0.8920248474899641,1.0,3/20,12.23%,UFL1;RPL23;COMMD1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),0.6366007097822903,1.0725281748030606,0.4,0.8912064019556184,1.0,3/13,11.68%,RAPGEF3;RAP1A;PECAM1
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.6946987488375663,1.0723664137872098,0.3888888888888889,0.8908568555790807,1.0,6/7,30.56%,ANK2;AHNAK;DMD;YWHAE;CAMK2D;CALM1
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),-0.6306146786518528,-1.07185347008096,0.4857142857142857,1.0,1.0,2/5,11.53%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),0.5047218538015686,1.0717346871241376,0.3333333333333333,0.8922638400635597,1.0,15/56,20.51%,ANXA1;HYAL2;SMAD7;KLF4;RAP1A;MAGI2;ACAP2;BCAR1;FLT1;ACVR2A;EEF1A1;FOXC1;LIMS1;ZFP36;DUSP22
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),0.5357372796462493,1.0713382708234314,0.36619718309859156,0.8926577146938323,1.0,2/24,2.57%,WNT2B;ZNF160
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),0.4628040718413912,1.0712261899996318,0.3368421052631579,0.8921081363779212,1.0,48/199,20.77%,ZEB2;BCL6;ATF3;KLF2;TBX3;MAFK;BHLHE40;CALR;ZBTB1;ZFPM2;PURA;RPL23;KDM1A;SIN3B;ESR2;SMAD7;CBFB;ARID5A;RPS27A;KLF4;CREM;ZNF366;OTUD7B;JUN;SPEN;CNBP;PPM1A;REST;NEDD4L;LRRFIP1;NCOR2;SDCBP;MTDH;FOXC1;NR2C1;CRY1;MBD2;MCPH1;TPR;STAT3;RIF1;NR1D2;NFIB;NACC2;NFIC;ZFP36;DUSP22;NOTCH4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),0.5821706904408783,1.070124795423163,0.41333333333333333,0.8944844289739743,1.0,3/24,6.52%,ERBB4;FES;FGFR1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),0.5659490273996223,1.0699447259145989,0.42105263157894735,0.8942107869508154,1.0,5/23,19.76%,FGFR1;HIF1A;GATA2;VEGFC;EGFL7
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.5487908474531338,1.0694466710515773,0.47560975609756095,0.8948885138948767,1.0,2/24,8.72%,SEC22B;TMED10
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),0.6796507882625589,1.0692113024556105,0.4426229508196721,0.8949463570381386,1.0,2/8,8.80%,ANK2;ANK3
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.5841418448354091,1.0692008249056741,0.358974358974359,0.8940883132688482,1.0,5/15,22.07%,MAP1B;HSP90AA1;SEMA3F;ALCAM;PPP3CB
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.5944112343017962,1.06908635139607,0.4583333333333333,0.8935406379818062,1.0,8/19,27.41%,RFTN1;SDCBP;PLCB1;AKAP6;CSNK2A1;CDC42;RPS6KA3;EGFR
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.6009015287552807,1.0690088126452202,0.3924050632911392,0.8929390236799378,1.0,5/13,22.07%,MAP1B;HSP90AA1;SEMA3F;ALCAM;PPP3CB
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),0.7177753705533428,1.068969789932591,0.4603174603174603,0.8921626384183308,1.0,1/5,12.05%,SETD3
prerank,MSigDB_Hallmark_2020__Complement,0.5133216107303861,1.0685430335451198,0.37209302325581395,0.8925745901223796,1.0,11/60,14.56%,MAFF;SERPINE1;HSPA5;ZFPM2;DUSP6;GRB2;COL4A2;LAMP2;CFH;CD55;DOCK4
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),0.6434651516146884,1.0684207468132791,0.4931506849315068,0.8921184944955488,1.0,5/11,21.63%,MAP2;SSH1;HIP1R;TBCD;ARFGEF1
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.6604867437103896,1.0681066898540585,0.44,0.8922993647547235,1.0,2/6,12.46%,ITGA1;MAGI2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,0.6353367849210468,1.0677480348619477,0.4393939393939394,0.892611329817345,1.0,4/15,12.72%,ANK2;CTNND2;FGFR1;BCAR1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.6310083626108588,1.0673729861038883,0.43283582089552236,0.892988327497006,1.0,4/11,21.52%,HIF1A;GRB10;PTPN1;NEDD4
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.5760641348679558,1.0668818583200865,0.4,0.8937581491799037,1.0,8/22,21.39%,SERPINE1;SPOCK1;DUSP1;RASA1;FZD4;PLXNA2;PODXL;TBCD
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.653296980969515,1.0668422209276736,0.42857142857142855,0.8929536603763282,1.0,5/9,27.93%,KDM1A;DMD;MEF2C;NEBL;MRTFA
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),0.5275836929936437,1.0665890014134625,0.38271604938271603,0.8928709139450719,1.0,9/42,17.45%,CHPT1;SPNS2;VAPB;KDSR;SAMD8;PLPP1;GOLPH3;DMD;LPIN2
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),0.5190023484304667,1.0664160697177796,0.3488372093023256,0.8925376368308003,1.0,15/51,22.51%,NEDD9;PRKAG2;CCDC88A;PRNP;HSP90AA1;RAP1A;CDKN1A;TAB2;ECT2;PAK2;GRM5;PTPN1;GPRC5B;TAOK1;CAB39
prerank,MSigDB_Hallmark_2020__Allograft Rejection,-0.46437812331929396,-1.0661139339275085,0.3181818181818182,1.0,1.0,5/39,3.45%,GBP2;CD74;IL15;TAP1;STAT1
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.5486941373243583,1.0660768404489562,0.39473684210526316,0.8926841432309323,1.0,7/33,10.72%,PSMC6;BAZ1A;POLA1;PURA;RPS27A;NOC3L;RFC3
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.6539446286612571,1.0659083421872568,0.4533333333333333,0.8921776772262339,1.0,6/9,27.05%,RPS27A;AMFR;UGGT2;UBC;SEL1L;UGGT1
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.5252093895359125,1.0655078588594893,0.36363636363636365,0.8927154639091446,1.0,19/48,28.25%,ZEB2;PSMC6;GPC5;PPM1A;UBE2B;PSMA7;CSNK1G3;TNKS;SULF2;CSNK1D;USP34;GPRC5B;XIAP;CSNK2A1;WNK1;PSMB9;EGFR;VCP;SPIN1
prerank,PanglaoDB_Augmented_2021__Astrocytes,0.5695497298876817,1.065488052515826,0.46987951807228917,0.8918517315938544,1.0,10/32,13.58%,GRIA2;CADM2;S1PR1;GPM6B;NFASC;SNAP25;ADGRB3;GJA1;NRXN1;TMEM132C
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.515509159530175,1.0646660703603361,0.42168674698795183,0.893635967649218,1.0,5/39,13.89%,SEC22B;KLF2;CDKN1B;KLF4;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.5348218351755248,1.064645868433501,0.44871794871794873,0.8928272157187213,1.0,4/29,17.13%,ADM;GGT5;ADCY2;LGALS3
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.6444616515184666,1.0646268711961728,0.4714285714285714,0.8919984358789228,1.0,5/10,25.93%,DUSP1;FOXC1;OXSR1;LRCH1;WNK1
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.7365172160246507,1.064402546341739,0.4090909090909091,0.8908319289937713,1.0,2/5,19.29%,JAK1;STAT3
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.7365172160246507,1.064402546341739,0.4090909090909091,0.8908319289937713,1.0,2/5,19.29%,JAK1;STAT3
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),0.6735416331948931,1.064180670700809,0.44776119402985076,0.8906335062383962,1.0,4/8,24.45%,PTBP2;NCOR2;TMBIM6;PTBP3
prerank,MSigDB_Hallmark_2020__Apoptosis,0.496426829178315,1.0641447196346185,0.3924050632911392,0.8898209991019539,1.0,17/57,18.82%,NEDD9;ATF3;BCAP31;BNIP3L;ANXA1;TIMP3;EMP1;SMAD7;CDKN1B;JUN;CDKN1A;IFNGR1;SLC20A1;BCL2L1;LGALS3;PLAT;BTG2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.6345473322751882,1.0639413088998992,0.4084507042253521,0.8897316746550143,1.0,7/13,26.45%,CDKN1B;GJA1;JUN;CDKN1A;PPARG;MEF2C;ADAMTS1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.7262802183519627,1.0631946650668949,0.49206349206349204,0.8910842203183932,1.0,5/5,27.47%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.6591038255417555,1.0630521169272846,0.5070422535211268,0.8907036162757845,1.0,4/7,21.52%,PRKCE;COMMD1;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5755971969413545,-1.0626050715683775,0.3,1.0,1.0,1/8,6.07%,TMEM106B
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),0.6567967403356347,1.0625912336987047,0.4189189189189189,0.8913330959620674,1.0,1/9,3.09%,BHLHE40
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.6136022126484897,1.0620810561800529,0.41025641025641024,0.8923474942745291,1.0,2/17,8.75%,PSMC6;RPS27A
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.6581210854402911,-1.0614124080442637,0.4473684210526316,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.6581210854402911,-1.0614124080442637,0.4473684210526316,1.0,1.0,2/5,11.42%,SHLD1;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.7183245445041843,1.0614058702141922,0.39344262295081966,0.8927215967862004,1.0,1/5,5.79%,PPHLN1
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.7183245445041843,1.0614058702141922,0.39344262295081966,0.8927215967862004,1.0,1/5,5.79%,PPHLN1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.5293490350824482,1.0613272808078063,0.4074074074074074,0.8921273545548793,1.0,16/39,27.47%,ZEB2;PSMC6;GPC5;PPM1A;UBE2B;PSMA7;CSNK1G3;TNKS;CSNK1D;USP34;GPRC5B;XIAP;WNK1;PSMB9;EGFR;VCP
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),0.7101493369741491,1.0612445898030385,0.4782608695652174,0.8914488108842786,1.0,2/6,4.23%,IL1RAPL1;ANXA1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.70666729725732,1.0611096671766247,0.43137254901960786,0.8909210419265258,1.0,3/6,13.03%,SMAD7;MAGI2;ACVR2A
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.5563725859506511,1.0609202215256672,0.4358974358974359,0.890746206296777,1.0,11/36,18.17%,MT2A;MT1M;PRNP;FOS;ANK3;CDKN1B;JUN;ECT2;SYT1;TF;RYR3
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),0.7093496172073072,1.060812028223153,0.3709677419354839,0.8901029876085901,1.0,4/6,25.05%,ADGRB3;MYEF2;MEF2C;SORT1
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),0.6825586954600225,1.060672721651835,0.4444444444444444,0.8897909499330052,1.0,2/9,10.83%,SCP2;PITPNC1
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.6192018233159235,1.0603869227919565,0.45714285714285713,0.8897240607389985,1.0,1/10,4.10%,MAP3K5
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),0.6114875590696297,1.0603583409150934,0.391304347826087,0.8889987696152603,1.0,2/16,8.75%,MAP3K5;RPS27A
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.6362173344101788,1.0602777585453358,0.45454545454545453,0.8884128460934795,1.0,2/8,15.01%,HSP90AA1;PTTG1IP
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),0.588137068565308,1.0593758724472964,0.3835616438356164,0.8901390194733269,1.0,2/16,23.21%,YTHDC1;SETX
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),0.514022130927803,1.0588528464239115,0.3950617283950617,0.8909404557275317,1.0,17/52,23.91%,HYAL2;FOS;SMAD7;SMAD5;RPS27A;JUN;LRRC32;CLDN5;ITGB1;LIMS1;ZMIZ1;PXN;DUSP22;SMAD6;UBC;ADAM9;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),0.7189009392056004,1.0585349998431415,0.46875,0.8913382861184072,1.0,2/5,16.59%,RAP1A;SLC30A1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),0.6767990089260247,1.0579553325539774,0.44776119402985076,0.8920947048656126,1.0,2/5,5.35%,CHPT1;DHRS7B
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.4985112311374368,1.0574675683979446,0.41379310344827586,0.8926912571803036,1.0,16/66,17.58%,DOK5;LAMA5;ROBO2;PIK3R1;GRB2;SEMA6B;NRXN3;NRXN1;UNC5C;SEMA3F;GRB10;FEZ2;RAC1;PLXNA2;ALCAM;DAG1
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),0.6860567054428687,1.0569911586045786,0.4716981132075472,0.8933182923957271,1.0,1/5,4.65%,GRIN2B
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),0.615291446903368,1.0568763119459499,0.4,0.892784849775511,1.0,5/12,22.61%,HSP90AA1;OGT;PELI1;SDCBP;CDC37
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),0.5703224798410828,1.0568531312924376,0.52,0.8919892353632533,1.0,8/20,24.95%,FES;CBFB;CDK6;HSPA9;LGALS3;KMT2E;MEF2C;CREBBP
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.671788629098669,1.0564032159415884,0.4666666666666667,0.8923942417567023,1.0,2/6,24.30%,ANXA2;RAB3GAP2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.666103967854577,-1.0562670947335067,0.4,1.0,1.0,1/8,0.21%,CEMIP
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.7264089472084968,1.055591080711992,0.40298507462686567,0.8939017969480282,1.0,1/5,4.23%,ANXA1
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.47645187117948834,1.0555798412740465,0.38823529411764707,0.8930759221650755,1.0,19/76,20.12%,TBX3;JUNB;CALR;RPL23;JUND;DUSP1;CDK6;CDKN1B;RASSF1;JUN;CDKN1A;MAGI2;CRLF3;SDCBP;SND1;GRK5;UHRF2;STAT3;HBP1
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),0.7009879579608957,1.0554912590619208,0.42028985507246375,0.8924823761768396,1.0,2/6,21.31%,NRXN1;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),0.5481174090202239,1.0552786394276306,0.39473684210526316,0.8921938255162687,1.0,2/25,6.44%,BNIP3L;PINK1
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.47808430272733027,-1.0546944634938207,0.375,1.0,1.0,4/24,6.83%,GBP1;CARMIL1;LIMS2;EFNA5
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6792861128333089,-1.0535775037289778,0.4,1.0,1.0,3/6,12.72%,ATM;ATR;PMAIP1
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.6252353708305178,1.0534551605677032,0.423728813559322,0.8966265734771464,1.0,3/9,19.68%,BCAP31;TGM2;HERPUD1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.6314625004782544,1.053407287247345,0.4383561643835616,0.8959476584808246,1.0,3/8,12.77%,SLC4A10;ANO5;ANO6
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),-0.6750187863090293,-1.0530396476581774,0.5151515151515151,1.0,1.0,2/5,7.32%,STAT1;PKD2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.6051760974358095,1.0527346396308404,0.45714285714285713,0.8970773943583281,1.0,3/15,11.68%,RAPGEF3;RAP1A;PECAM1
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),0.5848785505198049,1.0525310961510128,0.410958904109589,0.8967959594092315,1.0,5/15,15.81%,MAP3K5;RPS27A;MAPK10;TAB2;SH2D3C
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),0.653461762861588,1.052410577564088,0.5084745762711864,0.8961918334268381,1.0,5/8,30.50%,OGT;SETD3;WDR82;TET2;KMT2A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6983828692043149,1.052268881513021,0.44594594594594594,0.8957867916562671,1.0,2/6,10.72%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.6737274364136976,1.0519486658918633,0.47761194029850745,0.89603815962489,1.0,3/6,25.83%,RAPGEF3;TAOK1;TERF2IP
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.7210761481824559,1.051806486425712,0.4393939393939394,0.8955612668052384,1.0,2/5,14.88%,RPL23;SMARCC1
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),0.510953540760965,1.0510614231868396,0.37037037037037035,0.8971107225425926,1.0,28/71,27.02%,NRCAM;FES;AAMDC;FGFR1;CTNNA1;GJA1;RAP1A;BOC;REST;ACVR2A;ECT2;WWTR1;SDCBP;FOXC1;ARHGEF2;ZFP36;BTG1;GPRC5B;PLCB1;PPARG;MEF2C;PRKCH;ZEB1;CDC42;SLC6A6;RPS6KA3;MTOR;ASXL2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.6564405565396257,1.05086090689819,0.4507042253521127,0.8969035142056816,1.0,3/6,17.03%,SULT1C4;SLC26A2;TPST2
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.7028814471952043,1.0507452760637217,0.5,0.8964789979795216,1.0,4/5,25.93%,ANK3;DMD;ATP1B1;WNK1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.558652433992412,1.0505743578101767,0.47692307692307695,0.8962002927966815,1.0,3/16,9.24%,WDR48;PINK1;OGT
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.6841994299808934,1.0502943507389908,0.5,0.89634635106653,1.0,3/8,16.82%,KCNMB4;ANK3;DMD
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.6563085949238023,1.0502123363019549,0.3880597014925373,0.8957478529447334,1.0,2/7,6.44%,HSPA5;PINK1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),0.6580680942177835,1.0494378454896967,0.47058823529411764,0.8974225060876114,1.0,4/7,31.54%,ATP1A1;TFPI;ABHD2;UBE3A
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.7060046789706265,1.0494298652009335,0.4918032786885246,0.896607456721599,1.0,5/5,29.49%,COMMD1;NEDD4L;NEDD4;WNK1;CAMK2D
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),0.5842523581760342,1.049230003145027,0.42424242424242425,0.8964021108481572,1.0,4/15,9.24%,SPOPL;UFL1;SMAD7;OGT
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),-0.5208188485367307,-1.0486191202803745,0.4482758620689655,1.0,1.0,3/12,11.66%,ATP10D;ATP9A;ATP9B
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.5126696911417797,1.048540318993956,0.4074074074074074,0.8977418264849534,1.0,8/50,11.37%,ANK2;NES;MAP1B;NFASC;COL4A2;GJA1;BOC;PCDH7
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.6061932755470353,1.0477068085396344,0.4722222222222222,0.8991818727544737,1.0,1/15,1.64%,LRRC7
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.5251587791778147,-1.0476828394229332,0.36,1.0,1.0,3/14,8.88%,SLCO1A2;ABCG2;SLC16A2
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),-0.3722698727294823,-1.0476467821638855,0.18181818181818182,1.0,1.0,13/132,8.64%,RNF213;ATG10;MSL2;ISG15;IFIH1;ANAPC16;HERC5;ZNRF3;NFX1;NUP214;RTF1;MDM2;HERC2
prerank,GO_Biological_Process_2021__heart development (GO:0007507),0.5261716218062134,1.0474662903457848,0.43902439024390244,0.8990466128791065,1.0,9/47,16.74%,ERBB4;CACNA1C;ZFPM2;CDKN1B;DLC1;CDKN1A;FOXF1;TAB2;FOXC1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.6090890145594934,1.0471567366525345,0.45454545454545453,0.8991580530443763,1.0,3/16,14.46%,REL;RPS27A;TAB2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.6688887937352223,1.0471378215491396,0.4492753623188406,0.8983562555207418,1.0,4/9,23.91%,CDKN1B;CDKN1A;PPARG;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.5383911440849268,-1.0471150828501568,0.4482758620689655,1.0,1.0,3/17,6.83%,GBP1;GCNT2;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),0.46973358309302526,1.0470509981156844,0.42857142857142855,0.8977199619564191,1.0,29/135,20.46%,ERBB4;TBX3;CALR;CD81;UFL1;FGFR1;RPS9;RPL23;CDKN1B;SMC6;CNBP;FLT1;CLDN5;CNOT6L;ADGRG1;WWTR1;KRAS;RAC1;SDCBP;GRK5;TGM2;GATA2;SLFN11;NAMPT;BCLAF1;VEGFC;CSPP1;ZFP36;DYNC1H1
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.7049600697155063,1.0469950801412053,0.4461538461538462,0.8969312841096423,1.0,4/5,29.49%,COMMD1;NEDD4L;CAB39;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),0.6562047450158897,1.04673867915503,0.43548387096774194,0.896676038024721,1.0,2/8,11.84%,GRB2;CDKN1A
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.6454436214160654,1.046736776856082,0.4714285714285714,0.8958285181400095,1.0,5/9,25.93%,DUSP1;FOXC1;OXSR1;LRCH1;WNK1
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.4749046707761139,1.0467235780883277,0.425,0.895003019430957,1.0,17/60,17.52%,CHPT1;KAZN;BHLHE40;INPP5F;FOS;DLC1;GJA1;KLF4;SLC2A1;FKBP5;SLC26A2;ADD3;AMFR;NCOR2;NAV2;FOXC1;TGM2
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.5226725591825333,1.0466919219337643,0.4025974025974026,0.894270884147431,1.0,4/24,4.80%,NEDD9;IL1RAPL1;CALR;PTPRD
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),-0.6527511435681107,-1.0465621383266073,0.5625,1.0,1.0,3/5,28.71%,PRKD1;HSPB1;PRKD2
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),0.6813538403305655,1.0464790757921723,0.49206349206349204,0.894080254028638,1.0,1/6,4.65%,GRIN2B
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),-0.6737473863701932,-1.0459967751085832,0.53125,1.0,1.0,1/6,0.73%,SLCO1A2
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.6845788812554129,1.0456200512067992,0.45901639344262296,0.8953561107257396,1.0,1/8,1.25%,NEDD9
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.6870682379143556,1.0452609638778676,0.3835616438356164,0.8948011263837384,1.0,2/7,10.72%,RPS27A;RFC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.6870682379143556,1.0452609638778676,0.3835616438356164,0.8948011263837384,1.0,2/7,10.72%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.5130205993938292,-1.0450284468648459,0.4166666666666667,1.0,1.0,3/12,8.46%,ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),-0.5952522053692461,-1.0449540441261047,0.45161290322580644,1.0,1.0,1/8,0.18%,GBP1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.6623928541037901,1.044791454580193,0.45588235294117646,0.8954432409350176,1.0,1/7,10.72%,RFC3
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),-0.5602209123465025,-1.0443023838236578,0.4411764705882353,1.0,1.0,3/10,11.42%,SHLD1;RNF169;SHLD2
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),0.6657099254455319,1.0442685399269505,0.5,0.8959522886633611,1.0,3/6,16.02%,INPP5F;ANXA2;KIF16B
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),0.6636525253969825,1.0441179415956194,0.4745762711864407,0.8946693209059771,1.0,1/8,3.58%,PPA1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),0.6636525253969825,1.0441179415956194,0.4745762711864407,0.8946693209059771,1.0,1/8,3.58%,PPA1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.5254177010333004,1.0437680190762957,0.4358974358974359,0.8947224992317419,1.0,4/32,12.69%,ADM;KLF4;GGT5;ADCY2
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),0.6093762153662108,1.0432943155773722,0.4794520547945205,0.8951494750066054,1.0,2/11,10.38%,TSG101;LAMP2
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),0.6849574090469988,1.0430688773963153,0.5142857142857142,0.8950304756615896,1.0,2/9,6.62%,PINK1;CCDC88A
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.7008753920106283,1.0429568415742976,0.4782608695652174,0.8944981531831744,1.0,1/5,2.86%,BCAP31
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.6498959542185638,1.0429090650509893,0.46153846153846156,0.8938055898500806,1.0,3/7,24.25%,ADGRB3;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),0.5728400277910024,1.0424725889241333,0.39705882352941174,0.8945036565999932,1.0,7/21,21.70%,IPO7;DUSP1;CDK6;CDKN1B;FOXC1;BTG2;BTG1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.6603139027860085,1.0424082080259522,0.5,0.8938526099122539,1.0,3/8,23.91%,REST;PDE4B;MEF2C
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.5381976370371507,1.042289982594325,0.4470588235294118,0.8933032630568961,1.0,7/27,17.81%,ARF1;MT2A;MT1M;PRNP;NDFIP1;SLC30A1;TF
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.6516823224737354,-1.0420308167173382,0.4634146341463415,1.0,1.0,1/6,4.60%,MTERF1
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.6714886840214246,1.0411556111828832,0.45161290322580644,0.8958772644843703,1.0,4/7,25.83%,RAPGEF3;DIP2A;TAOK1;TERF2IP
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),0.5070591682795561,1.0411151152566156,0.4230769230769231,0.8951164217978234,1.0,9/46,17.47%,DDIT4;PRKAG2;PRNP;SMAD7;TRIB2;PAK2;WWTR1;DMD;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),0.5624060539164494,1.0409313211889306,0.43243243243243246,0.8949281881614101,1.0,2/20,6.62%,RTN4;CCDC88A
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.42985910988462184,-1.0408456831956023,0.391304347826087,1.0,1.0,1/32,0.13%,VCAM1
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",0.5830379102436837,1.0404098577249792,0.4788732394366197,0.8957214548441523,1.0,8/16,34.66%,TAF1D;ZMIZ1;ACTB;SMARCA5;DEK;ARID1A;ATAD2B;EP300
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.6149144731833535,1.0403568592287336,0.5070422535211268,0.8951129051521476,1.0,2/10,7.89%,BCAP31;HSP90AA1
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),-0.55992674082975,-1.0403067598697355,0.5,1.0,1.0,2/11,2.18%,VCAM1;IL15
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.6331123684683749,1.0398754298594768,0.47619047619047616,0.8953149332809798,1.0,3/8,18.56%,PIKFYVE;LGALS3;PDE4B
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),0.5830004987810069,1.039715052802161,0.44776119402985076,0.8948975791391636,1.0,2/19,7.22%,B3GNT2;CHST11
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.5738153612425021,1.0394517797964098,0.43243243243243246,0.8947403400495407,1.0,6/15,33.44%,RPS27;NPM1;RPL10;RPS15;RPL24;DDX3X
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),0.6690838733042324,1.039396592220248,0.4745762711864407,0.8940552131893788,1.0,2/5,13.89%,SMAD7;NEDD4L
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),-0.5125693508077895,-1.0389195573827015,0.41935483870967744,1.0,1.0,1/9,1.27%,SLC38A3
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.571053937995809,1.0384806901417385,0.4444444444444444,0.8958206320381346,1.0,3/25,9.87%,SERPINE1;INPP5F;KLF4
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),0.6095855270880164,1.0379513550267918,0.46875,0.8965084964789976,1.0,4/9,27.10%,TGM2;PDE4B;ATP2B4;RYR2
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.6261866937417611,-1.0374060672798044,0.475,1.0,1.0,2/6,11.42%,SHLD1;SHLD2
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.5600911584858379,1.0372193601889157,0.527027027027027,0.8976423126104112,1.0,5/28,16.74%,NES;MAP1B;BOC;BCAR1;FOXC1
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.4888614951156081,1.03714290194734,0.4642857142857143,0.8970265405558198,1.0,15/63,21.18%,ARHGAP23;MYO9B;ARHGEF4;BCR;ARHGAP21;SRGAP1;DLC1;GNA13;ECT2;RAC1;FAM13A;TGM2;ARHGEF2;KALRN;PREX1
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,0.554579370249647,1.0358821020921427,0.4520547945205479,0.899655706146215,1.0,5/22,5.63%,GRIA2;MAP2;GPM6B;NPAS3;CTNND2
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.5892504393967687,1.0352509588486067,0.5428571428571428,0.9006745009421979,1.0,2/22,10.38%,PDK4;LAMP2
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.5899126454774599,1.0350550403667138,0.5,0.9003645975682468,1.0,3/20,7.17%,SERPINE1;NFKBIZ;HYAL2
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),0.6584327216465309,1.0350103554784855,0.47540983606557374,0.8997090176753697,1.0,2/5,20.04%,CHST11;SULF2
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.6405773684398572,1.0348091856468113,0.5151515151515151,0.8993610288530715,1.0,4/9,12.77%,ANK2;ANK3;ATP2B1;ANO6
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),0.48481317285009606,1.0347794059333135,0.4457831325301205,0.8986384406315315,1.0,17/63,20.15%,TRIM5;DOK5;MGLL;PRNP;CBFB;OGT;SIK2;RIC8B;PRAG1;CD55;WWTR1;AMFR;VWA2;CRK;GRK5;PXN;PTPN1
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,0.5289473272002527,1.0345268792928106,0.41975308641975306,0.8984696443475259,1.0,14/34,11.29%,GRIA2;DOK5;MAP2;ANK2;GPM6B;MAP1B;NPAS3;PTPRD;NFASC;LRRC4C;PPFIA2;ADGRB3;GJA1;BOC
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.5935334925079438,1.0343953699434352,0.5147058823529411,0.8979266049210897,1.0,6/15,22.40%,KDM1A;ALPL;RFC3;SMARCC1;GATA2;NPM1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.5933512871785338,1.0343940925093058,0.4852941176470588,0.8971186687532442,1.0,3/18,9.14%,TBX3;CALR;CDKN1B
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.7035058510869505,1.03397545945866,0.5538461538461539,0.8973649400316143,1.0,1/6,13.63%,AGO2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),0.6407511404999819,1.0337150600281941,0.4626865671641791,0.8972863827652231,1.0,2/8,19.29%,MALT1;STAT3
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.6536530514155396,1.033622338577281,0.47692307692307695,0.8967758533271324,1.0,2/8,15.26%,CANX;SYT1
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.5863913362189953,1.0334020380322102,0.4307692307692308,0.8965998543864859,1.0,4/15,9.24%,SPOPL;UFL1;SMAD7;OGT
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),0.6147089635980543,1.0331544204338279,0.42424242424242425,0.8963261447220083,1.0,5/12,21.42%,SMAD7;JAK1;ANK3;PODXL;AFDN
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.6439531859557867,1.0331498883493107,0.4782608695652174,0.8955436374150862,1.0,7/7,35.72%,ITGA1;MAGI2;MEF2C;MTOR;CALM1;MTMR9;HSP90AB1
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),0.6828424263129403,1.0331110399672465,0.43103448275862066,0.894850613590747,1.0,1/5,4.88%,ROBO2
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.48451949505503017,1.032521289428082,0.379746835443038,0.8957621717179676,1.0,7/56,10.33%,DDIT4;RTN4;GAPDH;PRKCE;OGT;DLC1;ADAM15
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),0.6866069299345878,1.0323806726094877,0.43333333333333335,0.8953143916416074,1.0,1/5,8.13%,RAB21
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),0.6267513834933143,1.0322905928423525,0.484375,0.8947307973625209,1.0,2/8,16.33%,PINK1;BCL2L1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),0.46922110934640254,1.0317896172103278,0.4117647058823529,0.8953767490343095,1.0,20/65,22.17%,SUN2;VAPB;ATP8B1;ARHGAP21;SRGN;TMED10;ANK3;TOR1AIP2;NPLOC4;WASHC4;DYSF;REEP3;RAB30;GOLPH3;VMP1;RAB2A;ARFGEF2;CSNK1D;ARFGEF1;DNAJC13
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.65071875939822,1.031448159266276,0.5,0.895427325792971,1.0,2/9,15.26%,CANX;SYT1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",0.5622278029481234,1.031245827741113,0.45588235294117646,0.895205304399459,1.0,9/25,23.21%,PPM1D;CBFB;JUN;CDKN1A;CCNC;BCLAF1;CDK8;MED4;SETX
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),0.5453482135695253,1.0308958871618077,0.43243243243243246,0.895343457169593,1.0,5/20,16.02%,PIK3R1;GRB2;BCAR1;ERBIN;KIF16B
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),0.6013159872267969,1.0307952181877522,0.4520547945205479,0.8947916032173237,1.0,3/9,19.00%,PINK1;SPIRE1;DDHD1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),0.6787739813250241,1.030646595079207,0.4918032786885246,0.8942892709625749,1.0,1/5,15.03%,SEMA3F
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.5549174476273789,1.030010521343846,0.3835616438356164,0.8950194199886321,1.0,7/17,22.30%,PPP2R3A;PGK1;LGALS3;DAG1;HNRNPH3;TAGLN2;PPARG
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.5189330910529748,1.0293993102204948,0.43037974683544306,0.8956513725771275,1.0,10/28,31.13%,PPM1D;PPHLN1;TAF1D;CREBZF;ACTB;MTF2;SMARCA5;MECP2;DEK;AEBP2
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),-0.39455351404653877,-1.0281445023301858,0.46153846153846156,1.0,1.0,7/87,3.50%,COL8A1;CARMIL1;PGM5;TLL1;RHOBTB1;ARHGAP12;EVL
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.6338083946375525,1.0280629107293044,0.5423728813559322,0.898305338463564,1.0,2/7,21.00%,PKIG;ATP2B4
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.5985442688113906,1.0279590790874933,0.4626865671641791,0.8977242889035911,1.0,6/11,23.75%,ROBO2;HYAL2;FOXC1;PRKX;SULF2;CEP290
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.682168916152935,1.0278347442593305,0.4714285714285714,0.8972505688503326,1.0,3/6,25.60%,GJA1;SLC1A2;SLC6A6
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.4459207994129095,1.0273815762905893,0.46153846153846156,0.8977913846594924,1.0,20/136,15.32%,PIK3R3;ANK2;GAPDH;VSIR;RPL23;NFE2L2;PIK3R1;ANK3;HIF1A;GJA1;KLF4;SLC38A2;LARP4;AGO2;CLDN5;NOS1AP;TAF1D;IFNGR1;TENT4A;KRAS
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.6102905218787669,1.0272913987962846,0.48484848484848486,0.897270222038185,1.0,2/13,6.36%,MBP;NFASC
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.6872601163683721,1.0261435749192234,0.5303030303030303,0.899843459290682,1.0,1/6,3.40%,NES
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6309561725871524,1.0258256612897263,0.49333333333333335,0.8999857570806414,1.0,1/8,4.00%,S1PR1
prerank,PanglaoDB_Augmented_2021__Alpha Cells,0.528437165037291,1.0252614682995036,0.4,0.9007049916695523,1.0,6/24,14.17%,PTPRD;NFASC;SNAP25;DEPP1;SHC2;MAPK10
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),0.6908152914174072,1.024993845195247,0.49230769230769234,0.9004714306680455,1.0,3/5,26.79%,DNM2;ASAP1;WASL
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5906343308450588,-1.0246048094975628,0.41935483870967744,1.0,1.0,1/6,1.35%,PGM5
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.6767491882342627,1.0243867027842568,0.49122807017543857,0.9015634635426361,1.0,3/5,23.78%,NEDD4L;AKAP6;YWHAE
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),-0.6013185499229211,-1.024376415832994,0.4864864864864865,1.0,1.0,1/7,11.76%,PTPN2
prerank,PanglaoDB_Augmented_2021__Osteocytes,0.517804116485298,1.0243759093055118,0.5256410256410257,0.9007826844137194,1.0,8/35,19.18%,PLS3;NES;COL4A2;GJA1;WWTR1;CTTNBP2NL;PLAT;VEGFC
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.5265252096498239,1.0241215273625066,0.5061728395061729,0.9007605615576448,1.0,14/31,28.97%,RAPGEF3;CPEB4;SSH1;CTNNA1;HSP90B1;RAP1A;GOLPH3;RYR3;ACTB;AKAP6;MEF2C;MTOR;SLC38A9;CAPN2
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),0.4879179847559671,1.0241112756734179,0.4358974358974359,0.8999914539547417,1.0,18/53,28.30%,GLUL;RPS9;RPL23;RPL34;RPL8;RPL37;RPLP2;RPL13A;RPS27;NPM1;RPLP1;RPL10;RPL37A;XPO1;MTREX;RPL21;RPS15;WDR43
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),-0.5640142194386962,-1.0239707582161066,0.4166666666666667,1.0,1.0,4/11,14.69%,STAT1;PLXND1;MAML3;MAML2
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.6432886668317304,1.0235983556459933,0.5,0.9004867832031025,1.0,1/10,4.54%,TIMP3
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),-0.624046985339445,-1.0232668730827008,0.4473684210526316,1.0,1.0,1/5,2.13%,CWC27
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),-0.624046985339445,-1.0232668730827008,0.4473684210526316,1.0,1.0,1/5,2.13%,CWC27
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),0.6718265123395843,1.0230115050278161,0.6190476190476191,0.9013732085957582,1.0,3/5,30.35%,ATP1A1;TFPI;ABHD2
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.6917707506893295,1.0228840128822942,0.4714285714285714,0.9008443942715103,1.0,1/5,4.26%,GPM6B
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",0.5033062595576204,1.0227604128283827,0.4473684210526316,0.9003546870956783,1.0,5/42,18.51%,KHDRBS3;YTHDC1;REST;SRSF7;TRA2B
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6516984390528859,1.022636998436118,0.5223880597014925,0.8999135186125141,1.0,4/8,32.68%,FOXF1;NOTCH4;CDH5;ACVRL1
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),-0.5865321325095672,-1.0221645585117622,0.4642857142857143,1.0,1.0,2/7,16.28%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),0.6928215524440225,1.0211464423346595,0.5,0.9031313424690975,1.0,3/7,20.40%,ANXA1;REST;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),0.5136629246692298,1.020854138262476,0.4666666666666667,0.903021643989038,1.0,5/27,14.36%,SLC2A13;PICALM;LARP4;NSMAF;IFNGR1
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7008979133654613,1.020469872677207,0.5161290322580645,0.9033591011381905,1.0,3/5,17.03%,PPA1;SULT1C4;TPST2
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.6281814962231277,-1.0203417338686334,0.5,1.0,1.0,1/6,1.12%,MSL2
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6656324876199762,1.0198703963880662,0.5409836065573771,0.9041710395852659,1.0,1/7,1.51%,CLIC2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6292827408208546,1.019869859584748,0.4925373134328358,0.9033772107533209,1.0,5/8,23.78%,PRKCE;NEDD4L;NEDD4;CAB39;YWHAE
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),0.6117269104333298,1.0198171249316998,0.5522388059701493,0.902727046874941,1.0,6/12,26.04%,KLF4;PAK2;YWHAE;XIAP;CSNK2A1;RPS6KA3
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.6660617456230806,1.0197176271293662,0.4666666666666667,0.9021159286567395,1.0,3/7,22.07%,SYT1;RIMS2;PPP3CB
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.5458935963655229,1.0195003590629472,0.4931506849315068,0.9019035454006722,1.0,9/21,23.47%,HSPA5;HSPH1;HSP90AA1;HSPA9;TMBIM6;HERPUD1;PTPN1;HSPA8;SERPINH1
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.46955325122306046,1.018541301565831,0.45348837209302323,0.9035362188626416,1.0,8/58,11.24%,MAP2;GRM7;GPM6B;CTNND2;PPP1R9A;MICALL2;CNTNAP2;GAS7
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.5403816262977432,1.0175089878456607,0.5063291139240507,0.9054779425953771,1.0,7/27,16.69%,POLA1;CDK6;CDKN1B;CDKN1A;CCNH;CRLF3;BRD4
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.5681796288399076,1.0174956941909665,0.43037974683544306,0.9047060189645107,1.0,8/14,35.20%,EEF1A1;FOXC1;ZFP36;DUSP22;EGFR;DAB2IP;GAREM1;IQGAP1
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),0.5622862723327031,1.0166279377191634,0.46835443037974683,0.9065018058412536,1.0,7/22,21.42%,RFTN1;ZDHHC6;ZDHHC14;PIKFYVE;SDCBP;VPS37A;AFDN
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.6429871255302981,1.0164712840695487,0.5072463768115942,0.9061262667564522,1.0,5/11,17.94%,NRCAM;FGFR1;REST;ECT2;ARHGEF2
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),0.66996498829133,1.016321932834637,0.4722222222222222,0.9056383572593245,1.0,3/6,31.57%,SCARB1;ABCA5;ABCG1
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),0.4980787359551164,1.015866110775927,0.4567901234567901,0.9058853179483378,1.0,6/41,5.48%,LRRC7;FES;IL1RAPL1;PTPRD;ROBO2;SCARB2
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),-0.5220610089826456,-1.015725651177676,0.3783783783783784,1.0,1.0,2/11,2.83%,ATM;BABAM2
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.5763506391859141,1.0153853503973564,0.47297297297297297,0.9064327240657647,1.0,5/24,9.24%,INPP5F;PLCL1;FGFR1;PIK3R1;OGT
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.7102929669887575,1.015317306351144,0.5357142857142857,0.9058612724639821,1.0,3/5,24.25%,ADGRB3;SCARF1;ANKS1A
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.5695056319081945,1.0149946566597414,0.4931506849315068,0.9061918706845651,1.0,1/15,0.13%,CCDC3
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),0.5159271828007997,1.0148861838235703,0.38961038961038963,0.9056685086055213,1.0,8/45,16.74%,ERBB4;CACNA1C;ZFPM2;CDKN1B;CDKN1A;FOXF1;TAB2;FOXC1
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),0.5044549629929463,1.0144574031837428,0.4583333333333333,0.9060923984150854,1.0,8/28,18.82%,RTN4;CALR;GAPDH;PRNP;GIGYF2;RPL13A;RTN3;BTG2
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.6300397184077866,-1.013938000979575,0.42857142857142855,1.0,1.0,2/6,6.54%,IFI27;NUP214
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.7209385646757427,1.0133844803320222,0.5230769230769231,0.9082380957256806,1.0,2/5,15.26%,KCNMB4;SYT1
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.6385073475536212,1.01256677747126,0.5076923076923077,0.909659858151435,1.0,2/5,12.07%,KCNMB4;ATP1B3
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),0.6347536538688747,1.0121235647970628,0.5147058823529411,0.91005116274332,1.0,2/6,16.72%,PPM1A;HDAC7
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.6763873980849063,1.0120596838040516,0.53125,0.909405341695528,1.0,2/5,15.03%,SEMA6B;SEMA3F
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",0.42758543150585976,1.0119331906476525,0.45263157894736844,0.9089845389955671,1.0,57/272,21.50%,ZEB2;BCL6;ATF3;KLF2;TBX3;MAFK;BHLHE40;PHF10;CALR;ZBTB1;ZFPM2;PURA;RPL23;KDM1A;SIN3B;ATP8B1;ESR2;SMAD7;CBFB;ARID5A;RPS27A;CDKN1B;KLF4;CREM;ZNF366;OTUD7B;JUN;SPEN;CNBP;PPM1A;REST;NEDD4L;ZBTB38;LRRFIP1;NCOR2;SDCBP;MTDH;FOXC1;NR2C1;CRY1;ATOH8;LIMS1;MBD2;MCPH1;TPR;BCLAF1;STAT3;RIF1;NR1D2;NACC2;NFIC;ZFP36;DUSP22;NOTCH4;RCOR3;CREBZF;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),0.4970494018182987,1.0115757130011946,0.4810126582278481,0.9091423815958255,1.0,9/28,22.30%,SMAD7;SMAD5;ACVR2A;SULF2;PTPN1;ATP2B4;SMAD6;NEDD4;PPARG
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.591215672258196,1.0113039579548395,0.5211267605633803,0.9082754858848184,1.0,7/13,34.37%,INSIG1;CNBP;RALY;SCARB1;ABCA5;ABCG1;LDLR
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.591215672258196,1.0113039579548395,0.5211267605633803,0.9082754858848184,1.0,7/13,34.37%,INSIG1;CNBP;RALY;SCARB1;ABCA5;ABCG1;LDLR
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),-0.4552690130545671,-1.0111398371162028,0.48,1.0,1.0,6/30,9.35%,ISG15;IFIH1;HERC5;IRF1;TRIM25;NLRC5
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),0.5970783032575955,1.0110438513231599,0.4626865671641791,0.9081174247671083,1.0,4/12,13.89%,IL1RAPL1;PTPRD;ADGRB3;NEDD4L
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),0.5239692492398158,1.0108388319167516,0.4852941176470588,0.9078853211934031,1.0,5/20,22.30%,SMAD7;SMAD5;ACVR2A;SMAD6;PPARG
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5509327819132971,-1.0108106831818013,0.5,1.0,1.0,3/9,6.20%,CD74;ATM;RC3H1
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),-0.644085337940188,-1.0107569220925956,0.5806451612903226,1.0,1.0,1/5,1.48%,PLA2G4A
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),-0.45932919619008294,-1.0104510225553904,0.4444444444444444,1.0,1.0,5/50,3.14%,RNF213;MLLT3;ANKRD6;NKD1;ZNRF3
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.6523788088251739,1.010212296330627,0.5142857142857142,0.9081085341796268,1.0,1/5,7.74%,TUBB4B
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.6523788088251739,1.010212296330627,0.5142857142857142,0.9081085341796268,1.0,1/5,7.74%,TUBB4B
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),0.5790377252938819,1.010132658608331,0.5135135135135135,0.9074971545164741,1.0,3/16,12.36%,RPS27A;RFC3;CCNH
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),0.6703839870373589,1.0097097262239956,0.5,0.9076737043332826,1.0,2/5,25.08%,TMTC1;TMTC2
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.4172340408349134,-1.0094376443129043,0.47368421052631576,1.0,1.0,8/54,7.40%,XAF1;EIF2AK2;ISG15;CD74;MX1;STAT1;SP100;GCH1
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),0.6630719591388273,1.009255584090089,0.5396825396825397,0.9081089387471085,1.0,1/7,1.12%,RFTN1
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.6130196275328977,1.0089219859625649,0.5277777777777778,0.9081090731418902,1.0,1/9,6.57%,DUSP6
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),0.5524821658027206,1.0088831772399658,0.5333333333333333,0.9074074441648375,1.0,11/25,33.64%,FGFR1;HIF1A;GATA2;ATP2B4;PPARG;ETS1;MEF2C;MECP2;RGCC;ACVRL1;ADAM17
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),0.5963634228886464,1.0085584035651574,0.4605263157894737,0.9075465645794084,1.0,3/13,10.77%,GLUL;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),0.6588663546541861,1.007893668732765,0.5571428571428572,0.9084321043136148,1.0,6/6,34.22%,UGGT2;UGGT1;VCP;DNAJB14;CUL3;ATXN3
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),0.6938550278046207,1.0077753693904545,0.5344827586206896,0.9080543476514631,1.0,2/5,26.14%,AFDN;CDH5
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.5184878261383377,1.007473812022607,0.4936708860759494,0.9080545279348587,1.0,4/23,9.84%,COL4A2;MSRB3;DLC1;GJA1
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4277281361385206,-1.007153696948058,0.4583333333333333,1.0,1.0,3/28,4.41%,EIF2AK2;ANKRD6;TPD52L1
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),-0.49712711635038953,-1.00641375499823,0.36363636363636365,1.0,1.0,3/14,10.80%,SLC38A3;SLC16A2;SLC38A6
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),0.521959086851764,1.0063566544437228,0.4246575342465753,0.9102154075436837,1.0,7/20,24.51%,SPOCK1;RAC1;FZD4;LIMS1;RSU1;TBCD;EMP2
prerank,PanglaoDB_Augmented_2021__Macrophages,-0.5053533818690872,-1.0061854358890179,0.3235294117647059,1.0,1.0,3/15,9.84%,CD74;PARP14;TNFRSF1B
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.6351230656981621,1.005831522066122,0.5205479452054794,0.9106822708377014,1.0,4/7,32.61%,SMC6;IHO1;CSNK2A1;ZNF207
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),0.5482624576281211,1.0048139464372179,0.42424242424242425,0.9125618853523656,1.0,6/19,17.47%,PRKAG2;CDKN1B;TRIB2;PAK2;WWTR1;SPRED1
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.4935795617243035,-1.0045140634192142,0.47058823529411764,1.0,1.0,7/15,23.16%,BICD1;EFNA5;CLASP1;CYLD;PHLDB1;MARK2;PHLDB2
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.6053430968277298,1.0044502002914049,0.5217391304347826,0.9126407814752913,1.0,6/12,26.40%,BCAP31;BCL2L1;BCLAF1;NACC2;NCK1;RACK1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),0.6513971881793715,1.0034667944741154,0.5161290322580645,0.9142498147816158,1.0,2/5,16.12%,ZBTB1;AP1G1
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),0.6549144633560509,1.0031492638827617,0.5084745762711864,0.9143088369782685,1.0,1/6,4.88%,ROBO2
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),0.6160217063092075,1.0031226949895036,0.5161290322580645,0.9135901968080331,1.0,1/7,1.84%,SUN2
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.511559057182607,1.0028903919122294,0.5,0.9132932144071706,1.0,13/42,29.18%,NES;KDM1A;CDKN1A;CLDN5;HIP1R;AMFR;CRK;TMBIM6;ACTB;ADD1;RACK1;MARK3;SPPL3
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),0.4916598300165674,1.0027073798782802,0.4691358024691358,0.9128962779065686,1.0,10/48,19.89%,PRKAG2;CCDC88A;CDKN1B;OGT;HIF1A;CDKN1A;BTBD10;SDCBP;TPR;GRM5
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),0.5748521681745876,1.0013905326464185,0.5151515151515151,0.9155567641088699,1.0,3/17,9.42%,LAMC1;BCR;DLC1
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),-0.608212086312486,-1.0010061665902543,0.5405405405405406,1.0,1.0,1/7,1.43%,CPQ
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),0.5726517165885118,1.0000371278554143,0.5362318840579711,0.9184042195968003,1.0,6/19,23.91%,FGFR1;HIF1A;FOXC1;LIMS1;NOTCH4;MEF2C
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.5979919737892097,0.9997490672341196,0.5217391304347826,0.9183683509221285,1.0,3/12,14.51%,GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.45315100898032074,-0.9996281834378901,0.4857142857142857,1.0,1.0,3/21,9.01%,IRF1;PARP9;SAMHD1
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),0.4702236158633959,0.9987383114042774,0.5232558139534884,0.9202165724082929,1.0,7/51,11.24%,NRCAM;MAP2;MAP1B;CTNND2;ANK3;CNTNAP2;GAS7
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),0.48817462925869964,0.99867497485622,0.4430379746835443,0.9196063216890936,1.0,14/45,23.83%,FOS;SMAD7;SMAD5;RPS27A;JUN;LRRC32;CLDN5;ITGB1;ZMIZ1;PXN;DUSP22;SMAD6;UBC;ADAM9
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),0.6034806758166334,0.9984221668778656,0.5454545454545454,0.9194514114176024,1.0,5/10,23.05%,PDE7A;RAPGEF3;ADCY2;RIMS2;AKAP6
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.5191441053342613,0.9983189030818573,0.5142857142857142,0.9190153225979297,1.0,9/24,26.04%,BCAP31;MAP3K5;KLF4;REST;MALT1;YWHAE;XIAP;CSNK2A1;RPS6KA3
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),0.6800677953669925,0.9970585010704308,0.4788732394366197,0.9217548332723672,1.0,4/5,31.80%,CFL1;PLCB1;RACK1;NR2C2
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6585087152424732,0.9965908583389325,0.55,0.9220154301928785,1.0,2/5,12.46%,RAP1A;MAGI2
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.6838827275772629,0.9960520080058857,0.546875,0.9227374392826692,1.0,1/5,14.36%,IFNGR1
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.5905364983147141,0.9956755494024452,0.5507246376811594,0.9230420191850063,1.0,5/19,9.24%,INPP5F;PLCL1;FGFR1;PIK3R1;OGT
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.6662294795997067,0.9951869611455005,0.5652173913043478,0.9233822526079974,1.0,4/8,23.83%,ANXA1;REST;ZFP36;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),0.4480561157506318,0.9946362995344616,0.5227272727272727,0.9239748460365867,1.0,38/129,25.39%,ANGPTL4;PDK4;HSPA5;TBX3;BNIP3L;ANXA1;PINK1;CPEB4;PIK3R1;RPS27A;HSP90B1;KLF4;HSPA9;ITGB1;NAA16;PAK2;RASA1;BCL2L1;MTDH;GOLPH3;GRK5;MALT1;TMBIM6;CFL1;SMAD6;MCL1;NPM1;TNFAIP8;SETX;RPL10;AVEN;UBC;YWHAE;MEF2C;PRKCH;XIAP;HIPK3;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.6920164770548218,0.9946257082590868,0.5454545454545454,0.9232306584170905,1.0,2/5,27.80%,AHCYL1;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.5566401132239052,0.9944677840102207,0.5375,0.9228664720199128,1.0,8/20,22.04%,CALR;ANXA1;ANXA2;NEDD4L;HIP1R;GATA2;DYNC1H1;ACTB
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5193512826199307,-0.9942278420758481,0.4166666666666667,1.0,1.0,3/10,8.46%,ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.6544658221368554,-0.9941855522031209,0.5714285714285714,1.0,1.0,2/5,22.98%,RORA;THRAP3
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.6063616465715254,0.9939944001613896,0.5,0.9232327493523647,1.0,4/10,28.89%,PPP1R10;TERF2IP;YLPM1;SMG1
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.5290035160589908,-0.9938313703505408,0.5,1.0,1.0,3/14,5.74%,ATM;ATR;SP100
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.6049396578050241,0.9937830236653974,0.5882352941176471,0.9229591984323942,1.0,1/10,0.88%,MTFR1
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.5096596308028694,0.9931774714146181,0.5061728395061729,0.9234687185276995,1.0,1/23,1.12%,RFTN1
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),0.6323215925180372,0.9920753938941576,0.5,0.925532334037989,1.0,2/6,15.94%,ESR2;PLPP1
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.623510222422523,0.991983655293657,0.5416666666666666,0.9249791548760309,1.0,2/10,3.35%,DTNA;SLC8A1
prerank,PanglaoDB_Augmented_2021__B Cells,-0.507526372053578,-0.991705383938475,0.46875,1.0,1.0,4/15,9.27%,CD74;EBF1;RASGRP3;RCSD1
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),0.49837343285105534,0.9916277711829118,0.5512820512820513,0.9250639902657894,1.0,13/37,26.79%,GRIN2B;ANKS1B;ARPC2;RASA1;RAC1;SDCBP;CRK;KALRN;ACTB;ANKS1A;FYN;CDC42;WASL
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),0.6233507095643049,0.9915044587809356,0.5522388059701493,0.924664534550556,1.0,4/13,15.26%,GRIK2;INPP5F;ANXA2;SYT1
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.6309374951745684,0.9910898869653864,0.5692307692307692,0.9249376147578011,1.0,3/7,31.72%,REST;WDR43;CNOT2
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.48580861204404546,0.9908313555304066,0.5185185185185185,0.9247268940029143,1.0,13/45,23.73%,RTN4;SGIP1;HSP90AA1;PICALM;AHCTF1;HIP1R;DMD;TPR;PXN;CHMP4B;TBCD;NCK1;UVRAG
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),0.6152499967945599,0.9908260843254113,0.546875,0.9239709682780375,1.0,3/7,22.95%,ADCY2;CRY1;ADCY9
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.5740446650679094,0.9907880185902892,0.575,0.9233145892228658,1.0,3/19,9.68%,PDK4;PCK1;BACE2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.6276715197485171,0.9905202017591146,0.5588235294117647,0.9232932340608442,1.0,3/6,21.52%,PRKCE;NEDD4L;NEDD4
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.654674584177502,0.9898642387527049,0.5303030303030303,0.9241194436759342,1.0,2/7,14.25%,TRIM5;CD55
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.5086877292070483,0.9897710090142905,0.4823529411764706,0.9236161037274577,1.0,16/27,37.54%,NEDD4L;SYT1;SDCBP;RIMS2;AKAP6;CSNK2A1;CDC42;RPS6KA3;EGFR;CDKL5;DDX3X;ADAM17;MTPN;RIMS1;MAP3K13;EIF4G2
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),0.6174365760142464,0.9884823765250322,0.5538461538461539,0.9260973261429324,1.0,1/6,4.62%,LAMA5
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.6505449674770738,0.9883734288717494,0.5694444444444444,0.9256554821992431,1.0,2/6,20.74%,EPS8;CHMP4B
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.5915741333476452,0.9873716435141396,0.47619047619047616,0.927419585179325,1.0,4/8,26.64%,KIF16B;NEDD4;UVRAG;MTOR
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),0.5161644234668004,0.9872219612309696,0.52,0.9272172680472807,1.0,8/24,24.79%,BNIP3L;PINK1;BTBD10;NPAS2;INPP5A;CHMP4B;NCK1;FYN
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),0.4612439194936532,0.987210892769709,0.5555555555555556,0.9264648833383967,1.0,27/105,23.39%,ANGPTL4;HSPA5;TBX3;BNIP3L;ANXA1;PIK3R1;RPS27A;HSP90B1;HSPA9;NAA16;PAK2;RASA1;BCL2L1;MTDH;GOLPH3;GRK5;MALT1;TMBIM6;CFL1;SMAD6;MCL1;NPM1;TNFAIP8;SETX;RPL10;AVEN;UBC
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.6429642779180675,0.9871527120544787,0.546875,0.9258556551934544,1.0,1/6,12.77%,ANO6
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.5759702005823485,0.9869156574762167,0.5,0.92571715751204,1.0,2/13,5.53%,S1PR1;CHSY1
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.5950838750768523,0.98662674138533,0.5416666666666666,0.925561175481821,1.0,6/9,24.90%,SLC12A6;ATP1A1;ATP1B3;ATP1B1;KCNQ5;SLC24A2
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.4397460736779746,0.9866166318490067,0.5609756097560976,0.9248126088019069,1.0,17/89,16.61%,RPS11;RRBP1;POLA1;RPS9;RPL23;RPS18;RPS27A;RFC3;RPL34;RPL8;RPL37;EEF1A1;AGO2;RPLP2;RPS12;RPL13A;GOLPH3
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),0.633792655387403,0.9857117767417618,0.5833333333333334,0.9262843879786222,1.0,4/6,36.21%,ADAM9;MTOR;MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.5208633991150218,0.9854974748146562,0.5131578947368421,0.9259958163456448,1.0,15/25,33.26%,RAB11FIP3;AHCTF1;ECT2;BCL2L1;SND1;DYNC1H1;UVRAG;IHO1;CSNK2A1;CAV2;CDC42;PIK3C3;CALM1;PRPF40A;RPRD1B
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),0.4162697256409839,0.9853471192551514,0.5473684210526316,0.9256282756593006,1.0,61/324,20.33%,LAMC1;B3GNT2;PSMC6;PDK4;PPP2R3A;FEM1C;PRKAG2;PKN3;MGAT4A;PPM1D;MAP3K5;ANXA1;PTPRD;UFL1;PRKCE;PLOD2;PINK1;FGFR1;DUSP6;BCR;DCAF10;ERO1A;ZDHHC6;JAK1;DUSP1;CDK6;SSH1;MACROD2;HIF1A;HSP90B1;MSRA;SIK2;TRIB2;SETD3;COMMD1;PPM1A;ACVR2A;STK38L;STK38;PRAG1;MAPK10;DUSP16;PAK2;CTTNBP2NL;TRIOBP;GRK5;TGM2;PLAT;TF;PPP1CB;TEC;MTMR6;PSMA7;CSNK1G3;RAB2A;TNKS;LIMK2;CSNK1D;PTPN1;MGAT1;ABL2
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),0.5944651314607764,0.9849544255368557,0.5633802816901409,0.9257905038465081,1.0,7/11,28.84%,ANK3;ATP1A1;ATP2B4;NEDD4;AHCYL1;WNK1;FGF12
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.4246422368281261,0.9846035901938175,0.5154639175257731,0.9259965291052383,1.0,34/149,17.89%,RTN4;ERBB4;TRIM5;BCAP31;NRG2;GAPDH;REL;PINK1;FGFR1;RPL23;PIK3R1;GRB2;HSP90AA1;GJA1;VWF;PPM1A;FLT1;PELI1;RPL37;NOS1AP;ITGB1;TAB2;ECT2;SLC20A1;NDFIP1;RAC1;BCL2L1;MTDH;GOLPH3;BRD4;ALPK1;TGM2;LIMS1;MALT1
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),0.5957510998627007,0.9843107250712381,0.5,0.9257971831006586,1.0,5/10,22.95%,SLC25A16;ADCY2;SLC26A2;ADSS2;ADCY9
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.5044449434995162,-0.9840976338010874,0.4864864864864865,1.0,1.0,3/11,8.49%,TPD52L1;DEPTOR;SGMS1
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.6826484877233275,0.9836914686319658,0.5806451612903226,0.926609926879706,1.0,2/6,15.26%,REST;SYT1
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.6285661932096049,0.9834840953917133,0.5970149253731343,0.9263840338965526,1.0,2/6,10.15%,PRKAG2;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.6303345149821377,0.9833233369116813,0.55,0.9259740509384246,1.0,2/7,22.30%,FOXC1;PPARG
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),-0.5648212834061892,-0.9829741544999833,0.4230769230769231,1.0,1.0,1/9,0.60%,PRIMPOL
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),0.620271089494375,0.9829476003792508,0.5074626865671642,0.9260474430293091,1.0,2/9,21.31%,NRXN1;RIMS2
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.5714110196826432,0.9827917787593213,0.5588235294117647,0.9256647063280046,1.0,1/11,4.00%,S1PR1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.4515369343204952,0.9823837203378705,0.5542168674698795,0.9257294678417437,1.0,9/70,9.50%,PNP;SERPINE1;RFTN1;ANXA1;GAPDH;MBP;HYAL2;TMED10;HIF1A
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),0.6230696205051736,0.9821810569151934,0.5352112676056338,0.9254351605937646,1.0,1/5,16.72%,HDAC7
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.47200909574401123,-0.9819669031378568,0.38095238095238093,1.0,1.0,2/16,0.67%,GBP1;HOMER2
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),-0.6601600136275316,-0.9817029056683253,0.5121951219512195,1.0,1.0,1/6,0.18%,GBP1
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),0.4290310092831051,0.9816285807228331,0.5483870967741935,0.9258936690257134,1.0,23/126,21.63%,MTFR1;NEDD9;VAPB;PINK1;ATP8B1;ARHGAP21;TMED10;TOR1AIP2;NPLOC4;LARP4;PIKFYVE;AGTPBP1;BRWD3;RAB30;GOLPH3;PDZD8;VMP1;RAB2A;CFL1;CSNK1D;CHMP4B;DPYSL2;ARFGEF1
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),0.5800906312605764,0.9816096572345014,0.5833333333333334,0.925188875003165,1.0,3/10,25.57%,RAC1;ALMS1;CDC42
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.45869227223144854,-0.9810055263787485,0.5909090909090909,1.0,1.0,5/18,17.19%,EIF2AK2;TGFBR3;FOXO1;ULK4;IGF1R
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),-0.4171478093572877,-0.9809398120325027,0.6086956521739131,1.0,1.0,5/33,5.82%,SLC22A5;SLC38A3;ABCG2;SLC25A29;MIA3
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.6297785835348343,0.9807306834811074,0.5846153846153846,0.9266250497056435,1.0,2/8,12.56%,ROBO2;REST
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),0.5929002577123226,0.9803618578872305,0.5753424657534246,0.9267062286804857,1.0,1/11,2.73%,TBX3
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.6513596515221387,0.9800050343251034,0.5675675675675675,0.9269878347298955,1.0,1/6,7.40%,ESR2
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),0.6067182320814538,0.9797260234841093,0.5571428571428572,0.9270947292042593,1.0,1/8,4.28%,TRMT9B
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.6331916005489948,0.9793541698052262,0.5573770491803278,0.9272623926475749,1.0,2/7,12.56%,JUN;REST
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),-0.5623022937012377,-0.9789949493465014,0.46153846153846156,1.0,1.0,2/10,15.65%,COG3;TRAPPC10
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),0.5610849376955622,0.9789503066708645,0.5588235294117647,0.9274645817896997,1.0,5/14,26.04%,KLF4;YWHAE;XIAP;CSNK2A1;RPS6KA3
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),0.678110817697157,0.9788324167608852,0.5789473684210527,0.927084090237072,1.0,3/5,21.91%,PIK3R1;GIGYF2;PLCB1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,0.47279918842286583,0.978693736924805,0.5180722891566265,0.9266173609790934,1.0,8/53,9.89%,AKAP12;TIMP3;PLSCR4;COL4A2;OGT;DLC1;GJA1;MIB1
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),-0.6352105604958835,-0.9779540675337328,0.52,1.0,1.0,3/5,17.19%,GSPT1;CLEC16A;IGF1R
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),-0.5882941193533588,-0.9777935984766402,0.5,1.0,1.0,2/6,3.79%,ATM;TENT2
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.5882941193533588,-0.9777935984766402,0.5,1.0,1.0,2/6,3.79%,ATM;TENT2
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.46590927650108815,-0.9777745347524859,0.43478260869565216,1.0,1.0,2/27,0.88%,GBP1;GBP2
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),0.48171876736920805,0.9765976363647548,0.5581395348837209,0.9305597660011088,1.0,14/58,17.58%,SERPINE1;CALR;HYAL2;SMAD7;NAV3;SRGAP1;DLC1;GJA1;ADAM15;MAGI2;CLDN5;ADGRG1;RAC1;DAG1
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),0.46312692874446193,0.976473862945728,0.5189873417721519,0.930108340005364,1.0,9/59,9.68%,TAMALIN;PKN3;TIMP3;TMEM184B;HYAL2;TMTC1;PLSCR4;COL4A2;BACE2
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.5423591056723556,0.9763419972775168,0.5138888888888888,0.9297269495809372,1.0,1/16,4.57%,VAPB
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.5233642085508199,0.9761431477107562,0.5714285714285714,0.9294413977471768,1.0,9/31,27.57%,PSMC6;RPS27A;CCNH;PSMA7;NPM1;UBC;NAP1L4;PSMB9;SMARCA5
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.5238734191557554,0.9759834538852492,0.5,0.9291130520258439,1.0,4/26,11.97%,PPM1D;CBFB;CDKN1A;CCNC
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),0.5878253516256153,0.9756598236954149,0.6290322580645161,0.9291482472971276,1.0,2/10,17.55%,RAC1;LIMS1
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),-0.4833036371677553,-0.975225398160104,0.3448275862068966,1.0,1.0,2/16,1.58%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.6807693081700519,0.9748333044191989,0.6212121212121212,0.930357928037011,1.0,3/6,29.49%,GSN;EMP2;CAMK2D
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),0.6328614905607725,0.9746131996276426,0.525,0.9302022258587009,1.0,2/7,11.32%,HIF1A;LRRC32
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),0.6105104329505735,0.9744610087002088,0.5230769230769231,0.9298743207711588,1.0,2/8,12.85%,CD81;FLT1
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),0.5496895889542833,0.9736139613940893,0.5138888888888888,0.9313906961874301,1.0,4/12,21.60%,RAB21;HIF1A;DYNC1H1;PAFAH1B1
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),0.5220649813756074,0.9734333395083652,0.5671641791044776,0.9310193228488632,1.0,3/19,9.24%,VSIR;SRGN;OGT
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),0.49669682540830007,0.9733643677173078,0.47058823529411764,0.9304592967727388,1.0,5/27,13.27%,NES;KDM1A;JUN;CDKN1A;WAPL
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),0.5007787750136903,0.9730879059897587,0.5769230769230769,0.9303471085890944,1.0,6/26,17.58%,SMAD7;WWTR1;SDCBP;FOXC1;SPRED1;DAG1
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),0.5106302276703885,0.9730229802982574,0.5443037974683544,0.9297799177582324,1.0,11/31,22.27%,GPM6B;EPS8;RAPGEF3;CCDC88A;DLC1;HIP1R;RAC1;CRK;ESAM;ABL2;TAOK1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.44203961616770193,-0.9728785673749094,0.5,1.0,1.0,2/27,1.92%,OAS3;IFIH1
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),-0.4763866855412856,-0.9728375832107719,0.4,1.0,1.0,1/12,1.27%,SLC38A3
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,0.4967506321887278,0.9724246624389058,0.569620253164557,0.9304236190242149,1.0,6/30,13.71%,SLC8A1;TIMP3;PLSCR4;COL4A2;GJA1;FOXF1
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),0.5315518862817846,0.9723261262239814,0.5903614457831325,0.9298829911981955,1.0,7/29,14.46%,ERBB4;PRKAG2;FGFR1;RAP1A;CDKN1A;FLT1;TAB2
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),-0.5273975809466281,-0.9722439370839093,0.5925925925925926,1.0,1.0,1/7,0.91%,EIF2AK2
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),0.5482402967914798,0.9720294587370772,0.5616438356164384,0.9297887510680872,1.0,4/17,15.26%,GRIK2;GRIN2B;NRXN1;SYT1
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.628499186867954,0.9714493393036566,0.5492957746478874,0.9305250886616911,1.0,3/11,19.29%,ANXA1;GGT5;STAT3
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.6321980919539401,0.9712872656028868,0.5142857142857142,0.9301653049488054,1.0,2/6,7.81%,CANX;JAK1
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.5925020433176771,0.9711988241175116,0.5079365079365079,0.9295667577370096,1.0,3/7,18.30%,TMF1;PLPP1;ZMIZ1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),0.5781930179573135,0.9711139568835068,0.575,0.9290289419176387,1.0,8/12,31.44%,HYAL2;DUSP1;STK38;PTPN1;HIPK3;DNAJA1;PIK3CB;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.41011197360929375,-0.9709705521521227,0.6190476190476191,1.0,1.0,4/24,12.59%,BABAM2;TOX;OTUD4;PDGFB
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.44572893713037903,0.9704457605025233,0.5666666666666667,0.9299257022568491,1.0,20/106,16.38%,PIK3R3;ERBB4;PRKAG2;CD81;RAPGEF3;PINK1;PRNP;HSP90AA1;RB1CC1;ENPP2;RAP1A;PECAM1;CDKN1A;ACVR2A;TAB2;PAK2;KRAS;SH2D3C;RAC1;SDCBP
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.5643789222385025,-0.97010477813802,0.5,1.0,1.0,1/5,2.96%,DCP1A
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),0.605097309248259,0.9698510580804677,0.5692307692307692,0.9305140631834102,1.0,4/9,25.70%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),0.46340927348581584,0.9695180697882719,0.5584415584415584,0.9305135726418118,1.0,13/44,24.95%,ATF3;HSPH1;PINK1;HSP90AA1;SLC38A2;AMFR;TPR;NPAS2;HSPA8;MCL1;NPM1;YWHAE;CREBBP
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),0.5889631131109615,0.9694639637055015,0.6065573770491803,0.9299426494821781,1.0,5/11,29.10%,AAMDC;ZFP36;PPARG;ASXL2;HNRNPU
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.6261167950157296,0.9690851362359002,0.5714285714285714,0.9301723045705598,1.0,1/5,6.26%,WDR48
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.6262509599023783,-0.968400791368169,0.5365853658536586,1.0,1.0,1/5,2.73%,ATM
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.6250001703481057,0.9682965199936461,0.5076923076923077,0.9311581470281227,1.0,2/6,18.30%,ZBTB1;ZMIZ1
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),0.6060735394928284,0.9681352139222218,0.5714285714285714,0.9301037458915643,1.0,2/5,22.95%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),0.6060735394928284,0.9681352139222218,0.5714285714285714,0.9301037458915643,1.0,2/5,22.95%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),0.6455204148064237,0.9677097593335918,0.5362318840579711,0.930519126094475,1.0,4/7,30.22%,PRNP;TRAM1;EGFR;VAPA
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5454505500410234,0.9671768196322832,0.56,0.930984698613494,1.0,1/14,0.83%,SERPINE1
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),0.5888735902482837,0.9670785417120478,0.5689655172413793,0.9304842741830374,1.0,3/6,20.33%,FGFR1;FLT1;ABL2
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),0.5448537081324436,0.9667500043813049,0.5342465753424658,0.9304922710408924,1.0,10/15,30.56%,HSP90AA1;HIF1A;NOS1AP;DNM2;ATP2B4;SCARB1;WASL;EGFR;PIK3CB;CALM1
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),0.4244115969201126,0.9662245467761115,0.5652173913043478,0.931168123038538,1.0,28/141,22.30%,BCL6;TBX3;BHLHE40;PHF10;CALR;ZFPM2;KDM1A;ATP8B1;ARID5A;CDKN1B;KLF4;JUN;SPEN;REST;ZBTB38;NCOR2;CRY1;ATOH8;LIMS1;MBD2;BCLAF1;NR1D2;NACC2;RCOR3;CREBZF;HSPA8;PLCB1;PPARG
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.559589760400916,0.9661921503864945,0.5068493150684932,0.9305504643519039,1.0,3/14,8.75%,ANXA1;PURA;RPS27A
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),0.6371878572776712,0.9660565039594314,0.5588235294117647,0.9300097373990821,1.0,2/6,9.87%,MBP;KLF4
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.5470331087300527,-0.9659832216971493,0.59375,1.0,1.0,2/8,12.90%,RHBDD1;SPPL2A
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),0.6058000017902209,0.9659229037681257,0.6,0.9295710648654691,1.0,1/6,7.89%,HSP90AA1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.5417459739079808,0.9658611778942141,0.5362318840579711,0.9290572271809812,1.0,10/20,28.71%,TIMP3;COL4A2;MSRB3;FOXF1;PLAT;VEGFC;CALD1;SERPINH1;ADAMTS1;ADGRL4
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.47122914282645223,0.9655282266214243,0.5256410256410257,0.92909998247837,1.0,20/55,22.07%,SERPINE1;CD9;TIMP3;SYTL4;SNAP25;DNAJC5;SRGN;TMED10;LAMP2;VWF;PCDH7;PECAM1;SYT1;PSAP;TF;ACTN1;VEGFC;TAGLN2;RIMS2;PPP3CB
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),0.5856715775904036,0.9651603947955519,0.5833333333333334,0.9292184021516697,1.0,5/10,28.89%,CRY1;NPAS2;BCLAF1;MCL1;SMG1
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.5804204868030091,0.9651277225245894,0.6025641025641025,0.9285799173337189,1.0,4/10,25.10%,PICALM;COMMD1;TF;XIAP
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),-0.5958498660782127,-0.9641745224284277,0.55,1.0,1.0,2/5,5.84%,CHKA;PLAAT3
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),0.6234246741747549,0.9641655221188223,0.5606060606060606,0.9301100041298478,1.0,1/6,7.22%,CHST11
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.4679505102145664,0.9640957412641478,0.5063291139240507,0.9295809528303789,1.0,14/37,21.83%,ERBB4;NEDD9;CD81;PRNP;ENPP2;PECAM1;PAK2;ARHGEF2;TEC;STAT3;GRM5;PTPN1;SOCS3;GPRC5B
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.5221466316564505,-0.9640622007531655,0.4666666666666667,1.0,1.0,1/11,2.73%,ATM
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),0.5836252263109273,0.9640032647001007,0.5492957746478874,0.9290611108367481,1.0,2/5,29.65%,SULF2;PCSK5
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.637314137097061,0.9639874006070703,0.5483870967741935,0.9283744361543218,1.0,2/5,17.06%,NAA16;NAA50
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.6233299263225491,0.963962468282233,0.5714285714285714,0.9277139515782044,1.0,1/6,0.39%,SLCO4A1
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.5657626449382616,0.963905770974342,0.6029411764705882,0.9271549169097284,1.0,3/13,16.38%,ARF1;MAGI2;SDCBP
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),0.5703761709297261,0.9632028571043659,0.5915492957746479,0.92815216909191,1.0,1/12,6.83%,KDM1A
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),0.4170595954889254,0.9622029531815718,0.5764705882352941,0.9296241731870412,1.0,26/123,23.99%,RPS11;RRBP1;RPS9;RPL23;RPS18;RPS27A;YTHDC1;RPL34;RPL8;RPL37;EEF1A1;AGO2;RPLP2;RPS12;RPL13A;SRSF7;GOLPH3;HNRNPH3;TPR;RPS27;RBMS2;RPLP1;RBPMS;SETX;RPL10;RPL37A
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.5029028258810345,0.9620299719703139,0.5512820512820513,0.9292987464536567,1.0,5/26,15.84%,PCK1;SLC8A1;CPEB4;MAP7;LARP1B
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6385120219071061,0.9617566508458092,0.5866666666666667,0.9291406844625566,1.0,1/8,9.87%,KLF4
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),0.4980756493438384,0.9610166961960603,0.5416666666666666,0.930083309865986,1.0,4/35,13.03%,IL1RAPL1;ROBO2;KLF4;ACVR2A
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.5706168454890684,0.9608269668883516,0.6333333333333333,0.9298832356232961,1.0,3/7,34.32%,RPS27;RPS15;PRKDC
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.595002438171552,0.9603376272678109,0.55,0.9302161963895309,1.0,2/7,7.55%,S1PR1;SMAD7
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.6113909628608388,0.9597900487854285,0.609375,0.9305320099966998,1.0,4/8,26.66%,CCDC60;VWA2;ATP1B1;NEBL
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.5931034539473143,0.9595495461983671,0.55,0.9302988079692986,1.0,1/7,4.54%,TIMP3
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.5582133370783743,-0.9595304037227985,0.5294117647058824,1.0,1.0,1/5,5.97%,IMMP2L
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.5595358660972797,0.959151960091168,0.6351351351351351,0.930539330891034,1.0,3/15,9.24%,PCK1;ANXA1;OGT
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),0.6284913897164887,0.9585971076656608,0.6571428571428571,0.931169505008173,1.0,3/8,16.23%,PRAG1;ADGRG1;RAC1
prerank,MSigDB_Hallmark_2020__UV Response Up,0.4738630257166051,0.9583453530095187,0.5487804878048781,0.9310192700339447,1.0,6/40,7.42%,ATF3;JUNB;PTPRD;PLCL1;HYAL2;FOS
prerank,MSigDB_Hallmark_2020__Androgen Response,0.46074547482770417,0.9582526633065176,0.5189873417721519,0.9304549858939036,1.0,15/50,18.59%,AKAP12;ELL2;SEC24D;NDRG1;CDK6;UBE2J1;SLC38A2;INSIG1;FKBP5;MAP7;SLC26A2;ZBTB10;PLPP1;ZMIZ1;ACTN1
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.49272328781791236,-0.9581870015059907,0.48148148148148145,1.0,1.0,3/20,4.23%,ATM;BABAM2;ATR
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.5714321988385483,0.9580862151779511,0.5394736842105263,0.930098546994251,1.0,2/12,3.71%,GLUL;GLUD1
prerank,PanglaoDB_Augmented_2021__Hepatocytes,0.5174448098308382,0.9576589472078325,0.5526315789473685,0.9301976635439227,1.0,2/20,3.27%,PCK1;GLUL
prerank,PanglaoDB_Augmented_2021__Principal Cells,0.5367024295587077,0.9576415973281044,0.5909090909090909,0.9295030364198474,1.0,5/18,21.83%,TMEM45B;ADGRG1;VWA2;LGALS3;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),0.5317513180427721,0.9575978223164835,0.6049382716049383,0.9288838130298349,1.0,6/24,22.25%,SERPINE1;BCL2L1;LGALS3;ARHGEF2;MCL1;TNFRSF10B
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.6574238147114597,0.9571358905010832,0.5396825396825397,0.928679158712568,1.0,3/6,21.31%,NEDD4L;SYT1;RIMS2
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.6574238147114597,0.9571358905010832,0.5396825396825397,0.928679158712568,1.0,3/6,21.31%,NEDD4L;SYT1;RIMS2
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),-0.48708098070910977,-0.9565673902536728,0.48,1.0,1.0,1/10,1.48%,PLA2G4A
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),-0.48708098070910977,-0.9565673902536728,0.48,1.0,1.0,1/10,1.48%,PLA2G4A
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.5851334658433186,0.9565407541994397,0.5967741935483871,0.9291910484610718,1.0,1/12,4.88%,ROBO2
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.49666679920114576,-0.9562382946703989,0.5555555555555556,1.0,1.0,2/16,6.54%,IFIH1;NUP214
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),0.5951447145191401,0.9560528667500634,0.5652173913043478,0.9296939233793214,1.0,6/10,30.56%,HSP90AA1;NOS1AP;DNM2;WASL;EGFR;CALM1
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),0.6340673549735378,0.9559306723916307,0.65,0.9292168012104994,1.0,4/10,21.31%,SNAP25;DNAJC5;SYT1;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.6046223652497646,0.9557209011189135,0.5932203389830508,0.9289377466214326,1.0,2/6,29.10%,REST;HNRNPU
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.46604132526234865,0.9549852885394591,0.5930232558139535,0.9299655128810141,1.0,7/52,11.63%,SEC22B;TSG101;ARF1;SEC24D;TMED10;LAMP2;ATP1A1
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.49357350158980273,0.9543724498077393,0.5443037974683544,0.9306140540887,1.0,7/26,20.61%,CANX;ARF1;SEC24D;PIKFYVE;AP1G1;DYNC1H1;DNM2
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),0.4848689713686262,0.9540154782589171,0.6153846153846154,0.9306709329659328,1.0,3/38,5.45%,PBRM1;BAZ1A;ZBTB1
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.4585779180318489,0.9537672031438045,0.5714285714285714,0.9305883656472537,1.0,18/51,20.07%,PLS3;NEDD9;EPS8;MYO1B;TPM4;PPP1R9A;MYO1E;BCAR1;DSTN;SPIRE1;HIP1R;MPRIP;TRIOBP;RAC1;ARHGEF2;ACTN1;GSN;ABI1
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),0.5438798281485795,0.9527825129511944,0.5915492957746479,0.9319885729498377,1.0,3/13,19.34%,HSP90AA1;KLF4;TNKS
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),0.5827801163139078,0.9527489132597227,0.5633802816901409,0.9313567225794293,1.0,6/10,33.20%,GJA1;ITGB1;PAFAH1B1;CDK5RAP2;KPNB1;NDEL1
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),-0.3565912581748948,-0.9527347852921372,0.42857142857142855,1.0,1.0,8/76,4.52%,PRIMPOL;MGMT;ATM;BABAM2;ASCC3;ATR;FAM111A;PARP9
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),0.6372021414710246,0.9522653281625448,0.6086956521739131,0.9317645663575304,1.0,4/5,36.21%,ADAM9;MTOR;MAPRE2;IQSEC1
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),-0.5831530833109928,-0.9513935521477521,0.5588235294117647,1.0,1.0,3/6,13.03%,NNT;ATP6V1H;SLC25A27
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.5252432906926071,-0.9505907132460166,0.5357142857142857,1.0,1.0,2/11,10.28%,TCF7L1;TLE4
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),0.46910411158725945,0.9503030060121911,0.5,0.9354572829613091,1.0,11/44,21.63%,SEC22B;ATP8B1;ARHGAP21;TMED10;NPLOC4;RAB30;GOLPH3;VMP1;RAB2A;CSNK1D;ARFGEF1
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),-0.46452892177897565,-0.9502390113637739,0.45454545454545453,1.0,1.0,2/15,1.58%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.6219953583970292,0.9500548213596811,0.5517241379310345,0.935420412502417,1.0,1/6,13.63%,AGO2
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.6206951057717924,0.9500546780818893,0.6190476190476191,0.9347144348326041,1.0,1/5,9.37%,ENPP2
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.5394633832208374,0.9500197534675997,0.5857142857142857,0.9340666025652994,1.0,3/11,33.15%,NPM1;RPL10;RPL24
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),0.6428908061949863,0.9500066920290193,0.6101694915254238,0.9333871537901034,1.0,1/5,3.71%,GLUD1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5915247028354711,0.9494657730759339,0.6142857142857143,0.9339300414543298,1.0,4/10,23.91%,CDKN1B;CDKN1A;PPARG;MEF2C
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.5525984648157516,0.9493912372566174,0.5616438356164384,0.9333981652343947,1.0,4/15,8.15%,SLCO4A1;SLC52A3;SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.5656494190311301,0.9491099767116887,0.618421052631579,0.9333386197849763,1.0,8/13,37.05%,NEDD4L;SYT1;RIMS2;PLCB1;CDKL5;RIMS1;INSR;MAP3K13
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.5848672002207382,0.9489830627477582,0.532258064516129,0.9329379668979759,1.0,4/9,31.44%,ARFGEF1;LRCH1;WNK1;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),0.5876173344739307,0.9487735805907974,0.5555555555555556,0.9326434448742793,1.0,4/9,24.45%,PTBP2;SRSF7;TMBIM6;PTBP3
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.5852864355653657,0.9486250806690613,0.5483870967741935,0.9322114684390255,1.0,1/7,1.90%,PCK1
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),0.5210631418359379,0.9477813646674483,0.5373134328358209,0.93331207285783,1.0,3/19,17.89%,BNIP3L;DENND3;MALT1
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),0.6517588758989818,0.9477224242433941,0.6212121212121212,0.9327506524097369,1.0,3/6,31.15%,PLPP1;ACER3;SPTLC2
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),0.5655974597890585,0.9477213020982513,0.547945205479452,0.9320524857537416,1.0,1/8,4.00%,S1PR1
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.5865485535478736,0.9463984582926068,0.6212121212121212,0.9341535621659177,1.0,3/11,21.31%,RAP1A;PREPL;RIMS2
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.47629035592943486,0.9459394512406,0.5384615384615384,0.9344897886936082,1.0,4/27,13.89%,SEC22B;VSIR;CDKN1B;NEDD4L
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.5958304228043931,0.9456360778292106,0.6,0.9345267306206693,1.0,5/7,36.99%,RAC1;ALMS1;CDC42;AKAP13;ACTG1
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),0.6407948642073237,0.9451023497498376,0.6610169491525424,0.934991283611432,1.0,4/5,35.80%,MYEF2;MEF2C;SORT1;AKAP13
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),0.41468455195182063,0.9450906506080545,0.6086956521739131,0.9343182387152863,1.0,39/179,22.51%,ERBB4;PDK4;PCK1;FES;PRKAG2;PKN3;MAP3K5;PRKCE;PINK1;FGFR1;BCR;SMAD7;JAK1;CDK6;SIK2;TRIB2;CCNH;FLT1;ACVR2A;STK38L;STK38;PRAG1;MAPK10;PAK2;CRY1;GRK5;PRKX;TEC;CSNK1G3;TNKS;LIMK2;ABI1;CSNK1D;ABL2;MORC3;CDK8;PPP3CB;TAOK1;CAB39
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.5952530605743833,0.9448194259359283,0.6153846153846154,0.9342021400792252,1.0,2/10,6.83%,NES;KDM1A
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),0.6133503008885038,0.9444464135008481,0.6142857142857143,0.9344726694724667,1.0,2/5,24.97%,EIF3A;EIF5
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,0.4644517774251773,0.9443715982752122,0.618421052631579,0.9339060998389506,1.0,17/46,30.66%,TIMP3;ARID5A;PLSCR4;COL4A2;VWF;TNS1;PARVB;PLXNA2;GSN;EPAS1;CALD1;CDH5;ADGRL4;TM4SF1;SLCO2A1;SASH1;ROBO4
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.5719460116096645,0.9441646593121227,0.581081081081081,0.9335976263417327,1.0,4/9,29.10%,BRD4;RNF168;WDR43;HNRNPU
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,-0.47036415048141045,-0.9438812266814843,0.5483870967741935,1.0,1.0,6/13,11.89%,IFIH1;TAP1;IRF1;HLA-F;PARP12;HLA-C
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.4694879949655627,-0.9436770163664253,0.47058823529411764,1.0,1.0,2/11,6.70%,ANAPC16;CDC14A
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.5424280806446115,0.9434998205679734,0.6212121212121212,0.9342214628680585,1.0,2/13,4.78%,ERBB4;INPP5F
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.5528809224464666,0.9432304877576864,0.5142857142857142,0.9340175673872566,1.0,5/10,28.97%,CPEB4;TMBIM6;MTOR;SLC38A9;CAPN2
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),0.5519676105484245,0.943138407964052,0.5714285714285714,0.9334690591527559,1.0,4/12,25.86%,NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.42155451940626637,-0.9428866179949325,0.4782608695652174,1.0,1.0,5/17,13.47%,SLC38A3;SLC25A29;SLC16A2;SLC38A6;SLC23A2
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.6292001453970905,0.9428633643891285,0.6,0.9333061004086557,1.0,1/5,17.99%,DIP2A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.5982803193746655,0.9423840624520118,0.6060606060606061,0.9336720036133325,1.0,2/6,20.20%,BCL2L1;NACC2
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.5310895133135813,0.9422205433951998,0.5753424657534246,0.9333090490567676,1.0,7/13,30.56%,DLC1;ITGA1;MAGI2;CDH5;MTOR;SPPL3;CALM1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.6305730636254328,0.9420052599259842,0.6086956521739131,0.9331145800433044,1.0,1/7,6.83%,KDM1A
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),-0.3274487989997916,-0.9416731326143678,0.7777777777777778,1.0,1.0,8/128,3.48%,VCAM1;GBP1;GBP4;GBP2;IL32;LEPR;STAT1;IRF1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.5349419395193886,0.9416034379089433,0.6197183098591549,0.9331921143464222,1.0,8/17,31.54%,ESR2;TMF1;PLPP1;ZMIZ1;NEDD4;ARID1A;UBR5;UBE3A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.559576258862778,0.941478096341164,0.6056338028169014,0.9327265037697611,1.0,2/12,7.17%,SERPINE1;HYAL2
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.5623762581777406,0.9411208217878729,0.6,0.9329239077386114,1.0,1/10,6.02%,NDUFA12
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),0.6268330022808813,0.941032883520876,0.6333333333333333,0.9323794420745567,1.0,2/6,18.87%,PPHLN1;TPR
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.45830919341535514,0.9407742735416471,0.5609756097560976,0.9322182469907592,1.0,4/41,4.54%,LAMC1;PLS3;NES;TIMP3
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5844760189806342,0.9406689215223383,0.5441176470588235,0.9317626872257984,1.0,1/6,7.89%,HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),0.5310662919304813,0.9394955363521237,0.6582278481012658,0.9332173241863226,1.0,7/19,23.78%,RAPGEF3;HYAL2;PIK3R1;ECT2;TPR;NEDD4;YWHAE
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6253608972524568,0.9391699906748352,0.59375,0.9332466808129516,1.0,1/7,13.63%,AGO2
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.4642425641768321,0.9390497886439481,0.5921052631578947,0.9327437015694549,1.0,6/34,10.38%,TSG101;PRKAG2;ATG12;PINK1;RB1CC1;LAMP2
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),0.5798477554789401,0.9389725092361157,0.5945945945945946,0.9321938279079893,1.0,2/8,11.16%,RPS27A;USP45
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),0.6178267166521233,0.9389496404094525,0.6376811594202898,0.9315812970244474,1.0,3/6,21.88%,FGFR1;BCL2L1;MCL1
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5924146961972031,-0.938888217545512,0.5588235294117647,1.0,1.0,2/6,1.82%,OAS3;CD74
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),0.5829418094349542,0.9387651789069748,0.6142857142857143,0.9313818783684381,1.0,2/8,23.75%,CSNK1D;CEP290
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",0.5653713105097974,0.9383313696951341,0.5671641791044776,0.931673877866397,1.0,3/7,37.75%,TRA2B;PRPF8;SRRM1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.657968365529848,0.9373017504751909,0.6176470588235294,0.9330261385744438,1.0,1/5,4.91%,UPP1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5910934046471134,-0.9370855388382604,0.625,1.0,1.0,2/5,11.58%,RC3H1;CPEB3
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,0.5202320344127085,0.9369083870662277,0.56,0.9333085982393167,1.0,3/16,9.84%,TIMP3;COL4A2;GJA1
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),-0.5351087572058371,-0.936794141347048,0.5909090909090909,1.0,1.0,2/12,3.09%,CD74;LEPR
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),-0.3174738065251859,-0.9363375012457072,0.625,1.0,1.0,23/174,11.19%,RNF213;MSL2;UBE3D;ISG15;ANAPC16;MARCHF8;HERC6;HERC5;ZNRF3;NFX1;RC3H1;RTF1;TRIM25;MDM2;PELI2;HERC2;PSMF1;UBE2E2;FBXO9;HECW2;FBXW4;PSMB1;WSB1
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.6059404020902799,0.9358656733138407,0.6164383561643836,0.934776247213161,1.0,4/8,31.57%,PPARG;PRKCH;ABCA5;ABCG1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.5687271454597967,0.9356288622350937,0.6428571428571429,0.9347015949743309,1.0,3/11,16.61%,ANK3;PREPL;GOLPH3
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),0.5836642315691744,0.9354929873568176,0.6190476190476191,0.9341771805637904,1.0,1/7,12.05%,SETD3
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),0.43536050341361754,0.9353952823456783,0.5882352941176471,0.9336693046026111,1.0,25/71,29.49%,PCK1;PKN3;PRKCE;PINK1;PIKFYVE;STK38L;STK38;PAK2;PRKX;CSNK1G3;TNKS;CSNK1D;MORC3;CAB39;PRKCH;HIPK3;CSNK2A1;WNK1;RPS6KA3;MTOR;TLK2;MARK3;SMG1;RPS6KA2;CAMK2D
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.5965547225068524,0.9341378089302095,0.6029411764705882,0.9356525559169093,1.0,2/6,27.10%,FOXF1;RYR2
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.5171787211028984,-0.9340648600808871,0.475,1.0,1.0,1/11,0.70%,THSD1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.5585831514778197,0.9340498564024985,0.5735294117647058,0.9351285947345471,1.0,4/10,25.86%,NAV3;ARHGEF2;TAOK1;HDGFL3
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.545653719134555,0.9334610310763487,0.5735294117647058,0.9357228651936365,1.0,5/11,24.04%,YBX3;SERPINB6;ARHGEF2;CAB39;OXSR1
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.5723449476210284,0.9328939213826689,0.6712328767123288,0.9355729443608765,1.0,4/9,33.33%,DLC1;DUSP22;ACVRL1;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.5723449476210284,0.9328939213826689,0.6712328767123288,0.9355729443608765,1.0,4/9,33.33%,DLC1;DUSP22;ACVRL1;FAM107A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.6267810626382363,0.9327906308432456,0.6764705882352942,0.9350584153854223,1.0,1/5,11.21%,ANXA2
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),-0.5081971480668914,-0.9327685993546259,0.5714285714285714,1.0,1.0,2/10,1.53%,FAXDC2;STARD3
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),-0.5073194142198808,-0.932279330182667,0.525,1.0,1.0,1/7,1.58%,ISG15
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.6361619365611964,0.9320799926421393,0.6029411764705882,0.9360747311996302,1.0,3/6,27.65%,NCOR2;EGFR;MAP2K1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),0.6439284574281112,0.9320256688811153,0.65625,0.9355213797499038,1.0,1/5,22.64%,RAB8B
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),0.510820053043438,0.9317002290293942,0.5753424657534246,0.9355329707436709,1.0,6/17,27.86%,RPL23;OGT;SDCBP;CSNK2A1;EIF3H;TLK2
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),0.4795725250063516,0.931282703882336,0.6627906976744186,0.9356776483360375,1.0,3/24,11.84%,PSMC6;CDKN1B;CDKN1A
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),0.4841184392814616,0.9311431730738684,0.55,0.9352822643173868,1.0,3/21,9.01%,UFL1;RPS27A;RB1CC1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.6140720199086261,0.930189000247816,0.6197183098591549,0.9366231120638564,1.0,2/6,19.29%,HIF1A;STAT3
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.5239720400230368,0.9301711094590205,0.5970149253731343,0.9359776118170666,1.0,2/17,6.44%,FES;PINK1
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.5222852371006723,0.9301369124987241,0.620253164556962,0.9353486576971698,1.0,8/20,25.57%,MYO9B;EPS8;GNA13;ADGRG1;CFL1;RHOJ;PHACTR4;CDC42
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.5407614486206554,0.9294579250216295,0.5866666666666667,0.9361560624167753,1.0,3/15,16.46%,AGO2;ZC3H7A;TUT7
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),0.5858580673770246,0.9292493322774317,0.6176470588235294,0.9359020821279679,1.0,2/7,22.01%,DLGAP2;DLGAP1
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),0.5863401977276844,0.9291188955202909,0.625,0.935469294944466,1.0,1/6,2.60%,PRKAG2
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.494377297738683,0.9289310416267944,0.6025641025641025,0.935192821243254,1.0,5/25,14.85%,TIMP3;PLSCR4;COL4A2;GJA1;TNS1
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),0.5146752745330482,0.9285617782030005,0.6266666666666667,0.9352979122083082,1.0,4/17,24.51%,CDK6;RAC1;LIMS1;EMP2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.5090118650123528,0.9280502976402617,0.6197183098591549,0.9357915182340412,1.0,14/24,31.44%,PGK1;COL4A2;KLF4;CLDN5;FOXC1;ATF2;SPRED1;ATP2B4;PPARG;ADAMTS1;SPARC;MECP2;RGCC;DAB2IP
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.4372209894946358,0.927681356649863,0.6627906976744186,0.9358416539352248,1.0,5/69,7.06%,PSMC6;SPOPL;FEM1C;TRIM9;NFE2L2
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.5106569861638716,0.927559148333479,0.6493506493506493,0.9353328419404117,1.0,7/18,31.98%,PBRM1;SMARCC1;MBD2;ACTB;SMARCA5;ARID1A;SMARCA1
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.48146538071654016,-0.9273343243093475,0.5483870967741935,1.0,1.0,1/12,0.21%,CEMIP
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.5156180061197801,0.9273083032514928,0.6582278481012658,0.9352048330752234,1.0,8/20,22.64%,ZDHHC6;ZDHHC14;PIKFYVE;TRAM1;SDCBP;VPS37A;CHMP4B;RAB8B
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),0.48573249749149017,0.9268294965588525,0.5394736842105263,0.9354955635789035,1.0,7/26,14.82%,CD9;CTNND2;SMAD7;CTNNA1;GJA1;CLDN5;PAK2
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),0.5541452957361921,0.9264481348281745,0.647887323943662,0.9356542043722247,1.0,4/10,18.87%,HYAL2;PIK3R1;ECT2;TPR
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.6121653236288016,0.9262982265227286,0.6111111111111112,0.9352863023021234,1.0,5/5,38.86%,LGALS3;MSN;STK10;PTK2;MAPK1
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),0.6046498129366424,0.9261504038428242,0.6081081081081081,0.9349034577562616,1.0,4/6,23.91%,BOC;BTG1;PLCB1;MEF2C
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),0.5589293279186537,0.9252910023456585,0.6197183098591549,0.9358659843370154,1.0,5/13,27.65%,AGO2;STAT3;ZFP36;EGFR;MAP2K1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.4521023030720741,0.925290751035331,0.5512820512820513,0.9351975086339176,1.0,10/52,16.10%,MAFF;FES;PRNP;VWF;LRRC32;PECAM1;ADGRG1;TNS1;DYSF;NCOR2
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),0.5880248408091939,0.9251501540501756,0.6349206349206349,0.9348695721363731,1.0,3/6,31.67%,DGKI;PGS1;DGKG
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),0.4653933124436381,0.9249754113076605,0.6785714285714286,0.9344881171114451,1.0,9/42,26.53%,PSMC6;AGO2;RAC1;FZD4;PSMA7;PLCB1;PPP3CB;CDC42;PSMB9
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.5389378631283998,0.9248495738265,0.582089552238806,0.9340917921825944,1.0,2/10,11.19%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.6157466221077056,0.9248253451857752,0.6349206349206349,0.9334649913784283,1.0,1/5,9.37%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.5286248965525782,0.9241583303271598,0.6486486486486487,0.9340396380129607,1.0,5/16,19.00%,PINK1;ZDHHC6;SPIRE1;HIP1R;DDHD1
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),0.4638498474687193,0.9236489258964967,0.620253164556962,0.9343904458285436,1.0,10/26,32.42%,TSG101;SDCBP;LGALS3;TPR;CDH5;RACK1;VCP;RGCC;DAB2IP;RAB7A
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),0.5811662200757035,0.9233818702510513,0.6666666666666666,0.9342489196400476,1.0,2/9,7.17%,GPC5;HYAL2
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),-0.5242407171787715,-0.9233747950358183,0.5789473684210527,1.0,1.0,2/6,13.21%,EZH1;ZNFX1
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.522485780371857,-0.9219172068447484,0.5,1.0,1.0,6/12,25.39%,PDGFB;STX3;IL6R;CDH13;PRKD1;HSPB1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),0.5997946857234155,0.9218936613211375,0.6571428571428571,0.9366187809098636,1.0,2/6,20.40%,STAT3;ZFP36
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),0.5553435643368472,0.9207374509432003,0.5757575757575758,0.938003003869704,1.0,3/8,28.27%,HSPA9;SPG7;ATP5F1E
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),0.4281383280714223,0.9196329321611662,0.6744186046511628,0.9398683837015739,1.0,24/70,29.49%,PCK1;PKN3;PRKCE;PINK1;STK38L;STK38;PAK2;PRKX;CSNK1G3;TNKS;CSNK1D;MORC3;CAB39;PRKCH;HIPK3;CSNK2A1;WNK1;RPS6KA3;MTOR;TLK2;MARK3;SMG1;RPS6KA2;CAMK2D
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),-0.44027053652961257,-0.9190696789552542,0.45161290322580644,1.0,1.0,2/17,1.58%,PRIMPOL;ISG15
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.579480891244444,0.9185585809085973,0.5797101449275363,0.9409418159074959,1.0,4/8,23.78%,ENSA;YWHAB;ARPP19;YWHAE
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),0.5510051236493301,0.9184538753173833,0.6164383561643836,0.9404132653773067,1.0,2/12,9.27%,IL1RAPL1;PPFIA2
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),0.4489290428111106,0.9184469979523897,0.6341463414634146,0.9397477216650792,1.0,3/46,5.45%,PBRM1;BAZ1A;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.44202553839833775,-0.918258010095786,0.5172413793103449,1.0,1.0,2/13,2.49%,CD74;SHLD1
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.5645007940313184,0.91815512847667,0.5915492957746479,0.9395342854156516,1.0,3/8,24.95%,NAA16;NAA50;CREBBP
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",-0.4935370626195009,-0.9175156493843892,0.65,1.0,1.0,3/10,8.44%,RHOBTB1;ARHGAP12;GULP1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),0.5860055739191921,0.9174772887586097,0.6065573770491803,0.9401693549994828,1.0,2/5,25.21%,NPM1;XPO1
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.5787392140708164,0.9173124524600145,0.6349206349206349,0.9397726564733065,1.0,3/10,21.31%,PREPL;SYT1;RIMS2
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5330533210247547,0.9166744159758923,0.6794871794871795,0.9405363832656264,1.0,7/16,32.68%,KLF4;ATP2B4;PPARG;MEF2C;MECP2;RGCC;ACVRL1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),0.585154721916185,0.9166183916455735,0.6363636363636364,0.9399493526189417,1.0,2/6,10.54%,ARID5A;ZNF366
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.5373127157209581,0.9158075061574639,0.6119402985074627,0.9410242959355486,1.0,3/13,5.45%,TBX3;ANXA1;ZBTB1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),0.4717214889025037,0.9150477415708116,0.620253164556962,0.9417855277843196,1.0,5/35,16.74%,CLIC2;CLDN5;HIP1R;AMFR;FOXC1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),0.5903883644920189,0.9149409495788698,0.6571428571428571,0.9412825587606574,1.0,2/7,7.22%,CHSY1;CHST11
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.48667253319256865,0.9143260145733687,0.582089552238806,0.9419284804013249,1.0,6/18,17.55%,NEDD9;CALR;TRIOBP;RAC1;CRK;LIMS1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,0.5893707084432815,0.9138921809541182,0.5970149253731343,0.942193568258004,1.0,3/5,28.30%,DDX18;NPM1;WDR43
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),0.575589101887382,0.9133975358700087,0.582089552238806,0.9423671656039855,1.0,3/10,15.26%,GRIK2;ANK3;SYT1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),0.5476708182539846,0.9133137185886874,0.6805555555555556,0.9418803759652554,1.0,7/13,34.48%,ADGRB3;NEDD4L;CSMD3;NEDD4;CDKL5;DAB2IP;CAMSAP2
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.4637052817842159,0.9128303993969102,0.6666666666666666,0.9422283477348093,1.0,9/42,13.42%,ANK2;NES;MAP1B;NFASC;COL4A2;GJA1;BOC;BCAR1;SHC2
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),0.46046987460670524,0.9128010867435362,0.6296296296296297,0.9415983704557427,1.0,5/42,7.17%,ST18;PSMC6;YBX3;NFE2L2;HYAL2
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4732215836270461,0.9127149859704357,0.6216216216216216,0.941075282288253,1.0,6/29,22.87%,BNIP3L;CDKN1B;SLFN11;NPAS2;CHMP4B;NCK1
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.423077641586473,-0.9126505000994121,0.5185185185185185,1.0,1.0,2/20,1.92%,CD74;IFIH1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),0.478420114048241,0.9126476177966238,0.6551724137931034,0.9405907592988376,1.0,4/30,15.08%,GPM6B;CDK6;ADAM15;RASA1
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),0.6035738652322943,0.9126176710073945,0.6857142857142857,0.940016178081771,1.0,3/8,23.78%,RAPGEF3;TPR;YWHAE
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.4818109937610811,-0.9124789636210383,0.5806451612903226,1.0,1.0,1/15,1.12%,MSL2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.5235724108850358,0.9112111437867041,0.5970149253731343,0.9420341214862188,1.0,1/11,0.78%,ERBB4
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.5939711035011941,0.910959305329858,0.6376811594202898,0.9418595252617928,1.0,4/6,39.62%,TRAK1;MTM1;TRAK2;MEF2A
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),-0.4415467640919198,-0.9106576104000584,0.5625,1.0,1.0,1/14,2.52%,PLCB4
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),-0.4415467640919198,-0.9106576104000584,0.5625,1.0,1.0,1/14,2.52%,PLCB4
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),0.6036920196521125,0.9102877993724379,0.6142857142857143,0.9426434504302751,1.0,3/5,31.57%,SCARB1;ABCA5;ABCG1
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),0.5606154353193833,0.9101554005517117,0.6521739130434783,0.9422650865368002,1.0,4/7,40.91%,NOTCH4;DLL4;NRP1;TGFBR2
prerank,PanglaoDB_Augmented_2021__Osteoblasts,-0.4164828388383445,-0.9097045157161396,0.5789473684210527,1.0,1.0,1/36,0.13%,VCAM1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),0.597608733465222,0.909518496630257,0.6071428571428571,0.942595537859141,1.0,3/6,19.52%,MYO1E;MAGI2;PODXL
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),-0.4392612793225248,-0.9089705765443155,0.5217391304347826,1.0,1.0,2/23,5.30%,EIF2AK2;NOD1
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.576951839752274,0.9089435853187049,0.6388888888888888,0.9430836532779412,1.0,3/7,26.53%,NFE2L2;PSMA7;PSMB9
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),0.5980785544528193,0.9087375803313117,0.6153846153846154,0.9428035913280847,1.0,4/5,39.07%,XIAP;DDX3X;BIRC2;PRKN
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),0.4770506793494391,0.9085625502922869,0.6282051282051282,0.9425840729560538,1.0,7/27,23.39%,MAP3K5;RPS27A;MAPK10;TAB2;SH2D3C;ZFP36;UBC
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),0.5874435597586807,0.9080634696424618,0.676923076923077,0.9428382437238598,1.0,4/6,30.94%,AKAP6;MEF2C;ATP11A;EFNB2
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.39022649227822875,-0.9079810800587829,0.5,1.0,1.0,1/24,0.18%,GBP1
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),0.4894597540561481,0.9078265239485859,0.6428571428571429,0.9426114973599692,1.0,2/21,8.75%,PSMC6;RPS27A
prerank,PanglaoDB_Augmented_2021__B Cells Naive,-0.46629424179358203,-0.9076664769278748,0.6,1.0,1.0,2/10,9.27%,CD74;RCSD1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),0.515161150958014,0.9075389425849129,0.589041095890411,0.9425576485832688,1.0,7/15,16.61%,S1PR1;ARHGEF4;CCDC88A;ITGB1;RAC1;PARVB;GOLPH3
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.476779685191722,0.907486982895451,0.654320987654321,0.9419639897014591,1.0,14/30,34.11%,ANXA1;CDK6;KLF4;CDKN1A;SLFN11;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;FAM107A;DDX3X;ADAM17;DLG1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),0.49773483695200255,0.9073862026799795,0.5921052631578947,0.9415210177013522,1.0,7/20,26.74%,CCDC88A;CNOT6L;SDCBP;DYNC1H1;RAB3GAP2;ASAP1;FSCN1
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),-0.46368163088033076,-0.9063914695184841,0.53125,1.0,1.0,2/16,2.18%,VCAM1;IL15
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.5310103078452841,0.9053971332113625,0.5138888888888888,0.9448076903495067,1.0,3/13,17.89%,ZBTB1;CD55;MALT1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),0.5756727429771193,0.9053955493865826,0.6056338028169014,0.9441538441970158,1.0,1/6,9.50%,HIF1A
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),-0.4012627405385643,-0.9047130582163719,0.5769230769230769,1.0,1.0,3/29,5.43%,PRIMPOL;ATR;RHBDD1
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5836557060345049,0.9046866559971665,0.6515151515151515,0.9448917466758308,1.0,5/6,27.47%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),0.4498984983296947,0.9045705163340777,0.6329113924050633,0.9444778658308951,1.0,8/29,18.48%,NEDD9;CALR;CDK6;TRIOBP;RAC1;CRK;LIMS1;RSU1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),0.5180610507556362,0.9038798785776949,0.6818181818181818,0.945035309435655,1.0,3/16,18.38%,ATG12;RB1CC1;VMP1
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.5422634035182858,0.9038724175844823,0.6507936507936508,0.9443905733301968,1.0,1/5,5.35%,DHRS7B
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.491339682431014,-0.9037491617893194,0.5,1.0,1.0,1/6,0.18%,GBP1
prerank,PanglaoDB_Augmented_2021__Fibroblasts,0.45424151374726873,0.903407574755701,0.6455696202531646,0.9445744567790647,1.0,11/49,9.87%,LAMC1;ZEB2;KLF2;KLF6;TIMP3;P4HA1;PLSCR4;COL4A2;HIF1A;FOSL2;KLF4
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.45215952319707564,0.9022267509758594,0.6463414634146342,0.9459578410866498,1.0,12/35,30.61%,TIMP3;PLSCR4;COL4A2;GJA1;FZD4;EPAS1;CALD1;CDH5;EGFR;ADGRL4;SLCO2A1;SASH1
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.4903743880461099,0.901319677482779,0.6164383561643836,0.9470786833759505,1.0,4/16,19.18%,ANXA1;FLT1;FOXC1;VEGFC
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5321377370111939,0.9012839393649364,0.6973684210526315,0.946471524031411,1.0,8/14,29.49%,PRKCE;ANK3;NEDD4L;DMD;NEDD4;WNK1;FGF12;CAMK2D
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),0.5445692215953659,0.9012271289822678,0.6825396825396826,0.945887509388776,1.0,3/8,9.50%,ARF1;HSP90AA1;HIF1A
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),0.622448533505711,0.900666855532668,0.7377049180327869,0.9462703800181371,1.0,1/5,12.56%,REST
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.6126493610063235,0.8998085046952536,0.7258064516129032,0.9470685975196382,1.0,3/6,25.93%,FOXC1;OXSR1;WNK1
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5224145033509259,-0.8998037713686423,0.5925925925925926,1.0,1.0,4/14,8.46%,CD74;ATM;ATR;MDM2
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),0.45281183452947915,0.8991514121488934,0.6375,0.9476282408282383,1.0,5/33,20.51%,GPM6B;DLC1;RAC1;LIMS1;DUSP22
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),0.4454309169617524,0.8990148982173863,0.6470588235294118,0.9472452701106338,1.0,12/56,11.68%,LAMC1;ADAMTS9;SERPINE1;GPM6B;LAMA5;PLOD2;P4HA1;COL4A2;ITGA1;ADAM15;VWF;PECAM1
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),0.5535142008432645,0.8983812230458376,0.6351351351351351,0.9476706266293168,1.0,5/10,26.77%,CANX;GOLPH3;MIA2;RAB8B;SEL1L
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.5659782404703386,0.8981374525064767,0.703125,0.9475399539287954,1.0,2/7,28.12%,UBE2B;USP22
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),0.535273462534799,0.8972695655977138,0.6338028169014085,0.9486010025549662,1.0,4/13,30.09%,RPS27A;DYNC1H1;UBC;DYNC1I2
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.37253140122290684,-0.8965321633886812,0.7333333333333333,1.0,1.0,12/47,12.93%,GBP1;CD74;GCNT2;TGFBR3;FN1;PDGFC;SEMA6A;PTPN2;SPRY3;PDGFB;MFHAS1;PTPRR
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),-0.5160773336822037,-0.8964541249061977,0.6666666666666666,1.0,1.0,1/8,3.76%,PATJ
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.520552699385675,0.8960773571164341,0.684931506849315,0.9503484111791052,1.0,8/13,33.64%,ANXA1;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;DDX3X;ADAM17
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),-0.4349883829783815,-0.8960767695937434,0.6153846153846154,1.0,1.0,2/18,4.88%,STAT1;PLXND1
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.5637260114878093,0.8953144302343964,0.6617647058823529,0.9510069882014867,1.0,6/9,34.87%,UGGT2;UGGT1;VCP;CUL3;ATXN3;NGLY1
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),-0.47441800171457343,-0.894617440247861,0.5185185185185185,1.0,1.0,1/8,2.10%,PLPPR4
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),0.41632662807667326,0.8944572584606811,0.6455696202531646,0.9518345370656504,1.0,17/52,30.82%,RPS9;RPL23;RPL34;RPL8;RPL37;RPLP2;RPL13A;RPS27;RPLP1;RPL10;RPL37A;MTREX;RPL21;RPS15;WDR43;RIOK3;XRN2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.42852639893783656,0.8944566420517974,0.6987951807228916,0.9511848206580972,1.0,15/54,23.83%,FOS;SMAD7;SMAD5;RPS27A;JUN;LRRC32;ACVR2A;CLDN5;ITGB1;ZMIZ1;PXN;DUSP22;SMAD6;UBC;ADAM9
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.5329379367071598,-0.8943576917366612,0.5909090909090909,1.0,1.0,2/7,8.00%,NKD1;SHROOM2
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),-0.4524197816969656,-0.8941910643932942,0.625,1.0,1.0,1/14,1.43%,CPQ
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.4556320006070944,0.8941539359367354,0.675,0.9510596612828152,1.0,7/29,20.61%,CANX;ARF1;SEC24D;PIKFYVE;AP1G1;DYNC1H1;DNM2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),0.5289075855726639,0.8937416346346595,0.6301369863013698,0.951273720843851,1.0,6/15,22.64%,CANX;ANXA1;GOLPH3;MIA2;RIMS2;RAB8B
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.46836281117871087,-0.8936568133860039,0.631578947368421,1.0,1.0,3/26,5.94%,PGM5;TTN;EPB41L5
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),-0.3585106035534074,-0.8935377364641337,0.5925925925925926,1.0,1.0,8/52,7.40%,ISG15;CD74;IFIH1;IFI27;MX1;SP100;TRIM25;GCH1
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),-0.5053090476858846,-0.893377804828387,0.6071428571428571,1.0,1.0,1/7,1.09%,SLC4A4
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.5004647100653116,0.8931840585285057,0.6805555555555556,0.9517894781423335,1.0,3/12,21.00%,CDKN1B;CDKN1A;ATP2B4
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),0.4081905246639032,0.892955997237043,0.7142857142857143,0.9514948694070977,1.0,7/91,10.15%,LAMC1;SEC22B;SEC24D;MCFD2;PICALM;TMED10;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.48852446691830564,-0.8928360768558822,0.5757575757575758,1.0,1.0,3/8,22.98%,LARP1;CIRBP;THRAP3
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),0.45316692321871527,0.8927800461505012,0.6388888888888888,0.9511344613411341,1.0,5/29,10.80%,PINK1;ERO1A;NFE2L2;SERPINB6;MSRA
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),0.5382083390440577,0.8923780426114339,0.6615384615384615,0.9513331868276927,1.0,4/8,11.03%,SCP2;PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.45237834494092843,0.8923238205795805,0.6933333333333334,0.9508485034383989,1.0,9/42,11.68%,SERPINE1;CD9;TIMP3;SYTL4;SRGN;LAMP2;VWF;PCDH7;PECAM1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),-0.5908210504572329,-0.8923139943416136,0.6551724137931034,1.0,1.0,2/5,9.45%,ALS2;AUTS2
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.47231561067393385,0.8922238701247561,0.5972222222222222,0.9504011811013195,1.0,8/24,22.64%,IPO7;HSP90AA1;LAMP2;PTTG1IP;TPR;STAT3;PPP1R10;RAB8B
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.5642685951436722,0.8916956243056836,0.6461538461538462,0.950754047462329,1.0,6/8,30.56%,ANK2;VMP1;ATP1B1;AKAP6;RYR2;CALM1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.49600220499599756,0.8916942063877763,0.631578947368421,0.9501167990861692,1.0,1/22,0.70%,ZEB2
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.589458765590977,0.8916765075280465,0.6307692307692307,0.9495390195702844,1.0,1/5,16.69%,BRD4
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),0.4855866085013892,0.8916310647909583,0.5897435897435898,0.94897666384877,1.0,8/23,23.91%,CDK6;REST;ACVR2A;WWTR1;HDAC7;SMAD6;PPARG;MEF2C
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),0.4969392635785385,0.890923499221526,0.6805555555555556,0.9495855906250315,1.0,8/17,30.56%,DLC1;HSP90B1;ENSA;YWHAB;ARPP19;CDH5;SPPL3;CALM1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),0.45839235936464484,0.890909423865431,0.6493506493506493,0.9489947206167567,1.0,6/24,20.46%,PRKCE;RAD21;ECT2;TPR;CSPP1;DYNC1H1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.4848289706841628,0.8908334496583202,0.6805555555555556,0.948433872575052,1.0,4/15,24.95%,PRNP;SERF2;GSN;CREBBP
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),-0.4935904937230128,-0.8908198004005041,0.5454545454545454,1.0,1.0,2/11,3.50%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.4717536004792593,0.8907211801903762,0.6301369863013698,0.9480563054325709,1.0,5/21,7.89%,FES;PRKCE;PINK1;NAV3;HSP90AA1
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.5833018275208287,0.8905930192851839,0.6833333333333333,0.9476646557995579,1.0,3/6,17.13%,ANK2;ATP2B1;LGALS3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.5315865031312277,0.8900904019022328,0.6521739130434783,0.9477693287544618,1.0,3/14,14.33%,ROBO2;PECAM1;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.41024321964771315,0.8900427033053814,0.6790123456790124,0.9471889596252562,1.0,18/72,21.91%,RTN4;SERPINE1;GAPDH;KDM1A;OGT;GJA1;REST;AGO2;WWTR1;GRB10;SDCBP;FOXC1;RIF1;CFL1;ALMS1;DYNC1H1;EPAS1;PLCB1
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),0.5291922999940244,0.8897935767688167,0.6716417910447762,0.9469151856668112,1.0,3/11,12.69%,PDE7A;RAPGEF3;ADCY2
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),0.5544974487003222,0.8896227443825178,0.7,0.9459033676192166,1.0,4/9,18.87%,HYAL2;PIK3R1;ECT2;TPR
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),0.5544974487003222,0.8896227443825178,0.7,0.9459033676192166,1.0,4/9,18.87%,HYAL2;PIK3R1;ECT2;TPR
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.38583576198801106,0.8891209394366977,0.7096774193548387,0.9462559367251374,1.0,35/168,22.30%,BCL6;TBX3;BHLHE40;PHF10;CALR;GAPDH;ZFPM2;KDM1A;ATP8B1;ARID5A;CDKN1B;KLF4;JUN;SPEN;CDKN1A;REST;WAPL;GIGYF2;ZBTB38;RPL13A;NCOR2;CRY1;ATOH8;LIMS1;MBD2;SLFN11;BTG2;BCLAF1;NR1D2;NACC2;RCOR3;CREBZF;HSPA8;PLCB1;PPARG
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.591757180108771,0.8888935510032104,0.65625,0.9460416185489269,1.0,1/6,10.12%,YTHDC1
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.5243915248403752,0.888791418738791,0.6666666666666666,0.9455735986240041,1.0,1/11,6.44%,PINK1
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),0.5564827559236114,0.8887865458112166,0.6351351351351351,0.9449466630733687,1.0,1/9,13.97%,GIGYF2
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),0.5417346945260031,0.8886292111688969,0.7162162162162162,0.9445814639876543,1.0,3/12,15.21%,PRKAG2;PIK3R1;GRB10
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5615740861324672,0.8880759555025785,0.7333333333333333,0.9449989180846949,1.0,2/10,7.58%,FES;NAV3
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),0.5212406242636907,0.8880086549541534,0.6376811594202898,0.9445328491505108,1.0,7/14,28.92%,GGT5;PELI1;TAB2;ERBIN;SMAD6;RPS6KA3;IFNAR1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.5830373039268352,0.8874920745587436,0.6724137931034483,0.9448123584627596,1.0,1/6,3.71%,GLUD1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5543504511451248,0.8869571245175097,0.6515151515151515,0.9452071378708656,1.0,3/7,19.68%,BCL2L1;TMBIM6;HERPUD1
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),0.5053675480189946,0.8868032427709361,0.5925925925925926,0.9448574303722482,1.0,1/16,4.26%,GPM6B
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.5577120867037292,0.8862777608762864,0.7014925373134329,0.9451722536724645,1.0,2/8,4.23%,PCK1;ANXA1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.43097608484614885,0.8862579575734956,0.6941176470588235,0.9445705715622805,1.0,11/56,18.15%,ERBB4;FES;PINK1;FGFR1;SIK2;PIKFYVE;FLT1;PAK2;GRK5;PRKX;TEC
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),0.5237673532337839,0.8862177356900953,0.704225352112676,0.9440129424654169,1.0,7/15,13.03%,SLC8A1;S1PR1;GPM6B;SRGN;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.45284821466060765,0.8861832532807417,0.5949367088607594,0.9434704636972987,1.0,9/36,22.30%,PSMC6;SIN3B;LSS;PLPP1;NCOR2;PSAP;PSMA7;NR1D2;PPARG
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.4768083301475474,-0.8858868152507972,0.6071428571428571,1.0,1.0,1/10,3.74%,TNRC6C
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.5057364215663216,0.8857942003568192,0.6575342465753424,0.9434830197426235,1.0,2/12,16.38%,PINK1;SDCBP
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.527672189325319,0.8849572009991522,0.6440677966101694,0.9445962523413696,1.0,4/8,16.90%,SEMA6B;SEMA3F;RAC1;PLXNA2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.5095452910524028,-0.884722324041345,0.6285714285714286,1.0,1.0,1/7,4.23%,ATR
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),0.517255102458795,0.8846761585741393,0.6527777777777778,0.9444858252248669,1.0,3/15,12.85%,MAP3K5;FGFR1;FLT1
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.5829733877970937,0.8846502862620166,0.6521739130434783,0.9432458874657724,1.0,1/6,11.19%,RAP1A
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.5829733877970937,0.8846502862620166,0.6521739130434783,0.9432458874657724,1.0,1/6,11.19%,RAP1A
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.5489506495124046,0.8845661616958858,0.7101449275362319,0.9427706523348464,1.0,4/8,36.99%,TF;ACTB;POC1B;ACTG1
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),0.4951395052569921,0.8844463055953804,0.5909090909090909,0.9423892603567116,1.0,3/12,27.10%,PPP1R9A;INPP5A;RYR2
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),0.5549329990617349,0.8839293571057999,0.7352941176470589,0.9426747624794631,1.0,5/10,30.79%,DUSP1;TOM1L2;CAV2;CDK5RAP2;RGCC
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.5001141509503877,0.8835756571796884,0.7,0.9425803681032349,1.0,6/14,28.97%,CPEB4;UBR1;FYN;MTOR;SLC38A9;CAPN2
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.46151080203623124,-0.882892902767374,0.5882352941176471,1.0,1.0,1/10,1.38%,MLLT3
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),0.6039675731582506,0.8823953078413118,0.7419354838709677,0.9441462870811718,1.0,4/6,30.50%,OGT;WDR82;TET2;KMT2A
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),0.47812004536282093,0.8822272560553639,0.6666666666666666,0.9437721455169209,1.0,4/20,17.13%,DYSF;CTTNBP2NL;NDFIP1;LGALS3
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),0.49277266193968366,0.8822026121467909,0.6438356164383562,0.9431912492910406,1.0,3/12,19.00%,PINK1;SPIRE1;DDHD1
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),0.5387729346014123,0.8821548480955063,0.6666666666666666,0.9426825384804305,1.0,6/11,36.94%,TRAK1;DYNC1H1;PAFAH1B1;NDEL1;RAB1A;TRAK2
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.4490792736991729,0.8819435853743804,0.6829268292682927,0.9423814748696848,1.0,10/46,17.58%,SERPINE1;SMAD7;NAV3;SRGAP1;DLC1;ADAM15;MAGI2;CLDN5;CRK;DAG1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),0.5185803953656625,0.8817139063525601,0.6216216216216216,0.9422805151644593,1.0,5/12,13.03%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.5780395398264404,0.8816532737243038,0.6323529411764706,0.9417947937700906,1.0,5/9,37.44%,CLDN5;ADD1;CDH5;VCL;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.5436331120341299,0.8814361942537399,0.7027027027027027,0.941559016832061,1.0,3/11,27.41%,BTBD10;SDCBP;EGFR
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.6119450942091228,0.8811811614246465,0.7571428571428571,0.9408394171794845,1.0,2/5,10.77%,ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.6119450942091228,0.8811811614246465,0.7571428571428571,0.9408394171794845,1.0,2/5,10.77%,ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),0.40689038723023063,0.8810568947293536,0.7011494252873564,0.9403417027531034,1.0,15/88,16.61%,EHD4;S1PR1;RAB11FIP3;NUDCD3;ARHGEF4;CCDC88A;EMP1;RAP1A;ANO6;ITGB1;BBS9;RAC1;SDCBP;PARVB;GOLPH3
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),0.5540888595415283,0.8809264507601218,0.6285714285714286,0.9399725191388989,1.0,1/7,2.44%,FES
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.5933639725058351,0.8784447188753904,0.6984126984126984,0.9437641866385923,1.0,1/5,7.48%,ARHGAP21
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),0.4294073575974605,0.8782727929642555,0.6746987951807228,0.9434074316783225,1.0,12/39,26.74%,NRCAM;CTNND2;NRXN1;CLDN5;LIMS1;VMP1;ACTB;ADGRL3;CDH18;CDC42;CDH5;FSCN1
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3899435286382443,0.877556348614016,0.7065217391304348,0.9440579658084853,1.0,10/108,10.31%,PSMC6;SPOPL;HSPA5;FEM1C;TRIM9;NFE2L2;RPS27A;UBE2J1;HSP90B1;NPLOC4
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),0.49373499529447507,0.8774329403835682,0.6623376623376623,0.9437156571889782,1.0,6/27,14.51%,ERBB4;FGFR1;CDKN1B;FLT1;EEF1A1;ECT2
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),0.4231486833669473,0.8768253585826271,0.6712328767123288,0.9441881123345713,1.0,15/49,28.30%,RPS9;RPL23;RPL34;RPL8;RPL37;RPLP2;RPL13A;RPS27;RPLP1;RPL10;RPL37A;MTREX;RPL21;RPS15;WDR43
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.4507030764007787,-0.876454415517065,0.6296296296296297,1.0,1.0,2/13,3.45%,FAXDC2;STAT1
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),-0.5607044319194255,-0.8764417659754432,0.5945945945945946,1.0,1.0,2/5,5.19%,SLCO1A2;ABCG2
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.5416079447980043,0.8761831030294653,0.6515151515151515,0.9445821090186561,1.0,2/10,14.95%,PINK1;TMF1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5743128299681849,0.8759284821190035,0.6986301369863014,0.9443108466443518,1.0,2/5,8.83%,FES;CDK6
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),0.5855319265872577,0.8755211077877596,0.6666666666666666,0.944393294829579,1.0,1/7,5.43%,SYTL4
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.5124157344124863,-0.8753160862535759,0.6060606060606061,1.0,1.0,3/7,22.04%,MOB3B;WWC3;MAPK14
prerank,PanglaoDB_Augmented_2021__B Cells Memory,0.5484323789667196,0.8751549006399568,0.6521739130434783,0.9444050102763103,1.0,1/6,7.45%,BACH2
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),-0.4724810640263766,-0.8748964385705266,0.5714285714285714,1.0,1.0,1/8,2.73%,ATM
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),0.5145420757879094,0.8748752727773679,0.676056338028169,0.9442543788814571,1.0,4/12,23.75%,TPR;DYNC1H1;NEDD4;CEP290
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.5468038532107469,0.874743728862646,0.6567164179104478,0.9439769847961338,1.0,3/7,23.36%,OGT;CRY1;ARPP19
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.5293937935198058,0.8746707342136715,0.5866666666666667,0.9434673455553282,1.0,3/9,23.39%,RPS27A;TAB2;UBC
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),-0.2973757089289447,-0.8740384252303088,0.9090909090909091,1.0,1.0,20/101,14.04%,SCFD2;CD74;OCLN;VPS45;BICD1;WLS;TBC1D5;STX17;HERC2;COG3;ITSN1;CEP68;PIGU;PACS2;EVI5;CNTLN;USP6NL;STX3;SNX13;SEPTIN9
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.6229931956561547,0.8739684872631002,0.7297297297297297,0.9436115775677585,1.0,1/5,7.24%,PRNP
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.6229931956561547,0.8739684872631002,0.7297297297297297,0.9436115775677585,1.0,1/5,7.24%,PRNP
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.438954003031951,0.8730616226623316,0.676056338028169,0.9444749828208725,1.0,4/34,11.84%,ITPR1;MAP3K5;ERO1A;CDKN1A
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.53296349285465,0.8729465441720589,0.7076923076923077,0.9440225881183971,1.0,6/12,26.04%,RPS27A;HSP90B1;TAB2;ALPK1;UBC;RPS6KA3
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4716330494155142,0.8728254687989003,0.6666666666666666,0.9436550908174327,1.0,4/20,11.53%,FES;NES;PRKCE;KATNBL1
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.5039661590499702,0.8727034277292403,0.6417910447761194,0.9433161557016037,1.0,3/9,14.33%,ANXA1;PRKCE;ITGB1
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.5716161915344569,0.872673043914812,0.6785714285714286,0.9427390936038955,1.0,3/6,37.67%,ETS1;ADAM17;ACTN4
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,0.4981250732920768,0.8719706988557626,0.6231884057971014,0.9433267922715735,1.0,3/13,9.50%,CD9;ANXA1;HIF1A
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),0.5220068767014353,0.8715848225846838,0.671875,0.9433321002164061,1.0,7/11,31.41%,SAMD8;NSMAF;PLPP1;ST6GALNAC3;ACER3;SPTLC2;CERK
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.5876651007801922,0.8709903483952331,0.7205882352941176,0.9429577776321965,1.0,3/5,35.23%,AKAP6;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),0.5876651007801922,0.8709903483952331,0.7205882352941176,0.9429577776321965,1.0,3/5,35.23%,AKAP6;SPPL3;PTBP1
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),0.47505934251425036,0.8706583051294763,0.717948717948718,0.9428653982510466,1.0,4/27,10.83%,SPNS2;SCP2;ATP8B1;PITPNC1
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),0.38226596744232644,0.8695421741793511,0.782608695652174,0.9442898508406489,1.0,42/152,23.91%,ERBB4;KLF2;KLF6;MAP3K5;NPAS3;ESR2;FOS;SMAD5;PICALM;HIF1A;KLF4;JUN;CNBP;SETD3;PPM1A;REST;FOXF1;NAA16;SMARCC1;CRLF3;FZD4;BRD4;FOXC1;ATOH8;ZMIZ1;NPAS2;STAT3;NR1D2;NFIB;KMT2E;DNM2;NOTCH4;RLF;PLCB1;PPP3CB;PPARG;NPM1;ETS1;MED4;CREB3L2;CEP290;MEF2C
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.5969541871249098,0.869485528078398,0.7297297297297297,0.9438195433482026,1.0,3/6,31.57%,PPARG;ABCA5;ABCG1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),0.5842988024388047,0.8693394213460116,0.7205882352941176,0.9434266278724628,1.0,2/5,40.84%,MTM1;DNAJB6
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.3967126567998155,-0.8687615697625184,0.6,1.0,1.0,2/21,4.02%,ALS2;SNX2
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.4527777740703661,0.8685686937895299,0.6867469879518072,0.9441433923700098,1.0,1/27,1.01%,PSMC6
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5113493679931537,0.8684885932608716,0.7419354838709677,0.943688031857706,1.0,4/10,11.03%,SCP2;PRKAG2;LBR;INSIG1
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.5180207603131605,0.8675942377761585,0.7246376811594203,0.9447729521389089,1.0,5/10,30.09%,CCDC88A;TUBA1B;TUBB;KIF1B;DYNC1I2
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.5013757240436236,0.8675417836207526,0.7164179104477612,0.9442133358454433,1.0,2/15,5.63%,MAP2;CTNND2
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.5466831222757886,0.8670884092311335,0.7435897435897436,0.944315447371876,1.0,1/10,1.48%,TSG101
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.5155831669876565,0.8666674074852345,0.6716417910447762,0.94438961356483,1.0,2/9,13.47%,CDKN1A;DCP2
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),0.49985967701860695,0.8662592363164713,0.6986301369863014,0.9446443592410153,1.0,6/12,36.47%,RPS27;NPM1;RPS15;RIOK3;RPS7;RPS6
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.4315529688756755,0.8660677098912292,0.6666666666666666,0.944343212238018,1.0,15/52,21.08%,ADM;SERPINE1;KLF6;ATP2B1;HIF1A;PCDH7;CDKN1A;ACVR2A;CD55;SLC1A2;PDE4B;BTG2;NAMPT;ABI1;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.49623212691217805,0.8657921860595723,0.7272727272727273,0.9440840924813403,1.0,7/19,21.37%,KDM1A;OGT;GJA1;GRB10;ALMS1;DYNC1H1;EPAS1
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),0.5585615055792509,0.8654725193866787,0.7105263157894737,0.9440749888722405,1.0,2/8,21.37%,REST;EPAS1
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.5239628038152259,0.8653942187909638,0.6883116883116883,0.9436222992882116,1.0,7/15,22.59%,CDK6;HIF1A;HSPA9;ACVR2A;STAT3;ZFP36;ETS1
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),0.44552642615096133,0.8652092731573447,0.6829268292682927,0.9427532706967463,1.0,9/43,11.68%,LAMC1;ADAMTS9;SERPINE1;LAMA5;COL4A2;ITGA1;ADAM15;VWF;PECAM1
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),0.44552642615096133,0.8652092731573447,0.6829268292682927,0.9427532706967463,1.0,9/43,11.68%,LAMC1;ADAMTS9;SERPINE1;LAMA5;COL4A2;ITGA1;ADAM15;VWF;PECAM1
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.5364443553921295,0.8647585786158981,0.6493506493506493,0.9428142209344078,1.0,4/9,34.37%,LPGAT1;SCARB1;MTOR;LDLR
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.5894791021125464,0.8646713453036157,0.6984126984126984,0.9411254425894848,1.0,3/5,33.64%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.5894791021125464,0.8646713453036157,0.6984126984126984,0.9411254425894848,1.0,3/5,33.64%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.5894791021125464,0.8646713453036157,0.6984126984126984,0.9411254425894848,1.0,3/5,33.64%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.5413662695016984,0.8643947089259715,0.7017543859649122,0.9410009692957081,1.0,3/7,29.10%,DCP2;TNKS;HNRNPU
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.422370485660338,0.8638702631495024,0.5866666666666667,0.9411386970646874,1.0,7/33,21.83%,SLC4A10;SCARB2;BCAR1;SHC2;CADPS2;ATP1B1;GPRC5B
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5494722549627402,0.8633746553128673,0.65625,0.9412969236369442,1.0,2/7,8.23%,CHSY1;SRGN
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),-0.5241575451884872,-0.8632187239601419,0.6875,1.0,1.0,2/6,4.52%,STAT1;PARP9
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.4329112173861787,0.8624311232008741,0.6842105263157895,0.9424122507327453,1.0,7/33,18.15%,NEDD9;LAMA5;ADAM15;BCAR1;ITGB1;ERBIN;TEC
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),0.4100233758509702,0.8623874304551563,0.6923076923076923,0.9419087277830577,1.0,17/63,28.30%,RPS9;RPL23;RPL34;RPL8;RPL37;AGO2;RPLP2;RPL13A;TUT7;RPS27;RPLP1;RPL10;RPL37A;MTREX;RPL21;RPS15;WDR43
prerank,PanglaoDB_Augmented_2021__Microfold Cells,0.45444039776047596,0.8620953398566248,0.7297297297297297,0.9419492314004233,1.0,13/30,21.81%,JUNB;EHD4;BHLHE40;NFE2L2;FOSL2;KLF4;LGALS3;SUSD6;NFIB;MGAT1;NFIC;ZFP36;B4GALT1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.5521565478249129,0.8611432067873673,0.7123287671232876,0.9429039162715172,1.0,2/8,12.36%,RPS27A;CCNH
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.47749053171021816,0.8606828717149633,0.6376811594202898,0.9431429534914562,1.0,5/13,34.89%,WWTR1;YWHAB;YWHAE;TEAD1;LATS2
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.5585360774804032,0.8606003948586779,0.7534246575342466,0.9426333801902851,1.0,1/9,1.48%,TSG101
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),-0.4570374369643371,-0.8604600076255635,0.5757575757575758,1.0,1.0,2/13,2.83%,ATM;BABAM2
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.5473308845146425,0.8600352000605744,0.7333333333333333,0.9429889200982285,1.0,4/10,21.63%,SSH1;HIP1R;GSN;ARFGEF1
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),0.446705097188989,0.8591235929559801,0.6708860759493671,0.9440365150952522,1.0,7/25,25.39%,PINK1;BCL2L1;LGALS3;TMBIM6;HERPUD1;MCL1;CSNK2A1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),0.4331231692208011,0.8590909699980895,0.6904761904761905,0.9434999357026951,1.0,15/52,25.03%,BCL6;LRRC4C;PPFIA2;ADGRB3;LARP4;NEDD4L;PAK2;PDZD8;DAG1;CFL1;NEDD4;ETS1;MEF2C;EMP2;TANC2
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.42080095888337216,-0.8587961204854835,0.6153846153846154,1.0,1.0,1/24,0.13%,VCAM1
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),0.5490713410476092,0.858604962814506,0.7358490566037735,0.9429899796212162,1.0,3/5,39.07%,TGM2;MAPK1;PRKN
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),0.5490713410476092,0.858604962814506,0.7358490566037735,0.9429899796212162,1.0,3/5,39.07%,TGM2;MAPK1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),0.524921573908089,0.8581409930710517,0.6933333333333334,0.942618009429029,1.0,5/10,13.03%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),0.524921573908089,0.8581409930710517,0.6933333333333334,0.942618009429029,1.0,5/10,13.03%,SLC8A1;GPM6B;ATP2B1;ANO6;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.4286905779457866,0.8578298940259901,0.7349397590361446,0.9424938513632124,1.0,5/31,16.23%,EPS8;CCDC88A;PIK3R1;ARPC2;RAC1
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),0.45797402167769646,0.8563792886350929,0.6666666666666666,0.944315315592053,1.0,4/23,10.83%,SCP2;SCARB2;ATP8B1;PITPNC1
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),0.515377805071856,0.8563287113166993,0.6571428571428571,0.943753642499019,1.0,6/9,35.72%,HSP90AA1;TPR;YWHAE;VCP;ATXN3;HSP90AB1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.5513649914774293,0.8554762475724919,0.7142857142857143,0.9443857553806738,1.0,6/8,37.18%,KPNA4;KPNA3;KPNA1;KPNB1;RANBP2;NUP54
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.610581251810097,0.8548314890150078,0.7538461538461538,0.9448808058311394,1.0,3/5,31.59%,KPNB1;ABCG1;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.47104448082221,0.8545276369285769,0.704225352112676,0.9448100857596178,1.0,7/23,21.37%,KDM1A;OGT;GJA1;GRB10;ALMS1;DYNC1H1;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),-0.5498773529889874,-0.8532255051228714,0.725,1.0,1.0,1/5,4.96%,BMP6
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),0.5772823891543679,0.8531619501017147,0.7936507936507936,0.9465086806805956,1.0,3/6,25.47%,MYL6;MEF2C;CAV2
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.5124941216574683,-0.8527023347860538,0.64,1.0,1.0,2/6,15.45%,MFF;PNPT1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),-0.30566369962538964,-0.8524102099427321,1.0,1.0,1.0,16/119,11.19%,RNF213;UBE3D;MARCHF8;IFI27;HERC6;HERC5;RC3H1;MDM2;PELI2;PSMF1;UBE2E2;FBXO9;HECW2;FBXW4;PSMB1;WSB1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.415323849930316,0.8520952814130988,0.7466666666666667,0.9476067006701328,1.0,5/37,15.01%,SEC22B;HSP90AA1;CDKN1B;NEDD4L;PTTG1IP
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),0.3848540081190359,0.8514601033153896,0.7261904761904762,0.9480373165632562,1.0,17/62,27.47%,DDIT4;CALR;GRB10;CRY1;GATA2;TMBIM6;EGFL7;SULF2;PTPN1;NEDD4;NCK1;YWHAB;PHACTR4;CSNK2A1;RACK1;EGFR;VCP
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),0.5431465671828841,0.8511858715187849,0.7424242424242424,0.947835745492769,1.0,2/6,31.44%,MORC3;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.5713866955934829,-0.8510825314838636,0.6666666666666666,1.0,1.0,2/5,12.59%,PDGFC;PDGFB
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.4898292198633946,0.8510051433721154,0.6666666666666666,0.9475461883193277,1.0,4/12,27.86%,OGT;SDCBP;EIF3H;TLK2
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.48362240053971156,0.85083390220864,0.7534246575342466,0.947236644343168,1.0,9/18,37.20%,CCDC88A;LIMK2;DYNC1H1;KPNB1;DST;DLG1;CAMSAP2;RAB11A;HOOK3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.5072107723574906,0.8503931214129604,0.6712328767123288,0.9473003399798109,1.0,1/14,3.30%,LRRC8B
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.42236340157872887,0.8502824922290665,0.7012987012987013,0.9468355159321462,1.0,9/47,11.27%,LAMC1;SERPINE1;SPOCK1;TIMP3;PLOD2;TPM4;COL4A2;GJA1;JUN
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),0.4498322992106699,0.8501957970763667,0.6329113924050633,0.9463983565172945,1.0,13/25,33.93%,RAB11FIP3;PRKCE;AHCTF1;ECT2;BCL2L1;CSPP1;UVRAG;CDC42;PIK3C3;CALM1;CDC14B;PRPF40A;CUL3
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),0.4676428413813792,0.8501536396897694,0.6753246753246753,0.9458670147633038,1.0,3/20,11.63%,ROBO2;ARID5A;ATP1A1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.41892546221061067,0.8500543187771719,0.7407407407407407,0.9454174835127703,1.0,3/40,10.15%,LAMC1;PICALM;SLC2A1
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.44834976085926315,0.8496397714008703,0.6944444444444444,0.9454483274116093,1.0,6/29,19.50%,BCR;TBC1D15;TBC1D9;ECT2;RALGAPB;RALGAPA1
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),-0.5053378874400436,-0.8494679311194581,0.7222222222222222,1.0,1.0,3/5,25.05%,CYLD;TRPM7;RIPK1
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),-0.5053378874400436,-0.8494679311194581,0.7222222222222222,1.0,1.0,3/5,25.05%,CYLD;TRPM7;RIPK1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),0.42369850854928964,0.8481999694374452,0.7011494252873564,0.9472553589887872,1.0,9/44,17.58%,TRIM5;FGFR1;DUSP1;PEBP1;PHLPP1;FLT1;PAK2;SPRED1;DAG1
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),-0.40244898433998294,-0.8479845379954349,0.6538461538461539,1.0,1.0,2/19,3.50%,CARMIL1;EVL
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.48176868201388884,0.8479199226950174,0.6714285714285714,0.9470825322621116,1.0,5/17,22.90%,TIMP3;COL4A2;TNS1;CALD1;RBPMS
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.40803121327212466,0.8471490232749145,0.7294117647058823,0.9476114308546055,1.0,15/54,17.89%,TRIM5;GAPDH;REL;PINK1;GJA1;PPM1A;PELI1;TAB2;ECT2;SLC20A1;NDFIP1;MTDH;BRD4;ALPK1;MALT1
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.4499774183787576,0.8468928528439015,0.7297297297297297,0.9473846689911306,1.0,6/23,14.98%,TSG101;CCDC88A;GRB2;ITGA1;ZFYVE28;HIP1R
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),0.3774880223325845,0.8467547680243246,0.8021978021978022,0.9469493464125779,1.0,22/146,17.94%,DDIT4;AKAP12;PRKAG2;ARHGAP23;UFL1;MYO9B;ARHGEF4;BCR;ARHGAP21;SRGAP1;DLC1;VWF;GNA13;RFC3;PHLPP1;ECT2;PAK2;RAC1;CRK;FAM13A;SPRED1;ARHGEF2
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),0.5623453755342099,0.8467086086716369,0.7333333333333333,0.9464337737304365,1.0,4/6,36.45%,JUN;CHD1;EP300;SMARCA4
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),0.4683108677702759,0.8466698610790172,0.7285714285714285,0.9453373090314684,1.0,4/12,25.57%,PRKCE;ECT2;CSPP1;CDC42
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),0.4683108677702759,0.8466698610790172,0.7285714285714285,0.9453373090314684,1.0,4/12,25.57%,PRKCE;ECT2;CSPP1;CDC42
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.4698273474688936,0.8460902740746005,0.7215189873417721,0.9458653200115793,1.0,5/22,16.15%,CDK6;CDKN1B;CDKN1A;CCNH;CRLF3
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.5105673866142086,0.8458449948464929,0.6944444444444444,0.9456337718061152,1.0,2/8,26.40%,DYSF;RACK1
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.37594863208248913,-0.8458137215770819,0.7272727272727273,1.0,1.0,3/24,5.37%,ATP10D;SLC4A4;SLC25A29
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),0.5534933414718055,0.8456023713178571,0.7808219178082192,0.9454159346383072,1.0,2/6,15.94%,HSP90AA1;PLPP1
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),-0.40230434993782244,-0.8452021815395087,0.72,1.0,1.0,2/20,3.50%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.4559973406158392,-0.8449954577817588,0.6666666666666666,1.0,1.0,1/11,1.09%,SLC4A4
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),0.4641098205245011,0.8440600909802359,0.703125,0.9472643164552108,1.0,7/23,19.31%,IPO7;PINK1;LAMP2;PTTG1IP;TPR;STAT3;PPP1R10
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),0.5294556271030567,0.8437061141786689,0.671875,0.9471999182583272,1.0,2/6,19.99%,ANO6;GSN
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),0.46240019652055453,0.84356408355949,0.6933333333333334,0.9468609279912447,1.0,7/17,16.61%,S1PR1;ARHGEF4;CCDC88A;ITGB1;RAC1;PARVB;GOLPH3
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.36711076235743545,-0.8435058211436556,0.7368421052631579,1.0,1.0,1/30,0.18%,GBP1
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),0.5409568706128303,0.8431198275378686,0.7571428571428571,0.94695084813199,1.0,1/11,1.64%,LRRC7
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5175390884360538,0.8428593952853249,0.734375,0.946859999373477,1.0,2/12,7.58%,FES;NAV3
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.5114344957955099,0.8427197613532517,0.6666666666666666,0.9464616662839122,1.0,2/11,13.71%,SMAD7;FOXF1
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.503301330666447,0.8424507408776822,0.6666666666666666,0.946344501152629,1.0,1/10,7.55%,SMAD7
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),-0.4178154655258635,-0.8418667567619103,0.6842105263157895,1.0,1.0,2/20,3.04%,CARMIL1;OCLN
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4472635590144575,-0.841473925450182,0.6190476190476191,1.0,1.0,1/12,6.88%,PDE9A
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),0.44806086230361913,0.8405584453331223,0.6746987951807228,0.9488521800809816,1.0,6/23,24.95%,ROBO2;JAG2;ZMIZ1;STAT3;NOTCH4;CREBBP
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),-0.4396041428003457,-0.8398761366700352,0.6875,1.0,1.0,3/12,8.46%,CD74;THOC1;MDM2
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),0.4918677591280382,0.8398111401050772,0.7361111111111112,0.9495279496651561,1.0,5/15,19.16%,BCAP31;HYAL2;PAK2;BCL2L1;BCLAF1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.5077732589571828,-0.8393112879725948,0.625,1.0,1.0,4/7,26.92%,SRPK1;SAFB2;DHX9;SLTM
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.4435649493455309,0.8392632914540534,0.6986301369863014,0.9497626401299416,1.0,6/29,9.29%,BCL6;ANXA1;GAPDH;POLA1;SRGN;ATP2B1
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.5090143971964778,0.8392411988402676,0.6911764705882353,0.9492170874268776,1.0,1/12,4.83%,YBX3
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,-0.4485953672371783,-0.8383394849664906,0.6129032258064516,1.0,1.0,3/11,8.13%,IFI27;TNFSF10;SAT1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5110168704514294,0.8363144739868249,0.6666666666666666,0.9533223976682577,1.0,4/10,19.29%,ANXA1;PRNP;ERBIN;STAT3
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,0.47361728210314347,0.8361035020679168,0.7076923076923077,0.952995040903955,1.0,2/13,2.34%,PCK1;AFF3
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),0.540982824727334,0.8358836161541833,0.7121212121212122,0.9527146647931387,1.0,4/6,31.59%,PPARG;SCARB1;ABCG1;SREBF2
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.43129568255517103,0.8350726997574854,0.7702702702702703,0.9533523159484383,1.0,9/25,24.71%,IPO7;RPL23;PTTG1IP;KPNA4;TPR;STAT3;PPP1R10;KPNA3;KPNA1
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3928919500025269,0.8345994840820533,0.7701149425287356,0.9535505614395264,1.0,17/74,17.89%,TRIM5;UFL1;GAPDH;REL;PINK1;GJA1;OTUD7B;PPM1A;PELI1;TAB2;ECT2;SLC20A1;NDFIP1;MTDH;BRD4;ALPK1;MALT1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.3745493323286974,-0.8344684497410069,0.75,1.0,1.0,4/42,3.14%,MLLT3;ANKRD6;NKD1;ZNRF3
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3225562919626481,-0.8344435303095442,0.8,1.0,1.0,8/79,9.42%,RNF213;ISG15;ANAPC16;ZNRF3;RC3H1;TRIM25;MDM2;PSMF1
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),0.5411885713231693,0.8341077157746469,0.7391304347826086,0.9537485633857852,1.0,1/12,7.24%,PRNP
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5339318521405837,0.8341043007596923,0.8064516129032258,0.9531630823769541,1.0,3/7,25.57%,ARHGAP21;UVRAG;CDC42
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.47774675339208644,0.8338854374959528,0.7215189873417721,0.9529298980989404,1.0,9/22,30.56%,MGLL;RIC8B;CRY1;GRK5;PLCB1;YWHAB;CAMKMT;GIT2;CALM1
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),0.5826347484890875,0.83366615353735,0.7887323943661971,0.9526638523282365,1.0,2/5,39.12%,NPM1;CORO1C
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3914904836040871,-0.8335543332920087,0.5789473684210527,1.0,1.0,3/23,4.88%,GMDS;STAT1;PLXND1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.48582715122423015,0.8333726915354418,0.7532467532467533,0.95257039362851,1.0,2/12,6.62%,IL1RAPL1;CCDC88A
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),0.5270636718881231,0.8328439552128843,0.7213114754098361,0.9529074382589331,1.0,1/6,1.71%,SCP2
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),0.5511115954666371,0.8326506546328903,0.734375,0.9526286600597706,1.0,2/7,11.19%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),-0.46992151102621194,-0.8320969779373841,0.6153846153846154,1.0,1.0,2/5,3.82%,PLA2G4A;GPCPD1
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.48223009658973415,-0.8315734598101601,0.6666666666666666,1.0,1.0,4/7,24.61%,SMYD3;NSD1;SMYD2;PRMT2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.4439268169981281,-0.8295660351726093,0.7419354838709677,1.0,1.0,2/13,1.92%,CD74;IFIH1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.4975548440173305,0.828930457365643,0.8260869565217391,0.9577003564119153,1.0,4/14,21.42%,ANK3;PREPL;GOLPH3;AFDN
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.423460713504912,-0.8286172174849257,0.7586206896551724,1.0,1.0,6/19,12.10%,GEMIN5;PARP9;RC3H1;GCNT2;LARP1;TDRD7
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.48211856660971536,-0.8279297620417556,0.6829268292682927,1.0,1.0,1/6,2.73%,ATM
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),0.4940694271182006,0.8277730306563831,0.703125,0.9590250311140547,1.0,3/10,25.18%,HSPA9;BCL2L1;SPG7
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),0.4632822168134108,0.8277057778712121,0.782051282051282,0.9585514762842072,1.0,4/20,11.84%,ZBTB1;KDM1A;HYAL2;CDKN1A
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),-0.4091466010654567,-0.8276274751914127,0.6521739130434783,1.0,1.0,2/15,5.19%,BMP6;ABCG2
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),0.5210314029076454,0.8275414930854752,0.7230769230769231,0.9581973204634807,1.0,6/9,31.67%,MGLL;DGKI;PGS1;SEL1L;ABHD2;DGKG
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.43216541730759606,-0.8273010209191446,0.7142857142857143,1.0,1.0,1/11,3.14%,ZNRF3
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",-0.36987685539732734,-0.8270164085220292,0.5652173913043478,1.0,1.0,8/29,19.06%,SNX2;TBC1D5;ANKFY1;EVI5;TRAPPC10;VPS50;TMEM87A;GBF1
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.4425464542717591,-0.82691654024948,0.6578947368421053,1.0,1.0,1/9,1.19%,ARID5B
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.4584078770283883,-0.8267423409178666,0.6428571428571429,1.0,1.0,4/7,27.36%,INO80;TOP2B;NSL1;LATS1
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.4594653647322651,0.8265202292783064,0.7246376811594203,0.9591036482323442,1.0,6/17,22.87%,OGT;SIK2;GRB10;VWA2;PTPN1;NCK1
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),0.4017389919317206,0.8263146396433676,0.7763157894736842,0.9588089255660893,1.0,7/49,11.01%,ADAMTS9;TINAGL1;SRGN;OGT;BACE2;ATG4C;GGT5
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),-0.5113766530461736,-0.8258913662788275,0.6666666666666666,1.0,1.0,1/5,8.72%,TAPT1
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),0.5059957806291913,0.8257460160010551,0.726027397260274,0.9590482781881305,1.0,1/9,8.02%,NAV1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),0.43765199740297833,0.8256120420502199,0.7051282051282052,0.9586222467294534,1.0,6/25,16.54%,GPM6B;CCDC88A;DLC1;HIP1R;RAC1;CRK
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",-0.36930530413779394,-0.825573717726903,0.7777777777777778,1.0,1.0,7/53,8.31%,MLLT3;MTERF1;NFX1;IVNS1ABP;RTF1;MLLT1;TAF3
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),0.4638213958101626,0.8248748946046326,0.7894736842105263,0.9591246642806851,1.0,6/17,19.55%,HYAL2;PIK3R1;ECT2;WWTR1;TPR;LIMK2
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.44361130879399124,0.8246941337644107,0.7564102564102564,0.9587846064722342,1.0,1/28,0.78%,ERBB4
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3928957785949949,-0.8233215814035665,0.625,1.0,1.0,3/19,8.64%,ATM;BABAM2;HERC2
prerank,PanglaoDB_Augmented_2021__NK Cells,-0.3976449383028133,-0.8232275582508806,0.5862068965517241,1.0,1.0,3/11,12.56%,IL32;SERPINB9;GIMAP4
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,0.5476348923602774,0.8232194615120404,0.7936507936507936,0.9603117126890692,1.0,1/5,7.61%,SMAD5
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.4178872837988449,-0.8228355200394044,0.6666666666666666,1.0,1.0,5/14,11.76%,PARP14;STAT1;PARP9;NLRC5;PTPN2
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),0.5474599468836615,0.8223778406876598,0.8285714285714286,0.961081520081784,1.0,3/5,42.55%,ABCG1;ADAM17;ADAM10
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),-0.4271939995196997,-0.82231159337789,0.6666666666666666,1.0,1.0,2/13,5.04%,EYS;ZIC2
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),0.48856666018946215,0.8218513443083488,0.6833333333333333,0.9612661002379712,1.0,2/11,16.90%,ROBO2;PLXNA2
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),0.4477592519225126,0.8214669939692159,0.7215189873417721,0.9612667455920593,1.0,12/23,35.18%,ANXA1;BRD4;KMT2E;PLCB1;ADAMTS1;EGFR;MECP2;RGCC;DDX3X;ADAM17;CUL3;RAB11A
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.5260186763240615,0.8209728322413488,0.7692307692307693,0.9613788612214326,1.0,2/7,33.15%,RPL10;RPL24
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),0.5396046593522734,0.8208006376665943,0.7714285714285715,0.9610124612186806,1.0,2/5,24.51%,RAP1A;EMP2
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),-0.34691886826334073,-0.8195646139911889,0.7916666666666666,1.0,1.0,2/20,3.50%,PSTPIP2;EVL
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.43639993196940663,0.8193141526408414,0.8,0.962755340335128,1.0,9/24,29.44%,ATF3;AGO2;TPR;NPM1;NCK1;CTIF;EIF5;EIF3H;DNAJC3
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),0.5467444754464744,0.8192154351139681,0.7681159420289855,0.9622969177077502,1.0,3/6,23.36%,ENSA;YWHAB;ARPP19
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.4735280732611056,-0.8191913045363586,0.6363636363636364,1.0,1.0,1/7,8.83%,HIPK2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.40056021863861285,0.8189585649181056,0.7368421052631579,0.9620679936207165,1.0,8/34,18.87%,CALR;GAPDH;CPEB4;AGO2;GIGYF2;RPL13A;BTG2;TPR
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),0.47473992582650004,0.8186900130062369,0.7466666666666667,0.9620027788225831,1.0,2/12,17.81%,SLC30A1;TF
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.5173619711849398,-0.8184785749793982,0.7857142857142857,1.0,1.0,1/6,10.10%,ATP6V1H
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.4955819051526905,-0.8181459256692651,0.6551724137931034,1.0,1.0,1/7,0.26%,DDX60
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.3921730314434592,0.8170040204201283,0.7590361445783133,0.9638780474925598,1.0,5/42,10.20%,MAP2;GPM6B;PPP1R9A;MICALL2;CNTNAP2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5195504264872677,0.8166683340827781,0.8153846153846154,0.9638052890247994,1.0,3/8,17.89%,SMAD7;CD55;MALT1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.42095096284393096,-0.8166403106297082,0.8,1.0,1.0,3/16,6.36%,DCP1A;RC3H1;PARN
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.42190090633130967,0.8166342002440875,0.8148148148148148,0.9632758359481481,1.0,8/28,20.61%,CANX;ARF1;SEC24D;PIKFYVE;MARCHF1;AP1G1;DYNC1H1;DNM2
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),0.45310801784456856,0.8153648110581417,0.7162162162162162,0.9644947909113671,1.0,2/15,16.61%,PINK1;GOLPH3
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),0.3610670930183475,0.8151813457591814,0.8651685393258427,0.9641285004145432,1.0,43/152,27.96%,PDK4;PRKAG2;PKN3;MAP3K5;PRKCE;PGK1;PINK1;FGFR1;BCR;JAK1;CDK6;SIK2;TRIB2;ACVR2A;STK38L;STK38;PRAG1;MAPK10;PAK2;DGKI;GRK5;TEC;STAT3;LIMK2;CSNK1D;MORC3;CDK8;PPP3CB;TAOK1;OXSR1;PRKCH;FYN;HIPK3;CSNK2A1;HK1;WNK1;DCLK1;FGR;MTOR;MAP2K1;CDKL5;TLK2;PPP4R1
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.38593696920315973,0.8150982727546932,0.7023809523809523,0.9636454051669443,1.0,14/68,19.50%,RAPGEF3;BCR;TBC1D15;PICALM;RGS7;RAP1A;TBC1D9;ITGB1;ECT2;RALGAPB;TGM2;LIMS1;RSU1;RALGAPA1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),0.4289261835143044,0.8148795736198058,0.7777777777777778,0.9633842230679319,1.0,6/24,20.77%,RAPGEF3;PINK1;CDK6;FOXC1;NFIB;NOTCH4
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.548632406140174,0.8144669088821601,0.7580645161290323,0.9634161177032151,1.0,3/6,27.80%,CSTF3;SETX;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),0.508853020554206,0.8144324639816676,0.6901408450704225,0.9622841576882514,1.0,4/5,29.91%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),0.508853020554206,0.8144324639816676,0.6901408450704225,0.9622841576882514,1.0,4/5,29.91%,HIF1A;NOS1AP;SCARB1;PIK3CB
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,0.43909640579751374,0.8143606901078665,0.7464788732394366,0.9618166091098522,1.0,3/23,7.14%,MAP2;SPOCK1;ANO2
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.40755795665202005,0.813603350316955,0.7752808988764045,0.962375075256647,1.0,5/44,9.50%,ST18;PSMC6;HYAL2;RPS27A;HIF1A
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.5662849483726762,0.8130817601687996,0.8028169014084507,0.9625890965075162,1.0,4/5,43.22%,GATA2;DLL4;PDCD10;PPP1R16B
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),0.4673071282922965,0.8122115781308771,0.7352941176470589,0.9631982893457512,1.0,3/13,7.55%,DDIT4;PRKAG2;SMAD7
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.48236540125483973,0.812114898487761,0.7647058823529411,0.9627442706942002,1.0,2/9,16.59%,ARF1;SLC30A1
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5750088394175306,0.811562354163411,0.7611940298507462,0.9630094837305923,1.0,4/5,37.31%,FOXF1;PCSK5;GLI3;NIPBL
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.48205822925405956,-0.8112206567411805,0.7419354838709677,1.0,1.0,2/8,4.52%,IFIH1;PARP9
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.4666600769734831,-0.8111332544857964,0.7142857142857143,1.0,1.0,1/8,7.40%,GCH1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.37324064603300905,0.811010372840495,0.813953488372093,0.9632096714214791,1.0,14/85,16.46%,RPS11;RPS9;RPL23;RPS18;RPS27A;RPL34;RPL8;RPL37;DCP2;CNOT6L;RPLP2;RPS12;RPL13A;TUT7
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),0.3820212271688812,0.8104486435091246,0.7176470588235294,0.9633772850462682,1.0,3/36,10.96%,HSPH1;KLF4;LARP4
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.5158378432330937,0.8102129907881463,0.7794117647058824,0.9631052104906244,1.0,2/7,20.09%,BBS9;CSNK1D
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.4634926805233963,-0.8101350583110789,0.6875,1.0,1.0,1/5,4.13%,BCOR
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),0.5142610423407453,0.8096926069967441,0.7543859649122807,0.9631305839695915,1.0,2/10,14.56%,BCAR1;DOCK4
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.466657675355129,0.8094266934832257,0.8208955223880597,0.9628783475799586,1.0,4/12,16.33%,BCAP31;HSP90AA1;SLC25A16;BCL2L1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.5155466393700121,0.809383576990957,0.782608695652174,0.9623425467495171,1.0,3/6,22.30%,REST;NFIB;PPARG
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.5127431528921826,0.8091976700721984,0.7352941176470589,0.9620266046853059,1.0,3/6,38.50%,CEP290;DNAJA1;KIAA0586
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),-0.466711276908251,-0.8086227932254875,0.5833333333333334,1.0,1.0,2/5,17.42%,HSPA1A;CASP4
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.4871448746559238,0.8085935038652964,0.7,0.9622007678199962,1.0,3/8,17.13%,PRNP;SLC30A1;LGALS3
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),0.43198300961615954,0.8083611363373795,0.8,0.9619625660622642,1.0,3/23,9.50%,PRKAG2;OGT;HIF1A
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),0.5406780440046561,0.807952405438498,0.78125,0.9619499123077756,1.0,1/6,5.50%,SEC24D
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),-0.4816592195657962,-0.80734317439411,0.7272727272727273,1.0,1.0,1/9,6.88%,PDE9A
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),0.44859626691080573,0.807339198386018,0.6712328767123288,0.962271753094689,1.0,5/12,23.78%,ANK2;NEDD4L;NEDD4;AHCYL1;YWHAE
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.5540867802671434,0.8072376992165183,0.782608695652174,0.9618346513063809,1.0,2/5,31.18%,KPNA1;KPNB1
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.5190381756864231,0.8070867102909178,0.8169014084507042,0.9614815894513606,1.0,1/8,11.73%,RBM17
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.5152627884070287,-0.805662015070345,0.7037037037037037,1.0,1.0,2/5,15.45%,MFF;PNPT1
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.44839388998416485,0.8056041728478305,0.782051282051282,0.9629845693379212,1.0,7/22,23.83%,MT2A;NDRG1;HIF1A;NEDD4L;NEDD4;AHCYL1;ADAM9
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),-0.4726171030381731,-0.8055023701498566,0.696969696969697,1.0,1.0,4/9,16.25%,RBMX;TRA2A;NCL;CIRBP
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.36117352848618395,0.8053660557839188,0.8571428571428571,0.9628622571210251,1.0,20/104,19.47%,BCL6;UFL1;ZBTB1;WDR48;POLA1;GRB2;MACROD2;RFC3;SMC6;USP45;CDKN1A;ZBTB38;BCL2L1;ATF2;UBE2B;SUSD6;CRY1;SLFN11;BTG2;RIF1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.39419618924010835,-0.8048786200820307,0.8,1.0,1.0,6/25,15.19%,EZH1;TCF7L1;MSH3;XPC;UBB;HMGN3
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.41014440218106973,-0.804277200522964,0.75,1.0,1.0,2/10,5.30%,IFIH1;NOD1
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),0.4925086501994122,0.8039255368177776,0.782608695652174,0.9642215443235823,1.0,1/9,8.18%,DUSP1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.5559739496211531,0.8036202234324815,0.7246376811594203,0.9641306909760292,1.0,4/6,37.31%,FOXF1;PCSK5;GLI3;NIPBL
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.5044173977198018,0.8027764308464306,0.796875,0.9647829976115275,1.0,4/7,29.10%,TPR;DYNC1H1;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),0.43782969665464044,0.8025220701563373,0.7236842105263158,0.9645126681596876,1.0,4/18,20.25%,UFL1;HSPA9;PRKX;KMT2E
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.4658908630953351,-0.8019982682904494,0.6666666666666666,1.0,1.0,2/6,9.55%,NKD1;PROM1
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.37698386171646736,-0.8016694185658237,0.7741935483870968,1.0,1.0,1/15,2.83%,BABAM2
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.3668147374336936,-0.8001880703557209,0.88,1.0,1.0,1/23,0.91%,EIF2AK2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),0.47814650120143254,0.799592064526251,0.7333333333333333,0.9678959411627244,1.0,5/13,23.26%,PICALM;TMED10;SAMD8;GRM5;RPL10
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),0.5042887118502727,0.7982095635251811,0.7536231884057971,0.9692162611369031,1.0,1/6,6.62%,CCDC88A
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),0.45274303163015456,0.798029598567516,0.7692307692307693,0.968867105097185,1.0,1/14,6.00%,NDRG1
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),0.5145251251318185,0.797482051732953,0.746031746031746,0.9684189641798971,1.0,1/7,12.36%,CCNH
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),0.5145251251318185,0.797482051732953,0.746031746031746,0.9684189641798971,1.0,1/7,12.36%,CCNH
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.38627093484307856,0.7974168418262831,0.8045977011494253,0.9679560714427136,1.0,13/64,18.82%,CLIC2;ELL2;BNIP3L;DCAF10;PICALM;SLC2A1;LAMP2;TNS1;AGPAT4;SDCBP;SLC30A1;LPIN2;BTG2
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.46374148846736984,0.7972702476206658,0.7857142857142857,0.9675829802870441,1.0,3/13,17.68%,DUSP1;PHLPP1;RELL1
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),0.42054604053102423,0.7969785723560437,0.7721518987341772,0.9674588232473158,1.0,9/28,27.47%,RAPGEF3;NRXN1;NEDD4L;LGALS3;ADD1;ASAP1;CDH5;RACK1;VCP
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),0.5454336618735205,0.7969677682690864,0.7741935483870968,0.9668954274106722,1.0,1/5,32.68%,ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.3871732917978734,-0.7968020606960847,0.68,1.0,1.0,4/10,12.59%,CD74;FN1;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),0.4691771251290068,0.7967937674466143,0.7638888888888888,0.9666509023350691,1.0,3/14,21.63%,SSH1;HIP1R;ARFGEF1
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.5128095355444522,0.7961188030526578,0.75,0.9671444721976111,1.0,4/6,35.70%,PRKX;ACVRL1;DLG1;CD34
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.4870373496300637,0.7957631493650653,0.7611940298507462,0.9670017949100099,1.0,1/10,1.82%,TRIM5
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.5195087118670331,0.7954770168682792,0.7164179104477612,0.966897402881125,1.0,2/7,7.17%,INPP5F;HYAL2
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),0.4922982631501033,0.7951949771006361,0.7721518987341772,0.9666661493910095,1.0,1/11,7.35%,PIK3R1
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.5076041496715372,0.7943965444367235,0.7903225806451613,0.9670697150145376,1.0,3/7,33.62%,RAB3GAP2;RYR2;SPCS3
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),0.39793532791944664,0.7943413176746698,0.8045977011494253,0.9665405692319837,1.0,8/42,16.54%,GPM6B;CCDC88A;DLC1;KATNBL1;PAK2;HIP1R;RAC1;CRK
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.5237197677372244,0.7940093783281537,0.8289473684210527,0.9664493683983199,1.0,4/7,27.23%,SDCBP;VEGFC;ANKS1A;ITGA2
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.3985958343376777,0.792982218031728,0.7407407407407407,0.9673527634311218,1.0,8/34,19.94%,RAPGEF5;ANK3;PPP1R9A;SLC12A6;SHC2;HIP1R;PODXL;KALRN
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),-0.38424161827637604,-0.7926030549515047,0.7083333333333334,1.0,1.0,1/16,0.93%,ATP10D
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),0.525092048214995,0.7922768843184473,0.8245614035087719,0.9676663533091534,1.0,3/6,30.22%,CFL1;CAV2;VAPA
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.43805831889100605,0.7920133381196236,0.7926829268292683,0.9675177116239878,1.0,9/21,21.42%,CTNNA1;MICALL2;PECAM1;CLDN5;ECT2;PAK2;ESAM;TBCD;AFDN
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.5064711489358176,0.7918055614016728,0.7142857142857143,0.9672238099113116,1.0,5/8,40.03%,TNFRSF10B;SORT1;DAB2IP;DDX3X;BAG3
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),0.5142540913409536,0.7913897234784287,0.8333333333333334,0.9672209494986076,1.0,3/5,21.60%,NRXN1;AGTPBP1;PAFAH1B1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.40704820661574587,-0.7910916191227437,0.8,1.0,1.0,2/15,10.33%,MX1;DNM3
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.45779748540603665,-0.7910785636998583,0.6538461538461539,1.0,1.0,2/5,14.80%,OPTN;TRIP11
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),0.4847969121345248,0.7909725890247298,0.7301587301587301,0.9671928291269779,1.0,1/7,18.87%,TPR
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),0.48293622309299,0.790258693581506,0.7333333333333333,0.9676129033947164,1.0,4/9,17.52%,ANXA1;XKR6;RAC1;TGM2
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.47276837757156687,0.7896314977702581,0.7397260273972602,0.9680451044049974,1.0,5/13,21.50%,HSPA5;HSPA9;TMBIM6;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.45903819818716274,0.7888954332618299,0.7397260273972602,0.9683633154040241,1.0,8/13,25.93%,SLC4A10;ACOX1;SLC4A7;NEDD4L;NR1D2;PPARG;PNPLA8;WNK1
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),0.41749055876693686,0.7888121451830156,0.8108108108108109,0.9679250231762442,1.0,6/30,27.39%,DCP2;SRSF7;CSTF3;ZFP36;HIPK3;SRSF11
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.40820871432556594,0.7879061794591239,0.7466666666666667,0.9686459691708089,1.0,8/24,23.83%,SMAD7;ADGRG1;RAC1;TGM2;LIMS1;RSU1;AFDN;ADAM9
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.455416010585303,0.7877511622747122,0.7671232876712328,0.9682835478639888,1.0,2/16,9.42%,TBX3;DLC1
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.4856398971687266,0.7876576592442602,0.7692307692307693,0.967814616416366,1.0,3/9,19.99%,SLC8A1;DMD;GSN
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),0.511370310380045,0.7875916986409537,0.7384615384615385,0.9673902353822791,1.0,1/5,12.77%,ANO6
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.464332451463334,-0.7870161916213487,0.7894736842105263,1.0,1.0,1/5,2.73%,ATM
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.5193674048047751,0.7868445665055129,0.7910447761194029,0.9677642626722235,1.0,5/6,27.47%,HSP90B1;NPLOC4;HERPUD1;SEL1L;VCP
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.4263117947930355,-0.7864641660113173,0.782608695652174,1.0,1.0,1/14,2.28%,IFI27
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.45633497178482074,-0.7863690191055679,0.71875,1.0,1.0,2/7,16.04%,BICD1;CLASP1
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.48412675279036016,0.7862845526744558,0.7638888888888888,0.9679620394115711,1.0,5/12,21.50%,HSPA5;HSPA9;TMBIM6;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),0.510485126946954,0.7859134674085303,0.7450980392156863,0.9679838724788201,1.0,2/5,29.10%,DCP2;HNRNPU
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),0.4962611544675254,0.7856540535400586,0.7666666666666667,0.9677171744979474,1.0,2/7,15.50%,SAMD8;AGPAT4
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.3554577977185446,0.78530919450845,0.8764044943820225,0.967601223194757,1.0,24/105,24.95%,BHLHE40;CALR;ZNF280D;ESR2;HIF1A;CREM;CNBP;REST;SBNO1;ZBTB38;WWTR1;RALY;FOXC1;ATF2;ZMIZ1;STAT3;NR1D2;DNM2;DENND4A;BTG1;NSD2;MEF2C;MTF2;CREBBP
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),-0.5174037464889762,-0.7852709818437956,0.7428571428571429,1.0,1.0,1/5,6.20%,RC3H1
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.3777411404979776,0.785073445228021,0.8513513513513513,0.9673601143307746,1.0,8/45,24.97%,HSP90AA1;YTHDC1;STRAP;EIF3A;RPS27;SETX;RPL10;EIF5
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.43006242336871603,-0.7844705161452092,0.7222222222222222,1.0,1.0,3/7,14.38%,SRGAP2C;SEMA6A;RAPGEF2
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),-0.4239416521629369,-0.7842466409296295,0.8,1.0,1.0,1/11,4.05%,EZH1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),0.514849853170188,0.7841269381820497,0.78125,0.9679958202817683,1.0,1/5,6.44%,PINK1
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.41270770172794263,0.7840144586376703,0.7804878048780488,0.967642129909314,1.0,3/30,11.89%,TSG101;TBC1D15;PIKFYVE
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.48407961775727987,0.783950383151992,0.7910447761194029,0.9672325651280134,1.0,2/7,26.90%,CDC42;MSN
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.33077427698002543,-0.7837924164765445,0.9090909090909091,1.0,1.0,5/23,8.83%,ATM;PLK2;SP100;MDM2;HIPK2
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),0.3914674543447216,0.7837124676638947,0.7777777777777778,0.9669797266156316,1.0,11/50,18.48%,RAPGEF3;PINK1;PICALM;RGS7;RAP1A;ITGB1;ECT2;PSAP;TGM2;LIMS1;RSU1
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.48701229132649504,-0.7833588272767836,0.6388888888888888,1.0,1.0,2/5,22.14%,POLR2A;DHX9
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),-0.3615632748007096,-0.783328162326828,0.7857142857142857,1.0,1.0,3/24,5.56%,CASP10;NOD1;TNFSF10
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.4079995731971338,0.7831145423396151,0.7808219178082192,0.9673393372970338,1.0,7/23,20.33%,PLOD2;ERO1A;MSRA;STK38;PLAT;CSNK1G3;ABL2
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.5065508062466861,0.7830347202327559,0.7972972972972973,0.9668931993813198,1.0,2/9,10.59%,ANXA1;JAG2
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.45329485068852016,-0.7824240591967869,0.696969696969697,1.0,1.0,2/7,8.46%,CD74;MDM2
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.3577606549624702,-0.7812344556912301,0.8571428571428571,1.0,1.0,4/24,11.58%,TNRC6C;RC3H1;ZC3HAV1;CPEB3
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),0.4958264960630109,0.7812304043661372,0.7837837837837838,0.9689245751693712,1.0,1/7,16.61%,GOLPH3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.43630994431460235,-0.7806650818445324,0.75,1.0,1.0,2/8,19.91%,RPS8;RPS16
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.3936878720888586,0.7806574581392561,0.7540983606557377,0.9690330143480829,1.0,10/21,35.44%,PINK1;MICALL2;PPP3CC;YWHAB;YWHAE;NPEPPS;YWHAQ;SREBF2;MAPK8;YWHAZ
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.5058644615373687,-0.7804924358088943,0.7567567567567568,1.0,1.0,1/5,7.40%,GCH1
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.4591647681775508,0.7800582632959014,0.765625,0.9692784347137856,1.0,5/12,30.82%,DCP2;SND1;ZFP36;MTREX;XRN2
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.3760207155869817,0.7792693398739163,0.7865168539325843,0.9697602557010798,1.0,5/52,12.85%,ERBB4;TRIM5;FGFR1;RAP1A;FLT1
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.4178709347858466,-0.7788438818216173,0.72,1.0,1.0,2/9,8.70%,USP25;OTUD4
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.34987170572649295,-0.778380862478159,0.9230769230769231,1.0,1.0,1/24,0.91%,EIF2AK2
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.492668127859938,0.7783543632919306,0.8333333333333334,0.9703411206953126,1.0,2/6,26.90%,CDC42;MSN
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),0.3773394474442553,0.7774423545356778,0.7682926829268293,0.9708715465232614,1.0,15/46,22.27%,PPA1;PTPRD;PGK1;ALPL;PPM1A;DUSP16;PAK2;SLC20A1;PLPP1;STAT3;INPP5A;LIMK2;PLCB1;PPP3CB;TAOK1
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),0.5195833494470996,0.7772956325115096,0.7936507936507936,0.9704562620976664,1.0,4/5,42.91%,SPG7;ATP5F1E;CHCHD3;IMMT
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3850077597154732,0.7771787577170883,0.8181818181818182,0.9700663117751508,1.0,11/44,20.33%,FES;DUSP1;ADGRG1;RASA1;PLXNA2;TGM2;PRKX;PPP1CB;RSU1;PODXL;ABL2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5032264902124198,0.7768830593515142,0.796875,0.969887970556571,1.0,3/7,26.45%,DOCK4;MEF2C;ADAMTS1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.45186650686571905,-0.7768766125791123,0.7297297297297297,1.0,1.0,2/6,11.53%,TNFRSF1B;PARD3
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.5069850787738425,0.776734376713532,0.7727272727272727,0.9696105211866769,1.0,3/5,31.44%,PTPN1;NEDD4;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.48828157542088063,0.7759143700453934,0.796875,0.9700281816692946,1.0,5/9,35.70%,CRY1;ATP2B4;FYN;EP300;CD34
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.3456575771623453,-0.7755384444925495,0.7916666666666666,1.0,1.0,6/35,8.00%,SLC38A3;ZNRF3;ARNT2;ABCG2;PTPN21;SHROOM2
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.501797043731211,0.7753373889913888,0.8,0.9703089645379491,1.0,2/6,34.61%,DIP2A;RPS6KA5
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5043558880242958,0.7753214208235256,0.8382352941176471,0.9697529135554059,1.0,2/7,26.14%,CDH18;CDH5
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),0.5035651392912137,0.7745701193977466,0.7727272727272727,0.9700830751430696,1.0,1/7,7.48%,ARHGAP21
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.47298675679400237,-0.7739862966741625,0.7105263157894737,1.0,1.0,4/7,16.25%,RBMX;TRA2A;NCL;CIRBP
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.3913730468225493,0.7733835321950665,0.8607594936708861,0.9709575164261957,1.0,8/29,22.27%,SUN2;AHCTF1;TNKS;SPC25;DYNC1H1;RPS27;PAFAH1B1;TAOK1
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),0.5011094784075738,0.7730364050107991,0.7611940298507462,0.9707731937952889,1.0,3/7,40.47%,CDKL5;MAP3K13;NRP1
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),-0.4365623857299952,-0.772624251386411,0.8285714285714286,1.0,1.0,2/11,9.01%,PKD2;SAMHD1
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.491788983485843,0.7721065141838144,0.7272727272727273,0.9714174986413618,1.0,3/7,19.42%,PSAP;ESYT2;ST6GALNAC3
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),-0.4488909610267899,-0.7708502368187691,0.7222222222222222,1.0,1.0,1/7,9.35%,NLRC5
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.45870410889762764,-0.7708476088538201,0.7222222222222222,1.0,1.0,2/6,11.53%,ADGRG6;PARD3
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,-0.38356579636833044,-0.7707901882385219,0.7619047619047619,1.0,1.0,3/18,6.18%,SLCO1A2;BMP6;OPTN
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),0.46537956808300923,0.7707001012145784,0.7419354838709677,0.9727036500151396,1.0,3/9,11.79%,GLUD1;SLC2A1;SLC2A3
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),-0.4183543209805055,-0.7705240468471541,0.7407407407407407,1.0,1.0,1/12,1.53%,STARD3
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),0.37609354926481453,0.7699873697361455,0.7948717948717948,0.9730373588033906,1.0,9/35,17.47%,PRKAG2;RAP1A;TRIB2;CDKN1A;TAB2;ECT2;PAK2;WWTR1;SPRED1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),-0.4567253271336949,-0.7687462673388643,0.7142857142857143,1.0,1.0,2/6,13.47%,ABCG2;SLC23A2
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.4148727190449448,-0.7685335218344087,0.75,1.0,1.0,3/10,17.26%,THOC1;CDK12;SCAF8
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),-0.39895439511185277,-0.7683971023604336,0.75,1.0,1.0,2/10,8.44%,ARHGAP12;GULP1
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),0.4682956340126993,0.7679354722645123,0.8115942028985508,0.9752160034807983,1.0,4/8,30.50%,OGT;RIF1;MTF2;KMT2A
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),0.45202667311763717,0.7668958273514267,0.7777777777777778,0.9760660194051585,1.0,4/15,18.22%,INPP5F;MTMR12;PLPP1;MTMR6
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),0.41429579861005783,0.7664503686901478,0.75,0.9760396941751072,1.0,6/20,17.29%,GLUD1;SYTL4;TMED10;MYH10;GOLPH3;FRMD4A
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),0.4282375121645229,0.765601481790112,0.8518518518518519,0.9766849564930722,1.0,4/17,18.72%,CCDC88A;WAPL;ZBTB38;SLFN11
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),0.413464408697107,0.7653767754853882,0.8,0.9763812181338473,1.0,9/27,23.83%,SYTL4;CNST;TMED10;MYH10;GOLPH3;FRMD4A;TPR;CEP290;ADAM9
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.44627144514374467,-0.7650728057433905,0.8387096774193549,1.0,1.0,1/8,1.82%,CD74
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.4358278936949409,-0.7649026409120302,0.6666666666666666,1.0,1.0,1/8,1.58%,ISG15
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),-0.43200424470305954,-0.7648408101240671,0.6410256410256411,1.0,1.0,1/5,4.28%,PLK2
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.4400013018001729,0.764777239028971,0.6891891891891891,0.9767978511542699,1.0,4/16,25.49%,CDK6;KLF4;PTPN1;KLF7
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),0.424853330942738,0.7643253945153511,0.7534246575342466,0.976765018971172,1.0,8/16,33.64%,ANXA1;KMT2E;PLCB1;ADAMTS1;EGFR;RGCC;DDX3X;ADAM17
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.44873281320727687,0.7637491223854296,0.7671232876712328,0.9768551654787506,1.0,5/12,22.90%,SMAD7;ACVR2A;SDCBP;SMAD6;RBPMS
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.35487563692875385,0.7627258945398827,0.9166666666666666,0.977614859260928,1.0,14/78,20.48%,ZEB2;PSMC6;GPC5;CTNND2;PPM1A;WWTR1;AMFR;FZD4;UBE2B;PSMA7;CSNK1G3;TNKS;CSNK1D;USP34
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,-0.3774162959265599,-0.7619675459738094,0.8064516129032258,1.0,1.0,7/18,12.56%,CD74;GIMAP8;TNFRSF1B;HLA-C;HLA-A;SERPINB9;GIMAP4
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.4925976415326452,-0.7613814594831098,0.7692307692307693,1.0,1.0,1/5,1.25%,EYS
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.48551471652127387,0.760785243085375,0.8028169014084507,0.9795218864523192,1.0,2/7,7.81%,CANX;JAK1
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),-0.4608653701756338,-0.7605164931692502,0.7906976744186046,1.0,1.0,2/7,11.81%,EEA1;MFF
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,-0.43941051674239917,-0.7597508509101104,0.7560975609756098,1.0,1.0,2/6,12.20%,LMO2;FOXO1
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.34139755673189887,-0.7596961891540763,0.84375,1.0,1.0,8/28,11.76%,LEPR;STAT1;IRF1;STAM2;PDGFC;STAT2;TNFRSF1B;PTPN2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,0.48662220887715746,0.7595971396534056,0.7903225806451613,0.9805369417451564,1.0,1/7,10.20%,CNTNAP2
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),0.4528989790421971,0.7594097504388532,0.8289473684210527,0.980238357598007,1.0,2/12,13.03%,KLF4;ACVR2A
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),0.43084084687366586,0.7589243343007384,0.8253968253968254,0.9802772424206774,1.0,2/19,9.01%,ATG12;RB1CC1
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.4091681298042487,0.7562584162946276,0.7922077922077922,0.9829319583945938,1.0,5/16,29.70%,SMARCC1;NPM1;NAP1L4;SMARCA5;ARID1A
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.4865230401002144,0.7560260620489767,0.7258064516129032,0.9826937523120305,1.0,2/7,22.95%,ADCY2;ADCY9
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.371614634948249,0.7558271181137683,0.8395061728395061,0.9823579080461835,1.0,4/35,13.89%,SEC22B;CDKN1B;EEF1A1;NEDD4L
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),0.3820250316562002,0.7550416143981793,0.9054054054054054,0.9827074106483913,1.0,7/28,26.14%,SMAD7;SMAD5;ACVR2A;SMAD6;PPARG;XIAP;CDH5
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.37763619872413595,0.7550168308194081,0.8607594936708861,0.9822007934241771,1.0,8/35,16.67%,PCK1;TIMP3;MT2A;PLSCR4;PIKFYVE;CFH;TNS1;FZD4
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.4429132200804769,0.7547793371390045,0.8688524590163934,0.981890232357309,1.0,1/12,7.55%,SMAD7
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.4461601080399363,0.7542914140786191,0.8153846153846154,0.9819158199164155,1.0,6/11,34.66%,NAA50;MORF4L1;CREBBP;PHF20L1;KAT6A;EP300
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),0.37829502036257745,0.7542040455654014,0.7777777777777778,0.9814288130309625,1.0,12/42,29.10%,PSMC6;CDKN1B;SDCBP;FOXC1;PSMA7;BTG2;BTG1;CAV2;PSMB9;USP22;HECA;HNRNPU
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.470182764277917,0.7523417250305034,0.7727272727272727,0.9831988113827596,1.0,5/8,35.62%,CHMP4B;KPNB1;CUL3;RAB11A;EML4
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.44417493376509687,-0.7511034189096057,0.7878787878787878,1.0,1.0,2/8,8.46%,CD74;MDM2
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.41250452817220795,0.7506937399963473,0.8571428571428571,0.9847108203957605,1.0,4/22,7.22%,B3GNT2;GPC5;CHSY1;CHST11
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5004351041460497,-0.7504355165846015,0.8157894736842105,1.0,1.0,1/6,11.73%,MTERF4
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),-0.4332562181974155,-0.7504046903083417,0.84375,1.0,1.0,1/12,3.97%,ZIC1
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.3611471731544828,-0.7504046710928003,0.7419354838709677,1.0,1.0,1/10,5.37%,SLC25A29
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),-0.44711977694974137,-0.7491304696192715,0.6764705882352942,1.0,1.0,1/5,5.82%,MIA3
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.31091499021425106,-0.7486693806446926,0.9375,1.0,1.0,7/58,9.24%,RTTN;EXOC5;CDC14A;PKD2;OFD1;RFX3;TTC17
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.4492991699665544,0.7478496752891374,0.8421052631578947,0.9877135819020076,1.0,2/12,8.75%,WDR48;RPS27A
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.3285776503240636,-0.7474345414966487,0.84,1.0,1.0,4/24,4.57%,TLN2;OCLN;SDK1;LIMS2
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),-0.41312883661039296,-0.7471523810655724,0.7878787878787878,1.0,1.0,1/7,4.28%,PLK2
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),0.5180056657454152,0.7471015204678935,0.8307692307692308,0.9881802591426502,1.0,3/6,31.18%,CFL1;DYNC1H1;KPNB1
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.47855871425300567,-0.7467013320831847,0.8648648648648649,1.0,1.0,1/5,8.72%,TAPT1
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4415153046854906,0.7462332991018791,0.8309859154929577,0.9886099023313842,1.0,5/11,22.61%,CDKN1B;CDKN1A;CCNH;ACTB;CDC37
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5034287668181635,0.745585156280187,0.8676470588235294,0.9883007711464826,1.0,3/7,16.82%,TPM4;MYL6;DMD
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5034287668181635,0.745585156280187,0.8676470588235294,0.9883007711464826,1.0,3/7,16.82%,TPM4;MYL6;DMD
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),0.44771622118825327,0.7454986738299754,0.8405797101449275,0.9878123660047674,1.0,3/9,20.15%,BCAR1;PLAT;PTPN1
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.4118109151694511,0.7452265881094117,0.8024691358024691,0.9875673547515144,1.0,4/17,10.77%,GLUL;ATG12;ZDHHC6;ZDHHC14
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.4160558299018068,0.7450580533854602,0.8529411764705882,0.9872255348228849,1.0,4/12,12.77%,SLC8A1;ATP1A1;ATP1B3;ANO6
prerank,GO_Biological_Process_2021__morphogenesis of an endothelium (GO:0003159),-0.4012621786341606,-0.7448501280901467,0.6,1.0,1.0,1/5,11.68%,CCM2
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.32439934310375673,-0.7448440826189133,0.8695652173913043,1.0,1.0,3/18,8.46%,ATM;PLK2;MDM2
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.45338178580553107,-0.7437927525896537,0.7142857142857143,1.0,1.0,1/5,5.22%,DISP1
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),-0.3336551635626882,-0.7432252854760674,0.7916666666666666,1.0,1.0,4/23,6.44%,EXOC5;STXBP6;OPTN;VPS35L
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.46202943365595794,0.7430389636018145,0.7714285714285715,0.9892976999224542,1.0,3/7,34.03%,RACK1;VCP;GLI3
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.4656053136049895,0.7428796769525965,0.8873239436619719,0.988407314227617,1.0,1/11,8.75%,RPS27A
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.4656053136049895,0.7428796769525965,0.8873239436619719,0.988407314227617,1.0,1/11,8.75%,RPS27A
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.4260781633650274,0.7427106885383038,0.8421052631578947,0.9880415729942462,1.0,7/17,26.40%,CALR;DYSF;TGM2;GATA2;SCARB1;FGR;RACK1
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.4301743264469493,0.7407335265564241,0.7534246575342466,0.989527771003311,1.0,2/11,9.37%,CHPT1;ENPP2
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.3493889090247268,0.7401160393710662,0.8625,0.9896214121330941,1.0,11/46,16.74%,CHPT1;CD9;FOS;JAK1;KLF4;FKBP5;SLC26A2;ADD3;AMFR;NCOR2;FOXC1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3928539520234736,0.7400917238224062,0.8,0.9890863739361946,1.0,4/14,13.89%,SLC8A1;ATP1B3;ANO6;NEDD4L
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.49661830255744227,0.7394427754278039,0.7868852459016393,0.98944594388742,1.0,2/5,17.52%,SPEN;TGM2
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.4694203138248001,0.739405604470387,0.8064516129032258,0.9889417873252346,1.0,1/5,24.30%,RAB3GAP2
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.4317068526374911,-0.7393574458071465,0.7894736842105263,1.0,1.0,1/6,6.36%,PARN
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),-0.44646975470566863,-0.7391692398741376,0.8529411764705882,1.0,1.0,2/8,18.35%,TRIP11;DYNC2H1
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.46148930412297917,0.7388991434021435,0.8142857142857143,0.9889269367986998,1.0,3/7,18.59%,CD9;CRK;ACTN1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),-0.38338718443393904,-0.7387889946062351,0.8275862068965517,1.0,1.0,3/13,12.59%,ATM;DACH1;PDGFB
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),0.44736655307089446,0.738005010188151,0.7681159420289855,0.9893764516002789,1.0,5/7,22.04%,SLC2A1;NEDD4L;CTTNBP2NL;NEDD4;ACTB
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.40411133278864575,0.7378061043273546,0.8714285714285714,0.9890780996709146,1.0,7/21,23.23%,IPO7;CDKN1B;CDKN1A;CCNH;ACTB;CDC37;CCNY
prerank,PanglaoDB_Augmented_2021__Microglia,0.4360571973795437,0.7370310802270492,0.8666666666666667,0.9893583634496399,1.0,2/14,11.68%,FOS;PECAM1
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),-0.41841306414684654,-0.7362500382587455,0.7142857142857143,1.0,1.0,1/8,5.43%,RHBDD1
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.4180008745032367,0.7361767883859874,0.8571428571428571,0.9898550506175651,1.0,1/12,4.34%,SLC4A10
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),0.40167082318323205,0.7348136959223657,0.8382352941176471,0.9908566197033009,1.0,4/18,26.30%,SYTL4;DYSF;SCARB1;PLEC
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),0.4706645149591995,0.734049202887734,0.8513513513513513,0.991249687624706,1.0,3/9,22.53%,INPP5A;PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.4071185155048836,0.7326187495126157,0.8382352941176471,0.9923335134761978,1.0,7/18,18.07%,SLC8A1;SLC20A2;SLC12A6;ANO6;SLC26A2;SLC20A1;SLC1A2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.3348030954680519,0.7321435509727204,0.9325842696629213,0.9924790350490974,1.0,20/104,14.85%,SPNS2;APOLD1;MGLL;CD9;TIMP3;HYAL2;EMP1;SRGN;PLSCR4;SLC2A1;VWF;GGT5;LRRC32;PECAM1;FLT1;CFH;CLDN5;FOXF1;CD55;TNS1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.49859691035395526,0.7319887807977676,0.8360655737704918,0.992078056859546,1.0,2/5,27.41%,TEC;EGFR
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),-0.2957687554279101,-0.7318996799593008,0.9565217391304348,1.0,1.0,9/54,15.86%,TENT2;THOC1;BICD1;PARN;RBMX;FASTKD1;DDX17;PNPT1;POLR2A
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,0.3676261808640426,0.7315893086930588,0.8311688311688312,0.9919295398501834,1.0,12/31,31.98%,LAMA5;TINAGL1;SEMA3F;WWTR1;EPAS1;EMP2;EGFR;TM4SF1;SLCO2A1;DAB2IP;DOCK1;SMARCA1
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),0.5083098478485178,0.7315695522432107,0.8955223880597015,0.9914093700904959,1.0,1/5,3.35%,SLC8A1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),0.4471103460724497,0.7313921149794355,0.8591549295774648,0.991069588977327,1.0,4/12,27.62%,RAB21;TRAK1;MAPK8IP3;KIF1B
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.4391336414476388,0.7309496329524775,0.7727272727272727,0.9910596569814403,1.0,4/10,22.87%,BCL2L1;TMBIM6;HERPUD1;NCK1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.332160091690427,-0.7303801587027272,0.7619047619047619,1.0,1.0,3/16,8.46%,ATM;PLK2;MDM2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.3341797137980079,-0.7303686371352631,0.8888888888888888,1.0,1.0,5/29,7.58%,ISG15;ATM;ATR;SLF2;WARS1
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),0.4498225905405388,0.7299705827153136,0.8235294117647058,0.9917562131328074,1.0,5/9,29.49%,COMMD1;NEDD4L;ATP2B4;FGF12;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.4203495826675806,0.7294577728340456,0.8428571428571429,0.9917518959307573,1.0,3/15,16.74%,WWTR1;SDCBP;FOXC1
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.38031291078513185,-0.7290334402192375,0.8571428571428571,1.0,1.0,2/11,5.74%,IFI27;SP100
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.3505210588311867,-0.7287909655431226,0.9230769230769231,1.0,1.0,2/19,4.28%,MLLT3;PLK2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.4772503142572747,0.7279002991534155,0.8805970149253731,0.9929855411225834,1.0,4/9,21.73%,SLC8A1;DMD;GSN;ATP1B1
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.4981978950304421,0.7276878114422299,0.9154929577464789,0.9926816908498203,1.0,1/6,11.32%,LRRC32
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.44471677583242064,-0.7276464438987902,0.8,1.0,1.0,2/7,8.46%,CD74;MDM2
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),-0.47242344842527856,-0.7274461955877946,0.7906976744186046,1.0,1.0,1/5,7.35%,STXBP4
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.41222366710013003,-0.7273970822383781,0.9393939393939394,1.0,1.0,7/7,58.88%,MAPKBP1;PCBP2;CARD8;ITCH;ILRUN;IFI16;IRAK3
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),-0.4094325751208535,-0.7271122829975597,0.6666666666666666,1.0,1.0,1/6,3.43%,TTN
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.5075726121066197,0.7269594843026157,0.8518518518518519,0.9930651706061259,1.0,1/5,18.30%,ZMIZ1
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),0.4635549490748496,0.7263825871116785,0.8,0.9931198458047396,1.0,1/7,7.50%,EMP1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.41656817846001903,0.7263469726735952,0.8,0.9926135373072683,1.0,2/16,6.83%,WDR48;KDM1A
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.473490397639943,0.7254040099668326,0.8709677419354839,0.9930978077359,1.0,2/6,11.89%,PINK1;PIKFYVE
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.32555607876445675,0.7253044694659251,0.9375,0.9926457158253658,1.0,19/93,23.21%,ELL2;ZBTB1;AFF4;ESR2;CBFB;ELP4;CCNH;WWTR1;NCOR2;HDAC7;NR2C1;CSTF3;NR1D2;NFIC;NOTCH4;PPARG;TFCP2;MED4;SETX
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.3409991268460118,-0.7252165414278745,0.9444444444444444,1.0,1.0,4/17,12.59%,CD74;FN1;PDGFC;PDGFB
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),0.4003032196647986,0.7251615197199477,0.8133333333333334,0.9922179517133594,1.0,4/16,25.57%,ARHGAP21;TRAK1;PAFAH1B1;CDC42
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.45432139613243705,0.7249548208618498,0.8115942028985508,0.9918918788474309,1.0,1/7,1.48%,TSG101
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),0.34339986846978193,0.7247611105271055,0.9204545454545454,0.9915483123479591,1.0,8/88,11.16%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;OTUD7B;USP45
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),-0.38363276064289864,-0.7246485945380721,0.8076923076923077,1.0,1.0,1/15,1.22%,ALS2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3685384966368767,0.7231888539417725,0.8421052631578947,0.9927336507649105,1.0,6/29,28.58%,SMAD7;TRIB2;CSNK1D;RACK1;VCP;RNF19A
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),-0.32404926352506147,-0.7228867239905427,0.9230769230769231,1.0,1.0,2/15,16.04%,OFD1;CLASP1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),0.45554115786354177,0.722680905054514,0.8552631578947368,0.9928358222028126,1.0,3/9,17.21%,AGO2;TUT7;SND1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),0.47091402090827783,0.7224177219230637,0.890625,0.9925873600100279,1.0,5/7,45.22%,ABHD2;ACACA;ELOVL7;CBR4;ABCD3
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3320096861806917,0.7223778874572023,0.9885057471264368,0.9921313484940423,1.0,25/118,24.95%,BHLHE40;CALR;ZNF280D;CCDC88A;ESR2;HIF1A;CREM;CNBP;REST;SBNO1;ZBTB38;WWTR1;FOXC1;ATF2;STAT3;GRM5;NR1D2;DNM2;DENND4A;BTG1;NSD2;RPL10;MEF2C;MTF2;CREBBP
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),0.3634256393168287,0.7220205809434236,0.8518518518518519,0.9920556467207239,1.0,2/27,8.00%,PSMC6;CBFB
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3189030654004194,-0.7214687053567722,0.8214285714285714,1.0,1.0,4/25,13.14%,IFIH1;NUP214;SENP6;SENP7
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),0.46357753126154544,0.7212717267748114,0.8548387096774194,0.9923714913637018,1.0,3/7,27.41%,GATA2;EGFL7;EGFR
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.4880684726532909,0.7212305259787969,0.8813559322033898,0.9919282042383125,1.0,3/5,29.10%,TPR;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.37194990839334474,-0.7207303133835767,0.8125,1.0,1.0,1/11,1.58%,ISG15
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),0.4414962139411436,0.7203916732741545,0.8450704225352113,0.9922674716340044,1.0,2/12,11.14%,UFL1;HSPA9
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.37955307902299257,-0.720262191675999,0.8055555555555556,1.0,1.0,3/9,11.76%,GRB14;KANK1;PTPN2
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),0.3988118058463411,0.7201334412783567,0.8405797101449275,0.9920438231839536,1.0,10/19,32.89%,PINK1;TAB2;STAT3;RASIP1;MCL1;MTOR;TLK2;SMG1;MTMR9;FOXK2
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),0.4364274857013723,0.7200899211820927,0.8656716417910447,0.9915481788040025,1.0,6/10,35.23%,DLC1;CDH5;SPPL3;CALM1;MTMR9;PTBP1
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.4048686740119068,0.7196373722796888,0.875,0.9915381099624259,1.0,8/17,21.42%,MICALL2;PECAM1;CLDN5;ECT2;PAK2;ESAM;TBCD;AFDN
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.4440089019735127,0.7196360934992091,0.7910447761194029,0.9909959896179958,1.0,2/7,26.95%,UBE2B;PEX5L
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),0.41406523754525665,0.7193709477297059,0.8289473684210527,0.9907794333911378,1.0,5/15,24.40%,CBFB;RAP1A;CLDN5;MEF2C;PRKCH
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.45537487002893484,-0.7192529492864017,0.725,1.0,1.0,1/5,10.57%,ATP9A
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.282277667130003,-0.7183960456376943,0.9375,1.0,1.0,5/60,7.22%,TENT2;THOC1;BICD1;IVNS1ABP;WBP4
prerank,PanglaoDB_Augmented_2021__Reticulocytes,0.3732615722683096,0.7166870152948525,0.8648648648648649,0.9930965081032758,1.0,11/21,43.43%,EIF3A;XPO1;UGGT1;KPNB1;PRPF8;PTBP1;POLR2B;UBAP2L;IMMT;NUP160;DHX15
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),0.4551903280284576,0.7164851021888147,0.8360655737704918,0.9927314886003813,1.0,1/6,19.34%,TNKS
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.41034736587059006,0.7161961329692383,0.7878787878787878,0.9924907443752643,1.0,1/15,1.82%,TRIM5
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),-0.4366226141660031,-0.7154097574472873,0.7142857142857143,1.0,1.0,1/8,2.31%,ZC4H2
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),0.40717757127746596,0.7153839090955558,0.8648648648648649,0.9928811013494415,1.0,9/15,36.99%,ACTN1;ACTB;STXBP3;CLIC1;PIK3CB;MYL12A;VCL;MYH9;ACTG1
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),0.3344112266805975,0.7148373300472389,0.9340659340659341,0.9928998069070359,1.0,8/88,11.16%,PSMC6;WDR48;SMAD7;RPS27A;OGT;HIF1A;OTUD7B;USP45
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.47913156928685047,0.7143453621246006,0.8840579710144928,0.992765371168656,1.0,1/7,3.35%,SLC8A1
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),0.4669237522006651,0.7136883634997871,0.8055555555555556,0.9928841823842358,1.0,2/5,17.81%,HIF1A;TF
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.4402020120705604,0.7136637548069511,0.7808219178082192,0.9923498671014515,1.0,1/8,5.01%,ARF1
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.40389112579341324,0.7130256739171773,0.803030303030303,0.9924158581147452,1.0,4/13,20.77%,MBP;KLF4;PODXL;NOTCH4
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),0.42154311504221637,0.7127442896867324,0.8714285714285714,0.9921585719125529,1.0,6/11,35.59%,BACE2;DAG1;ADAM9;SPPL3;ADAM17;MYH9
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.38477578166506127,-0.7120656940000606,0.8275862068965517,1.0,1.0,1/14,2.18%,IL15
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),-0.4336807259391783,-0.7119209942709229,0.7058823529411765,1.0,1.0,1/5,3.43%,TTN
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3894186108866098,-0.7118260796131837,0.8333333333333334,1.0,1.0,1/9,5.50%,THOC1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),0.35492629524999864,0.7106611852490469,0.8933333333333333,0.9937398991620482,1.0,9/36,28.12%,UFL1;SIN3B;UBE2B;NAA50;RCOR3;MORF4L1;CREBBP;PHF20L1;USP22
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),0.4075540857311577,0.7098825108179921,0.8947368421052632,0.9939987408005212,1.0,9/14,36.99%,ACTN1;ACTB;STXBP3;CLIC1;PIK3CB;MYL12A;VCL;MYH9;ACTG1
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),0.4332998554947699,0.7093220601974276,0.855072463768116,0.9939170214755515,1.0,5/8,42.34%,TRAK1;MTM1;TRAK2;MEF2A;MFN1
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.4418637300481555,0.7089232116657989,0.8552631578947368,0.9937591624729806,1.0,3/10,18.28%,CALR;ANO6;GATA2
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.45480397438315334,0.7088393351891191,0.8181818181818182,0.9933084476908274,1.0,1/6,19.99%,GSN
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.4061755211600348,0.7088227641051734,0.927536231884058,0.9928055049541368,1.0,3/16,15.26%,CANX;PICALM;SYT1
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.32862246402062045,0.7087466112601564,0.8974358974358975,0.9923499403584787,1.0,8/52,10.10%,CD81;RAPGEF3;PINK1;HYAL2;PRNP;PIK3R1;ANK3;MICALL2
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.41321771094619886,-0.7079529923399207,0.7878787878787878,1.0,1.0,2/8,9.29%,HOMER1;GNA14
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.474839020496113,0.707144260779536,0.8985507246376812,0.9930952337744777,1.0,1/6,8.75%,RPS27A
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.474839020496113,0.707144260779536,0.8985507246376812,0.9930952337744777,1.0,1/6,8.75%,RPS27A
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),0.45967099191360994,0.7066664683784882,0.8356164383561644,0.9930669143283951,1.0,5/7,34.40%,SAMD8;DMD;PCSK5;SPTLC2;PAM
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),0.46998937974646526,0.7063106838135191,0.9032258064516129,0.9929159531177159,1.0,3/6,31.59%,PPARG;ABCA5;SREBF2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.47734852013262397,0.7058718790565037,0.8,0.9928293771885242,1.0,4/5,36.19%,SETX;UVRAG;CALCOCO2;INSR
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),0.4665884896693346,0.7053342167867144,0.8873239436619719,0.9929821393864522,1.0,2/6,30.01%,ATP2B4;RIOK3
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),-0.36015982953216885,-0.7036904830547637,0.8333333333333334,1.0,1.0,1/12,1.01%,PSTPIP2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),-0.3702650367832071,-0.7036599753079802,0.8846153846153846,1.0,1.0,2/19,9.84%,IFI27;TNFRSF1B
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.4044628760402249,0.7026251516878168,0.8309859154929577,0.9952576171138935,1.0,3/12,27.57%,NPM1;NAP1L4;SMARCA5
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.370584518291046,-0.7025439313540127,0.8181818181818182,1.0,1.0,3/10,11.76%,GRB14;KANK1;PTPN2
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.34219537080663875,0.701661480411696,0.9404761904761905,0.9957061817698483,1.0,19/42,35.62%,SUN2;AHCTF1;TNKS;SPC25;DYNC1H1;RPS27;PAFAH1B1;TAOK1;XPO1;VCP;MECP2;SMC3;DYNC1I2;KPNB1;ZNF207;NDEL1;RANBP2;RAB11A;EML4
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.3692477327486997,0.7013699441696177,0.8783783783783784,0.9954318633358131,1.0,4/25,11.24%,SLC8A1;MGLL;CPEB4;GAS7
prerank,PanglaoDB_Augmented_2021__Plasma Cells,0.43905556541956836,0.701147313332963,0.868421052631579,0.9951753083453689,1.0,2/9,9.87%,CD9;KLF4
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.3971748508532867,0.7010867125441399,0.8734177215189873,0.9947037067902279,1.0,8/19,21.42%,MICALL2;PECAM1;CLDN5;ECT2;PAK2;ESAM;TBCD;AFDN
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),0.45472969894002446,0.700213754849307,0.8873239436619719,0.995256299482213,1.0,1/8,4.23%,ANXA1
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),0.3182050922608472,0.6998604267958373,0.9888888888888889,0.9950409456085492,1.0,19/131,19.70%,PSMC6;SPOPL;TSG101;FEM1C;TRIM9;PINK1;NFE2L2;MIB1;NPLOC4;OTUD7B;PELI1;NEDD4L;AMFR;NDFIP1;UBE2B;PSMA7;VPS37A;HERPUD1;RNF11
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.4034868412864553,0.6998512942573375,0.8933333333333333,0.9945062648210111,1.0,2/17,6.83%,ZBTB1;KDM1A
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.37332816024649074,0.6996437317365368,0.8375,0.9941579833490631,1.0,8/25,29.80%,ATP8B1;TBC1D15;RAC1;PODXL;CDC42;FSCN1;CDKL5;RABGAP1
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.37507280192642384,0.6994954479527782,0.8356164383561644,0.9937172131390136,1.0,3/25,7.58%,FES;PRKCE;NAV3
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.38620616602019214,0.6985847034187159,0.875,0.9941296335708864,1.0,6/18,29.49%,ECT2;SYT1;RYR3;MEF2C;ADD1;CAMK2D
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),0.4242398641515401,0.6984743902003923,0.8181818181818182,0.9936835535472024,1.0,1/10,3.76%,IL1RAPL1
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.45980084750072975,0.6984702728741732,0.8142857142857143,0.9931568274695387,1.0,4/6,30.56%,PDZD8;VMP1;AHCYL1;CALM1
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),0.42346337618360463,0.6977840870744374,0.864406779661017,0.9934298898410651,1.0,6/11,35.28%,GSN;ARFGEF1;CDH5;RACK1;CYRIB;RAP1B
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.377321796254684,-0.6971323467111382,0.9310344827586207,1.0,1.0,3/17,7.94%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.377321796254684,-0.6971323467111382,0.9310344827586207,1.0,1.0,3/17,7.94%,MLLT3;RTF1;MLLT1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),0.45449324435564586,0.6960552448946415,0.8709677419354839,0.9945361864810602,1.0,3/6,13.94%,SLC4A10;SLC4A7;TMEM165
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),0.3501820082734222,0.6957774694578298,0.974025974025974,0.9942933285061288,1.0,6/36,8.80%,DPP10;CD81;PRKCE;PRNP;PIK3R1;ANK3
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),0.4435692192915358,0.6957216522158001,0.8181818181818182,0.9938310071066712,1.0,2/7,19.42%,SAMD8;ST6GALNAC3
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),-0.35168942335779574,-0.694209840014349,0.9523809523809523,1.0,1.0,2/21,3.50%,CARMIL1;EVL
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.4063243741471364,0.6939288613918386,0.8450704225352113,0.9951202466418392,1.0,3/11,18.87%,CALR;DUSP16;TPR
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),0.31972648242381396,0.6938823380512105,0.925,0.9946868575008198,1.0,9/44,21.50%,ARF1;MYO1B;COMMD1;ACBD3;KIF16B;AP1G1;ARFGEF2;DNM2;HSPA8
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),0.3924186626537298,0.6935596475520936,0.8333333333333334,0.994427118950875,1.0,4/15,21.50%,STXBP5L;NDFIP1;PTPN1;HSPA8
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.43341019118831225,-0.6932071546053344,0.7755102040816326,1.0,1.0,2/5,14.20%,TNFRSF1B;SH3D19
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3387125653616473,0.6931274481926799,0.8974358974358975,0.9943349831561457,1.0,7/49,16.48%,TRIM5;UFL1;HSP90AA1;HIF1A;TMEM59;PTTG1IP;MTDH
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.34431930770096564,0.6931032562964947,0.961038961038961,0.9938392717815344,1.0,4/39,13.37%,PRKAG2;RPL23;RFC3;RPL37
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),0.33674736581703407,0.6926760598301868,0.9310344827586207,0.9936610921325185,1.0,11/57,23.39%,PSMC6;RPS27A;DCP2;GIGYF2;PSMA7;CARHSP1;ZFP36;HSPA8;NPM1;YWHAB;UBC
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),0.3912740333462679,0.6914387548935644,0.8714285714285714,0.9943356747999906,1.0,9/14,39.72%,WAPL;TOM1L2;PPP1R10;MAX;DAB2IP;CBX5;YAF2;RBBP4;RYBP
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.3681366175712941,0.6912934831076056,0.935064935064935,0.9939156031733171,1.0,5/25,18.46%,PSMC6;CBFB;FOXC1;GATA2;PSMA7
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.4245823627149335,0.6909839930724576,0.859375,0.9937088949156913,1.0,4/7,15.55%,PRKAG2;LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.46684322133316714,0.6909251719504282,0.8431372549019608,0.9932723492705375,1.0,1/5,7.55%,SMAD7
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),0.3480592628463563,0.6905108457094561,0.927710843373494,0.9932156605124927,1.0,11/44,28.09%,NEDD9;LARP4;BRWD3;RAC1;PDZD8;CFL1;DPYSL2;SH3KBP1;FGD4;PPP2R3C;SIPA1L3
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),0.36631094926312374,0.689774126831372,0.918918918918919,0.9933026650026856,1.0,9/32,27.41%,JAG2;PRAG1;GATA2;ZMIZ1;STAT3;EGFL7;NOTCH4;CREBBP;EGFR
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),0.3401112855180317,0.6895768415506301,0.9294117647058824,0.9929646491724561,1.0,3/33,7.89%,HSPA5;PINK1;HSP90AA1
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4274907639609582,-0.6890197985490457,0.7631578947368421,1.0,1.0,2/5,11.84%,PARP12;PARP11
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.36855695844554603,0.6889587423573614,0.9615384615384616,0.992988563101856,1.0,3/30,7.17%,SERPINE1;NFKBIZ;HYAL2
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),-0.31078107830740526,-0.6886380745238859,0.8571428571428571,1.0,1.0,3/26,8.46%,ISG15;RHBDD1;MDM2
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.4407731663233851,0.688053020756278,0.9423076923076923,0.9933336775401341,1.0,2/5,29.88%,NDFIP1;DNAJA1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.2921714912124333,-0.6880221566633326,0.9545454545454546,1.0,1.0,4/22,16.04%,OFD1;STARD9;INO80;CLASP1
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.4009908821318403,0.6875740131319724,0.8695652173913043,0.993202575797664,1.0,1/13,6.78%,RPL23
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.4230749617877082,-0.6873810004712128,0.9259259259259259,1.0,1.0,2/7,12.93%,ARNT2;PTPRR
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),0.467951540735503,0.6871100127383849,0.8873239436619719,0.9930773431045375,1.0,4/5,35.18%,LIMK2;KPNB1;DLG1;RAB11A
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.3885989679257832,0.6869515302792231,0.8970588235294118,0.9927403417875758,1.0,3/20,10.72%,BAZ1A;POLA1;RFC3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.45720972313752256,0.6868055149710611,0.8888888888888888,0.9918328479421217,1.0,4/6,21.91%,JAK1;GRB2;STAT3;PLCB1
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.45720972313752256,0.6868055149710611,0.8888888888888888,0.9918328479421217,1.0,4/6,21.91%,JAK1;GRB2;STAT3;PLCB1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.40111385632413454,-0.686234386891182,0.8333333333333334,1.0,1.0,1/9,4.96%,BMP6
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4476610201288342,0.6859893229789024,0.8548387096774194,0.9916530718233965,1.0,1/5,4.78%,INPP5F
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4476610201288342,0.6859893229789024,0.8548387096774194,0.9916530718233965,1.0,1/5,4.78%,INPP5F
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),0.4268117579602775,0.6853684614622165,0.9117647058823529,0.99175753200148,1.0,1/7,8.23%,SRGN
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),0.3879784511506912,0.6851649118317082,0.8939393939393939,0.9914280040275127,1.0,2/15,7.87%,NDRG1;GRB2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),0.44973106855795986,0.6850289024192967,0.875,0.9910246470571342,1.0,1/6,12.05%,SETD3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.45683527895293563,0.6848336027560215,0.8285714285714286,0.990690150332252,1.0,2/7,14.82%,HYAL2;PAK2
prerank,PanglaoDB_Augmented_2021__Mast Cells,0.3356964171475157,0.6842090283155745,0.9743589743589743,0.9907720982859138,1.0,15/72,15.78%,ADAMTS9;PDK4;GRIK2;LSAMP;DUSP1;PLSCR4;ENPP2;VWF;LRRC32;PCDH7;KCTD12;CFH;CD55;TNS1;DGKI
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.3667740878890045,0.6834070047643341,0.9240506329113924,0.9910704416157119,1.0,6/24,18.74%,SYTL4;TMED10;MYH10;GOLPH3;FRMD4A;CADPS2
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",-0.4238753129003543,-0.6829980312829954,0.8620689655172413,1.0,1.0,2/9,11.58%,TNRC6C;CPEB3
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",-0.4238753129003543,-0.6829980312829954,0.8620689655172413,1.0,1.0,2/9,11.58%,TNRC6C;CPEB3
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.39112246185136845,0.6824414417576083,0.8933333333333333,0.9913855523974429,1.0,10/20,32.89%,TIMP3;TAB2;STAT3;RASIP1;MCL1;MTOR;TLK2;DAB2IP;MTMR9;FOXK2
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),0.3775709127762234,0.6815612144012049,0.8831168831168831,0.991620659011628,1.0,6/19,16.23%,GRB2;PRAG1;ADGRG1;ERBIN;SHOC2;RAC1
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.3990124152751464,0.6812528234277817,0.8974358974358975,0.9913891107028165,1.0,6/14,29.10%,TOR1AIP2;ATP1B3;VMP1;ATP1B1;RYR2;HNRNPU
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),-0.3982302173825314,-0.6809605482592874,0.71875,1.0,1.0,2/7,16.28%,ACVR1;MDM4
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.35389456792586643,0.680953471169116,0.8904109589041096,0.9911976002199802,1.0,8/33,19.91%,RAPGEF3;CCDC88A;PIK3R1;DLC1;PAK2;RAC1;PXN;ALMS1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),0.36624412998339934,0.6809155573135288,0.9605263157894737,0.9906994673614865,1.0,5/25,18.46%,PSMC6;CBFB;FOXC1;GATA2;PSMA7
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),-0.4151366628113587,-0.6802680217432341,0.7857142857142857,1.0,1.0,1/5,5.63%,ST3GAL6
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),0.42494808650744653,0.6799838203754589,0.875,0.9909514771986019,1.0,3/11,20.40%,CNOT6L;TUT7;ZFP36
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.4049957185264001,0.6795541620107619,0.8701298701298701,0.9908229335314328,1.0,3/13,20.09%,TMED10;GOLPH3;CSNK1D
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4616718869084856,0.6787586994521408,0.9354838709677419,0.9911029790334428,1.0,1/5,6.44%,PINK1
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),-0.27955316218106196,-0.6783632711063249,1.0,1.0,1.0,2/29,3.45%,CD74;STAT1
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.457970900734305,0.6778212280643876,0.8732394366197183,0.9915188108658338,1.0,2/5,8.15%,SLC4A10;SLC4A7
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4029277146803998,0.6774230730783806,0.8571428571428571,0.9913675038479453,1.0,8/17,37.31%,DAG1;CFL1;PLCB1;RAB14;TRIP12;NR2C2;INSR;NIPBL
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.3676382894689508,0.6769988380749531,0.9285714285714286,0.9911823709831609,1.0,1/14,4.65%,GRIN2B
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),0.3107756741819047,0.6756677439434561,0.9772727272727273,0.9918522574128054,1.0,6/109,9.01%,TSG101;EHD4;RAB11FIP3;NUDCD3;ATG12;RB1CC1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.35706297760363115,-0.6753642484005865,0.8857142857142857,1.0,1.0,2/12,4.67%,ATR;SLF2
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),0.4349087993701587,0.6750458200295557,0.8970588235294118,0.9919273387672738,1.0,3/9,24.22%,CD55;MALT1;SLC7A5
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.40285076374325474,0.675045598452729,0.8787878787878788,0.9914085483181277,1.0,1/11,4.23%,ANXA1
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.4505702441371475,0.6747553457441053,0.8813559322033898,0.9912011722314312,1.0,2/5,29.00%,LIMK2;TCHP
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.3975766074632648,0.6741702351089113,0.8552631578947368,0.9911126473972601,1.0,4/14,23.26%,SSH1;KLF4;GRM5;RPL10
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),0.36716637178041545,0.6736455057907541,0.8985507246376812,0.9911032634228499,1.0,6/19,19.31%,IPO7;BACH2;PTTG1IP;TPR;STAT3;PPP1R10
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),0.3998331361415196,0.6732910754206893,0.8356164383561644,0.9909020147400063,1.0,2/10,20.61%,TF;DNM2
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.37614363905205506,-0.6730436254526895,0.71875,1.0,1.0,2/7,12.07%,NTNG1;SPRY3
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.3441188477747356,0.671147610036246,0.9743589743589743,0.9925453946363446,1.0,13/34,25.60%,SLC8A1;CACNA1C;ATP1A1;ATP1B3;ANO6;TMEM165;SLC30A1;RYR3;ATP2B4;ATP1B1;KCNQ5;SLC24A2;SLC6A6
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.46759797808678444,0.6689018331549677,0.9253731343283582,0.9940517612986719,1.0,3/5,13.86%,MGLL;GGT5;PON2
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),-0.3551415818794058,-0.6666961320559568,0.8333333333333334,1.0,1.0,4/15,11.42%,MGMT;SLF2;RNF169;SHLD2
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),0.4193762896309602,0.6659126633282559,0.9027777777777778,0.9960016870981455,1.0,1/7,4.31%,CD81
prerank,PanglaoDB_Augmented_2021__Crypt Cells,0.34703719584612475,0.6651194939510605,0.8831168831168831,0.9961362030656441,1.0,6/22,19.94%,ANK3;PPP1R9A;SHC2;TMEM132C;VWA2;KALRN
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.3884235122262831,-0.6628258656302721,0.75,1.0,1.0,1/6,5.04%,ZIC2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.25751832736846664,-0.6624434066711736,1.0,1.0,1.0,7/59,11.58%,EIF2AK2;GEMIN5;CAPRIN1;LARP4B;LARP1;GSPT1;CPEB3
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),0.42197168933676843,0.6623345903652931,0.8933333333333333,0.9981955872509416,1.0,3/8,25.03%,PPFIA2;MEF2C;TANC2
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),-0.23842486073276514,-0.6622684288294025,1.0,1.0,1.0,10/104,8.64%,SCFD2;CD74;VPS45;RANBP17;WLS;NUP214;TBC1D5;STX17;TECPR2;HERC2
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4251029568272402,0.661130533947627,0.8405797101449275,0.9986213608066294,1.0,3/6,13.89%,SLC4A10;SLC4A7;NEDD4L
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.37450121811644854,0.6606069846862355,0.9324324324324325,0.9985237688077708,1.0,2/12,11.19%,RAPGEF3;RAP1A
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),0.3537021663182906,0.6603495606834501,0.875,0.9982352015670672,1.0,4/17,22.30%,KDM1A;JUN;FOXC1;PPARG
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.440577629425278,0.6596380303571937,0.8787878787878788,0.9983794418415513,1.0,1/5,16.33%,BCL2L1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.31839976291562055,-0.6588789154734007,0.9666666666666667,1.0,1.0,4/13,14.77%,FAM120B;CTBP2;FOXO1;OSBPL8
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),-0.3226976968175825,-0.6587272745512806,0.96,1.0,1.0,1/17,1.01%,PSTPIP2
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.3504178182714413,-0.6568205172990412,0.9666666666666667,1.0,1.0,1/10,6.54%,NUP214
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.3504178182714413,-0.6568205172990412,0.9666666666666667,1.0,1.0,1/10,6.54%,NUP214
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.3504178182714413,-0.6568205172990412,0.9666666666666667,1.0,1.0,1/10,6.54%,NUP214
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.42269210961110687,0.65674112197432,0.9117647058823529,1.0,1.0,4/7,37.88%,SND1;MTREX;XRN2;ENTPD4
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),0.3178277093747949,0.6563835388169295,0.9775280898876404,0.9998009262664632,1.0,11/49,26.53%,PSMC6;RPS27A;DCP2;PSMA7;CARHSP1;ZFP36;HSPA8;YWHAB;UBC;XPO1;PSMB9
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.39773609894132195,0.6556016662560497,0.9117647058823529,0.9999665629750677,1.0,1/8,6.28%,POLA1
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),-0.4325193658590303,-0.6552201517109105,0.85,1.0,1.0,2/5,13.53%,PARN;MCM9
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),0.35201402690748923,0.6546058961302621,0.9210526315789473,1.0,1.0,4/18,26.79%,PIK3R1;CDC42;FSCN1;WASL
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),0.341829610563654,0.654214267104567,0.95,1.0,1.0,2/26,5.84%,HSPA5;RAPGEF3
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.38383203170465197,0.6537939622266589,0.9436619718309859,0.9998968912283801,1.0,3/19,12.85%,FGFR1;PIK3R1;FLT1
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.328916274343868,-0.6528581122860713,0.7894736842105263,1.0,1.0,1/11,3.04%,OCLN
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.36436420331399,0.6523889768564046,0.9558823529411765,1.0,1.0,1/18,5.09%,PLCL1
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.4085587630641796,0.6521766537183774,0.918918918918919,1.0,1.0,6/11,47.30%,GRM5;FAM107A;NIPBL;CYFIP1;SETD5;SHROOM4
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),-0.44098938988094005,-0.651622236133558,0.8275862068965517,1.0,1.0,1/5,7.74%,ACVR1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.3688318921300059,0.6512236230951338,0.8955223880597015,1.0,1.0,3/12,15.55%,LBR;INSIG1;LSS
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.3022853707616401,0.6508741216797971,0.9866666666666667,1.0,1.0,5/33,15.01%,HSP90AA1;OGT;KLF4;LARP4;PTTG1IP
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.43732650085818486,0.6502135715527736,0.9333333333333333,1.0,1.0,1/6,5.74%,EPS8
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.4050253360427115,0.6495168075118869,0.881578947368421,1.0,1.0,3/9,23.39%,RPS27A;TAB2;UBC
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.4294339274397098,0.6493327572678305,0.875,0.9999397371684628,1.0,3/5,48.57%,EGFR;LCOR;NRIP1
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.30521894094281316,0.6491952643963741,0.9540229885057471,0.9995578727465299,1.0,17/69,24.40%,TRIM5;CRTC3;KDM1A;ESR2;RPS27A;TAB2;MTDH;FZD4;ATF2;MALT1;ARHGEF2;STAT3;PPARG;ANXA3;NPM1;UBC;PRKCH
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.40501785099955784,0.6480048552123695,0.8676470588235294,0.9994638060879983,1.0,4/7,40.63%,UBR1;MTOR;SESN3;LARS1
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.40501785099955784,0.6480048552123695,0.8676470588235294,0.9994638060879983,1.0,4/7,40.63%,UBR1;MTOR;SESN3;LARS1
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.35645738860584397,0.6478086892549566,0.8714285714285714,0.9990994800812179,1.0,3/17,23.39%,RPS27A;GSN;UBC
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),0.34550332019141844,0.646065364159625,0.9487179487179487,0.9999431226549854,1.0,4/24,14.51%,KDM1A;GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),0.34816699647388794,0.6459008973260755,0.9397590361445783,0.9995344282297035,1.0,2/21,7.92%,CCDC88A;TBC1D15
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.4074561035272666,0.6457997370369182,0.9459459459459459,0.9990761210307508,1.0,2/6,26.64%,PPARG;MTOR
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.40263319404698006,0.645643615935771,0.8688524590163934,0.9986516230662064,1.0,2/9,16.33%,PINK1;BCL2L1
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),0.3463244407786219,0.6452150313175364,0.9333333333333333,0.9984830228195645,1.0,8/26,27.39%,CALR;WASHC4;SRSF7;MALT1;TPR;XPO1;THOC2;SRSF11
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.3920979807293278,0.6448505891051842,0.8873239436619719,0.9982091330660366,1.0,4/10,22.04%,LAMA5;DAG1;PRKX;ACTB
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.34317770025334404,0.6436970319971621,0.922077922077922,0.9985346884552431,1.0,12/34,30.56%,KCNMB4;ECT2;SYT1;RYR3;NEDD4;AHCYL1;ADAM9;MEF2C;ADD1;RYR2;CAMK2D;CALM1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),0.44057848292658985,0.6433829788105946,0.9545454545454546,0.9977770974092002,1.0,2/5,21.88%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),0.44057848292658985,0.6433829788105946,0.9545454545454546,0.9977770974092002,1.0,2/5,21.88%,BCL2L1;MCL1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),0.42072740144538373,0.6426177064385054,0.9152542372881356,0.9977977128778236,1.0,4/5,36.45%,MTOR;WDR43;EIF2AK3;SMARCA4
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),-0.2925809822361547,-0.6425757474669316,0.90625,1.0,1.0,24/24,70.95%,RBMX;POLR2A;WRN;TOPBP1;RBFOX2;HNRNPC;ATXN2;PCBP2;GTF2F2;HNRNPR;DDX24;WTAP;HNRNPM;HNRNPD;HNRNPA2B1;MMS19;HNRNPA3;HNRNPF;POLR2B;PTBP1;HNRNPK;HNRNPH1;XRN2;HNRNPU
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),0.40116565057740394,0.6415648172144848,0.88,0.9979456456528865,1.0,1/8,11.89%,PIKFYVE
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.43917667549474076,0.6406567724113494,0.9206349206349206,0.9981266287300016,1.0,4/5,55.74%,LRP6;CSNK1A1;CTNNB1;GSK3B
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),0.41053636697983875,0.6402284039810533,0.875,0.9979258022125408,1.0,2/7,16.12%,PIKFYVE;AP1G1
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.28204194096734697,-0.6401998606118989,1.0,1.0,1.0,8/17,22.95%,SAMHD1;RAD51B;INO80;MCM9;WRN;NUCKS1;NSMCE2;PSMD14
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.3809841117581644,-0.6393123081481226,0.8888888888888888,1.0,1.0,3/11,17.26%,TENT2;PNPT1;SCAF8
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.3809841117581644,-0.6393123081481226,0.8888888888888888,1.0,1.0,3/11,17.26%,TENT2;PNPT1;SCAF8
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.3993546198654837,-0.6371373711191379,0.8918918918918919,1.0,1.0,2/5,16.67%,LARP1;CLEC16A
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),-0.334724454144933,-0.6366699920147032,0.8620689655172413,1.0,1.0,4/8,28.71%,CCM2;RBPJ;STARD13;PRKD2
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),0.4090361346577197,0.6363740867027966,0.9054054054054054,1.0,1.0,2/8,13.66%,CBFB;CLDN5
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.3576892520423855,0.636153932135946,0.9565217391304348,1.0,1.0,4/25,14.51%,ANXA1;GRB2;CDKN1A;ECT2
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),0.401010225708896,0.6360757795441266,0.9565217391304348,0.999605269530961,1.0,5/9,37.98%,CSNK1D;HDGFL3;ZNF207;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),0.3621942615556596,0.6355827304205609,0.9295774647887324,0.9994316957589839,1.0,4/13,20.04%,FGFR1;FOXF1;FUT8;SULF2
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),0.3541826897352229,0.6355455995535297,0.9012345679012346,0.9989548817079641,1.0,3/18,20.40%,GIGYF2;TUT7;ZFP36
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3752109888604048,0.6353813593827361,0.8923076923076924,0.9985943451547834,1.0,5/12,27.80%,CCNH;TAF1D;CSTF3;SETX;PAPOLA
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.4544352754679214,0.6350673823010765,0.9411764705882353,0.9983333751359486,1.0,2/5,26.45%,DOCK4;ADAMTS1
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.40742733614150095,0.6349356624638799,0.88,0.9979074235385283,1.0,3/8,23.39%,RPS27A;TAB2;UBC
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),0.40832920282599894,0.6343466286230148,0.9142857142857143,0.9978232432476507,1.0,2/8,25.91%,SETD3;CAMKMT
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),0.3734047983463307,0.633205935540177,0.9041095890410958,0.9974956441082004,1.0,4/9,36.92%,ITGB1;FAM171A1;CUL3;PHACTR1
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),0.3734047983463307,0.633205935540177,0.9041095890410958,0.9974956441082004,1.0,4/9,36.92%,ITGB1;FAM171A1;CUL3;PHACTR1
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),0.3742567165222427,0.6328939760599472,0.9444444444444444,0.997219404884109,1.0,4/16,20.77%,AGO2;ZC3H7A;ZFP36;NOTCH4
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),-0.39381336106056664,-0.6328304257931966,0.9166666666666666,1.0,1.0,5/5,60.70%,FCHSD2;WASF2;CYFIP1;ABI2;NCKAP1
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),0.33641486823688094,0.6326400942376879,0.9506172839506173,0.9968830095927185,1.0,4/26,15.13%,PRNP;CDKN1B;CDKN1A;WWTR1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.32917434704950865,-0.632585748243695,0.9655172413793104,1.0,1.0,2/13,7.74%,BMP6;ACVR1
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.2777676558325974,-0.6325786784744647,0.9285714285714286,1.0,1.0,7/42,11.34%,ATM;BABAM2;PARP9;HERC2;SAMHD1;RAD51B;INO80
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),-0.3331733217178269,-0.6319873123796016,0.9142857142857143,1.0,1.0,2/7,18.69%,TMCC1;SPAST
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.4084941977958777,0.6315495952797068,0.9402985074626866,0.9972608463135432,1.0,4/7,29.10%,TPR;DYNC1H1;CHMP4B;HNRNPU
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),0.4346924653853147,0.6314790769315098,0.9152542372881356,0.9967930432689102,1.0,1/5,12.95%,DDX18
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.2820275605237629,0.6314745264329222,0.9666666666666667,0.996292799559807,1.0,18/82,25.47%,KLF2;PIK3R1;HIF1A;VWF;JAG2;NRXN1;GRB10;MGAT5;LIMS1;ZMIZ1;STAT3;SULF2;NOTCH4;RIMS2;EMP2;CREBBP;CSNK2A1;CAV2
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),0.42296851461070195,0.6309733257460401,0.9142857142857143,0.9956062122642444,1.0,2/6,22.53%,PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),0.42296851461070195,0.6309733257460401,0.9142857142857143,0.9956062122642444,1.0,2/6,22.53%,PPP3CB;PPP3CC
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.32380126017578775,0.6302504845968878,0.9726027397260274,0.9955674446153102,1.0,6/29,18.82%,CALR;GAPDH;GIGYF2;RPL13A;PLAT;BTG2
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),0.33637765902703654,0.6299939650512032,0.9436619718309859,0.9951947545790697,1.0,5/22,22.30%,AGO2;TPR;STAT3;ZFP36;PPARG
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.43291250995748864,0.6284088005252334,0.9090909090909091,0.9958730677636777,1.0,1/5,21.26%,MORF4L1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),-0.3904341044970106,-0.6277248758597508,0.8846153846153846,1.0,1.0,5/5,61.03%,UBN1;CABIN1;ATRX;NASP;RBBP4
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),-0.38394455690248575,-0.627656512330093,0.8611111111111112,1.0,1.0,2/6,8.46%,ZDHHC2;MDM2
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.38051846521539084,0.6276212736088801,0.9078947368421053,0.9959162626017682,1.0,4/11,22.59%,HIF1A;ACVR2A;STAT3;ETS1
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),-0.32497693277205203,-0.6273662147407544,1.0,1.0,1.0,2/23,5.50%,TENT2;THOC1
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),-0.31257324678445947,-0.6271894514198719,0.96,1.0,1.0,7/15,26.12%,THOC1;WDR70;SMARCAD1;NUCKS1;SUB1;MPHOSPH8;PARG
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),0.4005489536172261,0.6267769587607394,0.9242424242424242,0.9959430143318929,1.0,2/7,17.13%,CD55;LGALS3
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.33075458614492625,0.6258242874437107,0.9324324324324325,0.9960243761796561,1.0,3/20,10.72%,HSP90AA1;KLF4;RFC3
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),0.3271928022474504,0.6255006134750695,0.971830985915493,0.995204377591543,1.0,3/22,13.03%,SMAD7;SMAD5;ACVR2A
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),0.3271928022474504,0.6255006134750695,0.971830985915493,0.995204377591543,1.0,3/22,13.03%,SMAD7;SMAD5;ACVR2A
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.3544177818857864,-0.6253727693104816,0.896551724137931,1.0,1.0,2/8,7.74%,BMP6;ACVR1
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.33580803457196856,0.6246725901508172,0.922077922077922,0.9952641671793114,1.0,11/29,32.81%,FGFR1;PIK3R1;FLT1;NEDD4;DIPK2A;FGR;EGFR;PIP5K1C;PIK3CB;DAB2IP;PTK2
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.3356351371705027,0.6245685471360751,0.963855421686747,0.9948222485972208,1.0,12/23,37.31%,RAD21;TENT4A;NAA50;MCPH1;CHMP4B;CSNK2A1;KPNB1;ZNF207;CUL3;RAB11A;EML4;NIPBL
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),-0.3691131886874423,-0.6244651712539762,0.8666666666666667,1.0,1.0,1/7,7.35%,STXBP4
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),0.3752800597288827,0.624422381077348,0.9193548387096774,0.9944516247940167,1.0,3/11,19.34%,KDM1A;JUN;TNKS
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),-0.3294418724400401,-0.6240032869030786,0.9428571428571428,1.0,1.0,2/11,4.52%,STAT1;PARP9
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.29221487462489204,-0.6236708898270268,1.0,1.0,1.0,3/21,8.83%,ANKRD6;TPD52L1;HIPK2
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),0.37233687297479856,0.6234818957006745,0.9253731343283582,0.994566175243398,1.0,5/11,34.66%,NAA16;NAA50;CREBBP;KAT6A;EP300
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.37444123871184865,-0.6233457156796456,0.8148148148148148,1.0,1.0,3/6,17.11%,HSPD1;NFAT5;CD47
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.374947589663674,-0.623054103105437,0.8666666666666667,1.0,1.0,4/6,12.54%,FGD6;DNM3;SRGAP2;FGD5
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.4074617291414587,0.6221140713698445,0.9333333333333333,0.9950508334459088,1.0,1/7,11.01%,GGT5
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.34202533737564134,-0.6219302899069922,0.8518518518518519,1.0,1.0,1/9,3.04%,OCLN
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.38767119469087497,-0.6207617789770798,0.8928571428571429,1.0,1.0,4/8,17.06%,AGPAT3;PPIP5K2;TPK1;ITPKB
prerank,PanglaoDB_Augmented_2021__Myocytes,-0.26377697130361966,-0.620124025162335,1.0,1.0,1.0,1/19,3.43%,TTN
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.2917826178672286,0.6199790406593708,1.0,0.995845181715514,1.0,9/68,11.71%,ZBTB1;POLA1;PURA;RPS27A;NOC3L;RFC3;RAD21;USP45;CNBP
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.3414536966318868,-0.6195189239133164,0.9117647058823529,1.0,1.0,2/12,4.23%,ATM;ATR
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.40540963260543317,0.6192487654346117,0.935064935064935,0.9957304211495075,1.0,2/8,20.28%,RASA1;ESAM
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.333868497790654,-0.6182846268059886,0.8846153846153846,1.0,1.0,1/11,6.67%,MGA
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.333868497790654,-0.6182846268059886,0.8846153846153846,1.0,1.0,1/11,6.67%,MGA
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.3289708543579798,0.6174085995847073,0.9315068493150684,0.996501884022054,1.0,7/25,18.15%,CD81;PRNP;ENPP2;PECAM1;PAK2;ARHGEF2;TEC
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2837354757700124,0.6170320086961164,1.0,0.9962945390561337,1.0,11/109,12.10%,CANX;ARF1;LRP1B;TBC1D15;RAB21;TMED10;ANK3;HSP90B1;LAMP2;PREPL;TBC1D9
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),0.3519245983830277,0.6161591650984867,0.9473684210526315,0.996396957108623,1.0,5/11,40.63%,GOLPH3;SLC38A9;SIK3;WDR59;LARS1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.35824296994459526,-0.6161506254166089,0.9130434782608695,1.0,1.0,1/10,6.88%,PDE9A
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),0.4131362318154689,0.6158902437203381,0.86,0.996059599589392,1.0,2/7,25.18%,MICU2;SPG7
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),0.3431358924806114,0.61574480833019,0.9444444444444444,0.9956846032676783,1.0,3/16,19.57%,LARP4;PDZD8;CFL1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.3878447072005474,0.6142595330174356,0.8656716417910447,0.9960366133675388,1.0,5/8,23.75%,HYAL2;FOXF1;FOXC1;SULF2;CEP290
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.33827740106231685,0.6136616259859503,0.9125,0.9958517008657745,1.0,1/22,5.74%,EPS8
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.3805259702663938,-0.6122778417750877,1.0,1.0,1.0,3/8,17.39%,PTPN2;OSBPL8;PPARD
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.38147367764769724,-0.6121282092566767,0.8604651162790697,1.0,1.0,1/5,12.88%,MFHAS1
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.370166156732424,0.6119431308034415,0.918918918918919,0.9963278696893906,1.0,2/13,10.72%,RPS27A;RFC3
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),0.3436563475680296,0.6111309359500403,0.9130434782608695,0.99633250291152,1.0,2/16,9.87%,HSP90AA1;KLF4
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.3399565928566928,0.6110701808712192,0.926829268292683,0.9958825438177905,1.0,6/22,24.12%,FGFR1;HYAL2;PAK2;LGALS3;TNFRSF10B;BCL2L14
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),0.3129616994036141,0.611046732195271,0.9473684210526315,0.995384353450698,1.0,9/28,21.57%,CALR;IPO7;TOR1AIP2;PIKFYVE;PTTG1IP;TPR;STAT3;PPP1R10;MORC3
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",-0.3697180008669252,-0.6110208102379419,0.9393939393939394,1.0,1.0,1/7,3.74%,TNRC6C
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),-0.3697180008669252,-0.6110208102379419,0.9393939393939394,1.0,1.0,1/7,3.74%,TNRC6C
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),-0.3500023508956024,-0.6107295373528063,0.925,1.0,1.0,3/6,17.11%,TNFRSF1B;HSPD1;CD47
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),-0.4114679068189153,-0.6096120747605981,0.8571428571428571,1.0,1.0,3/5,18.48%,NMT1;NMT2;METAP2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.2869456895969956,0.6083040770946273,1.0,0.9967302253668227,1.0,21/71,26.40%,RAPGEF3;TBC1D15;PICALM;RGS7;RAP1A;ITGB1;ECT2;CRK;PLXNA2;TGM2;LIMS1;RSU1;AFDN;ARFGEF1;RASIP1;LRCH1;RAB3GAP2;CAV2;WNK1;FGD4;RACK1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.3364700131461827,-0.6081047781425376,0.9411764705882353,1.0,1.0,2/8,12.05%,HLA-F;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.32403295108164853,-0.6077211174860435,0.967741935483871,1.0,1.0,1/11,2.49%,SHLD1
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.3089924638867203,0.6070147015421244,0.9473684210526315,0.9970426559858312,1.0,7/30,28.89%,YTHDC1;SRSF7;TPR;ZFP36;THOC2;SRSF11;SMG1
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3032882258881631,0.606882016129651,0.9746835443037974,0.9965770383533509,1.0,13/47,27.73%,ESR2;CCNH;TAF1D;WWTR1;NCOR2;HDAC7;NR2C1;NR1D2;NOTCH4;PPARG;CREBBP;SMARCA5;NR4A1
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),0.4066690599438103,0.6058303706427158,0.8923076923076924,0.996716489522395,1.0,1/6,6.83%,KDM1A
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.33661836961322633,0.6055794849040026,0.92,0.9963917837711632,1.0,2/15,12.44%,OTUD7B;PPM1A
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),0.3267079886693881,0.6055606156264097,0.975,0.9959002231272008,1.0,6/28,29.18%,CLDN5;HIP1R;AMFR;ADD1;MARK3;SPPL3
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),-0.34148244473342004,-0.6054285512077646,0.967741935483871,1.0,1.0,7/7,65.94%,ROCK1;IKBKB;FMNL3;ROCK2;FMNL2;NCKAP1;DLG1
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),0.4062570136028265,0.6053950680423124,0.9,0.9954953953861871,1.0,3/6,31.49%,DYNC1H1;PAFAH1B1;DST
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,-0.37293116122535397,-0.6045971395979332,0.925,1.0,1.0,2/5,17.39%,TNFRSF1B;PPARD
prerank,PanglaoDB_Augmented_2021__Basophils,0.34259742689667,0.603417386779816,1.0,0.9961145941795791,1.0,3/18,18.28%,LAMA5;TEC;GATA2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),0.3509380403327818,0.6028369289105657,0.9436619718309859,0.9959577640208648,1.0,3/15,25.03%,PPFIA2;CFL1;TANC2
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),-0.24509214335574156,-0.6008812121557164,1.0,1.0,1.0,11/46,19.44%,SNX2;TBC1D5;ANKFY1;EEA1;EVI5;KLHL20;STX8;VPS50;TMEM87A;GBF1;VPS13A
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.39237951543140237,0.6005517214476064,0.9354838709677419,0.996818311944162,1.0,4/7,33.85%,FLT1;FGR;PTK2;AMBRA1
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.3761372498050429,-0.5997398213628121,0.8918918918918919,1.0,1.0,5/5,62.46%,ROCK1;IKBKB;PPP1R12A;ROCK2;NUAK1
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),0.38290400615743825,0.5996989655323596,0.9365079365079365,0.9967903945046482,1.0,1/6,6.83%,KDM1A
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),0.3423895154069705,0.5991922461290209,0.9746835443037974,0.996606578382243,1.0,4/14,21.26%,SIN3B;HDAC7;RCOR3;MORF4L1
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),-0.26865412462736216,-0.597600383152724,0.9565217391304348,1.0,1.0,4/28,6.83%,ARHGAP12;PLXND1;FGD6;EFNA5
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.3411118127220993,0.5963108347486562,0.9506172839506173,0.9978578301343755,1.0,3/15,16.23%,PIK3R1;ARPC2;RAC1
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),-0.33331747922266036,-0.5959387283453275,0.9705882352941176,1.0,1.0,1/10,3.19%,USP25
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),0.39465904067443347,0.5955022143982998,0.9230769230769231,0.9973178850104296,1.0,1/6,15.91%,SRSF7
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.39465904067443347,0.5955022143982998,0.9230769230769231,0.9973178850104296,1.0,1/6,15.91%,SRSF7
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.3948619357856384,0.5932282280708842,0.927536231884058,0.9980464090967194,1.0,2/9,11.27%,GJA1;JUN
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.3899400033382958,0.5921649383886645,0.972972972972973,0.9981466881009184,1.0,2/7,16.46%,AGO2;TUT7
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.336711553279082,0.5884522412413937,0.9620253164556962,0.9994691254397114,1.0,3/17,16.23%,PIK3R1;ARPC2;RAC1
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.3187096379370483,0.5878819101192493,0.9605263157894737,0.9993006938860882,1.0,8/26,25.57%,CTNND2;PPFIA2;LIMS1;VMP1;GRM5;ACTB;RAB8B;CDC42
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.32458728478277116,-0.586720998806455,0.9629629629629629,1.0,1.0,1/9,6.07%,TMEM106B
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),-0.2807219291006809,-0.5864318646405552,1.0,1.0,1.0,1/15,6.31%,BICD1
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),0.392791089181163,0.5850607074444435,0.9827586206896551,1.0,1.0,2/5,17.94%,ERBIN;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.3736653026237902,0.584784340683236,0.9420289855072463,0.9998261347898405,1.0,4/10,20.40%,AGO2;TENT4A;BTG2;ZFP36
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),-0.35697359470789247,-0.5844145008327908,0.7586206896551724,1.0,1.0,1/6,4.57%,LIMS2
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),-0.34876059003439,-0.5842527310291072,0.8787878787878788,1.0,1.0,1/5,9.94%,PIK3C2B
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.32709308372334894,-0.5803762767412929,0.975609756097561,1.0,1.0,6/6,67.37%,MBOAT2;PTPN11;TRPS1;ZBTB16;SOX5;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),-0.35125797007753967,-0.5800093855315188,0.8918918918918919,1.0,1.0,2/7,12.59%,PKD2;PDGFB
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.29133322702707176,0.5800034824979777,0.9868421052631579,1.0,1.0,2/32,7.89%,HSPH1;HSP90AA1
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),-0.29237432843021494,-0.5789870770030873,1.0,1.0,1.0,2/15,9.42%,USP25;PSMF1
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.28280111404567676,-0.5748041919579071,1.0,1.0,1.0,4/11,12.07%,SCAI;KANK1;ARHGAP35;SPRY3
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.35257644440766533,0.5726558969552378,0.9571428571428572,1.0,1.0,4/9,25.21%,BACH2;MALT1;NPM1;XPO1
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.36811438794912554,0.5713365508314799,0.9393939393939394,1.0,1.0,1/7,10.88%,RAD21
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),0.3716416517405435,0.5713143818127617,0.9253731343283582,1.0,1.0,2/5,19.18%,FOXC1;VEGFC
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.35377650383343573,-0.5707956655546977,0.9473684210526315,1.0,1.0,1/5,8.93%,ST3GAL1
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),0.38735182440628835,0.5704839399323257,0.948051948051948,1.0,1.0,2/6,26.40%,DAG1;RACK1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),0.32038200362713326,0.5700022493422592,0.9620253164556962,1.0,1.0,4/17,21.26%,SIN3B;REST;RCOR3;MORF4L1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.33669914048844185,-0.5693319109596208,0.7878787878787878,1.0,1.0,1/6,6.36%,PARN
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),0.31867517748934493,0.5688883243736794,0.9710144927536232,1.0,1.0,2/18,9.97%,PIK3R1;SLC38A2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),0.316493645993939,0.5686500190491512,0.9863013698630136,1.0,1.0,9/19,32.53%,CDK6;ATOH8;NFIB;MTSS1;CAV2;SPARC;RGCC;DAB2IP;CASK
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.40298307062883393,0.5676990383369988,0.9692307692307692,1.0,1.0,4/5,35.18%,BRD4;NPM1;MECP2;RAB11A
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),0.30437990766662204,0.5673328129390538,0.971830985915493,1.0,1.0,9/26,32.68%,HIF1A;ATOH8;VEGFC;EGFL7;CAV2;SPARC;NR4A1;RGCC;ACVRL1
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.3625299989599976,0.5667624084847331,0.9436619718309859,1.0,1.0,2/6,31.18%,KPNA1;KPNB1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.32701631048797114,0.5667423234324962,0.974025974025974,1.0,1.0,3/16,26.14%,KLF4;PPARG;CDH5
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.28158494419910857,0.5666567068659986,1.0,1.0,1.0,11/45,25.83%,TRIM5;RPS27A;TAB2;MTDH;MALT1;ARHGEF2;STAT3;NPM1;UBC;PRKCH;TERF2IP
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.3490772825166292,0.5666429556010756,1.0,1.0,1.0,2/14,7.24%,VSIR;PRNP
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.35670367007613696,-0.5653359774137561,0.918918918918919,1.0,1.0,1/5,12.59%,PDGFB
prerank,MSigDB_Hallmark_2020__Apical Surface,0.32638560479312856,0.5646480925057976,1.0,1.0,1.0,3/13,21.81%,ATP8B1;SULF2;B4GALT1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.35924745440168454,0.5644930701678721,0.9230769230769231,1.0,1.0,4/7,44.91%,ACACA;FAR1;CBR4;HSD17B4
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.37555099365012135,0.564174731571588,0.9642857142857143,1.0,1.0,2/5,16.90%,SEMA3F;PLXNA2
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),0.3458097934614764,0.5635275595331132,0.9285714285714286,1.0,1.0,7/12,30.79%,FLT1;ATOH8;PPARG;MEF2C;CAV2;SPARC;RGCC
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.3055168057825634,-0.5632008100732869,0.9743589743589743,1.0,1.0,4/11,18.22%,PPP1R13B;PMAIP1;NMT1;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.3055168057825634,-0.5632008100732869,0.9743589743589743,1.0,1.0,4/11,18.22%,PPP1R13B;PMAIP1;NMT1;YWHAG
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),0.33273428511652003,0.562857171944113,0.9459459459459459,1.0,1.0,2/12,16.33%,PINK1;BCL2L1
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),-0.32328995783269576,-0.5617654577650459,0.9285714285714286,1.0,1.0,2/8,9.06%,ST3GAL6;UGCG
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),0.3483323231640081,0.5609161917477008,0.9428571428571428,1.0,1.0,2/11,11.29%,CTNNA1;BOC
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),0.38284483274460157,0.5607788068620843,0.9736842105263158,1.0,1.0,1/5,13.91%,CNOT6L
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),0.2898591981329895,0.5603447119487113,1.0,1.0,1.0,8/29,24.45%,AHNAK;PTBP2;PRX;RASA1;HNRNPH3;TRA2B;ZNF326;PTBP3
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.28343299752283835,0.5596941872653803,1.0,1.0,1.0,9/42,22.30%,ESR2;CCNH;WWTR1;NCOR2;HDAC7;NR2C1;NR1D2;NOTCH4;PPARG
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),-0.3221528861154446,-0.5594899238171878,0.9354838709677419,1.0,1.0,6/6,67.86%,ACBD6;SUCLG2;OGDH;ACACB;ACOT9;ACACA
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.33284942494764946,-0.5593278696462117,0.9393939393939394,1.0,1.0,2/9,11.58%,TNRC6C;CPEB3
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),0.29484634911122226,0.5588107115102909,0.963855421686747,1.0,1.0,8/36,22.43%,MAP3K5;PINK1;PHLPP1;SDCBP;DUSP22;PLCB1;TAOK1;MAPK8IP3
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.32371294851794075,-0.557111284459222,1.0,1.0,1.0,6/6,67.71%,MTMR3;SMG7;SMG6;PPP1R16B;MTMR2;MTMR9
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),-0.2654868372472094,-0.5564995671014081,1.0,1.0,1.0,5/36,10.90%,NKD1;TCF7L1;WLS;APCDD1;KANK1
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.28828465033670364,-0.5554174285602091,0.9615384615384616,1.0,1.0,8/21,19.11%,PODN;ZNF521;LDB2;LAMA2;IGFBP7;CNRIP1;CXCL12;TEK
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),0.3829032460135362,0.5548460295828411,0.9722222222222222,1.0,1.0,1/5,17.58%,DAG1
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),0.3829032460135362,0.5548460295828411,0.9722222222222222,1.0,1.0,1/5,17.58%,DAG1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.35211887567553646,0.5543708801087545,0.958904109589041,1.0,1.0,4/8,33.64%,TMEFF2;MRTFA;ACVRL1;ADAM17
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.3564552125896524,0.5539245022271703,0.9545454545454546,1.0,1.0,3/8,33.64%,OXSR1;WNK1;ADAM17
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),0.37037619587581533,0.5537262613308006,0.9402985074626866,0.9996753859512323,1.0,2/6,37.44%,VCL;ZDHHC21
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.34867775512851995,0.5527210814488915,0.9661016949152542,0.9995305808950289,1.0,4/7,35.98%,RELL1;SASH1;GADD45B;PJA2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),-0.34318807951091934,-0.5522781224025074,0.9230769230769231,1.0,1.0,1/5,10.07%,PIGU
prerank,PanglaoDB_Augmented_2021__T Helper Cells,-0.29238071095791446,-0.5511952789961118,0.96875,1.0,1.0,4/11,24.01%,GIMAP4;RORA;GIMAP7;NFATC2
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),-0.27295838116576876,-0.5507129859071291,1.0,1.0,1.0,2/21,5.50%,TENT2;THOC1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",0.24961255111625058,0.5504060911440053,1.0,0.9998656610846283,1.0,10/77,18.51%,YTHDC1;U2SURP;SPEN;RBM17;STRAP;SRSF7;RALY;HNRNPH3;CSTF3;TRA2B
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.30783242258652094,-0.5502177483253391,0.9032258064516129,1.0,1.0,9/9,69.31%,POLR2A;BAZ2A;FUBP3;EPC1;PTMA;MMS19;MEF2A;POLR2B;THRB
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),0.38053273188638315,0.5484338037920611,0.96875,1.0,1.0,1/5,26.64%,MTOR
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),0.3646489918551644,0.5471662757119103,0.967741935483871,1.0,1.0,3/6,21.81%,FUT8;ST6GALNAC3;B4GALT1
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),-0.31826890845907685,-0.5469144653596673,0.9333333333333333,1.0,1.0,2/8,11.79%,DISP1;CFLAR
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.27723339898103694,-0.5428409131558735,0.96875,1.0,1.0,5/17,17.96%,RC3H1;NBDY;HSPA1A;PNPT1;XRN1
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),0.30009610483951066,0.5427272844910671,1.0,1.0,1.0,2/16,9.97%,PIK3R1;SLC38A2
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.2773352386432063,0.541518063627986,1.0,1.0,1.0,6/29,28.89%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.3276170903462322,0.5412798078847975,0.984375,1.0,1.0,3/10,29.39%,KIF16B;SORT1;RAB14
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.30851340796667537,-0.5406904061683617,0.9629629629629629,1.0,1.0,11/11,69.26%,PDGFB;NSMCE2;CDC16;ANAPC5;PHIP;CDC27;EDN1;RB1;INSR;CUL3;RGCC
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.3103459786322826,0.5378003509661649,0.987012987012987,1.0,1.0,4/18,22.07%,AGO2;FZD4;PLCB1;PPP3CB
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),-0.26884326754216803,-0.537404303581585,0.96,1.0,1.0,3/10,22.04%,HSPD1;CD47;MAPK14
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),0.2786366793528273,0.5373437243462157,1.0,1.0,1.0,6/28,28.89%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.2786366793528273,0.5373437243462157,1.0,1.0,1.0,6/28,28.89%,YTHDC1;SRSF7;TPR;THOC2;SRSF11;SMG1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),-0.3229894313855093,-0.5363257209501243,0.9230769230769231,1.0,1.0,2/8,12.59%,PKD2;PDGFB
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.3081564663914509,0.5358719473678524,0.9861111111111112,1.0,1.0,2/19,10.88%,SMC6;RAD21
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.2770258179894207,-0.5347571055557102,1.0,1.0,1.0,1/11,6.54%,NUP214
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),0.3569206663427118,0.5339822586515623,1.0,1.0,1.0,3/7,25.60%,SLC1A2;SLC7A5;SLC6A6
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.32988244306344805,0.5339319251205091,1.0,0.9999590726252144,1.0,2/13,11.29%,CTNNA1;BOC
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),0.3344624004135446,0.5338410229942692,0.9661016949152542,0.9995058089718625,1.0,3/8,21.68%,DLC1;ABL2;RASIP1
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),0.3069639424055228,0.5328746929129974,0.975,0.9993253973262112,1.0,4/12,28.09%,GOLPH3;CDC42;MSN;SIPA1L3
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.3589029981116475,0.5322265435219686,0.96875,0.9990927987057534,1.0,2/5,25.05%,AP1G1;SORT1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.29105966828627705,-0.5321579559171281,0.9411764705882353,1.0,1.0,1/12,2.99%,NKD1
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),0.27738976849035857,0.5264562336035198,1.0,1.0,1.0,8/28,25.83%,PRNP;WWTR1;ENSA;DMD;ATP2B4;YWHAB;ARPP19;TERF2IP
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.33957358294331774,-0.5260891865134723,0.9310344827586207,1.0,1.0,6/6,66.12%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.33957358294331774,-0.5260891865134723,0.9310344827586207,1.0,1.0,6/6,66.12%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.33957358294331774,-0.5260891865134723,0.9310344827586207,1.0,1.0,6/6,66.12%,NSMCE2;CDC16;ANAPC5;CDC27;RB1;CUL3
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),-0.3009385918359729,-0.5236526857363456,0.9411764705882353,1.0,1.0,1/7,5.69%,BMP2K
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.3016120644825793,-0.5198373190578326,0.9777777777777777,1.0,1.0,6/6,69.91%,GIMAP7;OPA1;LRRK2;MFN1;AK3;GNAI3
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),-0.3016120644825793,-0.5198373190578326,0.9777777777777777,1.0,1.0,6/6,69.91%,GIMAP7;OPA1;LRRK2;MFN1;AK3;GNAI3
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.2742399278709166,-0.5197142765100498,0.9736842105263158,1.0,1.0,1/11,7.32%,PKD2
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),0.3266375925294545,0.5179813304883911,0.9855072463768116,1.0,1.0,5/9,38.08%,LIMK2;DNM2;RAB11A;CCDC186;SYNJ1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),0.3404097595965896,0.5169456906945251,1.0,1.0,1.0,3/6,30.50%,SETD3;WDR82;KMT2A
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),0.2973150987433231,0.5131216241721588,0.9857142857142858,1.0,1.0,3/11,21.42%,SMAD7;PODXL;AFDN
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.3541088694144643,0.5114101691940779,0.967741935483871,1.0,1.0,3/5,26.77%,LPIN2;LPGAT1;SEL1L
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),0.3172311702927942,0.5112132146821987,0.971830985915493,1.0,1.0,5/9,37.20%,KIF16B;EMP2;PIK3C3;RAB7A;HOOK3
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),0.3066671125892323,0.5082574324653193,1.0,1.0,1.0,5/11,35.28%,ARFGEF1;CDH5;RACK1;CYRIB;RAP1B
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.28519402421018103,0.5077599826135095,1.0,1.0,1.0,3/15,17.03%,SULT1C4;ADSS2;TPST2
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.2971911745323266,0.5052519848439511,0.9871794871794872,1.0,1.0,3/17,17.81%,PICALM;NDFIP1;TF
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.27679500520291367,-0.5051082496161032,0.9696969696969697,1.0,1.0,8/8,72.40%,USP6NL;AKAP9;STX18;ARMH3;PDCD10;MAPK1;CAMSAP2;MAP2K1
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.29855903968950526,-0.5042451399099849,0.9354838709677419,1.0,1.0,1/6,8.88%,SLC16A2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.23319087422043547,0.5040480982913587,1.0,1.0,1.0,9/71,18.51%,YTHDC1;U2SURP;SPEN;RBM17;SRSF7;RALY;HNRNPH3;CSTF3;TRA2B
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),-0.3090212224812021,-0.5011648879617726,0.9777777777777777,1.0,1.0,2/6,20.72%,MFF;OPA1
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),0.33837797930567404,0.501053663335989,0.9692307692307692,1.0,1.0,4/6,36.19%,MAGI2;CD63;SCYL2;INSR
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),-0.21850330444996757,-0.5007974519325383,1.0,1.0,1.0,2/29,7.22%,IVNS1ABP;WBP4
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),-0.26680871896036507,-0.4978655236026191,1.0,1.0,1.0,2/10,11.60%,UTRN;LAMA2
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.28802595341821186,-0.497636531102576,1.0,1.0,1.0,3/10,13.63%,MRPS31;PTCD3;EEFSEC
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),-0.29903213352399244,-0.49615726409719524,0.9487179487179487,1.0,1.0,2/6,13.73%,VTA1;LYST
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.281477627471384,-0.4958734144499258,1.0,1.0,1.0,8/8,71.94%,ATXN7;UIMC1;TRRAP;SUPT3H;USP3;USP15;USP7;USP22
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.26036628520985927,0.49440633562861225,1.0,1.0,1.0,14/29,40.91%,TNKS;OXSR1;HIPK3;CSNK2A1;WNK1;MAP2K1;CAMK2D;MAPK8;PRKDC;NLK;TBK1;MAPK1;CDC42BPA;TGFBR2
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.3145364000385631,0.4903796565904747,0.9710144927536232,1.0,1.0,1/8,13.71%,FOXF1
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.28998583262669975,0.4899081739877769,0.9736842105263158,1.0,1.0,3/10,35.07%,MTOR;RGCC;MTPN
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.3063319623044426,0.48951164407586845,0.9722222222222222,1.0,1.0,3/7,37.98%,CSNK1D;NDEL1;RANBP9
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),-0.27666800744457576,-0.4885391736944385,1.0,1.0,1.0,2/10,14.88%,ELAPOR2;ZNF423
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),0.22006860151530674,0.4877265704218908,1.0,1.0,1.0,10/85,18.51%,YTHDC1;U2SURP;SPEN;RBM17;CCNH;SRSF7;RALY;HNRNPH3;CSTF3;TRA2B
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),0.27919046717441626,0.4867362515238663,1.0,1.0,1.0,2/13,20.61%,TF;DNM2
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.27772850480946165,0.4862736097894016,0.9855072463768116,1.0,1.0,6/15,27.10%,PRKX;PODXL;RASIP1;MEF2C;MTSS1;RYR2
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",-0.2665799739921976,-0.48552620803291086,1.0,1.0,1.0,7/7,73.42%,CLASP1;PHLDB2;CLASP2;PTEN;FERMT2;RREB1;MTOR
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.29803831270535036,0.4817850184207282,1.0,1.0,1.0,4/12,25.83%,KDM1A;PPP4R2;KPNA1;TERF2IP
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.2534555957792118,0.48169314306183203,1.0,1.0,1.0,5/23,21.99%,PEBP1;MAP7;PIAS2;CHFR;PGS1
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.3172014084042529,0.47908874196228385,0.9838709677419355,1.0,1.0,3/5,37.44%,ADCY9;AKAP13;ZDHHC21
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.27452511059068435,-0.47747333346574694,0.9523809523809523,1.0,1.0,9/9,72.64%,MDM4;PRKAA1;PDE3B;NCOR1;HDAC4;SNX3;IRAK3;CST3;EGFR
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.24484388498532467,0.47561926914243985,1.0,1.0,1.0,14/32,40.91%,TNKS;OXSR1;HIPK3;CSNK2A1;WNK1;MAP2K1;CAMK2D;MAPK8;PRKDC;NLK;TBK1;MAPK1;CDC42BPA;TGFBR2
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.2709308372334894,-0.47560433706366906,0.9310344827586207,1.0,1.0,6/6,72.98%,SMARCAD1;HDAC4;SIRT1;SFPQ;HDAC9;ELK4
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.2447011489025896,0.47538276907734545,1.0,1.0,1.0,9/29,31.54%,PELI1;NEDD4L;AMFR;UBE2B;UBE2Q2;UBE2R2;UBE2H;UBR5;UBE3A
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),-0.2965961295140956,-0.4707211245009068,0.9523809523809523,1.0,1.0,2/5,14.85%,MDM2;UBB
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),0.31910533690789455,0.4680557700853973,1.0,1.0,1.0,2/5,40.71%,ATP11A;HDAC9
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.2987121852531922,0.467590927400981,0.9864864864864865,1.0,1.0,2/7,30.79%,DAG1;RGCC
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.2938507974711162,-0.46540315773434426,0.9696969696969697,1.0,1.0,2/5,18.33%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.3114481131189051,0.46510350304484444,1.0,1.0,1.0,1/5,21.91%,PLCB1
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),0.30960743525979306,0.4638036854534459,0.9848484848484849,1.0,1.0,2/6,27.10%,FOXF1;RYR2
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.2895823320583219,-0.46002776565510656,0.9714285714285714,1.0,1.0,2/6,18.33%,SPG11;RAB27A
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.27625203740676657,0.45923179975318157,0.9848484848484849,1.0,1.0,3/12,26.90%,RAC1;MTOR;MSN
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,-0.2602133749674733,-0.45666027879700727,0.9655172413793104,0.9994919571040215,1.0,9/9,74.07%,BST2;MAP3K2;ETV6;PRKCA;TCF4;LCP2;NRP1;MAP3K8;FGR
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),0.3126937399676505,0.45438514484064607,0.9863013698630136,1.0,1.0,2/5,27.93%,TMEFF2;MRTFA
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),0.2739255435426525,0.45433482569850697,1.0,1.0,1.0,4/9,39.07%,UBE2B;UBE2H;UBE2D3;PRKN
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),0.2583643539230139,0.45286064807413445,0.9855072463768116,1.0,1.0,6/14,35.59%,BACE2;DAG1;ADAM9;SPPL3;ADAM17;MYH9
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),0.2537973486257289,0.4520972178656373,1.0,1.0,1.0,7/19,34.66%,ATF2;NAA50;MORF4L1;CREBBP;PHF20L1;KAT6A;EP300
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),0.2982073921414602,0.451760484985033,1.0,1.0,1.0,2/6,30.79%,FSCN1;RGCC
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.27626017483418797,0.45059403449944113,0.9859154929577465,1.0,1.0,2/7,36.79%,TMEM65;DLL4
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),0.3018864535154538,0.450157534368287,1.0,0.9996437311395894,1.0,3/5,31.44%,PIK3CB;CD63;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.253216006510118,0.4484148538593245,1.0,0.9994149665108132,1.0,7/13,35.44%,HIP1R;PPP3CC;YWHAB;YWHAE;YWHAQ;MAPK8;YWHAZ
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),-0.22442072376985162,-0.4463742208730226,1.0,0.9998858141023238,1.0,11/11,77.65%,CENPP;CENPC;UBN1;CABIN1;RSF1;ATRX;NASP;MIS18BP1;RBBP4;SMARCA5;NPM1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),0.2511125123741539,0.4456389472581066,1.0,0.9993047315964383,1.0,3/14,23.70%,ABL2;YWHAB;PHACTR4
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.286716922277099,-0.4322751793639683,0.9411764705882353,1.0,1.0,5/5,71.39%,WWC3;MAPK14;VGLL4;WWC2;MARK3
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),0.25945103440903117,0.43074922459787557,1.0,1.0,1.0,4/12,32.68%,CDKN1A;TERF2IP;KMT2A;ACVRL1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.2555022194811875,-0.42302600210370095,0.9743589743589743,0.9998356611257179,1.0,1/8,8.46%,MDM2
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.27561693268236254,0.41502723900565003,1.0,1.0,1.0,4/6,38.86%,DNAJC13;MAP2K1;USP7;MAPK1
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.2583831557057447,-0.41241173996391034,1.0,0.997669261974954,1.0,5/5,74.22%,POLR2A;ATRX;POT1;POLR2B;TERF2IP
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.2583831557057447,-0.41241173996391034,1.0,0.997669261974954,1.0,5/5,74.22%,POLR2A;ATRX;POT1;POLR2B;TERF2IP
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),0.2269672166245867,0.40846328684246236,1.0,1.0,1.0,2/17,18.87%,AGO2;TPR
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),0.2269672166245867,0.40846328684246236,1.0,1.0,1.0,2/17,18.87%,AGO2;TPR
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),0.23834755170923325,0.3769765460568831,1.0,1.0,1.0,3/6,35.02%,SH3KBP1;PRKDC;CYRIB
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.23046558295912942,0.3758751062140991,1.0,1.0,1.0,2/9,27.57%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.232126811213447,0.362991948497422,1.0,0.9996928212321964,1.0,2/8,27.57%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.232126811213447,0.362991948497422,1.0,0.9996928212321964,1.0,2/8,27.57%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.232126811213447,0.362991948497422,1.0,0.9996928212321964,1.0,2/8,27.57%,NPM1;SMARCA5
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.232126811213447,0.362991948497422,1.0,0.9996928212321964,1.0,2/8,27.57%,NPM1;SMARCA5
